group_id,max_val,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00016,1.0571265852310752,FUN_000210-T1,Peve_00022649,Pocillopora_meandrina_HIv1___TS.g6133.t2,three_way,62.794,FUN_000210-T1,Q9EQH2,ERAP1_MOUSE,,Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (VEGF-induced aminopeptidase),Mus musculus (Mouse),40.9,694.0,1.1e-145,518.8,sp|Q9EQH2|ERAP1_MOUSE Endoplasmic reticulum aminopeptidase 1 OS=Mus musculus OX=10090 GN=Erap1 PE=1 SV=2,GO:0002250; GO:0004177; GO:0005138; GO:0005576; GO:0005737; GO:0005789; GO:0006508; GO:0006509; GO:0008233; GO:0008235; GO:0008270; GO:0045766,adaptive immune response [GO:0002250]; membrane protein ectodomain proteolysis [GO:0006509]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576],aminopeptidase activity [GO:0004177]; interleukin-6 receptor binding [GO:0005138]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005576; GO:0016787; GO:0140096,"immune system process; catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_00043,1.0430666326510476,FUN_000270-T1,Peve_00027796,Pocillopora_meandrina_HIv1___RNAseq.g28983.t1,three_way,78.31466666666667,FUN_000270-T1,Q0P483,S2542_DANRE,,Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42),Danio rerio (Zebrafish) (Brachydanio rerio),51.5,324.0,5.3e-87,322.8,sp|Q0P483|S2542_DANRE Mitochondrial coenzyme A transporter SLC25A42 OS=Danio rerio OX=7955 GN=slc25a42 PE=2 SV=1,GO:0005347; GO:0005739; GO:0005743; GO:0007006; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0035349; GO:0043262; GO:0080121; GO:0080122,ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]; mitochondrial membrane organization [GO:0007006],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ADP phosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228],GO:0003824; GO:0005215; GO:0005739; GO:0007005; GO:0016787; GO:0043226; GO:0055085; GO:0061024,catalytic activity; transporter activity; mitochondrion; mitochondrion organization; hydrolase activity; organelle; transmembrane transport; membrane organization
OG_00051,1.1634210923415294,FUN_000320-T1,Peve_00033574,Pocillopora_meandrina_HIv1___RNAseq.g29014.t1,three_way,81.34316666666668,FUN_000320-T1,Q9Y4E6,,,,,41.7,1189.0,5.3e-228,792.7,sp|Q9Y4E6|WDR7_HUMAN WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=WDR7 PE=1 SV=2,,,,,,
OG_00057,2.2981943839642147,FUN_000348-T1,Peve_00033538,Pocillopora_meandrina_HIv1___RNAseq.g29111.t1,three_way,42.8425,,,,,,,,,,,,,,,,,
OG_00079,1.2058673094804055,FUN_000407-T2,Peve_00033597,Pocillopora_meandrina_HIv1___RNAseq.g2545.t1,three_way,54.79116666666667,FUN_000407-T2,Q92859,NEO1_HUMAN,,Neogenin (Immunoglobulin superfamily DCC subclass member 2),Homo sapiens (Human),29.2,991.0,3.1e-102,374.8,sp|Q92859|NEO1_HUMAN Neogenin OS=Homo sapiens OX=9606 GN=NEO1 PE=1 SV=2,GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0006879; GO:0007155; GO:0007411; GO:0007520; GO:0009306; GO:0009986; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0045296; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550,"axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; protein secretion [GO:0009306]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550]",cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic density membrane [GO:0098839],BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023],GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0007155; GO:0023052; GO:0043226; GO:0048870; GO:0060089,nucleoplasm; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; cell adhesion; signaling; organelle; cell motility; molecular transducer activity
OG_00082,1.1266424068402472,FUN_000411-T1,Peve_00010961,Pocillopora_meandrina_HIv1___RNAseq.g2317.t1,three_way,32.01166666666666,,,,,,,,,,,,,,,,,
OG_00089,2.0355006030999387,FUN_000445-T1,Peve_00019114,Pocillopora_meandrina_HIv1___RNAseq.g2334.t1,three_way,76.51133333333333,,,,,,,,,,,,,,,,,
OG_00107,1.0400301659808322,FUN_000499-T1,Peve_00024155,Pocillopora_meandrina_HIv1___RNAseq.g2414.t1,three_way,82.06683333333332,FUN_000499-T1,Q14432,PDE3A_HUMAN,,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE)",Homo sapiens (Human),37.6,1034.0,2.2e-143,511.5,"sp|Q14432|PDE3A_HUMAN cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A OS=Homo sapiens OX=9606 GN=PDE3A PE=1 SV=3",GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0009410; GO:0016020; GO:0019933; GO:0019934; GO:0030284; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130; GO:0106072; GO:0141162,apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; membrane [GO:0016020],"3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]; nuclear estrogen receptor activity [GO:0030284]",GO:0003013; GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0022414; GO:0060089; GO:0140110,circulatory system process; catalytic activity; cytosol; lipid metabolic process; hydrolase activity; reproductive process; molecular transducer activity; transcription regulator activity
OG_00111,2.3826032055303843,FUN_000503-T1,Peve_00043531,Pocillopora_meandrina_HIv1___RNAseq.g18598.t1,three_way,56.31033333333333,,,,,,,,,,,,,,,,,
OG_00126,1.5002119441458572,FUN_000550-T1,Peve_00039823,Pocillopora_meandrina_HIv1___RNAseq.g2362.t1,three_way,66.874,FUN_000550-T1,Q923Y6,,,,,23.8,332.0,7.3e-11,69.7,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_00133,1.6722452924424065,FUN_000564-T1,Peve_00041880,Pocillopora_meandrina_HIv1___TS.g4968.t1,three_way,70.89666666666666,,,,,,,,,,,,,,,,,
OG_00141,1.1774817475396568,FUN_000580-T1,Peve_00034764,Pocillopora_meandrina_HIv1___RNAseq.g29301.t1,three_way,44.83516666666667,FUN_000580-T1,Q7KM13,,,,,30.5,164.0,6.6e-08,60.5,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_00143,1.3764033353788905,FUN_000585-T1,Peve_00034705,Pocillopora_meandrina_HIv1___RNAseq.g29297.t1,three_way,50.52733333333334,FUN_000585-T1,Q6TLH3,,,,,33.4,326.0,2.6999999999999997e-31,137.5,sp|Q6TLH3|CUED2_DANRE CUE domain-containing protein 2 OS=Danio rerio OX=7955 GN=cuedc2 PE=2 SV=1,,,,,,
OG_00147,1.0758095471106597,FUN_000592-T1,Peve_00025298,Pocillopora_meandrina_HIv1___RNAseq.g29290.t1,three_way,64.05,,,,,,,,,,,,,,,,,
OG_00149,1.4214661774152682,FUN_000595-T1,Peve_00041242,Pocillopora_meandrina_HIv1___RNAseq.g29286.t2,three_way,74.10266666666666,FUN_000595-T1,Q9DB41,,,,,53.4,313.0,5.4e-80,299.3,sp|Q9DB41|GHC2_MOUSE Mitochondrial glutamate carrier 2 OS=Mus musculus OX=10090 GN=Slc25a18 PE=1 SV=4,,,,,,
OG_00166,1.02189489479261,FUN_000641-T1,Peve_00012249,Pocillopora_meandrina_HIv1___TS.g17921.t4,three_way,55.0825,FUN_000641-T1,A6QLA0,,,,,45.6,780.0,1.1e-188,662.1,sp|A6QLA0|NFX1_BOVIN Transcriptional repressor NF-X1 OS=Bos taurus OX=9913 GN=NFX1 PE=2 SV=1,,,,,,
OG_00174,1.0623731116440702,FUN_000862-T1,Peve_00004534,Pocillopora_meandrina_HIv1___RNAseq.g1860.t1,three_way,73.89966666666666,FUN_000862-T1,Q9NTM9,CUTC_HUMAN,,Copper homeostasis protein cutC homolog,Homo sapiens (Human),62.0,245.0,3.3e-85,316.2,sp|Q9NTM9|CUTC_HUMAN Copper homeostasis protein cutC homolog OS=Homo sapiens OX=9606 GN=CUTC PE=1 SV=1,GO:0005507; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006825; GO:0051262; GO:0055070,copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],copper ion binding [GO:0005507],GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0043226; GO:0065003,nucleus; nucleoplasm; nucleolus; cytosol; organelle; protein-containing complex assembly
OG_00195,3.075603937221542,FUN_000905-T1,Peve_00009733,Pocillopora_meandrina_HIv1___RNAseq.g29456.t1,three_way,66.77466666666666,FUN_000905-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),37.3,753.0,5.9e-130,466.5,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00196,1.7963520097619747,FUN_000908-T1,Peve_00010044,Pocillopora_meandrina_HIv1___RNAseq.g29495.t1,three_way,77.85966666666667,FUN_000908-T1,Q8QG61,,,,,64.7,499.0,3.3e-210,732.6,sp|Q8QG61|CRY1_CHICK Cryptochrome-1 OS=Gallus gallus OX=9031 GN=CRY1 PE=2 SV=1,,,,,,
OG_00213,1.2083738778383386,FUN_000932-T1,Peve_00009724,Pocillopora_meandrina_HIv1___RNAseq.g29460.t1,three_way,85.761,FUN_000932-T1,P00516,,,,,65.8,619.0,1.3e-240,833.9,sp|P00516|KGP1_BOVIN cGMP-dependent protein kinase 1 OS=Bos taurus OX=9913 GN=PRKG1 PE=1 SV=2,,,,,,
OG_00235,1.3687182987548454,FUN_000989-T1,Peve_00022150,Pocillopora_meandrina_HIv1___TS.g6419.t2,three_way,85.35733333333333,FUN_000989-T1,Q6NWZ9,CDO1_DANRE,,Cysteine dioxygenase type 1 (EC 1.13.11.20) (Cysteine dioxygenase type I) (CDO) (CDO-I),Danio rerio (Zebrafish) (Brachydanio rerio),61.7,188.0,1.1e-67,257.7,sp|Q6NWZ9|CDO1_DANRE Cysteine dioxygenase type 1 OS=Danio rerio OX=7955 GN=cdo1 PE=2 SV=1,GO:0008198; GO:0008270; GO:0016151; GO:0017172; GO:0019448; GO:0042412,L-cysteine catabolic process [GO:0019448]; taurine biosynthetic process [GO:0042412],,cysteine dioxygenase activity [GO:0017172]; ferrous iron binding [GO:0008198]; nickel cation binding [GO:0016151]; zinc ion binding [GO:0008270],GO:0003824; GO:0006520; GO:0006790; GO:0016491,catalytic activity; amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity
OG_00240,1.2921309622337218,FUN_000996-T1,Peve_00004446,Pocillopora_meandrina_HIv1___RNAseq.g29189.t1,three_way,48.307833333333335,,,,,,,,,,,,,,,,,
OG_00242,2.450067836429245,FUN_001005-T1,Peve_00015285,Pocillopora_meandrina_HIv1___TS.g6390.t1,three_way,40.208,,,,,,,,,,,,,,,,,
OG_00246,2.714450758736783,FUN_001009-T1,Peve_00041033,Pocillopora_meandrina_HIv1___TS.g6384.t1,three_way,55.748666666666665,FUN_001009-T1,P97739,,,,,36.8,749.0,9.2e-134,479.2,sp|P97739|ECE1_CAVPO Endothelin-converting enzyme 1 OS=Cavia porcellus OX=10141 GN=ECE1 PE=2 SV=1,,,,,,
OG_00247,1.14584795426166,FUN_001010-T1,Peve_00041051,Pocillopora_meandrina_HIv1___RNAseq.g29165.t1,three_way,58.97366666666667,FUN_001010-T1,Q5E9Y6,,,,,36.6,402.0,8.4e-51,202.6,sp|Q5E9Y6|PRUN1_BOVIN Exopolyphosphatase PRUNE1 OS=Bos taurus OX=9913 GN=PRUNE1 PE=2 SV=1,,,,,,
OG_00258,1.676448177972691,FUN_001025-T1,Peve_00041055,Pocillopora_meandrina_HIv1___RNAseq.g16888.t1,three_way,40.96733333333333,,,,,,,,,,,,,,,,,
OG_00264,1.890808173414462,FUN_001041-T1,Peve_00028475,Pocillopora_meandrina_HIv1___TS.g6804.t1,three_way,83.21833333333333,FUN_001041-T1,Q7Z5V6,SAXO4_HUMAN,,Stabilizer of axonemal microtubules 4 (Protein phosphatase 1 regulatory subunit 32),Homo sapiens (Human),33.2,455.0,1.0999999999999999e-62,242.3,sp|Q7Z5V6|SAXO4_HUMAN Stabilizer of axonemal microtubules 4 OS=Homo sapiens OX=9606 GN=SAXO4 PE=1 SV=1,GO:0005737; GO:0019902; GO:0030317; GO:0036064; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126],phosphatase binding [GO:0019902],GO:0005815; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,microtubule organizing center; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_00265,1.5257488697693131,FUN_001043-T1,Peve_00035617,Pocillopora_meandrina_HIv1___RNAseq.g4491.t1,three_way,58.299,,,,,,,,,,,,,,,,,
OG_00266,1.1512644915680113,FUN_001044-T1,Peve_00041039,Pocillopora_meandrina_HIv1___TS.g6802.t1a,three_way,45.7765,,,,,,,,,,,,,,,,,
OG_00279,1.069417228488446,FUN_001064-T1,Peve_00005413,Pocillopora_meandrina_HIv1___RNAseq.g29653.t1,three_way,61.42933333333333,FUN_001064-T1,P22758,,,,,41.1,671.0,1.3e-132,475.3,sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2,,,,,,
OG_00286,1.0127838189964058,FUN_001076-T1,Peve_00037405,Pocillopora_meandrina_HIv1___RNAseq.g2716.t1,three_way,76.12899999999999,FUN_001076-T1,Q75V66,ANO5_HUMAN,,Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E),Homo sapiens (Human),42.4,850.0,1.3999999999999999e-187,658.3,sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1,GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; plasma membrane; organelle; transmembrane transport; membrane organization
OG_00304,3.2539424854446923,FUN_001106-T1,Peve_00003165,Pocillopora_meandrina_HIv1___RNAseq.g29367.t1b,three_way,75.54033333333334,,,,,,,,,,,,,,,,,
OG_00308,1.0330386686662931,FUN_001110-T1,Peve_00029335,Pocillopora_meandrina_HIv1___RNAseq.g29363.t1,three_way,71.534,FUN_001110-T1,P15384,,,,,49.9,407.0,2.3e-84,314.7,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_00313,1.142196428255648,FUN_001116-T2,Peve_00029365,Pocillopora_meandrina_HIv1___RNAseq.g29354.t1,three_way,60.4465,FUN_001116-T2,Q12912,IRAG2_HUMAN,,"Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2]",Homo sapiens (Human),29.0,217.0,9e-15,84.7,"sp|Q12912|IRAG2_HUMAN Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3",GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005813; GO:0005886; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0035577,immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903],azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],microtubule binding [GO:0008017],GO:0002376; GO:0005635; GO:0005694; GO:0005815; GO:0005886; GO:0008092; GO:0022414; GO:0043226; GO:0061024,immune system process; nuclear envelope; chromosome; microtubule organizing center; plasma membrane; cytoskeletal protein binding; reproductive process; organelle; membrane organization
OG_00314,2.0877263273729976,FUN_001118-T1,Peve_00029370,Pocillopora_meandrina_HIv1___RNAseq.g22341.t1,three_way,65.59533333333333,FUN_001118-T1,P00918,CAH2_HUMAN,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Homo sapiens (Human),48.1,262.0,3.7e-63,243.0,sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0043226,catalytic activity; cytosol; plasma membrane; hydrolase activity; lyase activity; organelle
OG_00319,1.4224620635393597,FUN_001137-T1,Peve_00029385,Pocillopora_meandrina_HIv1___RNAseq.g29339.t1,three_way,81.55166666666666,FUN_001137-T1,Q9Y345,,,,,44.3,625.0,1.2e-152,541.6,sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3,,,,,,
OG_00323,1.0297754525890024,FUN_001142-T1,Peve_00029340,Pocillopora_meandrina_HIv1___RNAseq.g29332.t1,three_way,72.95883333333333,FUN_001142-T1,Q91827,,,,,38.8,178.0,1.4999999999999998e-24,114.4,sp|Q91827|AR1_XENLA Apoptosis regulator R1 (Fragment) OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_00332,1.3862237656460303,FUN_001153-T1,Peve_00002864,Pocillopora_meandrina_HIv1___RNAseq.g29322.t2,three_way,50.12916666666666,,,,,,,,,,,,,,,,,
OG_00342,1.5086637981968198,FUN_001167-T1,Peve_00015996,Pocillopora_meandrina_HIv1___RNAseq.g29154.t1,three_way,76.15266666666666,FUN_001167-T1,Q01617,,,,,51.7,172.0,6.1e-35,149.4,sp|Q01617|CPO_DROME Protein couch potato OS=Drosophila melanogaster OX=7227 GN=cpo PE=2 SV=4,,,,,,
OG_00349,1.791143311892458,FUN_001176-T1,Peve_00015993,Pocillopora_meandrina_HIv1___TS.g6373.t1,three_way,71.25133333333333,FUN_001176-T1,O43451,MGA_HUMAN,,"Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20)",Homo sapiens (Human),48.8,853.0,2.6e-247,856.7,sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6,GO:0000025; GO:0003824; GO:0004339; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027,dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821],"alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; oligo-1,6-glucosidase activity [GO:0004574]",GO:0003824; GO:0005886; GO:0005975; GO:0016787; GO:0043226,catalytic activity; plasma membrane; carbohydrate metabolic process; hydrolase activity; organelle
OG_00355,1.478620187133562,FUN_001185-T1,Peve_00040986,Pocillopora_meandrina_HIv1___RNAseq.g29540.t1,three_way,52.84166666666667,FUN_001185-T1,C0HL13,LRP2_PIG,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Sus scrofa (Pig),41.7,412.0,3.4e-63,245.0,sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1,GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167,coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223],apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0016192; GO:0022414; GO:0048856; GO:0050877; GO:0055085,vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process; transmembrane transport
OG_00356,1.0296100175179266,FUN_001188-T1,Peve_00009673,Pocillopora_meandrina_HIv1___TS.g6724.t2,three_way,43.03966666666667,,,,,,,,,,,,,,,,,
OG_00360,1.1922758851142854,FUN_001193-T1,Peve_00006937,Pocillopora_meandrina_HIv1___RNAseq.g29527.t1,three_way,63.272,FUN_001193-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),34.4,326.0,6.6e-40,166.4,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_00365,1.1854821517225476,FUN_001204-T1,Peve_00033826,Pocillopora_meandrina_HIv1___RNAseq.g29520.t1,three_way,71.753,FUN_001204-T1,Q5VXJ0,LIPK_HUMAN,,Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2),Homo sapiens (Human),40.4,396.0,2.8000000000000002e-89,330.5,sp|Q5VXJ0|LIPK_HUMAN Lipase member K OS=Homo sapiens OX=9606 GN=LIPK PE=1 SV=2,GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268,cornification [GO:0070268]; lipid catabolic process [GO:0016042],extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231],lipoprotein lipase activity [GO:0004465],GO:0003824; GO:0005576; GO:0006629; GO:0012501; GO:0016787; GO:0043226,catalytic activity; extracellular region; lipid metabolic process; programmed cell death; hydrolase activity; organelle
OG_00381,1.3469577497063183,FUN_001233-T1,Peve_00022952,Pocillopora_meandrina_HIv1___RNAseq.g29020.t1,three_way,84.606,FUN_001233-T1,Q32L68,,,,,36.4,349.0,3.4e-46,187.2,sp|Q32L68|HM20B_BOVIN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related OS=Bos taurus OX=9913 GN=HMG20B PE=2 SV=1,,,,,,
OG_00425,1.002442952369148,FUN_001333-T1,Peve_00036946,Pocillopora_meandrina_HIv1___RNAseq.g2283.t1,three_way,78.30966666666667,FUN_001333-T1,Q502W6,VWA3B_HUMAN,,von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B),Homo sapiens (Human),34.1,167.0,4.3e-21,105.1,sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3,GO:0005654; GO:0005829,,cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829,nucleoplasm; cytosol
OG_00430,1.7297664108859572,FUN_001338-T1,Peve_00036941,Pocillopora_meandrina_HIv1___TS.g4798.t2,three_way,67.19033333333333,FUN_001338-T1,Q8C9W3,ATS2_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS 2) (ADAM-TS2) (ADAMTS-2) (EC 3.4.24.14) (Procollagen I N-proteinase) (PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase) (pNPI),Mus musculus (Mouse),31.2,954.0,4.4e-135,484.6,sp|Q8C9W3|ATS2_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Mus musculus OX=10090 GN=Adamts2 PE=1 SV=2,GO:0004222; GO:0005576; GO:0007283; GO:0008233; GO:0008270; GO:0016485; GO:0030199; GO:0030324; GO:0030574; GO:0031012; GO:0043588,collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_00434,1.623981213145376,FUN_001344-T1,Peve_00037041,Pocillopora_meandrina_HIv1___TS.g4804.t1,three_way,84.807,FUN_001344-T1,Q9DGA5,CDK1_ORYCU,,Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase),Oryzias curvinotus (Hynann ricefish) (Aplocheilus curvinotus),68.6,299.0,4.0999999999999997e-120,432.6,sp|Q9DGA5|CDK1_ORYCU Cyclin-dependent kinase 1 OS=Oryzias curvinotus OX=104658 GN=cdk1 PE=2 SV=1,GO:0000086; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0007095; GO:0008353; GO:0051301; GO:0106310,cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic G2 DNA damage checkpoint signaling [GO:0007095],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00455,2.5016637431066857,FUN_001384-T1,Peve_00019346,Pocillopora_meandrina_HIv1___TS.g4636.t2,three_way,67.6845,,,,,,,,,,,,,,,,,
OG_00474,1.4433414684212116,FUN_001413-T1,Peve_00008749,Pocillopora_meandrina_HIv1___RNAseq.g2101.t1,three_way,46.56633333333333,,,,,,,,,,,,,,,,,
OG_00489,1.696996444349287,FUN_001455-T1,Peve_00018433,Pocillopora_meandrina_HIv1___RNAseq.g1953.t1,three_way,74.87066666666666,FUN_001455-T1,O94844,RHBT1_HUMAN,,Rho-related BTB domain-containing protein 1,Homo sapiens (Human),39.0,693.0,1.1999999999999999e-113,412.1,sp|O94844|RHBT1_HUMAN Rho-related BTB domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RHOBTB1 PE=1 SV=2,GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0007015; GO:0007163; GO:0007165; GO:0007264; GO:0008360; GO:0010008; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995,actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264],cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; hydrolase activity; cytoplasmic vesicle; organelle
OG_00498,1.2927459363745248,FUN_001471-T1,Peve_00022129,Pocillopora_meandrina_HIv1___RNAseq.g22905.t1,three_way,60.35333333333333,,,,,,,,,,,,,,,,,
OG_00511,1.995705238474,FUN_001503-T1,Peve_00018430,Pocillopora_meandrina_HIv1___RNAseq.g1086.t1,three_way,61.830666666666666,FUN_001503-T1,P86982,,,,,41.6,137.0,3.9e-21,103.6,sp|P86982|IMSP1_RUDPH Insoluble matrix shell protein 1 (Fragment) OS=Ruditapes philippinarum OX=129788 PE=1 SV=1,,,,,,
OG_00535,1.2389936384248148,FUN_001550-T1,Peve_00003916,Pocillopora_meandrina_HIv1___RNAseq.g2091.t1,three_way,65.51033333333334,FUN_001550-T1,Q54I58,,,,,32.0,219.0,6.2e-26,119.4,sp|Q54I58|NIPSN_DICDI Protein NipSnap homolog OS=Dictyostelium discoideum OX=44689 GN=nipsnap PE=3 SV=1,,,,,,
OG_00570,1.15785072289949,FUN_001628-T1,Peve_00009929,Pocillopora_meandrina_HIv1___RNAseq.g2165.t1,three_way,85.88366666666667,FUN_001628-T1,P49706,,,,,57.9,290.0,2.8e-88,326.6,sp|P49706|CCND2_CHICK G1/S-specific cyclin-D2 OS=Gallus gallus OX=9031 GN=CCND2 PE=3 SV=1,,,,,,
OG_00583,1.1176366992094382,FUN_001656-T1,Peve_00038363,Pocillopora_meandrina_HIv1___RNAseq.g29405.t1,three_way,83.438,FUN_001656-T1,A0PJE2,DHR12_HUMAN,,Dehydrogenase/reductase SDR family member 12 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 40C member 1) (Protein SDR40C1),Homo sapiens (Human),58.9,319.0,1.4e-104,380.9,sp|A0PJE2|DHR12_HUMAN Dehydrogenase/reductase SDR family member 12 OS=Homo sapiens OX=9606 GN=DHRS12 PE=1 SV=2,GO:0016491,,,oxidoreductase activity [GO:0016491],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_00588,1.566900552466418,FUN_001671-T2,Peve_00038393,Pocillopora_meandrina_HIv1___RNAseq.g29390.t1,three_way,54.833666666666666,FUN_001671-T2,O60293,,,,,28.7,1468.0,5.8000000000000005e-133,478.0,sp|O60293|ZC3H1_HUMAN Zinc finger C3H1 domain-containing protein OS=Homo sapiens OX=9606 GN=ZFC3H1 PE=1 SV=3,,,,,,
OG_00590,1.504108264667193,FUN_001723-T1,Peve_00041635,Pocillopora_meandrina_HIv1___TS.g5211.t1,three_way,45.939,,,,,,,,,,,,,,,,,
OG_00613,1.964641354605594,FUN_001779-T1,Peve_00026506,Pocillopora_meandrina_HIv1___TS.g5198.t1,three_way,47.594,,,,,,,,,,,,,,,,,
OG_00619,1.098727851030583,FUN_001787-T1,Peve_00008715,Pocillopora_meandrina_HIv1___RNAseq.g2639.t1,three_way,71.26766666666667,FUN_001787-T1,Q9HCE0,EPG5_HUMAN,,Ectopic P granules protein 5 homolog,Homo sapiens (Human),30.6,2484.0,0.0,1120.1,sp|Q9HCE0|EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens OX=9606 GN=EPG5 PE=1 SV=2,GO:0002385; GO:0005737; GO:0005764; GO:0006511; GO:0006862; GO:0006954; GO:0006986; GO:0008333; GO:0010467; GO:0032456; GO:0034162; GO:0034342; GO:0046530; GO:0048471; GO:0048874; GO:0048877; GO:0051402; GO:0051607; GO:0070841; GO:0097352; GO:0098544; GO:0140454; GO:0140888; GO:1990786,autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; defense response to virus [GO:0051607]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; inclusion body assembly [GO:0070841]; inflammatory response [GO:0006954]; interferon-mediated signaling pathway [GO:0140888]; maintenance of protein complex location [GO:0098544]; mucosal immune response [GO:0002385]; neuron apoptotic process [GO:0051402]; nucleotide transport [GO:0006862]; photoreceptor cell differentiation [GO:0046530]; protein aggregate center assembly [GO:0140454]; response to type III interferon [GO:0034342]; response to unfolded protein [GO:0006986]; toll-like receptor 9 signaling pathway [GO:0034162]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],,GO:0002376; GO:0005764; GO:0005773; GO:0006954; GO:0012501; GO:0016192; GO:0030154; GO:0043226,immune system process; lysosome; vacuole; inflammatory response; programmed cell death; vesicle-mediated transport; cell differentiation; organelle
OG_00622,1.3611869334833042,FUN_001793-T1,Peve_00008718,Pocillopora_meandrina_HIv1___RNAseq.g2635.t1a,three_way,54.11416666666666,FUN_001793-T1,Q60997,DMBT1_MOUSE,,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80),Mus musculus (Mouse),40.2,112.0,1.9e-13,79.3,sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2,GO:0001824; GO:0001833; GO:0002065; GO:0005576; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023,blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],zymogen binding [GO:0035375],GO:0005576; GO:0030154; GO:0030312; GO:0031012; GO:0048856,extracellular region; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_00623,1.3519919595971903,FUN_001794-T1,Peve_00037091,Pocillopora_meandrina_HIv1___RNAseq.g15131.t1,three_way,57.70583333333334,FUN_001794-T1,P05183,CP3A2_RAT,,Cytochrome P450 3A2 (EC 1.14.14.1) (CYPIIIA2) (Cytochrome P450-PCN2) (Cytochrome P450/6-beta-A) (Testosterone 6-beta-hydroxylase),Rattus norvegicus (Rat),39.3,504.0,7.0000000000000015e-90,332.8,sp|P05183|CP3A2_RAT Cytochrome P450 3A2 OS=Rattus norvegicus OX=10116 GN=Cyp3a2 PE=1 SV=2,GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006706; GO:0006805; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016098; GO:0016491; GO:0019899; GO:0020037; GO:0030343; GO:0032451; GO:0034875; GO:0042178; GO:0042359; GO:0042369; GO:0042572; GO:0042573; GO:0050649; GO:0062181; GO:0070576; GO:0070989; GO:0101020; GO:0101021,alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789],"1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]",GO:0003824; GO:0006629; GO:0006766; GO:0008289; GO:0016491,catalytic activity; lipid metabolic process; vitamin metabolic process; lipid binding; oxidoreductase activity
OG_00664,1.4621279460443055,FUN_001957-T1,Peve_00041244,Pocillopora_meandrina_HIv1___RNAseq.g2489.t1,three_way,78.50733333333334,FUN_001957-T1,Q8CHW4,EI2BE_MOUSE,,Translation initiation factor eIF2B subunit epsilon (eIF2B GDP-GTP exchange factor subunit epsilon),Mus musculus (Mouse),41.6,671.0,1e-123,445.7,sp|Q8CHW4|EI2BE_MOUSE Translation initiation factor eIF2B subunit epsilon OS=Mus musculus OX=10090 GN=Eif2b5 PE=1 SV=1,GO:0001541; GO:0002183; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0042552; GO:0043065; GO:0043434; GO:0045948; GO:0048708; GO:0050852,astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cytoplasmic translational initiation [GO:0002183]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634],guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369],GO:0002376; GO:0005634; GO:0005829; GO:0030154; GO:0043226; GO:0048856; GO:0098772,immune system process; nucleus; cytosol; cell differentiation; organelle; anatomical structure development; molecular function regulator activity
OG_00681,1.0881376445094193,FUN_002115-T1,Peve_00035152,Pocillopora_meandrina_HIv1___RNAseq.g1741.t1,three_way,74.249,FUN_002115-T1,Q8BP78,,,,,63.8,163.0,1.6e-60,234.2,sp|Q8BP78|F10C1_MOUSE Protein FRA10AC1 homolog OS=Mus musculus OX=10090 GN=Fra10ac1 PE=1 SV=3,,,,,,
OG_00698,1.415671475004152,FUN_002428-T1,Peve_00034033,Pocillopora_meandrina_HIv1___RNAseq.g14846.t1,three_way,88.449,,,,,,,,,,,,,,,,,
OG_00699,1.304622023813969,FUN_002429-T1,Peve_00034034,Pocillopora_meandrina_HIv1___RNAseq.g14851.t1,three_way,83.17716666666666,FUN_002429-T1,P09215,KPCD_RAT,,Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],Rattus norvegicus (Rat),51.9,696.0,1.1e-207,724.5,sp|P09215|KPCD_RAT Protein kinase C delta type OS=Rattus norvegicus OX=10116 GN=Prkcd PE=1 SV=1,GO:0001666; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006915; GO:0006974; GO:0006979; GO:0008047; GO:0008270; GO:0009410; GO:0009612; GO:0009749; GO:0016020; GO:0016064; GO:0016363; GO:0018105; GO:0019899; GO:0019901; GO:0023021; GO:0030837; GO:0032869; GO:0032930; GO:0032956; GO:0032963; GO:0034351; GO:0034599; GO:0034644; GO:0035556; GO:0036019; GO:0042100; GO:0042119; GO:0042149; GO:0042307; GO:0042325; GO:0042542; GO:0042742; GO:0043065; GO:0043200; GO:0043409; GO:0043410; GO:0043560; GO:0043687; GO:0045471; GO:0046326; GO:0046627; GO:0048471; GO:0050728; GO:0051490; GO:0060326; GO:0070301; GO:0070779; GO:0070976; GO:0071447; GO:0090331; GO:0090398; GO:0099524; GO:0106310; GO:0120283; GO:1904385; GO:1904627; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001235,apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; collagen metabolic process [GO:0032963]; D-aspartate import across plasma membrane [GO:0070779]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of D-glucose import [GO:0046326]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; post-translational protein modification [GO:0043687]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of phosphorylation [GO:0042325]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to phorbol 13-acetate 12-myristate [GO:1904627]; response to xenobiotic stimulus [GO:0009410]; termination of signal transduction [GO:0023021],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524],"ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; protein tyrosine kinase activity [GO:0004713]; TIR domain binding [GO:0070976]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005634; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0005886; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0048870; GO:0055085; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; plasma membrane; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; cell motility; transmembrane transport; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00711,1.149128944300807,FUN_002578-T1,Peve_00011540,Pocillopora_meandrina_HIv1___RNAseq.g25721.t1,three_way,67.49366666666667,FUN_002578-T1,Q9JMA7,,,,,37.9,496.0,6.6e-88,326.2,sp|Q9JMA7|CP341_MOUSE Cytochrome P450 3A41 OS=Mus musculus OX=10090 GN=Cyp3a41a PE=1 SV=2,,,,,,
OG_00714,1.9797241892445865,FUN_002582-T1,Peve_00002778,Pocillopora_meandrina_HIv1___RNAseq.g25727.t1,three_way,60.239666666666665,,,,,,,,,,,,,,,,,
OG_00727,1.1257184895320145,FUN_002690-T1,Peve_00009951,Pocillopora_meandrina_HIv1___RNAseq.g20729.t1,three_way,49.989,FUN_002690-T1,Q3ZBG4,HES1_BOVIN,,Transcription factor HES-1 (Hairy and enhancer of split 1),Bos taurus (Bovine),59.4,64.0,4.6e-11,69.7,sp|Q3ZBG4|HES1_BOVIN Transcription factor HES-1 OS=Bos taurus OX=9913 GN=HES1 PE=2 SV=1,GO:0000122; GO:0001227; GO:0005634; GO:0007219; GO:0021861; GO:0042531; GO:0042803; GO:0043388; GO:0043565; GO:0045665; GO:0045892; GO:0046425; GO:0046427; GO:0048711; GO:0048715; GO:0050767; GO:0060253; GO:0065003; GO:0070888; GO:0071820; GO:2000974; GO:2000978,forebrain radial glial cell differentiation [GO:0021861]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of DNA binding [GO:0043388]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of neurogenesis [GO:0050767]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425],nucleus [GO:0005634],"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0065003; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; protein-containing complex assembly; transcription regulator activity
OG_00762,1.1133035170569894,FUN_003388-T1,Peve_00014446,Pocillopora_meandrina_HIv1___TS.g13629.t1,three_way,66.48599999999999,,,,,,,,,,,,,,,,,
OG_00767,1.349221760191599,FUN_003693-T1,Peve_00040660,Pocillopora_meandrina_HIv1___RNAseq.g30052.t1,three_way,45.812,FUN_003693-T1,P06582,,,,,43.8,80.0,2.9e-12,75.1,sp|P06582|HSP12_CAEEL Heat shock protein hsp-16.2 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.2 PE=2 SV=1,,,,,,
OG_00772,1.5170260922260557,FUN_003840-T1,Peve_00003890,Pocillopora_meandrina_HIv1___RNAseq.g11708.t1,three_way,63.461333333333336,FUN_003840-T1,A7MBJ4,PTPRF_BOVIN,,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48),Bos taurus (Bovine),31.0,1540.0,1.8000000000000001e-162,575.5,sp|A7MBJ4|PTPRF_BOVIN Receptor-type tyrosine-protein phosphatase F OS=Bos taurus OX=9913 GN=PTPRF PE=2 SV=1,GO:0004725; GO:0007165; GO:0008201; GO:0016020; GO:0016477; GO:0035335; GO:0099560; GO:1900121,cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; peptidyl-tyrosine dephosphorylation [GO:0035335]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560],membrane [GO:0016020],heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0007155; GO:0016787; GO:0048870; GO:0140096,"catalytic activity; cell adhesion; hydrolase activity; cell motility; catalytic activity, acting on a protein"
OG_00775,1.062645137073167,FUN_003847-T1,Peve_00009243,Pocillopora_meandrina_HIv1___RNAseq.g11165.t1,three_way,62.71566666666666,FUN_003847-T1,Q80TL4,PHF24_MOUSE,,PHD finger protein 24,Mus musculus (Mouse),30.2,268.0,2.8e-31,137.9,sp|Q80TL4|PHF24_MOUSE PHD finger protein 24 OS=Mus musculus OX=10090 GN=Phf24 PE=1 SV=2,GO:0007214; GO:0008270; GO:0008277; GO:0030672; GO:0032228; GO:0050966; GO:0098978,"detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic transmission, GABAergic [GO:0032228]",glutamatergic synapse [GO:0098978]; synaptic vesicle membrane [GO:0030672],zinc ion binding [GO:0008270],GO:0023052,signaling
OG_00789,1.9163628903847456,FUN_003934-T1,Peve_00006586,Pocillopora_meandrina_HIv1___RNAseq.g11751.t1,three_way,62.47316666666666,FUN_003934-T1,Q60847,COCA1_MOUSE,,Collagen alpha-1(XII) chain,Mus musculus (Mouse),34.2,184.0,3e-23,113.2,sp|Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mus musculus OX=10090 GN=Col12a1 PE=2 SV=3,GO:0005581; GO:0005615; GO:0007155; GO:0035987; GO:0062023,cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],,GO:0005615; GO:0007155; GO:0030154,extracellular space; cell adhesion; cell differentiation
OG_00792,1.0723185269940647,FUN_003938-T1,Peve_00041389,Pocillopora_meandrina_HIv1___TS.g7868.t1,three_way,40.8085,,,,,,,,,,,,,,,,,
OG_00793,1.488656049238516,FUN_003940-T1,Peve_00038457,Pocillopora_meandrina_HIv1___RNAseq.g11757.t1,three_way,58.294,FUN_003940-T1,Q6DG99,,,,,53.7,95.0,7.6e-19,96.3,sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1,,,,,,
OG_00828,1.1169890785356331,FUN_004058-T1,Peve_00007134,Pocillopora_meandrina_HIv1___RNAseq.g17244.t1a,three_way,47.307,,,,,,,,,,,,,,,,,
OG_00843,1.2636289765181563,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_00854,1.0367934952826778,FUN_004117-T1,Peve_00038521,Pocillopora_meandrina_HIv1___RNAseq.g11674.t1,three_way,85.43533333333333,FUN_004117-T1,F1Q8K0,RAD54_DANRE,,DNA repair and recombination protein RAD54-like (EC 3.6.4.12),Danio rerio (Zebrafish) (Brachydanio rerio),66.8,744.0,3.7000000000000004e-292,1005.4,sp|F1Q8K0|RAD54_DANRE DNA repair and recombination protein RAD54-like OS=Danio rerio OX=7955 GN=rad54l PE=1 SV=1,GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0007131; GO:0008094; GO:0015616; GO:0016787; GO:0045003,double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; reciprocal meiotic recombination [GO:0007131],nucleus [GO:0005634],"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]",GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; reproductive process; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_00865,1.4968926730634686,FUN_004131-T1,Peve_00009433,Pocillopora_meandrina_HIv1___RNAseq.g16790.t1,three_way,49.26166666666666,,,,,,,,,,,,,,,,,
OG_00867,1.0100594996670345,FUN_004142-T1,Peve_00004368,Pocillopora_meandrina_HIv1___RNAseq.g144.t1,three_way,51.94683333333333,FUN_004142-T1,Q5T890,ER6L2_HUMAN,,DNA excision repair protein ERCC-6-like 2 (EC 3.6.4.-) (DNA repair and recombination protein RAD26-like) (Excision repair cross-complementation group 6-like 2),Homo sapiens (Human),31.5,1000.0,5.9999999999999986e-93,344.0,sp|Q5T890|ER6L2_HUMAN DNA excision repair protein ERCC-6-like 2 OS=Homo sapiens OX=9606 GN=ERCC6L2 PE=1 SV=3,GO:0000775; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0006974; GO:0016787; GO:0019901; GO:0032991; GO:0034614; GO:0036297; GO:0097680,cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; interstrand cross-link repair [GO:0036297],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0006281; GO:0016787; GO:0016853; GO:0043226; GO:0140657,DNA binding; catalytic activity; nucleus; mitochondrion; microtubule organizing center; DNA repair; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_00876,1.1831319964010778,FUN_004165-T1,Peve_00031563,Pocillopora_meandrina_HIv1___RNAseq.g16742.t1,three_way,88.557,FUN_004165-T1,Q8N6S4,AN13C_HUMAN,,Ankyrin repeat domain-containing protein 13C,Homo sapiens (Human),64.4,430.0,1.1000000000000002e-165,584.3,sp|Q8N6S4|AN13C_HUMAN Ankyrin repeat domain-containing protein 13C OS=Homo sapiens OX=9606 GN=ANKRD13C PE=1 SV=2,GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006612; GO:0006621; GO:0048471; GO:0071799; GO:0140597; GO:2000209,cellular response to prostaglandin D stimulus [GO:0071799]; protein retention in ER lumen [GO:0006621]; protein targeting to membrane [GO:0006612]; regulation of anoikis [GO:2000209],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471],protein carrier chaperone [GO:0140597]; signaling receptor binding [GO:0005102],GO:0005783; GO:0043226; GO:0140104,endoplasmic reticulum; organelle; molecular carrier activity
OG_00877,1.0121816894548583,FUN_004170-T1,Peve_00031564,Pocillopora_meandrina_HIv1___RNAseq.g16738.t1,three_way,85.395,,,,,,,,,,,,,,,,,
OG_00879,1.4974346074718257,FUN_004172-T1,Peve_00035080,Pocillopora_meandrina_HIv1___TS.g17566.t1,three_way,84.42933333333333,FUN_004172-T1,Q9H841,,,,,50.5,291.0,9.2e-76,285.4,sp|Q9H841|NPAL2_HUMAN NIPA-like protein 2 OS=Homo sapiens OX=9606 GN=NIPAL2 PE=1 SV=2,,,,,,
OG_00880,1.4886147613816174,FUN_004174-T1,Peve_00019597,Pocillopora_meandrina_HIv1___TS.g17559.t2,three_way,57.525333333333336,FUN_004174-T1,P23468,PTPRD_HUMAN,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Homo sapiens (Human),35.1,1661.0,5.0999999999999996e-250,867.1,sp|P23468|PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens OX=9606 GN=PTPRD PE=1 SV=2,GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007165; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560,cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],GO:0003824; GO:0005886; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0060089; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; hydrolase activity; signaling; cell differentiation; organelle; molecular transducer activity; membrane organization; catalytic activity, acting on a protein"
OG_00887,1.5254885518178578,FUN_004202-T1,Peve_00008456,Pocillopora_meandrina_HIv1___RNAseq.g16814.t1,three_way,83.68566666666666,FUN_004202-T1,Q91W43,GCSP_MOUSE,,"Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))",Mus musculus (Mouse),66.0,968.0,0.0,1327.0,"sp|Q91W43|GCSP_MOUSE Glycine dehydrogenase (decarboxylating), mitochondrial OS=Mus musculus OX=10090 GN=Gldc PE=1 SV=1",GO:0004375; GO:0005654; GO:0005739; GO:0005886; GO:0005960; GO:0006546; GO:0016594; GO:0016829; GO:0019464; GO:0019899; GO:0030170; GO:0036255; GO:0042803; GO:0065003; GO:0070280; GO:1903442; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein-containing complex assembly [GO:0065003]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255],glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005886; GO:0006520; GO:0016491; GO:0016829; GO:0043226; GO:0065003,catalytic activity; nucleoplasm; mitochondrion; plasma membrane; amino acid metabolic process; oxidoreductase activity; lyase activity; organelle; protein-containing complex assembly
OG_00913,1.2490217442856433,FUN_004247-T1,Peve_00019440,Pocillopora_meandrina_HIv1___RNAseq.g11529.t1,three_way,67.11033333333333,FUN_004247-T1,P41233,,,,,40.9,2521.0,0.0,1671.4,sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4,,,,,,
OG_00938,1.9537742890160248,FUN_004288-T1,Peve_00029197,Pocillopora_meandrina_HIv1___RNAseq.g11767.t1,three_way,35.059,,,,,,,,,,,,,,,,,
OG_00986,1.0148174579822111,FUN_004373-T2,Peve_00007253,Pocillopora_meandrina_HIv1___TS.g17451.t1,three_way,60.50866666666667,FUN_004373-T2,P16621,,,,,38.6,2020.0,0.0,1295.0,sp|P16621|LAR_DROME Tyrosine-protein phosphatase Lar OS=Drosophila melanogaster OX=7227 GN=Lar PE=1 SV=2,,,,,,
OG_01007,1.0946763500045402,FUN_004431-T1,Peve_00033220,Pocillopora_meandrina_HIv1___RNAseq.g11379.t1,three_way,81.504,FUN_004431-T1,Q7ZW46,,,,,57.3,321.0,2.5e-101,370.2,sp|Q7ZW46|S35B4_DANRE UDP-xylose and UDP-N-acetylglucosamine transporter OS=Danio rerio OX=7955 GN=slc35b4 PE=2 SV=1,,,,,,
OG_01017,1.1006386665553054,FUN_004446-T1,Peve_00024328,Pocillopora_meandrina_HIv1___RNAseq.g12519.t3,three_way,72.83733333333333,FUN_004446-T1,Q6DCD1,,,,,55.2,554.0,3.5000000000000005e-180,632.9,sp|Q6DCD1|FGGY_XENLA FGGY carbohydrate kinase domain-containing protein OS=Xenopus laevis OX=8355 GN=fggy PE=2 SV=2,,,,,,
OG_01023,1.2084524238464225,FUN_004455-T1,Peve_00024319,Pocillopora_meandrina_HIv1___RNAseq.g4970.t1,three_way,67.10066666666667,FUN_004455-T1,Q16651,PRSS8_HUMAN,,Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain],Homo sapiens (Human),39.0,249.0,2.0999999999999999e-41,173.3,sp|Q16651|PRSS8_HUMAN Prostasin OS=Homo sapiens OX=9606 GN=PRSS8 PE=1 SV=1,GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0010765; GO:0070062,positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005576; GO:0005615; GO:0005886; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; extracellular region; extracellular space; plasma membrane; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01055,1.9102933429530804,FUN_004508-T1,Peve_00012959,Pocillopora_meandrina_HIv1___RNAseq.g11640.t1,three_way,76.12733333333334,FUN_004508-T1,H9JW43,,,,,39.8,364.0,4.4e-76,286.6,sp|H9JW43|CDA8_BOMMO Chitin deacetylase 8 OS=Bombyx mori OX=7091 GN=CDA8 PE=1 SV=2,,,,,,
OG_01062,1.6127055281216145,FUN_004517-T1,Peve_00044062,Pocillopora_meandrina_HIv1___RNAseq.g11317.t1,three_way,69.30250000000001,FUN_004517-T1,Q5R5M5,ENPP3_PONAB,,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (Alkaline phosphodiesterase I) (EC 3.1.4.1) (Dinucleoside polyphosphatase) (EC 3.6.1.-) (Nucleotide diphosphatase) (Nucleotide pyrophosphatase) (NPPase) (EC 3.6.1.9) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),35.5,766.0,1.2e-133,478.8,sp|Q5R5M5|ENPP3_PONAB Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 OS=Pongo abelii OX=9601 GN=ENPP3 PE=2 SV=1,GO:0002276; GO:0003676; GO:0004081; GO:0004528; GO:0005509; GO:0005524; GO:0005576; GO:0005886; GO:0006220; GO:0008270; GO:0009143; GO:0009897; GO:0016324; GO:0033007; GO:0034432; GO:0036219; GO:0036221; GO:0046034; GO:0047429; GO:0047693; GO:0047710; GO:0050728; GO:0070667,ATP metabolic process [GO:0046034]; basophil activation involved in immune response [GO:0002276]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell proliferation [GO:0070667]; nucleoside triphosphate catabolic process [GO:0009143]; pyrimidine nucleotide metabolic process [GO:0006220],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP diphosphatase activity [GO:0047693]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; calcium ion binding [GO:0005509]; GTP diphosphatase activity [GO:0036219]; nucleic acid binding [GO:0003676]; nucleoside triphosphate diphosphatase activity [GO:0047429]; phosphodiesterase I activity [GO:0004528]; UTP diphosphatase activity [GO:0036221]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0055086; GO:1901135,immune system process; catalytic activity; extracellular region; plasma membrane; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01089,1.2573637352480744,FUN_004582-T1,Peve_00012392,Pocillopora_meandrina_HIv1___RNAseq.g6604.t1,three_way,71.762,,,,,,,,,,,,,,,,,
OG_01090,2.19034732761957,FUN_004583-T1,Peve_00012403,Pocillopora_meandrina_HIv1___RNAseq.g6603.t1,three_way,58.695,,,,,,,,,,,,,,,,,
OG_01091,1.8198615425109967,FUN_004584-T1,Peve_00012393,Pocillopora_meandrina_HIv1___RNAseq.g6602.t1,three_way,49.74033333333333,,,,,,,,,,,,,,,,,
OG_01092,1.592326249322208,FUN_004588-T1,Peve_00012396,Pocillopora_meandrina_HIv1___RNAseq.g6598.t1,three_way,60.343833333333336,,,,,,,,,,,,,,,,,
OG_01102,1.2548570204824032,FUN_004616-T1,Peve_00012390,Pocillopora_meandrina_HIv1___RNAseq.g8689.t1,three_way,73.84366666666666,FUN_004616-T1,F1PZV2,,,,,45.6,456.0,1.4e-106,388.3,sp|F1PZV2|MFS12_CANLF Major facilitator superfamily domain-containing protein 12 OS=Canis lupus familiaris OX=9615 GN=MFSD12 PE=1 SV=3,,,,,,
OG_01141,1.2838136555885211,FUN_004721-T1,Peve_00005068,Pocillopora_meandrina_HIv1___RNAseq.g8837.t2,three_way,47.232,,,,,,,,,,,,,,,,,
OG_01143,1.1604261526980977,FUN_004723-T1,Peve_00005075,Pocillopora_meandrina_HIv1___RNAseq.g8839.t1,three_way,56.89366666666667,FUN_004723-T1,Q8WZ42,TITIN_HUMAN,,Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14),Homo sapiens (Human),25.3,194.0,5.5e-09,64.7,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,GO:0000794; GO:0002020; GO:0003009; GO:0003300; GO:0004672; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0045214; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0070062; GO:0097493; GO:0106310; GO:1990733,cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941],condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433],GO:0000228; GO:0003012; GO:0003824; GO:0005198; GO:0005576; GO:0005694; GO:0005829; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140096,"nuclear chromosome; muscle system process; catalytic activity; structural molecule activity; extracellular region; chromosome; cytosol; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01145,1.03279383944544,FUN_004737-T1,Peve_00016797,Pocillopora_meandrina_HIv1___RNAseq.g8830.t1,three_way,67.98533333333333,FUN_004737-T1,P41413,,,,,45.9,878.0,2.600000000000001e-196,688.0,sp|P41413|PCSK5_RAT Proprotein convertase subtilisin/kexin type 5 OS=Rattus norvegicus OX=10116 GN=Pcsk5 PE=2 SV=3,,,,,,
OG_01159,1.0007169361936177,FUN_004777-T1,Peve_00037749,Pocillopora_meandrina_HIv1___RNAseq.g6694.t2,three_way,76.02633333333334,FUN_004777-T1,P46859,,,,,34.6,179.0,1.2e-21,104.8,sp|P46859|GNTK_ECOLI Thermoresistant gluconokinase OS=Escherichia coli (strain K12) OX=83333 GN=gntK PE=1 SV=4,,,,,,
OG_01177,2.1753734812101206,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.1999999999999999e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_01190,1.1054350646213145,FUN_004844-T1,Peve_00019431,Pocillopora_meandrina_HIv1___RNAseq.g8621.t1,three_way,65.215,,,,,,,,,,,,,,,,,
OG_01191,1.242713031256295,FUN_004845-T1,Peve_00019432,Pocillopora_meandrina_HIv1___RNAseq.g8622.t1,three_way,81.704,FUN_004845-T1,Q9PTS8,ACHA9_CHICK,,Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9),Gallus gallus (Chicken),39.9,476.0,7.3000000000000015e-87,322.8,sp|Q9PTS8|ACHA9_CHICK Neuronal acetylcholine receptor subunit alpha-9 OS=Gallus gallus OX=9031 GN=CHRNA9 PE=1 SV=1,GO:0005231; GO:0005262; GO:0005886; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:1902495; GO:1904315,chemical synaptic transmission [GO:0007268]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391],neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495],acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_01193,1.1873357809317338,FUN_004851-T1,Peve_00043739,Pocillopora_meandrina_HIv1___RNAseq.g8640.t1,three_way,62.76883333333333,FUN_004851-T1,Q04912,RON_HUMAN,,Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain],Homo sapiens (Human),35.8,293.0,2.2e-49,198.7,sp|Q04912|RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens OX=9606 GN=MST1R PE=1 SV=3,GO:0001725; GO:0004714; GO:0005011; GO:0005524; GO:0005773; GO:0005886; GO:0006909; GO:0006952; GO:0007165; GO:0007169; GO:0007338; GO:0007399; GO:0008284; GO:0009615; GO:0009986; GO:0016477; GO:0019899; GO:0043235; GO:0043406; GO:0045087; GO:0051897,cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338],cell surface [GO:0009986]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0002376; GO:0003824; GO:0005773; GO:0005886; GO:0016192; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0098542; GO:0140096,"immune system process; catalytic activity; vacuole; plasma membrane; vesicle-mediated transport; transferase activity; reproductive process; organelle; anatomical structure development; cell motility; molecular transducer activity; defense response to other organism; catalytic activity, acting on a protein"
OG_01210,2.1520546401848257,FUN_004887-T1,Peve_00005850,Pocillopora_meandrina_HIv1___RNAseq.g10661.t1,three_way,61.143166666666666,FUN_004887-T1,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),31.4,1097.0,1.9e-124,450.7,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01223,1.3011564461085148,FUN_004905-T1,Peve_00028658,Pocillopora_meandrina_HIv1___RNAseq.g8333.t1,three_way,69.76066666666667,FUN_004905-T1,Q61555,FBN2_MOUSE,,Fibrillin-2 [Cleaved into: Placensin],Mus musculus (Mouse),53.2,2537.0,9.1e-126,454.5,sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2,GO:0001527; GO:0005179; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023,bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527],calcium ion binding [GO:0005509]; hormone activity [GO:0005179],GO:0005576; GO:0048018; GO:0048856; GO:0098772,extracellular region; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01234,1.228748874128253,FUN_004919-T1,Peve_00044506,Pocillopora_meandrina_HIv1___RNAseq.g8352.t1,three_way,72.428,FUN_004919-T1,Q16566,KCC4_HUMAN,,Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR),Homo sapiens (Human),63.4,290.0,1e-102,374.8,sp|Q16566|KCC4_HUMAN Calcium/calmodulin-dependent protein kinase type IV OS=Homo sapiens OX=9606 GN=CAMK4 PE=1 SV=1,GO:0001650; GO:0002250; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006468; GO:0006954; GO:0007165; GO:0007616; GO:0009931; GO:0033081; GO:0035556; GO:0043011; GO:0045670; GO:0045893; GO:0070062; GO:0106310,adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of DNA-templated transcription [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005783; GO:0006355; GO:0006954; GO:0016740; GO:0030154; GO:0043226; GO:0050877; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; endoplasmic reticulum; regulation of DNA-templated transcription; inflammatory response; transferase activity; cell differentiation; organelle; nervous system process; catalytic activity, acting on a protein"
OG_01240,1.7060497259519372,FUN_004926-T1,Peve_00034769,Pocillopora_meandrina_HIv1___RNAseq.g8365.t1,three_way,75.525,,,,,,,,,,,,,,,,,
OG_01241,1.2683093716830252,FUN_004929-T1,Peve_00034771,Pocillopora_meandrina_HIv1___RNAseq.g8368.t1,three_way,72.67233333333333,,,,,,,,,,,,,,,,,
OG_01244,1.429679865840498,FUN_004939-T1,Peve_00014400,Pocillopora_meandrina_HIv1___RNAseq.g8389.t1,three_way,65.75466666666667,,,,,,,,,,,,,,,,,
OG_01250,2.1682471239962537,FUN_004969-T1,Peve_00043270,Pocillopora_meandrina_HIv1___TS.g20136.t1,three_way,49.14716666666666,,,,,,,,,,,,,,,,,
OG_01277,2.328878101711528,FUN_005057-T1,Peve_00016734,Pocillopora_meandrina_HIv1___RNAseq.g8302.t1,three_way,72.20533333333333,FUN_005057-T1,Q8K596,NAC2_MOUSE,,Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2),Mus musculus (Mouse),37.3,499.0,1.4e-72,275.8,sp|Q8K596|NAC2_MOUSE Sodium/calcium exchanger 2 OS=Mus musculus OX=10090 GN=Slc8a2 PE=1 SV=1,GO:0002931; GO:0005432; GO:0005516; GO:0005886; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015085; GO:0016323; GO:0035725; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0070050; GO:0070588; GO:0098815; GO:0099608; GO:0106056; GO:1902533; GO:1990034,calcium ion export across plasma membrane [GO:1990034]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of intracellular signal transduction [GO:1902533]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808],axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],calcium ion transmembrane transporter activity [GO:0015085]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0055085,transporter activity; plasma membrane; cell junction organization; organelle; nervous system process; transmembrane transport
OG_01284,1.1964968168241643,FUN_005105-T1,Peve_00007471,Pocillopora_meandrina_HIv1___RNAseq.g8274.t1,three_way,65.54833333333333,FUN_005105-T1,Q43116,,,,,31.2,125.0,1.3e-11,71.2,sp|Q43116|PDI_RICCO Protein disulfide-isomerase OS=Ricinus communis OX=3988 PE=2 SV=1,,,,,,
OG_01292,1.0317720699571655,FUN_005115-T1,Peve_00007461,Pocillopora_meandrina_HIv1___RNAseq.g8266.t1,three_way,64.81533333333333,FUN_005115-T1,Q8BUN9,NCKX2_MOUSE,,Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2),Mus musculus (Mouse),44.7,622.0,6.2e-134,479.6,sp|Q8BUN9|NCKX2_MOUSE Sodium/potassium/calcium exchanger 2 OS=Mus musculus OX=10090 GN=Slc24a2 PE=1 SV=1,GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007602; GO:0007612; GO:0007613; GO:0008273; GO:0015293; GO:0016020; GO:0034220; GO:0036368; GO:0051649; GO:0060291; GO:0060292; GO:0070050; GO:0071486; GO:0098703; GO:0098793; GO:0098794,calcium ion import across plasma membrane [GO:0098703]; calcium ion transport [GO:0006816]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; establishment of localization in cell [GO:0051649]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; monoatomic ion transmembrane transport [GO:0034220]; neuron cellular homeostasis [GO:0070050]; phototransduction [GO:0007602],membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793],"calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]",GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_01297,2.8806982020229803,FUN_005131-T1,Peve_00027431,Pocillopora_meandrina_HIv1___RNAseq.g22688.t1,three_way,57.669,FUN_005131-T1,P12256,,,,,31.2,321.0,7.1e-39,162.9,sp|P12256|PAC_LYSSH Penicillin V acylase OS=Lysinibacillus sphaericus OX=1421 PE=1 SV=1,,,,,,
OG_01301,1.2419389705886428,FUN_005155-T1,Peve_00014626,Pocillopora_meandrina_HIv1___RNAseq.g8081.t2,three_way,50.48,,,,,,,,,,,,,,,,,
OG_01312,1.723374225206871,FUN_005175-T1,Peve_00011874,Pocillopora_meandrina_HIv1___RNAseq.g7581.t1,three_way,61.32216666666667,FUN_005175-T1,Q9VW71,,,,,22.0,2889.0,4.9e-74,283.1,sp|Q9VW71|FAT2_DROME Fat-like cadherin-related tumor suppressor homolog OS=Drosophila melanogaster OX=7227 GN=kug PE=2 SV=3,,,,,,
OG_01317,1.0736215297080591,FUN_005182-T1,Peve_00023411,Pocillopora_meandrina_HIv1___RNAseq.g8094.t1,three_way,60.54366666666667,FUN_005182-T1,Q9UGM3,,,,,32.5,830.0,4.1999999999999995e-95,352.1,sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2,,,,,,
OG_01330,1.0011912840231438,FUN_005220-T1,Peve_00035492,Pocillopora_meandrina_HIv1___TS.g19865.t1,three_way,97.09066666666666,FUN_005220-T1,Q9TTR8,,,,,73.7,266.0,5e-111,402.1,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_01342,1.837297506629856,FUN_005243-T1,Peve_00014457,Pocillopora_meandrina_HIv1___RNAseq.g8139.t1,three_way,80.71866666666666,FUN_005243-T1,Q9Z211,,,,,32.9,246.0,2.2999999999999997e-24,114.0,sp|Q9Z211|PX11A_MOUSE Peroxisomal membrane protein 11A OS=Mus musculus OX=10090 GN=Pex11a PE=1 SV=1,,,,,,
OG_01349,1.0030084211860275,FUN_005251-T1,Peve_00003359,Pocillopora_meandrina_HIv1___RNAseq.g8148.t1,three_way,73.81333333333333,FUN_005251-T1,A4UTP7,MEF2C_PIG,,Myocyte-specific enhancer factor 2C,Sus scrofa (Pig),48.2,305.0,3.9e-58,227.3,sp|A4UTP7|MEF2C_PIG Myocyte-specific enhancer factor 2C OS=Sus scrofa OX=9823 GN=MEF2C PE=2 SV=1,GO:0000122; GO:0000165; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0001649; GO:0001782; GO:0001947; GO:0001958; GO:0001974; GO:0002062; GO:0002467; GO:0002634; GO:0003138; GO:0003139; GO:0003151; GO:0003185; GO:0003211; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006959; GO:0007507; GO:0007519; GO:0007521; GO:0007611; GO:0010628; GO:0010629; GO:0014033; GO:0016528; GO:0016607; GO:0030182; GO:0030220; GO:0030279; GO:0030318; GO:0030501; GO:0030890; GO:0032991; GO:0035051; GO:0035984; GO:0042100; GO:0043524; GO:0045652; GO:0045663; GO:0045666; GO:0045669; GO:0045893; GO:0045944; GO:0046983; GO:0048643; GO:0048666; GO:0050853; GO:0051145; GO:0055012; GO:0060025; GO:0060045; GO:0061333; GO:0071222; GO:0071277; GO:0071374; GO:0071466; GO:0071498; GO:0071560; GO:0072102; GO:0072160; GO:2000111; GO:2000727; GO:2000987; GO:2001013; GO:2001016,B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac ventricle formation [GO:0003211]; cardiocyte differentiation [GO:0035051]; cellular response to calcium ion [GO:0071277]; cellular response to fluid shear stress [GO:0071498]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; germinal center formation [GO:0002467]; glomerulus morphogenesis [GO:0072102]; heart development [GO:0007507]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; learning or memory [GO:0007611]; MAPK cascade [GO:0000165]; melanocyte differentiation [GO:0030318]; muscle cell fate determination [GO:0007521]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule epithelial cell differentiation [GO:0072160]; neural crest cell differentiation [GO:0014033]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary heart field specification [GO:0003138]; regulation of germinal center formation [GO:0002634]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of synaptic activity [GO:0060025]; renal tubule morphogenesis [GO:0061333]; secondary heart field specification [GO:0003139]; sinoatrial valve morphogenesis [GO:0003185]; skeletal muscle tissue development [GO:0007519]; smooth muscle cell differentiation [GO:0051145]; ventricular cardiac muscle cell differentiation [GO:0055012],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]",GO:0002376; GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140110,immune system process; DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_01379,1.3415576591521934,FUN_005336-T1,Peve_00003298,Pocillopora_meandrina_HIv1___RNAseq.g8196.t1,three_way,77.24866666666667,FUN_005336-T1,Q5ZK14,,,,,57.0,100.0,7e-21,101.3,sp|Q5ZK14|DDA1_CHICK DET1- and DDB1-associated protein 1 OS=Gallus gallus OX=9031 GN=DDA1 PE=3 SV=1,,,,,,
OG_01396,1.445192681988838,FUN_005372-T2,Peve_00041488,Pocillopora_meandrina_HIv1___RNAseq.g6635.t1,three_way,84.41483333333333,FUN_005372-T2,P19120,HSP7C_BOVIN,,Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8),Bos taurus (Bovine),82.6,650.0,4.8e-293,1008.1,sp|P19120|HSP7C_BOVIN Heat shock cognate 71 kDa protein OS=Bos taurus OX=9913 GN=HSPA8 PE=1 SV=2,GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0016191; GO:0016887; GO:0030674; GO:0031072; GO:0042026; GO:0042470; GO:0044183; GO:0045892; GO:0051085; GO:0061740; GO:0072318; GO:0098793; GO:0140662; GO:1990904,chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; RNA splicing [GO:0008380]; synaptic vesicle uncoating [GO:0016191],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005634; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0006457; GO:0006886; GO:0016071; GO:0016787; GO:0031410; GO:0043226; GO:0044183; GO:0060090; GO:0140657,catalytic activity; nucleus; nucleolus; cytosol; plasma membrane; regulation of DNA-templated transcription; protein folding; intracellular protein transport; mRNA metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; protein folding chaperone; molecular adaptor activity; ATP-dependent activity
OG_01409,1.070940944763215,FUN_005480-T1,Peve_00001975,Pocillopora_meandrina_HIv1___RNAseq.g6644.t1,three_way,42.841166666666666,,,,,,,,,,,,,,,,,
OG_01419,1.0157460810748833,FUN_005730-T1,Peve_00004979,Pocillopora_meandrina_HIv1___RNAseq.3034_t,three_way,61.8795,FUN_005730-T1,Q6BEA0,PLXA4_DANRE,,Plexin-A4,Danio rerio (Zebrafish) (Brachydanio rerio),37.4,1904.0,3.2e-310,1066.6,sp|Q6BEA0|PLXA4_DANRE Plexin-A4 OS=Danio rerio OX=7955 GN=plxna4 PE=2 SV=1,GO:0001763; GO:0002116; GO:0005886; GO:0007411; GO:0007414; GO:0007416; GO:0016020; GO:0017154; GO:0030334; GO:0071526,axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416],membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116],semaphorin receptor activity [GO:0017154],GO:0005886; GO:0034330; GO:0060089,plasma membrane; cell junction organization; molecular transducer activity
OG_01437,1.0629918385278427,FUN_005873-T1,Peve_00015756,Pocillopora_meandrina_HIv1___RNAseq.g19664.t1,three_way,58.21833333333333,,,,,,,,,,,,,,,,,
OG_01443,1.1025142103452874,FUN_005883-T1,Peve_00015767,Pocillopora_meandrina_HIv1___RNAseq.g19677.t1,three_way,79.88083333333334,FUN_005883-T1,Q6XPS3,TPTE2_HUMAN,,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase)",Homo sapiens (Human),46.4,468.0,6e-103,376.3,"sp|Q6XPS3|TPTE2_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 OS=Homo sapiens OX=9606 GN=TPTE2 PE=1 SV=2",GO:0000139; GO:0005216; GO:0005737; GO:0005789; GO:0005829; GO:0006661; GO:0016314; GO:0051800,phosphatidylinositol biosynthetic process [GO:0006661],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],"monoatomic ion channel activity [GO:0005216]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]",GO:0003824; GO:0005215; GO:0005829; GO:0006629; GO:0016787,catalytic activity; transporter activity; cytosol; lipid metabolic process; hydrolase activity
OG_01450,1.0995079084902766,FUN_005904-T1,Peve_00035815,Pocillopora_meandrina_HIv1___RNAseq.2460_t,three_way,73.63866666666667,FUN_005904-T1,P55115,,,,,42.3,239.0,1e-48,195.3,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_01457,1.4196564301603534,FUN_005931-T1,Peve_00011544,Pocillopora_meandrina_HIv1___TS.g26522.t1,three_way,59.55316666666667,,,,,,,,,,,,,,,,,
OG_01463,2.032761570194604,FUN_005998-T1,Peve_00036045,Pocillopora_meandrina_HIv1___RNAseq.g19934.t1,three_way,70.90683333333334,FUN_005998-T1,P23780,BGAL_MOUSE,,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),Mus musculus (Mouse),50.4,625.0,1.3e-181,637.9,sp|P23780|BGAL_MOUSE Beta-galactosidase OS=Mus musculus OX=10090 GN=Glb1 PE=1 SV=1,GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005794; GO:0006516; GO:0006689; GO:0016020; GO:0016787; GO:0016936; GO:0019388; GO:0042340; GO:0042803; GO:0051413; GO:1904016,galactose catabolic process [GO:0019388]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; keratan sulfate proteoglycan catabolic process [GO:0042340]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020],beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005794; GO:0005975; GO:0006629; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; Golgi apparatus; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_01481,1.1623011170119075,FUN_006108-T1,Peve_00011648,Pocillopora_meandrina_HIv1___RNAseq.g20395.t1,three_way,81.35466666666666,FUN_006108-T1,Q8BYW9,,,,,55.0,484.0,1.7000000000000001e-161,570.9,sp|Q8BYW9|EOGT_MOUSE EGF domain-specific O-linked N-acetylglucosamine transferase OS=Mus musculus OX=10090 GN=Eogt PE=1 SV=1,,,,,,
OG_01482,2.493857437767198,FUN_006116-T1,Peve_00011320,Pocillopora_meandrina_HIv1___RNAseq.g20399.t1,three_way,43.202666666666666,FUN_006116-T1,A0A0K3AV08,MLK1_CAEEL,,Mitogen-activated protein kinase kinase kinase mlk-1 (EC 2.7.11.25) (Mixed lineage kinase homolog 1),Caenorhabditis elegans,29.0,207.0,7.1e-10,67.4,sp|A0A0K3AV08|MLK1_CAEEL Mitogen-activated protein kinase kinase kinase mlk-1 OS=Caenorhabditis elegans OX=6239 GN=mlk-1 PE=1 SV=1,GO:0000165; GO:0001934; GO:0004672; GO:0004709; GO:0005080; GO:0005524; GO:0005737; GO:0007165; GO:0007254; GO:0008340; GO:0019901; GO:0030971; GO:0031103; GO:0038066; GO:0042594; GO:0046688; GO:0046872; GO:0048680; GO:0048691; GO:0050829; GO:0097110; GO:0106310,axon regeneration [GO:0031103]; defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein phosphorylation [GO:0001934]; response to copper ion [GO:0046688]; response to starvation [GO:0042594]; signal transduction [GO:0007165],cytoplasm [GO:0005737],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_01483,1.7280859873691128,FUN_006117-T1,Peve_00011322,Pocillopora_meandrina_HIv1___RNAseq.g20401.t1,three_way,36.36283333333333,,,,,,,,,,,,,,,,,
OG_01486,2.982641106107612,FUN_006162-T1,Peve_00024180,Pocillopora_meandrina_HIv1___RNAseq.g20422.t1,three_way,46.14,FUN_006162-T1,Q90827,,,,,30.2,129.0,2.5e-09,65.1,sp|Q90827|NEL_CHICK Protein NEL OS=Gallus gallus OX=9031 GN=NEL PE=2 SV=1,,,,,,
OG_01496,1.4200282153475776,FUN_006220-T1,Peve_00020217,Pocillopora_meandrina_HIv1___RNAseq.g20437.t1,three_way,69.87716666666667,FUN_006220-T1,P83094,STIM_DROME,,Stromal interaction molecule homolog,Drosophila melanogaster (Fruit fly),37.4,390.0,8.200000000000001e-59,229.9,sp|P83094|STIM_DROME Stromal interaction molecule homolog OS=Drosophila melanogaster OX=7227 GN=Stim PE=1 SV=1,GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0007476; GO:0012505; GO:0015279; GO:0016020; GO:0022416; GO:0048763; GO:0051924; GO:0140268,chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular calcium ion homeostasis [GO:0006874]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; store-operated calcium channel activity [GO:0015279],GO:0005215; GO:0005783; GO:0005886; GO:0043226; GO:0048856; GO:0098772,transporter activity; endoplasmic reticulum; plasma membrane; organelle; anatomical structure development; molecular function regulator activity
OG_01516,1.0059571738439466,FUN_006259-T1,Peve_00031978,Pocillopora_meandrina_HIv1___TS.g29759.t1a,three_way,91.737,FUN_006259-T1,Q8R323,,,,,75.8,351.0,2.9e-159,562.8,sp|Q8R323|RFC3_MOUSE Replication factor C subunit 3 OS=Mus musculus OX=10090 GN=Rfc3 PE=1 SV=1,,,,,,
OG_01546,1.0367964876339208,FUN_006421-T1,Peve_00043551,Pocillopora_meandrina_HIv1___RNAseq.g20280.t2,three_way,73.73433333333334,FUN_006421-T1,A7RS11,,,,,57.5,207.0,3.2e-66,253.1,sp|A7RS11|HPF1_NEMVE Histone PARylation factor 1 OS=Nematostella vectensis OX=45351 GN=HPF1 PE=1 SV=1,,,,,,
OG_01576,1.3613680483634445,FUN_006581-T1,Peve_00015613,Pocillopora_meandrina_HIv1___RNAseq.g20271.t1,three_way,58.029,FUN_006581-T1,P18460,,,,,34.3,769.0,1.3e-91,339.3,sp|P18460|FGFR3_CHICK Fibroblast growth factor receptor 3 OS=Gallus gallus OX=9031 GN=FGFR3 PE=2 SV=1,,,,,,
OG_01583,1.1872567743059887,FUN_006619-T1,Peve_00040865,Pocillopora_meandrina_HIv1___RNAseq.g20179.t1,three_way,71.24033333333334,FUN_006619-T1,Q92598,HS105_HUMAN,,Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein) (Heat shock protein family H member 1),Homo sapiens (Human),51.3,686.0,5.6e-181,636.0,sp|Q92598|HS105_HUMAN Heat shock protein 105 kDa OS=Homo sapiens OX=9606 GN=HSPH1 PE=1 SV=1,GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006457; GO:0006986; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682; GO:0140662,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662],GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006457; GO:0008092; GO:0043226; GO:0044183; GO:0098772; GO:0140657,extracellular region; nucleus; nucleoplasm; cytosol; protein folding; cytoskeletal protein binding; organelle; protein folding chaperone; molecular function regulator activity; ATP-dependent activity
OG_01589,1.164998421167189,FUN_006629-T1,Peve_00040873,Pocillopora_meandrina_HIv1___RNAseq.g20167.t1,three_way,52.60733333333334,,,,,,,,,,,,,,,,,
OG_01620,2.536382161633542,FUN_006729-T1,Peve_00039560,Pocillopora_meandrina_HIv1___RNAseq.g20015.t1,three_way,68.16666666666667,FUN_006729-T1,O55240,RDH5_MOUSE,,Retinol dehydrogenase 5 (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (11-cis retinol dehydrogenase) (11-cis RDH) (11-cis RoDH) (9-cis retinol dehydrogenase) (Cis-retinol dehydrogenase),Mus musculus (Mouse),44.6,285.0,1.7999999999999994e-68,261.2,sp|O55240|RDH5_MOUSE Retinol dehydrogenase 5 OS=Mus musculus OX=10090 GN=Rdh5 PE=1 SV=1,GO:0001523; GO:0004745; GO:0005788; GO:0005789; GO:0007601; GO:0008202; GO:0042572; GO:0042803; GO:0044297; GO:0047023; GO:0047044; GO:0106429,retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; visual perception [GO:0007601],cell body [GO:0044297]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],"11-cis-retinol dehydrogenase [GO:0106429]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0006629; GO:0016491; GO:0050877,catalytic activity; lipid metabolic process; oxidoreductase activity; nervous system process
OG_01636,2.106379447533632,FUN_006769-T1,Peve_00027411,Pocillopora_meandrina_HIv1___RNAseq.g20028.t1,three_way,57.7305,FUN_006769-T1,Q9Y2U8,MAN1_HUMAN,,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),Homo sapiens (Human),42.9,317.0,7.4e-55,216.9,sp|Q9Y2U8|MAN1_HUMAN Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2,GO:0003677; GO:0005637; GO:0016020; GO:0030512; GO:0030514; GO:0031965; GO:0032926; GO:1990446,negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965],DNA binding [GO:0003677]; U1 snRNP binding [GO:1990446],GO:0003677,DNA binding
OG_01642,2.2896397360223437,FUN_006790-T1,Peve_00028070,Pocillopora_meandrina_HIv1___RNAseq.g20501.t1,three_way,54.868,FUN_006790-T1,P35918,,,,,31.5,961.0,9.8e-99,363.6,sp|P35918|VGFR2_MOUSE Vascular endothelial growth factor receptor 2 OS=Mus musculus OX=10090 GN=Kdr PE=1 SV=2,,,,,,
OG_01645,2.2789048967216967,FUN_006796-T1,Peve_00019185,Pocillopora_meandrina_HIv1___RNAseq.g20496.t1,three_way,33.34466666666667,FUN_006796-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),28.9,287.0,1.3e-17,92.4,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_01656,1.476618751279024,FUN_006826-T1,Peve_00023770,Pocillopora_meandrina_HIv1___RNAseq.g20475.t1,three_way,76.18166666666667,,,,,,,,,,,,,,,,,
OG_01669,1.2710423596840852,FUN_006856-T1,Peve_00016201,Pocillopora_meandrina_HIv1___RNAseq.g19911.t1,three_way,74.561,FUN_006856-T1,P24861,,,,,48.5,454.0,1.7e-95,351.3,sp|P24861|CCNA_PATVU G2/mitotic-specific cyclin-A OS=Patella vulgata OX=6465 PE=2 SV=1,,,,,,
OG_01679,1.0528568889272705,FUN_006889-T1,Peve_00009369,Pocillopora_meandrina_HIv1___RNAseq.g19815.t1,three_way,70.95,FUN_006889-T1,P61328,FGF12_HUMAN,,Fibroblast growth factor 12 (FGF-12) (Fibroblast growth factor homologous factor 1) (FHF-1) (Myocyte-activating factor),Homo sapiens (Human),29.0,131.0,3.1e-16,87.0,sp|P61328|FGF12_HUMAN Fibroblast growth factor 12 OS=Homo sapiens OX=9606 GN=FGF12 PE=1 SV=1,GO:0005615; GO:0005634; GO:0005737; GO:0007165; GO:0007254; GO:0007267; GO:0007268; GO:0007399; GO:0007507; GO:0008083; GO:0008201; GO:0008344; GO:0010765; GO:0017080; GO:0022008; GO:0044325; GO:0045202; GO:0050905; GO:0086002; GO:0098908; GO:1902305; GO:1905150,adult locomotory behavior [GO:0008344]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; heart development [GO:0007507]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuromuscular process [GO:0050905]; positive regulation of sodium ion transport [GO:0010765]; regulation of neuronal action potential [GO:0098908]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; synapse [GO:0045202],growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325],GO:0005615; GO:0005634; GO:0023052; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0050877; GO:0098772,extracellular space; nucleus; signaling; cell differentiation; organelle; receptor ligand activity; anatomical structure development; nervous system process; molecular function regulator activity
OG_01680,2.501882002362809,FUN_006890-T1,Peve_00009370,Pocillopora_meandrina_HIv1___RNAseq.g19814.t1,three_way,60.797666666666665,FUN_006890-T1,Q19791,GON1_CAEEL,,A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1),Caenorhabditis elegans,25.1,338.0,3.3e-18,94.4,sp|Q19791|GON1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs gon-1 OS=Caenorhabditis elegans OX=6239 GN=gon-1 PE=1 SV=3,GO:0004222; GO:0005576; GO:0005604; GO:0005783; GO:0005794; GO:0006508; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0030198; GO:0031012; GO:0048644; GO:1905607,cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]; proteolysis [GO:0006508],basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005783; GO:0005794; GO:0016192; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; endoplasmic reticulum; Golgi apparatus; vesicle-mediated transport; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_01724,1.1749361707068249,FUN_007013-T1,Peve_00021641,Pocillopora_meandrina_HIv1___RNAseq.g20538.t1,three_way,66.045,,,,,,,,,,,,,,,,,
OG_01758,1.2683203213514114,FUN_007101-T2,Peve_00033792,Pocillopora_meandrina_HIv1___RNAseq.g19049.t1a,three_way,71.41833333333334,FUN_007101-T2,Q80T79,CSMD3_MOUSE,,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),Mus musculus (Mouse),37.4,361.0,2.8e-67,259.2,sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3,GO:0005886; GO:0050773,regulation of dendrite development [GO:0050773],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_01788,1.200853235897806,FUN_007166-T1,Peve_00042484,Pocillopora_meandrina_HIv1___RNAseq.g19745.t1,three_way,75.658,FUN_007166-T1,P57695,,,,,37.9,457.0,8.7e-76,285.8,sp|P57695|GLRA1_BOVIN Glycine receptor subunit alpha-1 OS=Bos taurus OX=9913 GN=GLRA1 PE=1 SV=1,,,,,,
OG_01845,1.267531451604314,FUN_007791-T1,Peve_00022040,Pocillopora_meandrina_HIv1___TS.g24621.t1,three_way,47.446,FUN_007791-T1,Q9UHC1,MLH3_HUMAN,,DNA mismatch repair protein Mlh3 (MutL protein homolog 3),Homo sapiens (Human),27.8,1446.0,1.3e-121,439.5,sp|Q9UHC1|MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens OX=9606 GN=MLH3 PE=1 SV=3,GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664,female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130],chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0043226; GO:0098772; GO:0140013; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; hydrolase activity; reproductive process; organelle; molecular function regulator activity; meiotic nuclear division; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01853,1.19950511729013,FUN_007804-T1,Peve_00022057,Pocillopora_meandrina_HIv1___RNAseq.g18346.t1,three_way,62.281666666666666,,,,,,,,,,,,,,,,,
OG_01862,1.4224207956571782,FUN_007821-T1,Peve_00038746,Pocillopora_meandrina_HIv1___RNAseq.g18388.t1,three_way,57.14966666666667,,,,,,,,,,,,,,,,,
OG_01866,1.0929515585017426,FUN_007832-T1,Peve_00003986,Pocillopora_meandrina_HIv1___RNAseq.g29997.t1,three_way,76.73700000000001,FUN_007832-T1,Q7Q107,,,,,61.9,202.0,2.9e-67,256.9,sp|Q7Q107|MED6_ANOGA Mediator of RNA polymerase II transcription subunit 6 OS=Anopheles gambiae OX=7165 GN=MED6 PE=3 SV=3,,,,,,
OG_01868,1.207893701638514,FUN_007834-T1,Peve_00003993,Pocillopora_meandrina_HIv1___RNAseq.g18432.t1b,three_way,72.9755,FUN_007834-T1,Q3UFK8,,,,,35.4,378.0,1.6e-61,238.4,sp|Q3UFK8|FRMD8_MOUSE FERM domain-containing protein 8 OS=Mus musculus OX=10090 GN=Frmd8 PE=1 SV=2,,,,,,
OG_01875,1.505780797204034,FUN_007848-T1,Peve_00039903,Pocillopora_meandrina_HIv1___RNAseq.g18285.t1,three_way,77.36716666666668,FUN_007848-T1,B1ANS9,,,,,38.4,690.0,2.5999999999999997e-135,485.0,sp|B1ANS9|WDR64_HUMAN WD repeat-containing protein 64 OS=Homo sapiens OX=9606 GN=WDR64 PE=1 SV=1,,,,,,
OG_01895,1.1674288598844622,FUN_007895-T1,Peve_00009865,Pocillopora_meandrina_HIv1___RNAseq.g18241.t1a,three_way,47.54166666666666,,,,,,,,,,,,,,,,,
OG_01897,1.5322355546803264,FUN_007904-T1,Peve_00040656,Pocillopora_meandrina_HIv1___RNAseq.g30059.t1,three_way,60.9685,FUN_007904-T1,P06582,,,,,37.0,100.0,1.1e-11,72.0,sp|P06582|HSP12_CAEEL Heat shock protein hsp-16.2 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.2 PE=2 SV=1,,,,,,
OG_01911,1.167022753484873,FUN_007927-T1,Peve_00040689,Pocillopora_meandrina_HIv1___RNAseq.g18108.t1,three_way,68.03966666666666,FUN_007927-T1,Q10AZ7,GPA3_ORYSJ,,Protein GLUTELIN PRECURSOR ACCUMULATION 3,Oryza sativa subsp. japonica (Rice),24.2,194.0,2.9e-12,75.1,sp|Q10AZ7|GPA3_ORYSJ Protein GLUTELIN PRECURSOR ACCUMULATION 3 OS=Oryza sativa subsp. japonica OX=39947 GN=GPA3 PE=1 SV=1,GO:0000325; GO:0000326; GO:0005802; GO:0006886,intracellular protein transport [GO:0006886],plant-type vacuole [GO:0000325]; protein storage vacuole [GO:0000326]; trans-Golgi network [GO:0005802],,GO:0005773; GO:0006886; GO:0043226,vacuole; intracellular protein transport; organelle
OG_01919,1.8614448206043457,FUN_007948-T1,Peve_00044442,Pocillopora_meandrina_HIv1___RNAseq.g18135.t1,three_way,64.81733333333334,FUN_007948-T1,Q3TTY0,PLB1_MOUSE,,"Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3)",Mus musculus (Mouse),39.7,345.0,6.200000000000003e-66,253.4,"sp|Q3TTY0|PLB1_MOUSE Phospholipase B1, membrane-associated OS=Mus musculus OX=10090 GN=Plb1 PE=1 SV=2",GO:0004622; GO:0004806; GO:0016324; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344,diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; positive regulation of acrosome reaction [GO:2000344]; triglyceride catabolic process [GO:0019433],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526],calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_01941,1.6696956167148929,FUN_007993-T1,Peve_00018053,Pocillopora_meandrina_HIv1___RNAseq.g5090.t1,three_way,42.72566666666666,FUN_007993-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),25.9,587.0,7.1e-39,163.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_01952,1.8555551934880976,FUN_008018-T1,Peve_00031314,Pocillopora_meandrina_HIv1___RNAseq.g30339.t1,three_way,80.18366666666667,FUN_008018-T1,P18754,RCC1_HUMAN,,Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1),Homo sapiens (Human),49.0,433.0,2.4e-107,390.6,sp|P18754|RCC1_HUMAN Regulator of chromosome condensation OS=Homo sapiens OX=9606 GN=RCC1 PE=1 SV=1,GO:0000082; GO:0000785; GO:0000794; GO:0003682; GO:0005085; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007052; GO:0007059; GO:0007084; GO:0007088; GO:0007346; GO:0016032; GO:0031267; GO:0031491; GO:0031492; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051301; GO:1901673,cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]; viral process [GO:0016032],chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199],GO:0000228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0007010; GO:0007059; GO:0042393; GO:0043226; GO:0061024; GO:0098772,nuclear chromosome; DNA binding; nucleus; nucleoplasm; chromosome; cytoskeleton organization; chromosome segregation; histone binding; organelle; membrane organization; molecular function regulator activity
OG_01955,1.698057549397756,FUN_008021-T1,Peve_00031303,Pocillopora_meandrina_HIv1___RNAseq.g30342.t1,three_way,69.569,,,,,,,,,,,,,,,,,
OG_01966,1.2028103942961514,FUN_008049-T1,Peve_00045150,Pocillopora_meandrina_HIv1___RNAseq.g30360.t1,three_way,52.505,,,,,,,,,,,,,,,,,
OG_01969,1.047712430905663,FUN_008060-T1,Peve_00017191,Pocillopora_meandrina_HIv1___RNAseq.g17907.t1,three_way,77.13,,,,,,,,,,,,,,,,,
OG_01994,1.4802850733673156,FUN_008103-T1,Peve_00017193,Pocillopora_meandrina_HIv1___RNAseq.g17899.t1,three_way,61.52516666666666,FUN_008103-T1,Q3T1I9,,,,,33.8,1354.0,5.6000000000000005e-182,640.2,sp|Q3T1I9|RPAP1_RAT RNA polymerase II-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Rpap1 PE=1 SV=1,,,,,,
OG_01995,1.232382563792918,FUN_008104-T1,Peve_00019588,Pocillopora_meandrina_HIv1___RNAseq.g17898.t1,three_way,90.90516666666667,FUN_008104-T1,O57521,HS90B_DANRE,,Heat shock protein HSP 90-beta,Danio rerio (Zebrafish) (Brachydanio rerio),82.0,727.0,2.3e-304,1045.8,sp|O57521|HS90B_DANRE Heat shock protein HSP 90-beta OS=Danio rerio OX=7955 GN=hsp90ab1 PE=1 SV=2,GO:0001568; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007517; GO:0016887; GO:0030511; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0043627; GO:0046983; GO:0048471; GO:0050821; GO:0050900; GO:0051082; GO:0051726; GO:0120293; GO:0140662; GO:0141069,blood vessel development [GO:0001568]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; response to estrogen [GO:0043627],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; receptor ligand inhibitor activity [GO:0141069]; unfolded protein binding [GO:0051082],GO:0002376; GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0048856; GO:0048870; GO:0098772; GO:0140657,immune system process; catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; protein folding; hydrolase activity; organelle; protein folding chaperone; anatomical structure development; cell motility; molecular function regulator activity; ATP-dependent activity
OG_02000,2.855220419747418,FUN_008111-T1,Peve_00022340,Pocillopora_meandrina_HIv1___RNAseq.g17893.t1,three_way,53.2585,FUN_008111-T1,B3EWY9,,,,,33.3,1402.0,3.9e-139,498.4,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02004,1.1420747410155545,FUN_008119-T1,Peve_00022345,Pocillopora_meandrina_HIv1___RNAseq.g17886.t1,three_way,94.39433333333334,,,,,,,,,,,,,,,,,
OG_02012,1.6673263843142638,FUN_008185-T1,Peve_00018749,Pocillopora_meandrina_HIv1___RNAseq.g29992.t1,three_way,52.86033333333334,FUN_008185-T1,O57382,,,,,29.0,317.0,5.399999999999999e-31,137.5,sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1,,,,,,
OG_02039,1.45042426552222,FUN_008244-T1,Peve_00031788,Pocillopora_meandrina_HIv1___RNAseq.g17947.t1,three_way,64.75966666666667,FUN_008244-T1,P47747,,,,,30.3,333.0,3.8e-23,110.5,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_02040,1.5686984537626258,FUN_008245-T1,Peve_00031789,Pocillopora_meandrina_HIv1___RNAseq.g17949.t1,three_way,80.146,,,,,,,,,,,,,,,,,
OG_02043,1.1500292473513591,FUN_008248-T1,Peve_00031792,Pocillopora_meandrina_HIv1___RNAseq.g17952.t2,three_way,55.662,FUN_008248-T1,P83618,,,,,25.9,185.0,9.7e-14,78.6,sp|P83618|RN28_PANGI Ribonuclease-like storage protein OS=Panax ginseng OX=4054 PE=1 SV=2,,,,,,
OG_02090,2.44995562790997,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02093,1.353611684445425,FUN_008333-T1,Peve_00040480,Pocillopora_meandrina_HIv1___RNAseq.g5440.t1,three_way,84.943,FUN_008333-T1,O15160,,,,,63.2,261.0,9.3e-97,354.8,sp|O15160|RPAC1_HUMAN DNA-directed RNA polymerases I and III subunit RPAC1 OS=Homo sapiens OX=9606 GN=POLR1C PE=1 SV=1,,,,,,
OG_02094,1.9291109970915907,FUN_008365-T1,Peve_00005520,Pocillopora_meandrina_HIv1___RNAseq.g5716.t1,three_way,73.69866666666667,FUN_008365-T1,H9J9M0,,,,,27.5,258.0,2.9e-20,100.5,sp|H9J9M0|CDA1_BOMMO Chitin deacetylase 1 OS=Bombyx mori OX=7091 GN=CDA1 PE=1 SV=1,,,,,,
OG_02101,2.7322898393848227,FUN_008377-T1,Peve_00024686,Pocillopora_meandrina_HIv1___RNAseq.g18396.t1,three_way,53.3375,,,,,,,,,,,,,,,,,
OG_02103,1.508365954108521,FUN_008382-T1,Peve_00002119,Pocillopora_meandrina_HIv1___TS.g21432.t1,three_way,43.963,FUN_008382-T1,Q9Y3Q0,NALD2_HUMAN,,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),Homo sapiens (Human),31.3,747.0,3.3999999999999998e-68,261.2,sp|Q9Y3Q0|NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens OX=9606 GN=NAALAD2 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129,carboxylic acid catabolic process [GO:0046395]; proteolysis [GO:0006508],membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_02112,1.5372896165918055,FUN_008397-T1,Peve_00043603,Pocillopora_meandrina_HIv1___RNAseq.g6179.t1,three_way,31.29733333333333,FUN_008397-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),35.4,99.0,4.4e-07,60.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_02145,1.158920115382772,FUN_008451-T1,Peve_00015483,Pocillopora_meandrina_HIv1___RNAseq.g18071.t1,three_way,76.60533333333333,,,,,,,,,,,,,,,,,
OG_02180,1.1585070559885553,FUN_008531-T1,Peve_00011876,Pocillopora_meandrina_HIv1___RNAseq.g14744.t1,three_way,54.064,,,,,,,,,,,,,,,,,
OG_02184,1.3532013665792844,FUN_008537-T1,Peve_00044625,Pocillopora_meandrina_HIv1___RNAseq.g14737.t1,three_way,73.81949999999999,FUN_008537-T1,Q7Z6B7,SRGP1_HUMAN,,SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13),Homo sapiens (Human),33.9,834.0,3.3e-120,434.5,sp|Q7Z6B7|SRGP1_HUMAN SLIT-ROBO Rho GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=SRGAP1 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005829; GO:0007266; GO:0016477; GO:0030336; GO:0031267,cell migration [GO:0016477]; negative regulation of cell migration [GO:0030336]; Rho protein signal transduction [GO:0007266],cytoplasm [GO:0005737]; cytosol [GO:0005829],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005829; GO:0048870; GO:0098772,cytosol; cell motility; molecular function regulator activity
OG_02190,1.0766099331461063,FUN_008544-T1,Peve_00013775,Pocillopora_meandrina_HIv1___RNAseq.g6331.t2,three_way,81.17266666666667,FUN_008544-T1,Q99MD6,TRXR3_MOUSE,,Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2),Mus musculus (Mouse),60.5,588.0,1.7000000000000002e-209,730.3,sp|Q99MD6|TRXR3_MOUSE Thioredoxin reductase 3 OS=Mus musculus OX=10090 GN=Txnrd3 PE=1 SV=3,GO:0001825; GO:0004791; GO:0005634; GO:0005783; GO:0006749; GO:0007283; GO:0030154; GO:0045454; GO:0050660,blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],flavin adenine dinucleotide binding [GO:0050660]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005634; GO:0005783; GO:0006575; GO:0006790; GO:0016209; GO:0016491; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; modified amino acid metabolic process; sulfur compound metabolic process; antioxidant activity; oxidoreductase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_02201,1.6851656899985752,FUN_008576-T1,Peve_00044725,Pocillopora_meandrina_HIv1___RNAseq.g12787.t1,three_way,63.60733333333333,,,,,,,,,,,,,,,,,
OG_02212,1.1457676392224745,FUN_008594-T1,Peve_00002263,Pocillopora_meandrina_HIv1___RNAseq.g12762.t1,three_way,68.02633333333334,FUN_008594-T1,P02469,LAMB1_MOUSE,,Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta),Mus musculus (Mouse),43.3,1409.0,5.4e-246,853.2,sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3,GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007566; GO:0007611; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0051149; GO:0062023; GO:0098637; GO:0110011; GO:2001046,cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637],enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178],GO:0005198; GO:0005576; GO:0005615; GO:0005634; GO:0007155; GO:0008289; GO:0022414; GO:0030154; GO:0030312; GO:0031012; GO:0043226; GO:0048870; GO:0050877,structural molecule activity; extracellular region; extracellular space; nucleus; cell adhesion; lipid binding; reproductive process; cell differentiation; external encapsulating structure; extracellular matrix; organelle; cell motility; nervous system process
OG_02216,1.0376515360869718,FUN_008605-T1,Peve_00020826,Pocillopora_meandrina_HIv1___RNAseq.g12755.t1,three_way,59.71116666666666,FUN_008605-T1,Q4V8X0,,,,,39.7,267.0,3e-41,170.6,sp|Q4V8X0|TPRA1_DANRE Transmembrane protein adipocyte-associated 1 homolog OS=Danio rerio OX=7955 GN=tpra1 PE=2 SV=1,,,,,,
OG_02226,2.8955828202210903,FUN_008631-T1,Peve_00012388,Pocillopora_meandrina_HIv1___RNAseq.g14912.t1,three_way,62.56166666666666,,,,,,,,,,,,,,,,,
OG_02227,1.0076455942291245,FUN_008633-T1,Peve_00012386,Pocillopora_meandrina_HIv1___RNAseq.g14915.t1,three_way,74.2705,FUN_008633-T1,Q8VDT1,,,,,45.9,573.0,4.5e-140,500.0,sp|Q8VDT1|SC5A9_MOUSE Sodium/glucose cotransporter 4 OS=Mus musculus OX=10090 GN=Slc5a9 PE=1 SV=3,,,,,,
OG_02252,1.2901101851849857,FUN_008697-T1,Peve_00045001,Pocillopora_meandrina_HIv1___RNAseq.g26978.t1,three_way,53.163833333333336,,,,,,,,,,,,,,,,,
OG_02280,1.2592044495807264,FUN_008772-T1,Peve_00036716,Pocillopora_meandrina_HIv1___RNAseq.g12702.t1,three_way,55.00416666666666,FUN_008772-T1,P30974,,,,,26.0,412.0,1.6e-18,95.9,sp|P30974|TLR1_DROME Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2,,,,,,
OG_02288,1.9132703414279195,FUN_008795-T1,Peve_00042598,Pocillopora_meandrina_HIv1___RNAseq.g12685.t1a,three_way,70.187,FUN_008795-T1,Q8IYQ7,,,,,47.4,685.0,3.8e-168,593.2,sp|Q8IYQ7|THNS1_HUMAN Threonine synthase-like 1 OS=Homo sapiens OX=9606 GN=THNSL1 PE=1 SV=2,,,,,,
OG_02289,1.8803533583782088,FUN_008798-T1,Peve_00042590,Pocillopora_meandrina_HIv1___RNAseq.g54.t1,three_way,49.41266666666667,,,,,,,,,,,,,,,,,
OG_02294,2.2260233473073674,FUN_008872-T1,Peve_00000784,Pocillopora_meandrina_HIv1___RNAseq.g4010.t1,three_way,45.396166666666666,,,,,,,,,,,,,,,,,
OG_02311,1.1291320887369076,FUN_008898-T1,Peve_00041461,Pocillopora_meandrina_HIv1___RNAseq.g3963.t1,three_way,52.316500000000005,FUN_008898-T1,Q2EMV9,PAR14_MOUSE,,Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14),Mus musculus (Mouse),31.0,775.0,1.8e-87,326.6,sp|Q2EMV9|PAR14_MOUSE Protein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3,GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019899; GO:0045087; GO:0060336; GO:0140807; GO:1902216; GO:1990404,innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_02317,1.076331691130909,FUN_008908-T1,Peve_00017912,Pocillopora_meandrina_HIv1___TS.g30016.t1,three_way,61.309333333333335,FUN_008908-T1,G8HTB6,,,,,95.7,349.0,1.3e-187,657.1,sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02325,1.1347926120003056,FUN_008917-T1,Peve_00033005,Pocillopora_meandrina_HIv1___RNAseq.g3982.t1,three_way,74.89333333333333,FUN_008917-T1,Q6V5K9,,,,,46.8,269.0,1e-59,232.6,sp|Q6V5K9|ZN474_MOUSE Zinc finger protein 474 OS=Mus musculus OX=10090 GN=Znf474 PE=2 SV=2,,,,,,
OG_02336,1.2813209855236978,FUN_008931-T1,Peve_00036391,Pocillopora_meandrina_HIv1___RNAseq.g14259.t1,three_way,74.031,FUN_008931-T1,Q8BSY0,ASPH_MOUSE,,Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase),Mus musculus (Mouse),55.5,429.0,5.6e-143,509.2,sp|Q8BSY0|ASPH_MOUSE Aspartyl/asparaginyl beta-hydroxylase OS=Mus musculus OX=10090 GN=Asph PE=1 SV=1,GO:0005737; GO:0005886; GO:0007389; GO:0008283; GO:0008285; GO:0016020; GO:0031647; GO:0032541; GO:0033017; GO:0035108; GO:0045862; GO:0046872; GO:0060021; GO:0060325; GO:0062101; GO:1901879,cell population proliferation [GO:0008283]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; positive regulation of proteolysis [GO:0045862]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; roof of mouth development [GO:0060021],cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017],metal ion binding [GO:0046872]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101],GO:0003824; GO:0005886; GO:0016491; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; oxidoreductase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_02338,2.05253434122773,FUN_008934-T1,Peve_00036402,Pocillopora_meandrina_HIv1___RNAseq.g14257.t1,three_way,76.08966666666667,FUN_008934-T1,A5D7I4,EXT1_BOVIN,,Exostosin-1 (EC 2.4.1.225) (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase),Bos taurus (Bovine),50.3,749.0,7.999999999999999e-217,755.0,sp|A5D7I4|EXT1_BOVIN Exostosin-1 OS=Bos taurus OX=9913 GN=EXT1 PE=2 SV=1,GO:0000139; GO:0000271; GO:0001958; GO:0001974; GO:0002067; GO:0002524; GO:0003128; GO:0003415; GO:0003416; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0007033; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008375; GO:0008543; GO:0009642; GO:0010467; GO:0010803; GO:0014033; GO:0015012; GO:0015020; GO:0017145; GO:0019882; GO:0021554; GO:0021772; GO:0030163; GO:0030199; GO:0030210; GO:0030509; GO:0031069; GO:0032836; GO:0033627; GO:0035176; GO:0035249; GO:0035264; GO:0035988; GO:0036022; GO:0036336; GO:0036339; GO:0042044; GO:0042060; GO:0042311; GO:0042596; GO:0042803; GO:0043931; GO:0045165; GO:0045202; GO:0045453; GO:0046872; GO:0046982; GO:0048733; GO:0050508; GO:0050509; GO:0050891; GO:0050901; GO:0051923; GO:0055078; GO:0060047; GO:0060070; GO:0060218; GO:0060351; GO:0060441; GO:0060506; GO:0060560; GO:0060792; GO:0061484; GO:0061744; GO:0061974; GO:0062094; GO:0065003; GO:0070593; GO:0071503; GO:0071625; GO:0071711; GO:0072112; GO:0072498; GO:0097021; GO:0097241; GO:0098586; GO:0120193; GO:1901706; GO:1902494; GO:1904888; GO:1990823,"antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; glycosaminoglycan biosynthetic process [GO:0006024]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal-level water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; polysaccharide biosynthetic process [GO:0000271]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]",catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; synapse [GO:0045202],acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003013; GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006790; GO:0006954; GO:0007155; GO:0009101; GO:0016740; GO:0023052; GO:0030154; GO:0030163; GO:0030198; GO:0034330; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0065003; GO:1901135,immune system process; circulatory system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; sulfur compound metabolic process; inflammatory response; cell adhesion; glycoprotein biosynthetic process; transferase activity; signaling; cell differentiation; protein catabolic process; extracellular matrix organization; cell junction organization; wound healing; organelle; anatomical structure development; cell motility; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_02341,2.3488328787221837,FUN_008940-T1,Peve_00007194,Pocillopora_meandrina_HIv1___TS.g30103.t1,three_way,71.29533333333333,FUN_008940-T1,P31422,GRM3_RAT,,Metabotropic glutamate receptor 3 (mGluR3),Rattus norvegicus (Rat),41.0,808.0,1.2999999999999998e-173,611.7,sp|P31422|GRM3_RAT Metabotropic glutamate receptor 3 OS=Rattus norvegicus OX=10116 GN=Grm3 PE=1 SV=1,GO:0001641; GO:0005246; GO:0005886; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170,"cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]",astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110],GO:0005886; GO:0043226; GO:0050877; GO:0060089; GO:0098772,plasma membrane; organelle; nervous system process; molecular transducer activity; molecular function regulator activity
OG_02348,1.0552868722525912,FUN_008949-T1,Peve_00011191,Pocillopora_meandrina_HIv1___RNAseq.g4054.t1,three_way,69.88833333333334,FUN_008949-T1,Q2TAA2,IAH1_HUMAN,,Isoamyl acetate-hydrolyzing esterase 1 homolog (EC 3.1.-.-),Homo sapiens (Human),38.6,233.0,6.6e-44,179.1,sp|Q2TAA2|IAH1_HUMAN Isoamyl acetate-hydrolyzing esterase 1 homolog OS=Homo sapiens OX=9606 GN=IAH1 PE=1 SV=1,GO:0010467; GO:0016042; GO:0016788; GO:0042802,gene expression [GO:0010467]; lipid catabolic process [GO:0016042],,"hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]",GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_02354,1.069878176573664,FUN_008956-T1,Peve_00021626,Pocillopora_meandrina_HIv1___RNAseq.g4047.t1,three_way,86.82350000000001,FUN_008956-T1,Q9NV58,,,,,68.9,360.0,7.5e-154,545.4,sp|Q9NV58|RN19A_HUMAN E3 ubiquitin-protein ligase RNF19A OS=Homo sapiens OX=9606 GN=RNF19A PE=1 SV=3,,,,,,
OG_02395,1.5330201593216368,FUN_009023-T1,Peve_00044350,Pocillopora_meandrina_HIv1___RNAseq.g3942.t1,three_way,93.496,FUN_009023-T1,Q92519,TRIB2_HUMAN,,Tribbles homolog 2 (TRB-2),Homo sapiens (Human),54.1,338.0,2.2000000000000001e-100,367.1,sp|Q92519|TRIB2_HUMAN Tribbles homolog 2 OS=Homo sapiens OX=9606 GN=TRIB2 PE=1 SV=1,GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106; GO:0061629,negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634],mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106],GO:0005634; GO:0005856; GO:0043226; GO:0098772,nucleus; cytoskeleton; organelle; molecular function regulator activity
OG_02403,1.2023006376120629,FUN_009044-T1,Peve_00002709,Pocillopora_meandrina_HIv1___RNAseq.g14411.t2,three_way,67.5345,FUN_009044-T1,O35604,NPC1_MOUSE,,NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein),Mus musculus (Mouse),48.0,1270.0,1.3e-312,1073.5,sp|O35604|NPC1_MOUSE NPC intracellular cholesterol transporter 1 OS=Mus musculus OX=10090 GN=Npc1 PE=1 SV=2,GO:0001889; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0009410; GO:0010467; GO:0010878; GO:0012501; GO:0015485; GO:0015918; GO:0016020; GO:0016125; GO:0016236; GO:0016242; GO:0022008; GO:0030301; GO:0031579; GO:0031902; GO:0031982; GO:0032365; GO:0032367; GO:0033344; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0051649; GO:0071383; GO:0071404; GO:0090150; GO:0120020; GO:1904036; GO:1904262; GO:2000900,adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; cholesterol transport [GO:0030301]; cyclodextrin metabolic process [GO:2000900]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intracellular cholesterol transport [GO:0032367]; intracellular lipid transport [GO:0032365]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; macroautophagy [GO:0016236]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TORC1 signaling [GO:1904262]; neurogenesis [GO:0022008]; programmed cell death [GO:0012501]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; sterol metabolic process [GO:0016125]; sterol transport [GO:0015918]; symbiont entry into host cell [GO:0046718],endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982],cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020],GO:0005215; GO:0005576; GO:0005635; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0005975; GO:0006486; GO:0006629; GO:0006914; GO:0008289; GO:0012501; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0061024,transporter activity; extracellular region; nuclear envelope; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; carbohydrate metabolic process; protein glycosylation; lipid metabolic process; autophagy; lipid binding; programmed cell death; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; membrane organization
OG_02439,2.4871598947786,FUN_009459-T2,Peve_00010355,Pocillopora_meandrina_HIv1___RNAseq.g25133.t1,three_way,61.281333333333336,FUN_009459-T2,Q24JV9,,,,,58.1,105.0,3.1999999999999997e-31,139.0,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_02443,1.2859506312136275,FUN_009512-T1,Peve_00040630,Pocillopora_meandrina_HIv1___TS.g24209.t1,three_way,57.00666666666667,FUN_009512-T1,A6LX31,,,,,46.4,252.0,2.1e-56,221.5,sp|A6LX31|Y2760_CLOB8 Putative hydro-lyase Cbei_2760 OS=Clostridium beijerinckii (strain ATCC 51743 / NCIMB 8052) OX=290402 GN=Cbei_2760 PE=3 SV=1,,,,,,
OG_02451,1.0165913026589173,FUN_009528-T1,Peve_00014183,Pocillopora_meandrina_HIv1___RNAseq.g24497.t1,three_way,84.42966666666666,,,,,,,,,,,,,,,,,
OG_02473,1.313793448707362,FUN_009675-T1,Peve_00009262,Pocillopora_meandrina_HIv1___RNAseq.g24569.t1,three_way,75.73666666666666,FUN_009675-T1,Q8K078,SO4A1_MOUSE,,Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12),Mus musculus (Mouse),38.1,637.0,2.3e-114,414.5,sp|Q8K078|SO4A1_MOUSE Solute carrier organic anion transporter family member 4A1 OS=Mus musculus OX=10090 GN=Slco4a1 PE=1 SV=2,GO:0005886; GO:0006811; GO:0008514; GO:0015132; GO:0015711,monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711],plasma membrane [GO:0005886],organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_02484,1.535507457412135,FUN_009778-T1,Peve_00026798,Pocillopora_meandrina_HIv1___RNAseq.g24554.t1,three_way,71.61233333333334,FUN_009778-T1,P41216,,,,,47.2,642.0,8e-176,618.6,sp|P41216|ACSL1_MOUSE Long-chain-fatty-acid--CoA ligase 1 OS=Mus musculus OX=10090 GN=Acsl1 PE=1 SV=2,,,,,,
OG_02487,1.0171896017704631,FUN_009819-T1,Peve_00042915,Pocillopora_meandrina_HIv1___RNAseq.g24549.t1,three_way,82.49433333333333,FUN_009819-T1,Q711T7,NADE_MOUSE,,Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase) (NH3-dependent NAD(+) synthetase-like protein),Mus musculus (Mouse),68.4,708.0,4.4e-291,1001.9,sp|Q711T7|NADE_MOUSE Glutamine-dependent NAD(+) synthetase OS=Mus musculus OX=10090 GN=Nadsyn1 PE=1 SV=1,GO:0003952; GO:0004359; GO:0005524; GO:0005829; GO:0008795; GO:0009435; GO:0034354; GO:0034355,'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; NAD biosynthetic process [GO:0009435]; NAD biosynthetic process via the salvage pathway [GO:0034355],cytosol [GO:0005829],ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD+ synthase activity [GO:0008795],GO:0003824; GO:0005829; GO:0006520; GO:0016787; GO:0016874; GO:0055086,catalytic activity; cytosol; amino acid metabolic process; hydrolase activity; ligase activity; nucleobase-containing small molecule metabolic process
OG_02498,1.1721787767191756,FUN_009837-T1,Peve_00000550,Pocillopora_meandrina_HIv1___RNAseq.g24514.t1,three_way,66.32433333333333,FUN_009837-T1,Q7PIR5,,,,,34.9,461.0,2.1e-83,311.2,sp|Q7PIR5|TRET1_ANOGA Facilitated trehalose transporter Tret1 OS=Anopheles gambiae OX=7165 GN=Tret1 PE=1 SV=3,,,,,,
OG_02501,1.371640474205737,FUN_009856-T1,Peve_00009092,Pocillopora_meandrina_HIv1___RNAseq.g24507.t1,three_way,69.30833333333334,,,,,,,,,,,,,,,,,
OG_02504,1.3845150813597833,FUN_009960-T1,Peve_00007862,Pocillopora_meandrina_HIv1___RNAseq.g15623.t1b,three_way,73.25516666666667,,,,,,,,,,,,,,,,,
OG_02540,1.3056168553299523,FUN_010623-T1,Peve_00004505,Pocillopora_meandrina_HIv1___RNAseq.g21294.t1,three_way,68.17916666666667,FUN_010623-T1,Q91VZ6,SMAP1_MOUSE,,Stromal membrane-associated protein 1,Mus musculus (Mouse),63.0,138.0,4.2999999999999996e-46,187.2,sp|Q91VZ6|SMAP1_MOUSE Stromal membrane-associated protein 1 OS=Mus musculus OX=10090 GN=Smap1 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005886; GO:0008270; GO:0030276; GO:0045648; GO:2000369,positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005886; GO:0098772,plasma membrane; molecular function regulator activity
OG_02548,1.3009590618660103,FUN_010635-T1,Peve_00009633,Pocillopora_meandrina_HIv1___RNAseq.g21307.t2,three_way,60.11416666666666,FUN_010635-T1,P07996,TSP1_HUMAN,,Thrombospondin-1 (Glycoprotein G),Homo sapiens (Human),59.6,525.0,5.4e-56,221.5,sp|P07996|TSP1_HUMAN Thrombospondin-1 OS=Homo sapiens OX=9606 GN=THBS1 PE=1 SV=2,GO:0001666; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002020; GO:0002040; GO:0002544; GO:0002581; GO:0002605; GO:0004866; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0006915; GO:0006954; GO:0006955; GO:0006986; GO:0007155; GO:0008201; GO:0008284; GO:0008285; GO:0009410; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0031093; GO:0032026; GO:0032570; GO:0032693; GO:0032695; GO:0032720; GO:0032760; GO:0032914; GO:0033574; GO:0034605; GO:0034976; GO:0038060; GO:0040037; GO:0042327; GO:0042803; GO:0043032; GO:0043066; GO:0043236; GO:0043394; GO:0043410; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048661; GO:0050431; GO:0050921; GO:0051592; GO:0051895; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0070062; GO:0071356; GO:0071363; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027; GO:2001237,apoptotic process [GO:0006915]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide-cGMP-mediated signaling [GO:0038060]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phosphorylation [GO:0042327]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040],cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141],calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; endopeptidase inhibitor activity [GO:0004866]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431],GO:0002376; GO:0005198; GO:0005576; GO:0005615; GO:0005783; GO:0006954; GO:0007155; GO:0008289; GO:0012501; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048870; GO:0061024; GO:0098772,immune system process; structural molecule activity; extracellular region; extracellular space; endoplasmic reticulum; inflammatory response; cell adhesion; lipid binding; programmed cell death; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; cell motility; membrane organization; molecular function regulator activity
OG_02574,1.037021142361803,FUN_010680-T1,Peve_00044789,Pocillopora_meandrina_HIv1___RNAseq.g21344.t1,three_way,49.747,,,,,,,,,,,,,,,,,
OG_02622,1.0129822695453177,FUN_010769-T1,Peve_00004500,Pocillopora_meandrina_HIv1___RNAseq.g21287.t1,three_way,72.27866666666667,FUN_010769-T1,F1MV99,,,,,25.5,286.0,3.5e-11,70.9,sp|F1MV99|SSR5_BOVIN Somatostatin receptor type 5 OS=Bos taurus OX=9913 GN=SSTR5 PE=3 SV=2,,,,,,
OG_02633,1.3171608174810288,FUN_010786-T1,Peve_00014207,Pocillopora_meandrina_HIv1___RNAseq.g21213.t1,three_way,53.632,,,,,,,,,,,,,,,,,
OG_02638,1.4222399183549677,FUN_010805-T1,Peve_00006505,Pocillopora_meandrina_HIv1___RNAseq.g26670.t1,three_way,61.43866666666667,FUN_010805-T1,P31228,OXDD_BOVIN,,D-aspartate oxidase (DASOX) (DASPO) (DDO) (EC 1.4.3.1),Bos taurus (Bovine),26.8,406.0,3.7999999999999995e-24,114.0,sp|P31228|OXDD_BOVIN D-aspartate oxidase OS=Bos taurus OX=9913 GN=DDO PE=1 SV=3,GO:0005737; GO:0005782; GO:0005829; GO:0008445; GO:0019478; GO:0047821; GO:0050877; GO:0071949,D-amino acid catabolic process [GO:0019478]; nervous system process [GO:0050877],cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782],D-aspartate oxidase activity [GO:0008445]; D-glutamate oxidase activity [GO:0047821]; FAD binding [GO:0071949],GO:0003824; GO:0005829; GO:0006520; GO:0016491; GO:0050877,catalytic activity; cytosol; amino acid metabolic process; oxidoreductase activity; nervous system process
OG_02656,1.0178595173512537,FUN_010839-T1,Peve_00014584,Pocillopora_meandrina_HIv1___RNAseq.g21009.t1,three_way,68.30383333333333,FUN_010839-T1,Q8TAC1,,,,,46.9,128.0,1.1000000000000001e-30,134.4,sp|Q8TAC1|RFESD_HUMAN Rieske domain-containing protein OS=Homo sapiens OX=9606 GN=RFESD PE=1 SV=1,,,,,,
OG_02671,1.2629027337259924,FUN_010896-T1,Peve_00044943,Pocillopora_meandrina_HIv1___RNAseq.g20992.t1,three_way,75.72,FUN_010896-T1,Q10075,PCS_SCHPO,,Glutathione gamma-glutamylcysteinyltransferase (EC 2.3.2.15) (Phytochelatin synthase),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),44.3,235.0,1.8e-53,211.1,sp|Q10075|PCS_SCHPO Glutathione gamma-glutamylcysteinyltransferase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC3H1.10 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0010273; GO:0016756; GO:0046870; GO:0046938; GO:0071276; GO:0098849,cellular detoxification of cadmium ion [GO:0098849]; cellular response to cadmium ion [GO:0071276]; detoxification of copper ion [GO:0010273]; phytochelatin biosynthetic process [GO:0046938],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],cadmium ion binding [GO:0046870]; glutathione gamma-glutamylcysteinyltransferase activity [GO:0016756],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0098754,catalytic activity; nucleus; cytosol; transferase activity; organelle; detoxification
OG_02676,1.231410401657256,FUN_010925-T1,Peve_00005955,Pocillopora_meandrina_HIv1___RNAseq.g21797.t1,three_way,57.31033333333333,,,,,,,,,,,,,,,,,
OG_02692,1.1340456996843142,FUN_010955-T1,Peve_00015012,Pocillopora_meandrina_HIv1___RNAseq.g21823.t1,three_way,51.78366666666667,,,,,,,,,,,,,,,,,
OG_02695,1.0884544380944896,FUN_010959-T1,Peve_00007919,Pocillopora_meandrina_HIv1___RNAseq.g21826.t1,three_way,37.18416666666666,,,,,,,,,,,,,,,,,
OG_02712,1.2751407094403449,FUN_010990-T1,Peve_00013396,Pocillopora_meandrina_HIv1___TS.g29847.t1,three_way,54.55116666666667,FUN_010990-T1,Q6J4K2,NCLX_HUMAN,,"Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)",Homo sapiens (Human),39.1,539.0,1.6e-99,365.2,sp|Q6J4K2|NCLX_HUMAN Mitochondrial sodium/calcium exchanger protein OS=Homo sapiens OX=9606 GN=SLC8B1 PE=1 SV=2,GO:0005432; GO:0005739; GO:0005743; GO:0005886; GO:0006811; GO:0006851; GO:0006874; GO:0015368; GO:0016020; GO:0030061; GO:0031966; GO:0042383; GO:0042593; GO:0042803; GO:0050796; GO:0051480; GO:0051560; GO:0086036; GO:0086038; GO:0099093; GO:1901623; GO:2001256,calcium export from the mitochondrion [GO:0099093]; glucose homeostasis [GO:0042593]; intracellular calcium ion homeostasis [GO:0006874]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; monoatomic ion transport [GO:0006811]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256],membrane [GO:0016020]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],calcium:monoatomic cation antiporter activity [GO:0015368]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; protein homodimerization activity [GO:0042803],GO:0005215; GO:0005739; GO:0005886; GO:0043226; GO:0055085,transporter activity; mitochondrion; plasma membrane; organelle; transmembrane transport
OG_02718,2.40624146804982,FUN_011001-T1,Peve_00013415,Pocillopora_meandrina_HIv1___RNAseq.g22019.t1,three_way,62.246,FUN_011001-T1,A8WFU8,KIF22_DANRE,,Kinesin-like protein KIF22,Danio rerio (Zebrafish) (Brachydanio rerio),41.6,632.0,3.4e-120,433.7,sp|A8WFU8|KIF22_DANRE Kinesin-like protein KIF22 OS=Danio rerio OX=7955 GN=kif22 PE=2 SV=1,GO:0001756; GO:0001966; GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0007409; GO:0007420; GO:0008017; GO:0016887; GO:0021952; GO:0048592,axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; eye morphogenesis [GO:0048592]; microtubule-based movement [GO:0007018]; somitogenesis [GO:0001756]; thigmotaxis [GO:0001966],cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003677; GO:0003774; GO:0003824; GO:0005634; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0140657,DNA binding; cytoskeletal motor activity; catalytic activity; nucleus; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; anatomical structure development; ATP-dependent activity
OG_02754,1.35726947914355,FUN_011684-T1,Peve_00027010,Pocillopora_meandrina_HIv1___RNAseq.g23917.t1b,three_way,67.25733333333334,FUN_011684-T1,Q9KX40,,,,,31.0,187.0,4.1e-13,78.2,sp|Q9KX40|ESTB_BURGA Esterase EstB OS=Burkholderia gladioli OX=28095 GN=estB PE=1 SV=1,,,,,,
OG_02770,1.3027062032404264,FUN_011709-T1,Peve_00025138,Pocillopora_meandrina_HIv1___RNAseq.g23817.t1,three_way,57.62166666666666,,,,,,,,,,,,,,,,,
OG_02805,1.207622788482781,FUN_011776-T1,Peve_00006118,Pocillopora_meandrina_HIv1___RNAseq.g23292.t1,three_way,81.48183333333333,FUN_011776-T1,Q01196,RUNX1_HUMAN,,Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit),Homo sapiens (Human),48.8,320.0,7.1e-71,269.6,sp|Q01196|RUNX1_HUMAN Runt-related transcription factor 1 OS=Homo sapiens OX=9606 GN=RUNX1 PE=1 SV=3,GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001503; GO:0002062; GO:0002573; GO:0003677; GO:0003700; GO:0005509; GO:0005524; GO:0005634; GO:0005654; GO:0006357; GO:0010755; GO:0016513; GO:0030097; GO:0030099; GO:0030182; GO:0030853; GO:0030854; GO:0032743; GO:0032967; GO:0042803; GO:0043231; GO:0043371; GO:0043378; GO:0045595; GO:0045766; GO:0045893; GO:0045944; GO:0046982; GO:0048935; GO:0060043; GO:0061026; GO:0071425; GO:0140297; GO:1903055; GO:1905203,"cardiac muscle tissue regeneration [GO:0061026]; chondrocyte differentiation [GO:0002062]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell differentiation [GO:0045595]; regulation of connective tissue replacement [GO:1905203]; regulation of plasminogen activation [GO:0010755]; regulation of transcription by RNA polymerase II [GO:0006357]",chromatin [GO:0000785]; core-binding factor complex [GO:0016513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02807,1.153977520841897,FUN_011778-T1,Peve_00006120,Pocillopora_meandrina_HIv1___RNAseq.g23294.t1,three_way,92.68933333333334,FUN_011778-T1,Q80Y75,DJB13_MOUSE,,DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein),Mus musculus (Mouse),63.5,315.0,1.6e-116,420.6,sp|Q80Y75|DJB13_MOUSE DnaJ homolog subfamily B member 13 OS=Mus musculus OX=10090 GN=Dnajb13 PE=1 SV=1,GO:0001534; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0006457; GO:0007618; GO:0030317; GO:0031514; GO:0036126; GO:0051082; GO:0097729; GO:0120212; GO:1904158,axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; protein folding [GO:0006457],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126]; sperm head-tail coupling apparatus [GO:0120212],unfolded protein binding [GO:0051082],GO:0005576; GO:0005929; GO:0006457; GO:0007018; GO:0022414; GO:0043226; GO:0048870,extracellular region; cilium; protein folding; microtubule-based movement; reproductive process; organelle; cell motility
OG_02811,1.0112122976243971,FUN_011794-T1,Peve_00034591,Pocillopora_meandrina_HIv1___RNAseq.g23258.t1a,three_way,52.43483333333333,,,,,,,,,,,,,,,,,
OG_02828,1.091869944122894,FUN_011843-T1,Peve_00034373,Pocillopora_meandrina_HIv1___RNAseq.g23373.t1,three_way,84.43299999999999,FUN_011843-T1,Q9SEE4,,,,,41.8,297.0,9.3e-61,235.3,sp|Q9SEE4|PIRL_SOLLC Pirin-like protein OS=Solanum lycopersicum OX=4081 PE=2 SV=1,,,,,,
OG_02836,1.388599808109761,FUN_011855-T1,Peve_00034401,Pocillopora_meandrina_HIv1___RNAseq.g23382.t1,three_way,65.68350000000001,FUN_011855-T1,Q5R673,RIOX2_PONAB,,Ribosomal oxygenase 2 (Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA) (EC 1.14.11.79) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),33.7,409.0,5.4e-54,213.8,sp|Q5R673|RIOX2_PONAB Ribosomal oxygenase 2 OS=Pongo abelii OX=9601 GN=RIOX2 PE=2 SV=1,GO:0005654; GO:0005730; GO:0032453; GO:0036139; GO:0042254; GO:0042802; GO:0046872; GO:0051864,ribosome biogenesis [GO:0042254],nucleolus [GO:0005730]; nucleoplasm [GO:0005654],histone H3K36 demethylase activity [GO:0051864]; histone H3K4 demethylase activity [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-histidine dioxygenase activity [GO:0036139],GO:0003824; GO:0005654; GO:0005730; GO:0016491; GO:0042254; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; nucleolus; oxidoreductase activity; ribosome biogenesis; organelle; catalytic activity, acting on a protein"
OG_02853,1.1694777881888054,FUN_011890-T1,Peve_00042786,Pocillopora_meandrina_HIv1___RNAseq.g13675.t1,three_way,73.18133333333333,FUN_011890-T1,Q9ULI1,,,,,28.0,898.0,2.4e-78,296.2,sp|Q9ULI1|NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NWD2 PE=1 SV=3,,,,,,
OG_02865,1.671488418922201,FUN_011912-T1,Peve_00020699,Pocillopora_meandrina_HIv1___RNAseq.g23360.t1,three_way,69.96266666666666,FUN_011912-T1,Q92562,FIG4_HUMAN,,"Polyphosphoinositide phosphatase (EC 3.1.3.-) (EC 3.1.3.36) (EC 3.1.3.86) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4) (EC 3.1.3.16)",Homo sapiens (Human),45.8,1014.0,7.2e-216,752.3,sp|Q92562|FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens OX=9606 GN=FIG4 PE=1 SV=1,GO:0000139; GO:0004438; GO:0004439; GO:0004722; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037,locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033],early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037],"phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein serine/threonine phosphatase activity [GO:0004722]",GO:0003824; GO:0005768; GO:0005811; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endosome; lipid droplet; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02927,1.4642700972056977,FUN_012020-T1,Peve_00030377,Pocillopora_meandrina_HIv1___RNAseq.g24050.t1,three_way,58.77833333333333,FUN_012020-T1,Q5UAW9,GP157_HUMAN,,G-protein coupled receptor 157,Homo sapiens (Human),34.6,289.0,1.7e-39,164.9,sp|Q5UAW9|GP157_HUMAN G-protein coupled receptor 157 OS=Homo sapiens OX=9606 GN=GPR157 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007166; GO:0007189; GO:0007200; GO:0048512; GO:0060019; GO:0060170,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; radial glial cell differentiation [GO:0060019],ciliary membrane [GO:0060170]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0030154; GO:0060089,plasma membrane; cell differentiation; molecular transducer activity
OG_02950,1.4960276821605782,FUN_012068-T1,Peve_00004102,Pocillopora_meandrina_HIv1___RNAseq.g23635.t1,three_way,68.446,FUN_012068-T1,Q7Z020,,,,,26.3,578.0,1.1e-39,167.2,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02959,1.084811817399566,FUN_012105-T1,Peve_00000984,Pocillopora_meandrina_HIv1___RNAseq.9341_t,three_way,72.279,,,,,,,,,,,,,,,,,
OG_02969,1.360640986065068,FUN_012132-T1,Peve_00035465,Pocillopora_meandrina_HIv1___RNAseq.g23782.t1,three_way,56.359,FUN_012132-T1,Q07113,MPRI_MOUSE,,Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222),Mus musculus (Mouse),30.7,2462.0,7.5e-280,966.1,sp|Q07113|MPRI_MOUSE Cation-independent mannose-6-phosphate receptor OS=Mus musculus OX=10090 GN=Igf2r PE=1 SV=1,GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005520; GO:0005537; GO:0005615; GO:0005634; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005802; GO:0007041; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030139; GO:0030140; GO:0031100; GO:0031995; GO:0032526; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:1904772; GO:1905394,animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; spermatogenesis [GO:0007283],cell surface [GO:0009986]; clathrin coat [GO:0030118]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140],D-mannose binding [GO:0005537]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023],GO:0005615; GO:0005634; GO:0005768; GO:0008289; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060089,extracellular space; nucleus; endosome; lipid binding; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular transducer activity
OG_02975,1.3818315439994993,FUN_012141-T1,Peve_00001102,Pocillopora_meandrina_HIv1___RNAseq.9491_t,three_way,51.589,,,,,,,,,,,,,,,,,
OG_02976,1.1348689090177606,FUN_012142-T1,Peve_00001101,Pocillopora_meandrina_HIv1___RNAseq.g23866.t1,three_way,57.71,,,,,,,,,,,,,,,,,
OG_02980,1.239181493817039,FUN_012150-T1,Peve_00035454,Pocillopora_meandrina_HIv1___RNAseq.9397_t,three_way,84.231,FUN_012150-T1,Q00796,DHSO_HUMAN,,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) ((R,R)-butanediol dehydrogenase) (EC 1.1.1.4) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Ribitol dehydrogenase) (RDH) (EC 1.1.1.56) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)",Homo sapiens (Human),58.6,263.0,1.2e-85,317.8,sp|Q00796|DHSO_HUMAN Sorbitol dehydrogenase OS=Homo sapiens OX=9606 GN=SORD PE=1 SV=4,GO:0000721; GO:0003939; GO:0005615; GO:0005829; GO:0006006; GO:0006062; GO:0008270; GO:0016020; GO:0019640; GO:0030246; GO:0030317; GO:0031514; GO:0031966; GO:0042802; GO:0046370; GO:0046526; GO:0047833; GO:0050255; GO:0051160; GO:0051164; GO:0051287; GO:0070062,D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; glucose metabolic process [GO:0006006]; sorbitol catabolic process [GO:0006062]; xylitol catabolic process [GO:0051160]; xylitol metabolic process [GO:0051164],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514],"(R,R)-butanediol dehydrogenase activity [GO:0000721]; carbohydrate binding [GO:0030246]; D-sorbitol dehydrogenase (acceptor) activity [GO:0047833]; D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase (NAD+) activity [GO:0003939]; NAD binding [GO:0051287]; ribitol 2-dehydrogenase (NAD+) activity [GO:0050255]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005615; GO:0005829; GO:0005929; GO:0005975; GO:0007018; GO:0016491; GO:0022414; GO:0043226; GO:0048870; GO:1901135,catalytic activity; extracellular space; cytosol; cilium; carbohydrate metabolic process; microtubule-based movement; oxidoreductase activity; reproductive process; organelle; cell motility; carbohydrate derivative metabolic process
OG_02993,1.0669771590279291,FUN_012169-T1,Peve_00008636,Pocillopora_meandrina_HIv1___RNAseq.g23452.t1,three_way,71.68166666666667,,,,,,,,,,,,,,,,,
OG_02998,1.578880440777688,FUN_012177-T1,Peve_00040996,Pocillopora_meandrina_HIv1___RNAseq.g23859.t1,three_way,91.90766666666669,FUN_012177-T1,P18654,KS6A3_MOUSE,,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),Mus musculus (Mouse),67.4,742.0,1e-291,1003.8,sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus OX=10090 GN=Rps6ka3 PE=1 SV=2,GO:0000287; GO:0002224; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0019901; GO:0032496; GO:0035556; GO:0043066; GO:0045944; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03049,1.0073900692513618,FUN_012296-T1,Peve_00002353,Pocillopora_meandrina_HIv1___RNAseq.g23873.t1,three_way,63.77733333333334,FUN_012296-T1,Q4R3G4,,,,,23.3,1242.0,3.8999999999999995e-46,189.1,sp|Q4R3G4|RNF17_MACFA RING finger protein 17 OS=Macaca fascicularis OX=9541 GN=RNF17 PE=2 SV=2,,,,,,
OG_03068,1.3137085517725615,FUN_012338-T1,Peve_00021550,Pocillopora_meandrina_HIv1___RNAseq.g24073.t1,three_way,51.0305,,,,,,,,,,,,,,,,,
OG_03080,1.4583971343470643,FUN_012352-T1,Peve_00042523,Pocillopora_meandrina_HIv1___RNAseq.g23279.t1,three_way,78.2095,FUN_012352-T1,Q2KIT4,,,,,47.1,365.0,5.2e-84,312.8,sp|Q2KIT4|DNJB4_BOVIN DnaJ homolog subfamily B member 4 OS=Bos taurus OX=9913 GN=DNAJB4 PE=2 SV=1,,,,,,
OG_03086,1.0346985070549548,FUN_012359-T1,Peve_00042556,Pocillopora_meandrina_HIv1___RNAseq.g23272.t1,three_way,74.21950000000001,FUN_012359-T1,Q9UDY4,DNJB4_HUMAN,,DnaJ homolog subfamily B member 4 (Heat shock 40 kDa protein 1 homolog) (HSP40 homolog) (Heat shock protein 40 homolog) (Human liver DnaJ-like protein),Homo sapiens (Human),45.7,341.0,5.000000000000001e-81,302.8,sp|Q9UDY4|DNJB4_HUMAN DnaJ homolog subfamily B member 4 OS=Homo sapiens OX=9606 GN=DNAJB4 PE=1 SV=1,GO:0000122; GO:0001671; GO:0005654; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0030018; GO:0051082; GO:0051085; GO:0051087,chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Z disc [GO:0030018],ATPase activator activity [GO:0001671]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0098772,nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; molecular function regulator activity
OG_03099,1.6234383779574226,FUN_012386-T1,Peve_00030648,Pocillopora_meandrina_HIv1___RNAseq.g23347.t1,three_way,52.83716666666666,,,,,,,,,,,,,,,,,
OG_03107,1.3472210902370505,FUN_012403-T1,Peve_00023468,Pocillopora_meandrina_HIv1___RNAseq.g23671.t1,three_way,40.333,,,,,,,,,,,,,,,,,
OG_03118,1.0536205372274057,FUN_012466-T1,Peve_00034217,Pocillopora_meandrina_HIv1___RNAseq.g24003.t1,three_way,65.63133333333333,FUN_012466-T1,P46029,,,,,41.7,672.0,1.1e-136,488.8,sp|P46029|S15A2_RABIT Solute carrier family 15 member 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC15A2 PE=1 SV=1,,,,,,
OG_03122,2.956776231015923,FUN_012476-T1,Peve_00004005,Pocillopora_meandrina_HIv1___RNAseq.g23990.t1,three_way,74.48633333333333,FUN_012476-T1,O15247,CLIC2_HUMAN,,Chloride intracellular channel protein 2 (Glutaredoxin-like oxidoreductase CLIC2) (EC 1.8.-.-) (Glutaredoxin-like peroxidase CLIC2) (EC 1.11.1.-) (XAP121),Homo sapiens (Human),31.7,230.0,1.5e-23,111.3,sp|O15247|CLIC2_HUMAN Chloride intracellular channel protein 2 OS=Homo sapiens OX=9606 GN=CLIC2 PE=1 SV=3,GO:0004602; GO:0005254; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006821; GO:0007165; GO:0010880; GO:0010881; GO:0016020; GO:0034707,chloride transport [GO:0006821]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; signal transduction [GO:0007165],chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; glutathione peroxidase activity [GO:0004602],GO:0003824; GO:0005215; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016209; GO:0016491; GO:0043226,catalytic activity; transporter activity; nucleus; nucleoplasm; cytosol; plasma membrane; antioxidant activity; oxidoreductase activity; organelle
OG_03126,1.4804587629178676,FUN_012482-T1,Peve_00004001,Pocillopora_meandrina_HIv1___RNAseq.g23996.t2,three_way,49.154,FUN_012482-T1,O15287,FANCG_HUMAN,,Fanconi anemia group G protein (Protein FACG) (DNA repair protein XRCC9),Homo sapiens (Human),26.7,243.0,4.6e-08,61.6,sp|O15287|FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens OX=9606 GN=FANCG PE=1 SV=1,GO:0000785; GO:0001541; GO:0003684; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006974; GO:0007005; GO:0007286; GO:0009314; GO:0016607; GO:0036297; GO:0043240,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; mitochondrion organization [GO:0007005]; ovarian follicle development [GO:0001541]; response to radiation [GO:0009314]; spermatid development [GO:0007286],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],damaged DNA binding [GO:0003684],GO:0003677; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0007005; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleoplasm; mitochondrion; cytosol; DNA repair; mitochondrion organization; reproductive process; organelle; anatomical structure development
OG_03168,1.03071793059296,FUN_012590-T1,Peve_00038782,Pocillopora_meandrina_HIv1___RNAseq.g13637.t1,three_way,72.70233333333334,FUN_012590-T1,Q53FA7,QORX_HUMAN,,Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein),Homo sapiens (Human),53.7,322.0,9.4e-97,355.1,sp|Q53FA7|QORX_HUMAN Quinone oxidoreductase PIG3 OS=Homo sapiens OX=9606 GN=TP53I3 PE=1 SV=2,GO:0003960; GO:0005829; GO:0006739; GO:0042803; GO:0048038; GO:0070402,NADP metabolic process [GO:0006739],cytosol [GO:0005829],NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038],GO:0003824; GO:0005829; GO:0016491; GO:0055086,catalytic activity; cytosol; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_03171,2.0686509133779416,FUN_012594-T1,Peve_00042400,Pocillopora_meandrina_HIv1___RNAseq.g13631.t1,three_way,63.02033333333333,FUN_012594-T1,Q91YI6,GLD2_MOUSE,,Poly(A) RNA polymerase GLD2 (mGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4) (Terminal nucleotidyltransferase 2),Mus musculus (Mouse),35.1,328.0,2.3e-38,161.0,sp|Q91YI6|GLD2_MOUSE Poly(A) RNA polymerase GLD2 OS=Mus musculus OX=10090 GN=Tent2 PE=1 SV=1,GO:0002244; GO:0005524; GO:0005634; GO:0005737; GO:0031124; GO:0046872; GO:0071044; GO:0140958; GO:1990817; GO:2000626,hematopoietic progenitor cell differentiation [GO:0002244]; histone mRNA catabolic process [GO:0071044]; mRNA 3'-end processing [GO:0031124]; negative regulation of miRNA catabolic process [GO:2000626]; target-directed miRNA degradation [GO:0140958],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003824; GO:0005634; GO:0016071; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nucleus; mRNA metabolic process; transferase activity; cell differentiation; organelle
OG_03193,1.3685395933950646,FUN_012670-T1,Peve_00008660,Pocillopora_meandrina_HIv1___RNAseq.g22885.t1,three_way,76.15866666666666,FUN_012670-T1,Q5F464,,,,,48.0,256.0,2.8e-72,273.5,sp|Q5F464|LPP_CHICK Lipoma-preferred partner homolog OS=Gallus gallus OX=9031 GN=LPP PE=2 SV=1,,,,,,
OG_03234,1.0058849766487947,FUN_012779-T1,Peve_00017054,Pocillopora_meandrina_HIv1___RNAseq.g12883.t1,three_way,75.45166666666667,FUN_012779-T1,Q9WVK0,ATRAP_MOUSE,,Type-1 angiotensin II receptor-associated protein (AT1 receptor-associated protein),Mus musculus (Mouse),46.3,121.0,1.7000000000000002e-22,107.5,sp|Q9WVK0|ATRAP_MOUSE Type-1 angiotensin II receptor-associated protein OS=Mus musculus OX=10090 GN=Agtrap PE=1 SV=2,GO:0000139; GO:0001666; GO:0004945; GO:0005789; GO:0005886; GO:0005938; GO:0008217; GO:0030659,regulation of blood pressure [GO:0008217]; response to hypoxia [GO:0001666],cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],angiotensin type II receptor activity [GO:0004945],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_03241,1.0544184839500264,FUN_012795-T1,Peve_00022361,Pocillopora_meandrina_HIv1___TS.g1884.t1,three_way,59.97133333333333,FUN_012795-T1,Q05793,PGBM_MOUSE,,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) [Cleaved into: Endorepellin; LG3 peptide],Mus musculus (Mouse),32.0,1366.0,6.4e-204,713.0,sp|Q05793|PGBM_MOUSE Basement membrane-specific heparan sulfate proteoglycan core protein OS=Mus musculus OX=10090 GN=Hspg2 PE=1 SV=1,GO:0001525; GO:0001958; GO:0002020; GO:0002062; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007420; GO:0008104; GO:0030198; GO:0031012; GO:0048704; GO:0048738; GO:0060351; GO:0062023,angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796],calcium ion binding [GO:0005509]; protease binding [GO:0002020],GO:0005576; GO:0016192; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; vesicle-mediated transport; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_03250,1.2138318944764177,FUN_012970-T1,Peve_00000426,Pocillopora_meandrina_HIv1___RNAseq.g12971.t1,three_way,92.84033333333332,FUN_012970-T1,A1Z6E0,GUS_DROME,,Protein gustavus,Drosophila melanogaster (Fruit fly),59.8,281.0,4.3e-97,355.9,sp|A1Z6E0|GUS_DROME Protein gustavus OS=Drosophila melanogaster OX=7227 GN=gus PE=1 SV=2,GO:0005634; GO:0005737; GO:0005938; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0008354; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449,cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; wing disc morphogenesis [GO:0007472],cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005],,GO:0005634; GO:0022414; GO:0030163; GO:0043226; GO:0048856; GO:0048870,nucleus; reproductive process; protein catabolic process; organelle; anatomical structure development; cell motility
OG_03269,2.907049946406259,FUN_013138-T1,Peve_00042391,Pocillopora_meandrina_HIv1___TS.g15900.t1,three_way,81.306,FUN_013138-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),39.4,251.0,5.999999999999999e-44,179.5,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_03270,1.0728512239516752,FUN_013139-T1,Peve_00042385,Pocillopora_meandrina_HIv1___RNAseq.g23012.t1,three_way,50.720333333333336,FUN_013139-T1,Q63341,MMP12_RAT,,Macrophage metalloelastase (MME) (EC 3.4.24.65) (Matrix metalloproteinase-12) (MMP-12),Rattus norvegicus (Rat),36.7,267.0,1.2e-34,148.7,sp|Q63341|MMP12_RAT Macrophage metalloelastase OS=Rattus norvegicus OX=10116 GN=Mmp12 PE=2 SV=1,GO:0000122; GO:0001046; GO:0001666; GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0005634; GO:0005737; GO:0006508; GO:0006606; GO:0008270; GO:0009410; GO:0010628; GO:0030198; GO:0030574; GO:0031012; GO:0032727; GO:0035313; GO:0043565; GO:0045944; GO:0048286; GO:0050679; GO:0050691; GO:0060054; GO:0060309; GO:0060339; GO:0060340; GO:0060435; GO:0098586; GO:1901163; GO:1904905,"bronchiole development [GO:0060435]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix organization [GO:0030198]; lung alveolus development [GO:0048286]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; regulation of trophoblast cell migration [GO:1901163]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; wound healing, spreading of epidermal cells [GO:0035313]",cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter sequence-specific DNA binding [GO:0001046]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005615; GO:0005634; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0030163; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096; GO:1901135,"DNA binding; catalytic activity; extracellular space; nucleus; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; protein catabolic process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03281,1.064029237660148,FUN_013162-T1,Peve_00022440,Pocillopora_meandrina_HIv1___RNAseq.g13110.t3,three_way,66.35566666666666,FUN_013162-T1,Q924H0,,,,,27.5,360.0,9.1e-18,92.8,sp|Q924H0|NPFF2_MOUSE Neuropeptide FF receptor 2 OS=Mus musculus OX=10090 GN=Npffr2 PE=2 SV=2,,,,,,
OG_03309,1.5259480151713345,FUN_013385-T1,Peve_00015992,Pocillopora_meandrina_HIv1___RNAseq.g22980.t2,three_way,65.83083333333333,FUN_013385-T1,Q24180,DEAF1_DROME,,Deformed epidermal autoregulatory factor 1 (Protein DEAF-1),Drosophila melanogaster (Fruit fly),45.2,84.0,2.6e-16,87.8,sp|Q24180|DEAF1_DROME Deformed epidermal autoregulatory factor 1 OS=Drosophila melanogaster OX=7227 GN=Deaf1 PE=1 SV=1,GO:0000981; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776,embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]; polytene chromosome [GO:0005700],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005694; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; chromosome; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_03313,1.6169199432230352,FUN_013391-T1,Peve_00028095,Pocillopora_meandrina_HIv1___RNAseq.g22975.t1,three_way,66.52533333333334,,,,,,,,,,,,,,,,,
OG_03315,1.4490616379021506,FUN_013393-T2,Peve_00028093,Pocillopora_meandrina_HIv1___TS.g15814.t1,three_way,82.98983333333334,FUN_013393-T2,Q9WU45,CLCN2_CAVPO,,Chloride channel protein 2 (ClC-2),Cavia porcellus (Guinea pig),49.5,831.0,5.4e-204,712.6,sp|Q9WU45|CLCN2_CAVPO Chloride channel protein 2 OS=Cavia porcellus OX=10141 GN=CLCN2 PE=1 SV=1,GO:0005247; GO:0005886; GO:0016323; GO:0030424; GO:0032347; GO:0032591; GO:0034707; GO:0045211,regulation of aldosterone biosynthetic process [GO:0032347],axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; dendritic spine membrane [GO:0032591]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],voltage-gated chloride channel activity [GO:0005247],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_03316,1.0024098318499386,FUN_013394-T1,Peve_00028092,Pocillopora_meandrina_HIv1___RNAseq.g22932.t1,three_way,67.747,FUN_013394-T1,Q7ZVH1,,,,,31.2,321.0,1e-37,159.1,sp|Q7ZVH1|MPRGA_DANRE Membrane progestin receptor gamma-A OS=Danio rerio OX=7955 GN=paqr5a PE=2 SV=2,,,,,,
OG_03335,1.4892133812406478,FUN_013556-T1,Peve_00038569,Pocillopora_meandrina_HIv1___RNAseq.g22960.t1,three_way,59.44166666666667,FUN_013556-T1,Q6NR09,EGRAP_DROME,,EGFR adapter protein,Drosophila melanogaster (Fruit fly),34.3,137.0,7.7e-13,77.0,sp|Q6NR09|EGRAP_DROME EGFR adapter protein OS=Drosophila melanogaster OX=7227 GN=Egfrap PE=1 SV=1,GO:0005925; GO:0030971; GO:0042059; GO:0045179,negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],apical cortex [GO:0045179]; focal adhesion [GO:0005925],receptor tyrosine kinase binding [GO:0030971],,
OG_03342,1.0373567527761909,FUN_013572-T1,Peve_00022291,Pocillopora_meandrina_HIv1___RNAseq.g13520.t1,three_way,69.9175,FUN_013572-T1,Q9TRC7,AOC1_PIG,,Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein) (Amine oxidase copper domain-containing protein 1) (Histaminase),Sus scrofa (Pig),39.3,746.0,1.2e-157,558.5,sp|Q9TRC7|AOC1_PIG Diamine oxidase [copper-containing] OS=Sus scrofa OX=9823 GN=AOC1 PE=1 SV=3,GO:0005507; GO:0005509; GO:0005615; GO:0005886; GO:0005923; GO:0008131; GO:0008201; GO:0009445; GO:0042803; GO:0048038; GO:0050232; GO:0052597; GO:0052598; GO:0070062,putrescine metabolic process [GO:0009445],bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; primary methylamine oxidase activity [GO:0008131]; protein homodimerization activity [GO:0042803]; putrescine oxidase activity [GO:0050232]; quinone binding [GO:0048038],GO:0003824; GO:0005615; GO:0005886; GO:0016491; GO:0043226,catalytic activity; extracellular space; plasma membrane; oxidoreductase activity; organelle
OG_03349,1.3408752669158155,FUN_013585-T1,Peve_00018185,Pocillopora_meandrina_HIv1___RNAseq.g13501.t1,three_way,78.13466666666666,FUN_013585-T1,O35454,CLCN6_MOUSE,,H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6) (ClC-6) (Chloride transport protein 6),Mus musculus (Mouse),54.1,857.0,1.0999999999999999e-249,864.4,sp|O35454|CLCN6_MOUSE H(+)/Cl(-) exchange transporter 6 OS=Mus musculus OX=10090 GN=Clcn6 PE=1 SV=1,GO:0005247; GO:0005524; GO:0006821; GO:0015297; GO:0031902,chloride transport [GO:0006821],late endosome membrane [GO:0031902],antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247],GO:0005215,transporter activity
OG_03413,1.1747534463683478,FUN_014461-T1,Peve_00014815,Pocillopora_meandrina_HIv1___RNAseq.g22645.t1,three_way,61.391666666666666,FUN_014461-T1,Q3T0X9,,,,,38.1,113.0,6e-13,75.1,sp|Q3T0X9|DPOD4_BOVIN DNA polymerase delta subunit 4 OS=Bos taurus OX=9913 GN=POLD4 PE=1 SV=1,,,,,,
OG_03421,1.3328937385135735,FUN_014475-T1,Peve_00015334,Pocillopora_meandrina_HIv1___RNAseq.g22820.t1,three_way,87.77716666666667,FUN_014475-T1,Q501Q9,MK15_XENLA,,Mitogen-activated protein kinase 15 (EC 2.7.11.24),Xenopus laevis (African clawed frog),72.5,353.0,5.7999999999999996e-151,535.8,sp|Q501Q9|MK15_XENLA Mitogen-activated protein kinase 15 OS=Xenopus laevis OX=8355 GN=mapk15 PE=1 SV=1,GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005911; GO:0005929; GO:0035253; GO:0035556; GO:0036064; GO:0106310; GO:1902017,intracellular signal transduction [GO:0035556]; regulation of cilium assembly [GO:1902017],cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0005929; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cilium; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03422,1.5839702088018883,FUN_014476-T1,Peve_00037307,Pocillopora_meandrina_HIv1___RNAseq.g22818.t1,three_way,61.25033333333334,,,,,,,,,,,,,,,,,
OG_03429,2.198994141477556,FUN_014485-T1,Peve_00037303,Pocillopora_meandrina_HIv1___RNAseq.g22811.t1,three_way,75.97416666666666,FUN_014485-T1,O35887,,,,,29.0,155.0,5.5e-09,63.5,sp|O35887|CALU_MOUSE Calumenin OS=Mus musculus OX=10090 GN=Calu PE=1 SV=1,,,,,,
OG_03457,1.1125631720429872,FUN_014533-T1,Peve_00040829,Pocillopora_meandrina_HIv1___RNAseq.g22609.t1,three_way,87.76966666666667,FUN_014533-T1,Q9UBR1,BUP1_HUMAN,,Beta-ureidopropionase (EC 3.5.1.6) (BUP-1) (Beta-alanine synthase) (N-carbamoyl-beta-alanine amidohydrolase),Homo sapiens (Human),71.8,379.0,2.1e-163,576.6,sp|Q9UBR1|BUP1_HUMAN Beta-ureidopropionase OS=Homo sapiens OX=9606 GN=UPB1 PE=1 SV=1,GO:0001701; GO:0001889; GO:0003837; GO:0005829; GO:0006248; GO:0006249; GO:0033396; GO:0042803; GO:0046050; GO:0046079; GO:0046135; GO:0051260; GO:0051289; GO:0070062,beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside catabolic process [GO:0046135]; UMP catabolic process [GO:0046050],cytosol [GO:0005829]; extracellular exosome [GO:0070062],beta-ureidopropionase activity [GO:0003837]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006520; GO:0016787; GO:0043226; GO:0048856; GO:0055086; GO:0065003; GO:1901135,catalytic activity; cytosol; amino acid metabolic process; hydrolase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_03470,1.441218621749003,FUN_014556-T1,Peve_00035993,Pocillopora_meandrina_HIv1___RNAseq.g22695.t1,three_way,72.46883333333334,FUN_014556-T1,E1BLT8,ZDHC5_BOVIN,,Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5),Bos taurus (Bovine),52.3,243.0,9.599999999999999e-70,265.4,sp|E1BLT8|ZDHC5_BOVIN Palmitoyltransferase ZDHHC5 OS=Bos taurus OX=9913 GN=ZDHHC5 PE=3 SV=1,GO:0005654; GO:0005886; GO:0006869; GO:0016409; GO:0019706; GO:0030425; GO:0045087; GO:0045335; GO:0062208; GO:0072659; GO:0098794; GO:0098978; GO:0140639; GO:1900227; GO:1903078; GO:1905171,innate immune response [GO:0045087]; lipid transport [GO:0006869]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein localization to plasma membrane [GO:0072659],dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0002376; GO:0003824; GO:0005654; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0072659; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleoplasm; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; protein localization to plasma membrane; defense response to other organism; catalytic activity, acting on a protein"
OG_03478,1.4423953185035767,FUN_014572-T1,Peve_00027631,Pocillopora_meandrina_HIv1___RNAseq.1861_t,three_way,78.95566666666666,FUN_014572-T1,Q6DDL7,,,,,50.4,282.0,2.600000000000001e-71,270.4,sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1,,,,,,
OG_03479,1.4562001932052209,FUN_014573-T3,Peve_00027630,Pocillopora_meandrina_HIv1___RNAseq.g22711.t1,three_way,76.72633333333333,FUN_014573-T3,Q6DFR1,,,,,31.8,494.0,5.1e-54,213.8,sp|Q6DFR1|S22AF_XENTR Solute carrier family 22 member 15 OS=Xenopus tropicalis OX=8364 GN=slc22a15 PE=2 SV=2,,,,,,
OG_03480,1.151693138043499,FUN_014574-T1,Peve_00027629,Pocillopora_meandrina_HIv1___TS.g27474.t1,three_way,69.878,FUN_014574-T1,Q9VCA2,,,,,36.1,527.0,8.1e-84,312.8,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_03495,1.6842240610758734,FUN_014604-T1,Peve_00028205,Pocillopora_meandrina_HIv1___RNAseq.g22749.t1,three_way,70.68266666666666,FUN_014604-T1,A2BGR3,,,,,54.5,635.0,3.2000000000000004e-185,650.2,sp|A2BGR3|ERC6L_DANRE DNA excision repair protein ERCC-6-like OS=Danio rerio OX=7955 GN=ercc6l PE=1 SV=1,,,,,,
OG_03500,1.6785617044115728,FUN_014610-T1,Peve_00027567,Pocillopora_meandrina_HIv1___TS.g27529.t1,three_way,75.49566666666666,FUN_014610-T1,P27465,,,,,48.5,361.0,3.7e-97,356.7,"sp|P27465|PISD_CRIGR Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Cricetulus griseus OX=10029 GN=Pisd PE=1 SV=2",,,,,,
OG_03544,1.3734803082002436,FUN_014670-T1,Peve_00030803,Pocillopora_meandrina_HIv1___RNAseq.g22675.t1,three_way,86.73983333333334,FUN_014670-T1,Q13356,PPIL2_HUMAN,,RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2),Homo sapiens (Human),58.3,527.0,1.1e-178,627.9,sp|Q13356|PPIL2_HUMAN RING-type E3 ubiquitin-protein ligase PPIL2 OS=Homo sapiens OX=9606 GN=PPIL2 PE=1 SV=1,GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006397; GO:0006457; GO:0008380; GO:0034450; GO:0061630; GO:0071013; GO:0072659,mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; RNA splicing [GO:0008380],catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0005654; GO:0005886; GO:0006457; GO:0016071; GO:0016740; GO:0043226; GO:0072659; GO:0140096,"catalytic activity; nucleus; nucleoplasm; plasma membrane; protein folding; mRNA metabolic process; transferase activity; organelle; protein localization to plasma membrane; catalytic activity, acting on a protein"
OG_03558,1.4124357764410174,FUN_014704-T1,Peve_00021212,Pocillopora_meandrina_HIv1___RNAseq.g22535.t1,three_way,50.87083333333333,,,,,,,,,,,,,,,,,
OG_03567,1.0325389044225115,FUN_014716-T2,Peve_00022399,Pocillopora_meandrina_HIv1___RNAseq.g22524.t1,three_way,51.833666666666666,FUN_014716-T2,P49791,,,,,27.7,285.0,6.9e-16,88.6,sp|P49791|NU153_RAT Nuclear pore complex protein Nup153 OS=Rattus norvegicus OX=10116 GN=Nup153 PE=1 SV=1,,,,,,
OG_03616,1.5929193358434943,FUN_014798-T1,Peve_00028870,Pocillopora_meandrina_HIv1___RNAseq.g22416.t1,three_way,83.49866666666667,FUN_014798-T1,O00560,SDCB1_HUMAN,,Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1),Homo sapiens (Human),53.2,301.0,5.7e-84,312.4,sp|O00560|SDCB1_HUMAN Syntenin-1 OS=Homo sapiens OX=9606 GN=SDCBP PE=1 SV=1,GO:0000122; GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007265; GO:0007268; GO:0007346; GO:0008093; GO:0008284; GO:0010718; GO:0016020; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0035556; GO:0035578; GO:0042327; GO:0042470; GO:0042802; GO:0045121; GO:0045202; GO:0045545; GO:0046330; GO:0046982; GO:0070062; GO:0072562; GO:0140311; GO:1903543; GO:1903553; GO:1903561,"actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]",adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],"cytoskeletal anchor activity [GO:0008093]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein sequestering activity [GO:0140311]; syndecan binding [GO:0045545]",GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0007010; GO:0008289; GO:0023052; GO:0031410; GO:0043226; GO:0060090; GO:0140313,extracellular region; extracellular space; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; lipid binding; signaling; cytoplasmic vesicle; organelle; molecular adaptor activity; molecular sequestering activity
OG_03619,1.0471733162244796,FUN_014805-T1,Peve_00010342,Pocillopora_meandrina_HIv1___RNAseq.g22412.t1,three_way,59.00483333333333,,,,,,,,,,,,,,,,,
OG_03623,1.0713572660182,FUN_014810-T1,Peve_00022206,Pocillopora_meandrina_HIv1___RNAseq.g22405.t1,three_way,74.15333333333334,FUN_014810-T1,Q9NXZ2,,,,,46.8,577.0,2.1e-146,521.2,sp|Q9NXZ2|DDX43_HUMAN Probable ATP-dependent RNA helicase DDX43 OS=Homo sapiens OX=9606 GN=DDX43 PE=1 SV=2,,,,,,
OG_03642,1.090101371561245,FUN_014868-T1,Peve_00012983,Pocillopora_meandrina_HIv1___RNAseq.g21041.t1,three_way,63.503,,,,,,,,,,,,,,,,,
OG_03643,1.2402912635419197,FUN_014871-T1,Peve_00012980,Pocillopora_meandrina_HIv1___RNAseq.g21043.t2a,three_way,72.989,FUN_014871-T1,Q05B54,,,,,27.7,213.0,3.2e-12,73.6,sp|Q05B54|TM134_BOVIN Transmembrane protein 134 OS=Bos taurus OX=9913 GN=TMEM134 PE=2 SV=2,,,,,,
OG_03671,1.188600615005706,FUN_014916-T1,Peve_00003523,Pocillopora_meandrina_HIv1___RNAseq.g21079.t1,three_way,45.37166666666666,FUN_014916-T1,P00919,,,,,41.5,253.0,1.2e-44,183.0,sp|P00919|CAH2_RABIT Carbonic anhydrase 2 OS=Oryctolagus cuniculus OX=9986 GN=CA2 PE=1 SV=3,,,,,,
OG_03707,1.2064465593324851,FUN_014980-T3,Peve_00024829,Pocillopora_meandrina_HIv1___RNAseq.g21142.t1,three_way,72.68066666666667,FUN_014980-T3,P51577,,,,,52.3,392.0,5.2000000000000004e-110,399.4,sp|P51577|P2RX4_RAT P2X purinoceptor 4 OS=Rattus norvegicus OX=10116 GN=P2rx4 PE=1 SV=1,,,,,,
OG_03736,1.3523192085107074,FUN_015036-T1,Peve_00024712,Pocillopora_meandrina_HIv1___RNAseq.g21165.t1,three_way,78.18966666666667,FUN_015036-T1,Q9BZ72,PITM2_HUMAN,,"Membrane-associated phosphatidylinositol transfer protein 2 (Phosphatidylinositol transfer protein, membrane-associated 2) (PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3) (NIR-3)",Homo sapiens (Human),42.6,1386.0,1.2e-287,991.1,sp|Q9BZ72|PITM2_HUMAN Membrane-associated phosphatidylinositol transfer protein 2 OS=Homo sapiens OX=9606 GN=PITPNM2 PE=1 SV=1,GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008525; GO:0008526; GO:0012505; GO:0016020; GO:0030971; GO:0031210; GO:0035091,phosphatidylinositol biosynthetic process [GO:0006661],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020],calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971],GO:0005215; GO:0005829; GO:0006629; GO:0008289,transporter activity; cytosol; lipid metabolic process; lipid binding
OG_03743,1.5147035999618153,FUN_015050-T1,Peve_00001172,Pocillopora_meandrina_HIv1___RNAseq.g21265.t1,three_way,70.01583333333333,FUN_015050-T1,Q8CHW5,,,,,38.3,120.0,7.4e-10,67.4,sp|Q8CHW5|BICL2_MOUSE BICD family-like cargo adapter 2 OS=Mus musculus OX=10090 GN=Bicdl2 PE=1 SV=1,,,,,,
OG_03752,1.1754473322981924,FUN_015061-T1,Peve_00015752,Pocillopora_meandrina_HIv1___RNAseq.g21278.t1,three_way,60.377,FUN_015061-T1,Q9UH36,,,,,47.6,187.0,2.4e-42,174.1,sp|Q9UH36|SRR1L_HUMAN SRR1-like protein OS=Homo sapiens OX=9606 GN=SRRD PE=1 SV=1,,,,,,
OG_03766,1.983355709139532,FUN_015091-T1,Peve_00010707,Pocillopora_meandrina_HIv1___RNAseq.g21185.t1,three_way,59.72,,,,,,,,,,,,,,,,,
OG_03770,1.554556906004764,FUN_015099-T1,Peve_00029475,Pocillopora_meandrina_HIv1___RNAseq.g22142.t1,three_way,61.8635,FUN_015099-T1,P27615,SCRB2_RAT,,Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36),Rattus norvegicus (Rat),35.1,450.0,3e-80,300.8,sp|P27615|SCRB2_RAT Lysosome membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Scarb2 PE=1 SV=2,GO:0001786; GO:0005044; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0007605; GO:0010976; GO:0015485; GO:0015917; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043470; GO:0051087; GO:0099638,aminophospholipid transport [GO:0015917]; endosome to plasma membrane protein transport [GO:0099638]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of carbohydrate catabolic process [GO:0043470]; sensory perception of sound [GO:0007605],endocytic vesicle membrane [GO:0030666]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],cargo receptor activity [GO:0038024]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; scavenger receptor activity [GO:0005044],GO:0005886; GO:0006886; GO:0008289; GO:0016192; GO:0038024; GO:0050877; GO:0072659,plasma membrane; intracellular protein transport; lipid binding; vesicle-mediated transport; cargo receptor activity; nervous system process; protein localization to plasma membrane
OG_03780,1.5743341869860934,FUN_015110-T1,Peve_00024794,Pocillopora_meandrina_HIv1___RNAseq.g7729.t1,three_way,38.797,FUN_015110-T1,P82596,,,,,31.1,135.0,1e-08,65.5,sp|P82596|PLC_HALLA Perlucin OS=Haliotis laevigata OX=36097 PE=1 SV=3,,,,,,
OG_03790,1.067966976726295,FUN_015155-T1,Peve_00001868,Pocillopora_meandrina_HIv1___RNAseq.g21762.t1,three_way,71.99633333333334,FUN_015155-T1,B6NK32,,,,,57.8,64.0,4.8e-15,81.6,sp|B6NK32|LYRM9_BRAFL LYR motif-containing protein 9 OS=Branchiostoma floridae OX=7739 GN=LYRM9 PE=3 SV=1,,,,,,
OG_03822,1.255550080212233,FUN_015236-T2,Peve_00003466,Pocillopora_meandrina_HIv1___TS.g26934.t1,three_way,62.57566666666666,FUN_015236-T2,Q91X60,ACHA2_MOUSE,,Neuronal acetylcholine receptor subunit alpha-2,Mus musculus (Mouse),38.2,325.0,4.2999999999999997e-61,237.3,sp|Q91X60|ACHA2_MOUSE Neuronal acetylcholine receptor subunit alpha-2 OS=Mus musculus OX=10090 GN=Chrna2 PE=2 SV=1,GO:0005654; GO:0005892; GO:0015464; GO:0022848; GO:0034703; GO:0045171; GO:0045211; GO:0048167; GO:0050997; GO:0071316; GO:0071944; GO:0098828; GO:0098878; GO:0120111; GO:1901363; GO:1905144,cellular response to nicotine [GO:0071316]; modulation of inhibitory postsynaptic potential [GO:0098828]; regulation of synaptic plasticity [GO:0048167]; response to acetylcholine [GO:1905144],acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cell periphery [GO:0071944]; intercellular bridge [GO:0045171]; neuron projection cytoplasm [GO:0120111]; neurotransmitter receptor complex [GO:0098878]; nucleoplasm [GO:0005654]; postsynaptic membrane [GO:0045211],acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; quaternary ammonium group binding [GO:0050997],GO:0005215; GO:0005654; GO:0060089,transporter activity; nucleoplasm; molecular transducer activity
OG_03830,1.008398353744368,FUN_015263-T1,Peve_00044771,Pocillopora_meandrina_HIv1___RNAseq.g22216.t1,three_way,70.697,FUN_015263-T1,Q9CQM5,,,,,45.2,115.0,2.1e-22,106.7,sp|Q9CQM5|TXD17_MOUSE Thioredoxin domain-containing protein 17 OS=Mus musculus OX=10090 GN=Txndc17 PE=1 SV=1,,,,,,
OG_03845,2.949825252492614,FUN_015318-T1,Peve_00023982,Pocillopora_meandrina_HIv1___RNAseq.g21728.t1,three_way,82.93366666666667,FUN_015318-T1,Q5QNI2,,,,,31.0,532.0,4.7999999999999997e-54,213.8,sp|Q5QNI2|NCL1_ORYSJ Sodium/calcium exchanger NCL1 OS=Oryza sativa subsp. japonica OX=39947 GN=NCL1 PE=2 SV=1,,,,,,
OG_03906,1.3939813078628434,FUN_015982-T1,Peve_00024012,Pocillopora_meandrina_HIv1___RNAseq.g21404.t2,three_way,57.955,FUN_015982-T1,Q00174,LAMA_DROME,,Laminin subunit alpha (Laminin A chain),Drosophila melanogaster (Fruit fly),29.8,729.0,2.6e-88,330.1,sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2,GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0031012; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0071711,"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]",axon [GO:0030424]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021],extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102],GO:0002376; GO:0005198; GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048856; GO:0098542,immune system process; structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism
OG_03910,1.8206549744153755,FUN_015986-T1,Peve_00024004,Pocillopora_meandrina_HIv1___RNAseq.g21398.t1,three_way,64.2585,,,,,,,,,,,,,,,,,
OG_03919,1.5322541966729095,FUN_016017-T1,Peve_00004545,Pocillopora_meandrina_HIv1___TS.g26118.t2,three_way,74.83916666666667,FUN_016017-T1,Q9QZB0,RGS17_MOUSE,,Regulator of G-protein signaling 17 (RGS17) (Regulator of Gz-selective protein signaling 2),Mus musculus (Mouse),49.4,89.0,2.6e-18,93.6,sp|Q9QZB0|RGS17_MOUSE Regulator of G-protein signaling 17 OS=Mus musculus OX=10090 GN=Rgs17 PE=1 SV=1,GO:0001975; GO:0005096; GO:0005634; GO:0005737; GO:0007186; GO:0009968; GO:0016020; GO:0043005; GO:0045202,G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; response to amphetamine [GO:0001975],cytoplasm [GO:0005737]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202],GTPase activator activity [GO:0005096],GO:0005634; GO:0043226; GO:0098772,nucleus; organelle; molecular function regulator activity
OG_03921,1.0872935125267074,FUN_016025-T1,Peve_00033607,Pocillopora_meandrina_HIv1___RNAseq.g22273.t1,three_way,56.42033333333333,,,,,,,,,,,,,,,,,
OG_03931,1.053800867875787,FUN_016047-T2,Peve_00011791,Pocillopora_meandrina_HIv1___RNAseq.g21637.t1,three_way,75.40733333333333,FUN_016047-T2,O43272,PROD_HUMAN,,"Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase) (Proline oxidase 2) (p53-induced gene 6 protein)",Homo sapiens (Human),49.1,556.0,4.5e-144,513.1,"sp|O43272|PROD_HUMAN Proline dehydrogenase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PRODH PE=1 SV=4",GO:0004657; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0006560; GO:0006562; GO:0008631; GO:0010133; GO:0019470; GO:0043231; GO:0071949; GO:1903376,4-hydroxyproline catabolic process [GO:0019470]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376],intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657],GO:0003824; GO:0005654; GO:0005739; GO:0006520; GO:0006575; GO:0016491; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_03934,1.0759745306732766,FUN_016050-T1,Peve_00011794,Pocillopora_meandrina_HIv1___RNAseq.g21635.t1,three_way,66.26,,,,,,,,,,,,,,,,,
OG_03969,1.1599541247846628,FUN_016123-T1,Peve_00013454,Pocillopora_meandrina_HIv1___RNAseq.g21533.t1,three_way,88.006,FUN_016123-T1,Q9YHZ6,,,,,47.3,566.0,1.3e-150,534.6,sp|Q9YHZ6|CDC45_XENLA Cell division control protein 45 homolog OS=Xenopus laevis OX=8355 GN=cdc45 PE=1 SV=2,,,,,,
OG_03995,1.1504152083769148,FUN_016279-T1,Peve_00003394,Pocillopora_meandrina_HIv1___RNAseq.g406.t1,three_way,53.544,,,,,,,,,,,,,,,,,
OG_04052,1.038971980825856,FUN_016371-T1,Peve_00022927,Pocillopora_meandrina_HIv1___RNAseq.g9747.t1,three_way,64.89166666666667,FUN_016371-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),56.4,133.0,4.6e-27,123.2,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04083,1.1367840665296884,FUN_016419-T1,Peve_00023004,Pocillopora_meandrina_HIv1___RNAseq.g9801.t1,three_way,61.829,,,,,,,,,,,,,,,,,
OG_04089,1.2517961775369937,FUN_016428-T1,Peve_00004356,Pocillopora_meandrina_HIv1___RNAseq.g9809.t1,three_way,74.45816666666666,FUN_016428-T1,Q15147,,,,,38.6,1257.0,9.2e-231,802.4,"sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3",,,,,,
OG_04091,1.0131122059307165,FUN_016430-T1,Peve_00004353,Pocillopora_meandrina_HIv1___RNAseq.g9811.t1,three_way,63.04533333333333,,,,,,,,,,,,,,,,,
OG_04096,1.6497124000598746,FUN_016436-T1,Peve_00002886,Pocillopora_meandrina_HIv1___TS.g23399.t2,three_way,66.57249999999999,FUN_016436-T1,P05455,LA_HUMAN,,Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B),Homo sapiens (Human),46.4,196.0,2.2e-38,160.6,sp|P05455|LA_HUMAN Lupus La protein OS=Homo sapiens OX=9606 GN=SSB PE=1 SV=2,GO:0000049; GO:0000781; GO:0001682; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0006409; GO:0008033; GO:0008266; GO:0008334; GO:0010494; GO:0042780; GO:0045727; GO:0071045; GO:0075522; GO:1903608; GO:1990825; GO:1990904,histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; positive regulation of translation [GO:0045727]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]",mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005829; GO:0006399; GO:0006913; GO:0016071; GO:0043226,RNA binding; nucleus; cytosol; tRNA metabolic process; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_04109,1.39595854794178,FUN_016475-T1,Peve_00040144,Pocillopora_meandrina_HIv1___RNAseq.g10194.t1,three_way,66.4755,FUN_016475-T1,P0C5Y8,ALS2_RAT,,Alsin (Amyotrophic lateral sclerosis 2 protein homolog),Rattus norvegicus (Rat),30.6,1765.0,3.8e-188,661.0,sp|P0C5Y8|ALS2_RAT Alsin OS=Rattus norvegicus OX=10116 GN=Als2 PE=1 SV=1,GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072,"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]",axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267],GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0016192; GO:0023052; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,nucleus; endosome; microtubule organizing center; cytosol; vesicle-mediated transport; signaling; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_04160,1.280553797954268,FUN_016638-T1,Peve_00026352,Pocillopora_meandrina_HIv1___RNAseq.g102.t1,three_way,61.59666666666666,FUN_016638-T1,Q62136,,,,,27.0,1183.0,6.6999999999999995e-90,333.6,sp|Q62136|PTN21_MOUSE Tyrosine-protein phosphatase non-receptor type 21 OS=Mus musculus OX=10090 GN=Ptpn21 PE=1 SV=1,,,,,,
OG_04170,1.077081996738727,FUN_016651-T1,Peve_00042780,Pocillopora_meandrina_HIv1___TS.g6961.t1,three_way,81.653,FUN_016651-T1,Q6TMK4,POXA_DICDI,,Peroxinectin A (EC 1.11.1.7),Dictyostelium discoideum (Social amoeba),34.7,521.0,3.3e-86,322.0,sp|Q6TMK4|POXA_DICDI Peroxinectin A OS=Dictyostelium discoideum OX=44689 GN=poxA PE=1 SV=1,GO:0004447; GO:0004601; GO:0005576; GO:0005783; GO:0006955; GO:0006979; GO:0020037; GO:0036393; GO:0042742; GO:0042744; GO:0140825,defense response to bacterium [GO:0042742]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; response to oxidative stress [GO:0006979],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; lactoperoxidase activity [GO:0140825]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393],GO:0002376; GO:0003824; GO:0005576; GO:0005783; GO:0016209; GO:0016491; GO:0043226,immune system process; catalytic activity; extracellular region; endoplasmic reticulum; antioxidant activity; oxidoreductase activity; organelle
OG_04181,1.4450889333868449,FUN_016677-T1,Peve_00035082,Pocillopora_meandrina_HIv1___RNAseq.g388.t3,three_way,77.881,FUN_016677-T1,A2RUC4,TYW5_HUMAN,,tRNA wybutosine-synthesizing protein 5 (hTYW5) (tRNA yW-synthesizing protein 5) (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase),Homo sapiens (Human),64.9,302.0,2.1999999999999998e-116,420.2,sp|A2RUC4|TYW5_HUMAN tRNA wybutosine-synthesizing protein 5 OS=Homo sapiens OX=9606 GN=TYW5 PE=1 SV=1,GO:0000049; GO:0005506; GO:0005737; GO:0031591; GO:0042803; GO:0102524,wybutosine biosynthetic process [GO:0031591],cytoplasm [GO:0005737],iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524],GO:0003723; GO:0003824; GO:0006399; GO:0016491; GO:0140098; GO:1901135,"RNA binding; catalytic activity; tRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA; carbohydrate derivative metabolic process"
OG_04193,1.0492373866640556,FUN_016717-T1,Peve_00014667,Pocillopora_meandrina_HIv1___RNAseq.g226.t1,three_way,70.61533333333334,,,,,,,,,,,,,,,,,
OG_04199,1.6627431436722844,FUN_016732-T1,Peve_00014684,Pocillopora_meandrina_HIv1___RNAseq.g234.t1,three_way,56.1385,,,,,,,,,,,,,,,,,
OG_04204,1.679357931904812,FUN_016759-T1,Peve_00003676,Pocillopora_meandrina_HIv1___RNAseq.g14956.t1,three_way,68.49566666666666,FUN_016759-T1,Q2QUN2,,,,,25.6,629.0,2.7e-41,172.6,sp|Q2QUN2|LAC24_ORYSJ Laccase-24 OS=Oryza sativa subsp. japonica OX=39947 GN=LAC24 PE=2 SV=1,,,,,,
OG_04205,1.4569714111243208,FUN_016777-T1,Peve_00032303,Pocillopora_meandrina_HIv1___RNAseq.g10047.t1,three_way,85.97500000000001,FUN_016777-T1,Q86SR1,GLT10_HUMAN,,Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10),Homo sapiens (Human),41.8,584.0,1.1e-123,445.3,sp|Q86SR1|GLT10_HUMAN Polypeptide N-acetylgalactosaminyltransferase 10 OS=Homo sapiens OX=9606 GN=GALNT10 PE=1 SV=2,GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0030246; GO:0046872,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04227,1.5767392402217948,FUN_017022-T1,Peve_00018298,Pocillopora_meandrina_HIv1___RNAseq.g20360.t1,three_way,58.69716666666667,FUN_017022-T1,Q8BV79,,,,,28.2,2731.0,2.9e-254,881.7,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_04239,1.0700231823743258,FUN_017760-T1,Peve_00037315,Pocillopora_meandrina_HIv1___RNAseq.g439.t1,three_way,80.33866666666667,,,,,,,,,,,,,,,,,
OG_04244,1.3778752039846038,FUN_017766-T1,Peve_00035953,Pocillopora_meandrina_HIv1___RNAseq.g462.t1,three_way,86.78283333333333,FUN_017766-T1,P19517,,,,,56.8,405.0,1.8e-114,414.5,sp|P19517|CACB1_RABIT Voltage-dependent L-type calcium channel subunit beta-1 OS=Oryctolagus cuniculus OX=9986 GN=CACNB1 PE=1 SV=1,,,,,,
OG_04271,1.063260816630209,FUN_017829-T1,Peve_00029495,Pocillopora_meandrina_HIv1___RNAseq.g9642.t1,three_way,83.37966666666667,FUN_017829-T1,Q9NES8,,,,,59.1,477.0,9.1e-164,578.2,sp|Q9NES8|PPP5_CAEEL Serine/threonine-protein phosphatase 5 OS=Caenorhabditis elegans OX=6239 GN=pph-5 PE=1 SV=2,,,,,,
OG_04285,1.3356993375472974,FUN_017848-T2,Peve_00013267,Pocillopora_meandrina_HIv1___RNAseq.g9584.t1a,three_way,68.80566666666667,FUN_017848-T2,Q09328,MGT5A_HUMAN,,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]",Homo sapiens (Human),37.0,873.0,6.1e-166,586.3,"sp|Q09328|MGT5A_HUMAN Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Homo sapiens OX=9606 GN=MGAT5 PE=1 SV=1",GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1904894,positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]",GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04297,1.398422572051945,FUN_017864-T1,Peve_00018760,Pocillopora_meandrina_HIv1___RNAseq.g9560.t1,three_way,71.19116666666666,FUN_017864-T1,Q9VM21,,,,,27.0,629.0,9.8e-54,213.4,sp|Q9VM21|GUDU_DROME Armadillo repeat-containing protein gudu OS=Drosophila melanogaster OX=7227 GN=gudu PE=2 SV=1,,,,,,
OG_04299,1.4653754751014496,FUN_017868-T1,Peve_00020409,Pocillopora_meandrina_HIv1___RNAseq.g9556.t1,three_way,92.76516666666666,FUN_017868-T1,Q6DKN2,,,,,73.3,86.0,6.7e-28,125.6,sp|Q6DKN2|OTX2B_XENLA Homeobox protein OTX2-B OS=Xenopus laevis OX=8355 GN=otx2-b PE=2 SV=1,,,,,,
OG_04302,1.482323023556432,FUN_017878-T1,Peve_00021114,Pocillopora_meandrina_HIv1___TS.g7116.t1,three_way,74.763,FUN_017878-T1,P97259,,,,,45.1,587.0,8.600000000000001e-145,515.4,"sp|P97259|MGT5A_CRIGR Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Cricetulus griseus OX=10029 GN=MGAT5 PE=1 SV=1",,,,,,
OG_04304,1.822620010691293,FUN_017889-T1,Peve_00001917,Pocillopora_meandrina_HIv1___RNAseq.g9667.t1,three_way,53.98566666666667,FUN_017889-T1,Q90X67,,,,,33.7,184.0,1.3e-19,97.8,sp|Q90X67|SOCS3_CHICK Suppressor of cytokine signaling 3 OS=Gallus gallus OX=9031 GN=SOCS3 PE=2 SV=1,,,,,,
OG_04319,1.2764823317344474,FUN_017919-T1,Peve_00005940,Pocillopora_meandrina_HIv1___RNAseq.g312.t1,three_way,45.6825,FUN_017919-T1,O88488,PTPRQ_RAT,,Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.36) (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Protein-tyrosine phosphatase receptor-type expressed by glomerular mesangial cells protein 1) (rPTP-GMC1) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q),Rattus norvegicus (Rat),26.4,1078.0,1.7e-50,203.8,sp|O88488|PTPRQ_RAT Phosphatidylinositol phosphatase PTPRQ OS=Rattus norvegicus OX=10116 GN=Ptprq PE=1 SV=1,GO:0002244; GO:0004439; GO:0004725; GO:0009925; GO:0016314; GO:0016324; GO:0032421; GO:0034485; GO:0042472; GO:0043235; GO:0043813; GO:0045598; GO:0050885; GO:0050910; GO:0052629; GO:0060116; GO:0120044,detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; receptor complex [GO:0043235]; stereocilium base [GO:0120044]; stereocilium bundle [GO:0032421],"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]",GO:0003824; GO:0016787; GO:0030154; GO:0050877; GO:0140096,"catalytic activity; hydrolase activity; cell differentiation; nervous system process; catalytic activity, acting on a protein"
OG_04334,1.1983362121182908,FUN_017946-T1,Peve_00001582,Pocillopora_meandrina_HIv1___TS.g6988.t2,three_way,85.60566666666666,FUN_017946-T1,A7SGZ5,,,,,70.4,216.0,1.4e-84,313.9,sp|A7SGZ5|EIF3K_NEMVE Eukaryotic translation initiation factor 3 subunit K OS=Nematostella vectensis OX=45351 GN=v1g170558 PE=3 SV=1,,,,,,
OG_04346,1.2188061452226302,FUN_017970-T1,Peve_00000395,Pocillopora_meandrina_HIv1___TS.g25528.t2,three_way,63.346833333333336,FUN_017970-T1,Q9VM21,,,,,33.0,624.0,2.1999999999999997e-53,212.2,sp|Q9VM21|GUDU_DROME Armadillo repeat-containing protein gudu OS=Drosophila melanogaster OX=7227 GN=gudu PE=2 SV=1,,,,,,
OG_04351,1.3751770867589552,FUN_017990-T1,Peve_00037470,Pocillopora_meandrina_HIv1___RNAseq.g25285.t1,three_way,80.066,FUN_017990-T1,Q16665,,,,,40.2,388.0,3.2e-77,291.2,sp|Q16665|HIF1A_HUMAN Hypoxia-inducible factor 1-alpha OS=Homo sapiens OX=9606 GN=HIF1A PE=1 SV=1,,,,,,
OG_04376,1.087115900397162,FUN_018042-T1,Peve_00021780,Pocillopora_meandrina_HIv1___RNAseq.g25354.t1,three_way,62.6125,FUN_018042-T1,P25931,,,,,24.0,263.0,3.1e-06,54.7,sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2,,,,,,
OG_04398,1.0497566321989873,FUN_018403-T1,Peve_00033495,Pocillopora_meandrina_HIv1___RNAseq.g10162.t1,three_way,77.55466666666666,FUN_018403-T1,Q28811,,,,,61.2,485.0,7.3000000000000005e-180,631.7,sp|Q28811|PHR_POTTR Deoxyribodipyrimidine photo-lyase OS=Potorous tridactylus OX=9310 GN=PHR PE=2 SV=1,,,,,,
OG_04401,1.5864043936465442,FUN_018412-T1,Peve_00031696,Pocillopora_meandrina_HIv1___TS.g23694.t2,three_way,59.120666666666665,FUN_018412-T1,P28648,CD63_RAT,,CD63 antigen (Mast cell antigen AD1) (CD antigen CD63),Rattus norvegicus (Rat),36.8,242.0,2.3e-35,150.6,sp|P28648|CD63_RAT CD63 antigen OS=Rattus norvegicus OX=10116 GN=Cd63 PE=1 SV=2,GO:0002092; GO:0005615; GO:0005654; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0007160; GO:0009986; GO:0010008; GO:0010633; GO:0015031; GO:0016477; GO:0030855; GO:0031902; GO:0031904; GO:0032585; GO:0032991; GO:0035646; GO:0042470; GO:0043473; GO:0044877; GO:0045785; GO:0045807; GO:0048757; GO:0050931; GO:0070062; GO:0097487; GO:1900746; GO:1901379; GO:2001046,cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigment cell differentiation [GO:0050931]; pigment granule maturation [GO:0048757]; pigmentation [GO:0043473]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],"cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]",protein-containing complex binding [GO:0044877],GO:0005615; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0007155; GO:0030154; GO:0031410; GO:0043226; GO:0048870,extracellular space; nucleoplasm; lysosome; endosome; vacuole; plasma membrane; cell adhesion; cell differentiation; cytoplasmic vesicle; organelle; cell motility
OG_04404,1.106815191016128,FUN_018418-T2,Peve_00031690,Pocillopora_meandrina_HIv1___RNAseq.g10175.t1,three_way,54.339,,,,,,,,,,,,,,,,,
OG_04437,1.8707976556540429,FUN_018822-T1,Peve_00035783,Pocillopora_meandrina_HIv1___RNAseq.g9871.t1,three_way,38.3045,FUN_018822-T1,Q9Y2C9,TLR6_HUMAN,,Toll-like receptor 6 (CD antigen CD286),Homo sapiens (Human),36.5,148.0,1.2e-13,79.7,sp|Q9Y2C9|TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens OX=9606 GN=TLR6 PE=1 SV=2,GO:0001540; GO:0001774; GO:0002224; GO:0002755; GO:0004888; GO:0005102; GO:0005794; GO:0005886; GO:0006954; GO:0006955; GO:0007165; GO:0007250; GO:0010628; GO:0030670; GO:0032717; GO:0032720; GO:0032731; GO:0032755; GO:0034136; GO:0035355; GO:0035663; GO:0035666; GO:0038023; GO:0038124; GO:0042496; GO:0042498; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043507; GO:0045087; GO:0045121; GO:0045429; GO:0046209; GO:0046982; GO:0050729; GO:0061809; GO:0071723; GO:0071726; GO:0140052; GO:1900017; GO:1900227; GO:1903428; GO:1904646; GO:2001238,activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide metabolic process [GO:0046209]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355],"amyloid-beta binding [GO:0001540]; diacyl lipopeptide binding [GO:0042498]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003824; GO:0005794; GO:0005886; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060089; GO:0098542,immune system process; catalytic activity; Golgi apparatus; plasma membrane; inflammatory response; lipid binding; hydrolase activity; organelle; molecular transducer activity; defense response to other organism
OG_04439,1.0538524695177938,FUN_018835-T2,Peve_00035787,Pocillopora_meandrina_HIv1___RNAseq.g9856.t1,three_way,77.22033333333333,FUN_018835-T2,Q9C0G6,DYH6_HUMAN,,Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6),Homo sapiens (Human),37.1,4337.0,0.0,2654.0,sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3,GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729,cilium movement involved in cell motility [GO:0060294],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_04450,1.0393506006475333,FUN_019023-T1,Peve_00009450,Pocillopora_meandrina_HIv1___RNAseq.g9987.t1,three_way,68.78166666666667,,,,,,,,,,,,,,,,,
OG_04463,1.1820382617514338,FUN_019342-T1,Peve_00032901,Pocillopora_meandrina_HIv1___RNAseq.g20862.t1,three_way,54.33,FUN_019342-T1,Q01071,ESMD_DROME,,Enhancer of split mdelta protein (E(spl)mdelta) (HLH-mdelta) (Split locus enhancer protein mC),Drosophila melanogaster (Fruit fly),36.6,123.0,2e-12,74.3,sp|Q01071|ESMD_DROME Enhancer of split mdelta protein OS=Drosophila melanogaster OX=7227 GN=E(spl)mdelta-HLH PE=1 SV=1,GO:0000122; GO:0000978; GO:0005634; GO:0007219; GO:0007525; GO:0043565; GO:0045466; GO:0046983; GO:0048052; GO:0050767; GO:1902692; GO:1990837,negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; R1/R6 cell differentiation [GO:0048052]; R7 cell differentiation [GO:0045466]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; somatic muscle development [GO:0007525],nucleus [GO:0005634],protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development
OG_04476,1.900200139497528,FUN_020920-T1,Peve_00017285,Pocillopora_meandrina_HIv1___RNAseq.g15907.t1a,three_way,47.4085,FUN_020920-T1,O95450,,,,,28.7,905.0,8.1e-97,356.7,sp|O95450|ATS2_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Homo sapiens OX=9606 GN=ADAMTS2 PE=1 SV=2,,,,,,
OG_04490,1.5805038841051255,FUN_021819-T1,Peve_00036137,Pocillopora_meandrina_HIv1___TS.g20331.t1a,three_way,68.62833333333333,,,,,,,,,,,,,,,,,
OG_04508,1.9034689944348488,FUN_022036-T1,Peve_00019003,Pocillopora_meandrina_HIv1___RNAseq.g9285.t1,three_way,61.077333333333335,,,,,,,,,,,,,,,,,
OG_04513,1.1641165814645698,FUN_022046-T1,Peve_00007833,Pocillopora_meandrina_HIv1___RNAseq.g9288.t1,three_way,85.22166666666666,FUN_022046-T1,Q8WVP7,LMBR1_HUMAN,,Limb region 1 protein homolog (Differentiation-related gene 14 protein),Homo sapiens (Human),51.5,464.0,4.4000000000000006e-118,426.4,sp|Q8WVP7|LMBR1_HUMAN Limb region 1 protein homolog OS=Homo sapiens OX=9606 GN=LMBR1 PE=1 SV=1,GO:0004888; GO:0005886; GO:0007165; GO:0042733,embryonic digit morphogenesis [GO:0042733]; signal transduction [GO:0007165],plasma membrane [GO:0005886],transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_04514,1.3112663202129342,FUN_022047-T1,Peve_00017133,Pocillopora_meandrina_HIv1___RNAseq.g4597.t1,three_way,56.1085,FUN_022047-T1,Q8JZM8,,,,,27.0,852.0,8.8e-68,261.5,sp|Q8JZM8|MUC4_MOUSE Mucin-4 OS=Mus musculus OX=10090 GN=Muc4 PE=2 SV=2,,,,,,
OG_04515,1.2136019871225492,FUN_022048-T1,Peve_00017132,Pocillopora_meandrina_HIv1___RNAseq.g4598.t1,three_way,56.047666666666665,FUN_022048-T1,Q7TN88,,,,,27.8,1834.0,3.2e-182,642.5,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_04516,1.2107827856505022,FUN_022049-T1,Peve_00032394,Pocillopora_meandrina_HIv1___RNAseq.g4599.t1,three_way,67.69266666666667,FUN_022049-T1,Q9C098,DCLK3_HUMAN,,Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3),Homo sapiens (Human),59.1,269.0,2e-91,338.6,sp|Q9C098|DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens OX=9606 GN=DCLK3 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0034504; GO:0106310,protein localization to nucleus [GO:0034504],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04544,1.6911103755622447,FUN_022106-T1,Peve_00025701,Pocillopora_meandrina_HIv1___RNAseq.g9229.t1,three_way,68.26433333333333,FUN_022106-T1,Q5E9J9,,,,,39.2,375.0,1.3e-70,268.5,sp|Q5E9J9|STRAA_BOVIN STE20-related kinase adapter protein alpha OS=Bos taurus OX=9913 GN=STRADA PE=2 SV=1,,,,,,
OG_04553,1.3810038209296298,FUN_022183-T1,Peve_00036603,Pocillopora_meandrina_HIv1___RNAseq.g4789.t1,three_way,67.36933333333333,FUN_022183-T1,Q5E9T4,TPK1_BOVIN,,Thiamine pyrophosphokinase 1 (EC 2.7.6.-),Bos taurus (Bovine),49.1,230.0,3.7e-60,233.0,sp|Q5E9T4|TPK1_BOVIN Thiamine pyrophosphokinase 1 OS=Bos taurus OX=9913 GN=TPK1 PE=2 SV=1,GO:0004788; GO:0005524; GO:0006772; GO:0009229; GO:0016301; GO:0030975; GO:0141200,thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772],,ATP binding [GO:0005524]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; UTP thiamine diphosphokinase activity [GO:0141200],GO:0003824; GO:0006766; GO:0006790; GO:0016740,catalytic activity; vitamin metabolic process; sulfur compound metabolic process; transferase activity
OG_04560,1.4950757307553828,FUN_022199-T1,Peve_00041449,Pocillopora_meandrina_HIv1___RNAseq.g4798.t1,three_way,67.538,,,,,,,,,,,,,,,,,
OG_04601,1.2563299201435172,FUN_022288-T1,Peve_00003595,Pocillopora_meandrina_HIv1___RNAseq.g4695.t1,three_way,67.76066666666667,FUN_022288-T1,Q9Z340,PARD3_RAT,,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (Atypical PKC-specific-binding protein) (ASBP),Rattus norvegicus (Rat),32.5,805.0,1.7e-76,289.7,sp|Q9Z340|PARD3_RAT Partitioning defective 3 homolog OS=Rattus norvegicus OX=10116 GN=Pard3 PE=1 SV=1,GO:0000226; GO:0002092; GO:0003383; GO:0005546; GO:0005547; GO:0005737; GO:0005819; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007155; GO:0008104; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0032970; GO:0032991; GO:0033269; GO:0035091; GO:0042802; GO:0043025; GO:0043219; GO:0043220; GO:0043296; GO:0044295; GO:0044319; GO:0045197; GO:0051301; GO:0051642; GO:0051660; GO:0060341; GO:0070830; GO:0090162; GO:0120157,"apical constriction [GO:0003383]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome localization [GO:0051642]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; positive regulation of receptor internalization [GO:0002092]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; regulation of actin filament-based process [GO:0032970]; regulation of cellular localization [GO:0060341]; wound healing, spreading of cells [GO:0044319]",adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; lateral loop [GO:0043219]; neuronal cell body [GO:0043025]; PAR polarity complex [GO:0120157]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]",GO:0007010; GO:0007155; GO:0007163; GO:0008289; GO:0034330; GO:0043226; GO:0048870,cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; lipid binding; cell junction organization; organelle; cell motility
OG_04604,1.2260217514608929,FUN_022293-T1,Peve_00003688,Pocillopora_meandrina_HIv1___RNAseq.g4691.t1,three_way,65.73366666666666,,,,,,,,,,,,,,,,,
OG_04618,1.4569137745437373,FUN_022319-T1,Peve_00021701,Pocillopora_meandrina_HIv1___TS.g22054.t1,three_way,56.806333333333335,,,,,,,,,,,,,,,,,
OG_04675,1.0201727376740135,FUN_022437-T1,Peve_00017892,Pocillopora_meandrina_HIv1___RNAseq.g4335.t1,three_way,81.93833333333333,FUN_022437-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),42.7,450.0,4.5e-92,340.1,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_04677,1.7440792408782857,FUN_022446-T1,Peve_00037587,Pocillopora_meandrina_HIv1___RNAseq.g4330.t1,three_way,71.33800000000001,FUN_022446-T1,Q29496,CP3AO_SHEEP,,Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24),Ovis aries (Sheep),38.8,485.0,1.4999999999999999e-92,341.7,sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1,GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0016712; GO:0020037; GO:0050649; GO:0070989,oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; testosterone 6-beta-hydroxylase activity [GO:0050649]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_04692,1.37431506918042,FUN_022484-T1,Peve_00002924,Pocillopora_meandrina_HIv1___RNAseq.g4295.t1,three_way,86.47083333333333,FUN_022484-T1,Q8VID6,PDE11_RAT,,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)",Rattus norvegicus (Rat),47.6,930.0,9.3e-242,838.2,"sp|Q8VID6|PDE11_RAT Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A OS=Rattus norvegicus OX=10116 GN=Pde11a PE=1 SV=1",GO:0004115; GO:0004118; GO:0005829; GO:0010754; GO:0019933; GO:0030553; GO:0043204; GO:0046872; GO:0047555; GO:0141162,cAMP-mediated signaling [GO:0019933]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754],cytosol [GO:0005829]; perikaryon [GO:0043204],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787,catalytic activity; cytosol; hydrolase activity
OG_04693,2.7246603729129397,FUN_022485-T1,Peve_00002925,Pocillopora_meandrina_HIv1___RNAseq.g4293.t1,three_way,88.12733333333333,,,,,,,,,,,,,,,,,
OG_04723,1.0298514977349846,FUN_022586-T1,Peve_00020593,Pocillopora_meandrina_HIv1___RNAseq.g4434.t2,three_way,67.00133333333333,FUN_022586-T1,Q9BE31,,,,,29.9,632.0,8e-77,289.7,sp|Q9BE31|RHG12_MACFA Rho GTPase-activating protein 12 OS=Macaca fascicularis OX=9541 GN=ARHGAP12 PE=2 SV=1,,,,,,
OG_04724,1.292652278402417,FUN_022589-T1,Peve_00020263,Pocillopora_meandrina_HIv1___RNAseq.g4431.t1,three_way,80.9065,FUN_022589-T1,O70172,,,,,50.9,450.0,7.000000000000003e-110,399.1,sp|O70172|PI42A_MOUSE Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha OS=Mus musculus OX=10090 GN=Pip4k2a PE=1 SV=1,,,,,,
OG_04737,1.7859880941776405,FUN_022613-T1,Peve_00012263,Pocillopora_meandrina_HIv1___RNAseq.g4397.t1,three_way,68.725,FUN_022613-T1,A0A0R4IKU3,RECK_DANRE,,Reversion-inducing cysteine-rich protein with Kazal motifs,Danio rerio (Zebrafish) (Brachydanio rerio),38.2,961.0,2.3000000000000002e-201,704.1,sp|A0A0R4IKU3|RECK_DANRE Reversion-inducing cysteine-rich protein with Kazal motifs OS=Danio rerio OX=7955 GN=reck PE=1 SV=3,GO:0001944; GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0015026; GO:0016055; GO:0030198; GO:0045765; GO:0051726; GO:0060070; GO:0060828; GO:0090049; GO:0090210; GO:0098552; GO:1904684; GO:1990791; GO:1990909,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; dorsal root ganglion development [GO:1990791]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909],coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005886; GO:0030198; GO:0048856; GO:0060089; GO:0098772,plasma membrane; extracellular matrix organization; anatomical structure development; molecular transducer activity; molecular function regulator activity
OG_04747,1.2888385893291894,FUN_022630-T1,Peve_00012283,Pocillopora_meandrina_HIv1___RNAseq.g2910.t1,three_way,68.43933333333334,FUN_022630-T1,P07228,,,,,38.2,815.0,1.2e-144,515.4,sp|P07228|ITB1_CHICK Integrin beta-1 OS=Gallus gallus OX=9031 GN=ITGB1 PE=1 SV=1,,,,,,
OG_04748,1.299057704299822,FUN_022631-T1,Peve_00012222,Pocillopora_meandrina_HIv1___RNAseq.g2907.t1,three_way,61.568000000000005,FUN_022631-T1,C3ZQF9,,,,,31.4,322.0,7.4e-33,143.3,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_04754,1.283434107425948,FUN_022639-T1,Peve_00022141,Pocillopora_meandrina_HIv1___RNAseq.g9366.t2,three_way,68.227,FUN_022639-T1,Q9H330,,,,,37.4,854.0,4.4999999999999997e-129,463.8,sp|Q9H330|TM245_HUMAN Transmembrane protein 245 OS=Homo sapiens OX=9606 GN=TMEM245 PE=1 SV=3,,,,,,
OG_04757,1.0349449988700852,FUN_022644-T2,Peve_00044335,Pocillopora_meandrina_HIv1___RNAseq.g9376.t1,three_way,70.68516666666667,FUN_022644-T2,Q9UNS1,TIM_HUMAN,,Protein timeless homolog (hTIM),Homo sapiens (Human),42.1,1053.0,1.1e-205,718.8,sp|Q9UNS1|TIM_HUMAN Protein timeless homolog OS=Homo sapiens OX=9606 GN=TIMELESS PE=1 SV=2,GO:0000076; GO:0000785; GO:0002009; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007623; GO:0008047; GO:0009582; GO:0030324; GO:0031297; GO:0031298; GO:0035861; GO:0042752; GO:0042802; GO:0043111; GO:0044770; GO:0045892; GO:0048754; GO:0051301; GO:0072711; GO:0072719; GO:1904976; GO:1905168; GO:2000781,branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork processing [GO:0031297],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861],DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802],GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006355; GO:0043226; GO:0048856; GO:0098772,DNA binding; nucleus; nucleoplasm; DNA repair; regulation of DNA-templated transcription; organelle; anatomical structure development; molecular function regulator activity
OG_04764,1.2388855543289503,FUN_022664-T2,Peve_00027942,Pocillopora_meandrina_HIv1___RNAseq.g3154.t1,three_way,68.32866666666666,FUN_022664-T2,O19094,OCTC_BOVIN,,Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137),Bos taurus (Bovine),42.1,598.0,9.4e-137,488.8,sp|O19094|OCTC_BOVIN Peroxisomal carnitine O-octanoyltransferase OS=Bos taurus OX=9913 GN=CROT PE=1 SV=1,GO:0005777; GO:0006091; GO:0006631; GO:0006635; GO:0008458; GO:0009437; GO:0015936; GO:0051791,carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791],peroxisome [GO:0005777],carnitine O-octanoyltransferase activity [GO:0008458],GO:0003824; GO:0005777; GO:0006091; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; peroxisome; generation of precursor metabolites and energy; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_04819,1.8500237324374864,FUN_022805-T1,Peve_00018106,Pocillopora_meandrina_HIv1___RNAseq.g3479.t1,three_way,60.698,,,,,,,,,,,,,,,,,
OG_04825,2.268657634768,FUN_022817-T1,Peve_00014997,Pocillopora_meandrina_HIv1___TS.g9632.t1,three_way,48.804,,,,,,,,,,,,,,,,,
OG_04843,1.262546943413879,FUN_022852-T1,Peve_00028878,Pocillopora_meandrina_HIv1___RNAseq.g3393.t1,three_way,64.0195,FUN_022852-T1,Q5ZJS6,,,,,34.9,129.0,1.5e-07,57.4,sp|Q5ZJS6|PAIP2_CHICK Polyadenylate-binding protein-interacting protein 2 OS=Gallus gallus OX=9031 GN=PAIP2 PE=2 SV=1,,,,,,
OG_04862,1.875944120341681,FUN_022879-T1,Peve_00012290,Pocillopora_meandrina_HIv1___RNAseq.g3622.t1,three_way,61.50833333333333,,,,,,,,,,,,,,,,,
OG_04870,1.749879605325838,FUN_022897-T1,Peve_00001717,Pocillopora_meandrina_HIv1___RNAseq.g3698.t1,three_way,60.53266666666666,FUN_022897-T1,Q0VCR4,PPR3C_BOVIN,,Protein phosphatase 1 regulatory subunit 3C (Protein phosphatase 1 regulatory subunit 5) (PP1 subunit R5) (Protein targeting to glycogen) (PTG),Bos taurus (Bovine),35.8,176.0,3e-26,120.2,sp|Q0VCR4|PPR3C_BOVIN Protein phosphatase 1 regulatory subunit 3C OS=Bos taurus OX=9913 GN=PPP1R3C PE=2 SV=1,GO:0000164; GO:0005829; GO:0005977; GO:0005978; GO:0005979; GO:0008157; GO:0019903; GO:0060090; GO:2001069,glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979],cytosol [GO:0005829]; protein phosphatase type 1 complex [GO:0000164],glycogen binding [GO:2001069]; molecular adaptor activity [GO:0060090]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903],GO:0005829; GO:0005975; GO:0006091; GO:0060090,cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; molecular adaptor activity
OG_04895,1.240710107344831,FUN_022939-T1,Peve_00026755,Pocillopora_meandrina_HIv1___RNAseq.g3742.t1,three_way,61.73183333333333,FUN_022939-T1,A8WG21,,,,,39.9,153.0,2.9e-19,97.1,sp|A8WG21|SNXAB_DANRE Sorting nexin-10B OS=Danio rerio OX=7955 GN=snx10b PE=2 SV=1,,,,,,
OG_04910,1.0805951999554388,FUN_022960-T1,Peve_00011908,Pocillopora_meandrina_HIv1___RNAseq.g3769.t1a,three_way,65.96483333333333,FUN_022960-T1,P41596,,,,,28.2,358.0,1.7e-21,105.5,sp|P41596|DOPR1_DROME Dopamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=Dop1R1 PE=2 SV=2,,,,,,
OG_04912,1.0401998845788014,FUN_022965-T1,Peve_00011899,Pocillopora_meandrina_HIv1___RNAseq.g3764.t1,three_way,81.05166666666666,FUN_022965-T1,Q6NTV9,,,,,55.1,98.0,1.2e-22,107.5,sp|Q6NTV9|NHP2_XENLA H/ACA ribonucleoprotein complex subunit 2-like protein OS=Xenopus laevis OX=8355 GN=nhp2 PE=2 SV=1,,,,,,
OG_04976,1.1737310698337264,FUN_023085-T1,Peve_00027837,Pocillopora_meandrina_HIv1___RNAseq.g1661.t1,three_way,55.247166666666665,FUN_023085-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),30.7,313.0,4.7e-31,137.1,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_04997,1.1410765543485024,FUN_023132-T1,Peve_00008526,Pocillopora_meandrina_HIv1___RNAseq.g1755.t1,three_way,43.72866666666667,FUN_023132-T1,O16264,,,,,38.7,75.0,4.9e-09,62.4,sp|O16264|PEBPH_CAEEL Phosphatidylethanolamine-binding protein homolog F40A3.3 OS=Caenorhabditis elegans OX=6239 GN=F40A3.3 PE=3 SV=1,,,,,,
OG_04999,1.6240198142561062,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_05032,1.0155097110570792,FUN_023211-T1,Peve_00010008,Pocillopora_meandrina_HIv1___RNAseq.g688.t1,three_way,82.62133333333334,FUN_023211-T1,Q6IND7,,,,,42.0,300.0,9.999999999999999e-64,245.4,sp|Q6IND7|LR2BP_XENLA LRP2-binding protein OS=Xenopus laevis OX=8355 GN=lrp2bp PE=2 SV=1,,,,,,
OG_05047,1.0720296931978488,FUN_023236-T1,Peve_00029852,Pocillopora_meandrina_HIv1___TS.g16967.t1,three_way,66.868,FUN_023236-T1,Q8AW42,,,,,44.2,353.0,1.7e-70,268.1,sp|Q8AW42|S39AD_DANRE Zinc transporter ZIP13 OS=Danio rerio OX=7955 GN=slc39a13 PE=2 SV=1,,,,,,
OG_05083,1.0957757883281611,FUN_023316-T2,Peve_00017883,Pocillopora_meandrina_HIv1___RNAseq.g17768.t1,three_way,78.326,FUN_023316-T2,P63138,GBRB2_RAT,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Rattus norvegicus (Rat),32.2,391.0,1.6000000000000002e-48,194.9,sp|P63138|GBRB2_RAT Gamma-aminobutyric acid receptor subunit beta-2 OS=Rattus norvegicus OX=10116 GN=Gabrb2 PE=1 SV=1,GO:0004890; GO:0005237; GO:0005254; GO:0005886; GO:0007214; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0048666; GO:0048787; GO:0051932; GO:0060119; GO:0060384; GO:0071420; GO:0090102; GO:0098978; GO:0098982; GO:0099507; GO:0099634; GO:1902476; GO:1902710; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; neuron development [GO:0048666]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA receptor complex [GO:1902710]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynaptic active zone membrane [GO:0048787],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; inhibitory extracellular ligand-gated monoatomic ion channel activity [GO:0005237]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; anatomical structure development; transmembrane transport; molecular transducer activity
OG_05087,1.1038423175455327,FUN_023324-T2,Peve_00004283,Pocillopora_meandrina_HIv1___RNAseq.g17837.t1,three_way,49.6935,FUN_023324-T2,Q9D733,GP2_MOUSE,,Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2),Mus musculus (Mouse),35.4,164.0,5.600000000000001e-23,111.3,sp|Q9D733|GP2_MOUSE Pancreatic secretory granule membrane major glycoprotein GP2 OS=Mus musculus OX=10090 GN=Gp2 PE=1 SV=3,GO:0002412; GO:0003823; GO:0005615; GO:0005768; GO:0009897; GO:0016324; GO:0042589; GO:0045087; GO:0045121; GO:0051649,antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]; establishment of localization in cell [GO:0051649]; innate immune response [GO:0045087],apical plasma membrane [GO:0016324]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; zymogen granule membrane [GO:0042589],antigen binding [GO:0003823],GO:0002376; GO:0005615; GO:0005768; GO:0016192; GO:0031410; GO:0043226; GO:0098542,immune system process; extracellular space; endosome; vesicle-mediated transport; cytoplasmic vesicle; organelle; defense response to other organism
OG_05099,1.886860914553252,FUN_023351-T1,Peve_00035607,Pocillopora_meandrina_HIv1___RNAseq.g17430.t1,three_way,83.50133333333333,FUN_023351-T1,Q802G6,MSB1A_DANRE,,Methionine-R-sulfoxide reductase B1-A (MsrB) (MsrB1-A) (EC 1.8.4.12) (EC 1.8.4.14) (Selenoprotein X-A) (SePR) (SelX-A),Danio rerio (Zebrafish) (Brachydanio rerio),58.6,99.0,5.799999999999997e-29,128.3,sp|Q802G6|MSB1A_DANRE Methionine-R-sulfoxide reductase B1-A OS=Danio rerio OX=7955 GN=msrb1 PE=2 SV=3,GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0030041; GO:0030091; GO:0033743; GO:0033745; GO:0045087; GO:0046872,actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]; protein repair [GO:0030091],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634],actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743],GO:0002376; GO:0003824; GO:0005634; GO:0005856; GO:0008092; GO:0016491; GO:0043226; GO:0065003; GO:0098542,immune system process; catalytic activity; nucleus; cytoskeleton; cytoskeletal protein binding; oxidoreductase activity; organelle; protein-containing complex assembly; defense response to other organism
OG_05136,1.8603837908217904,FUN_023407-T1,Peve_00016102,Pocillopora_meandrina_HIv1___RNAseq.g17552.t1,three_way,89.46416666666667,FUN_023407-T1,P24032,,,,,63.5,170.0,1.6e-54,213.8,"sp|P24032|MLRN_CHICK Myosin regulatory light chain 2, smooth muscle minor isoform OS=Gallus gallus OX=9031 PE=1 SV=2",,,,,,
OG_05138,1.6573379676955131,FUN_023410-T1,Peve_00017394,Pocillopora_meandrina_HIv1___RNAseq.g17575.t1,three_way,54.03783333333333,FUN_023410-T1,Q1LYG0,,,,,34.5,313.0,3.9e-50,201.8,sp|Q1LYG0|SPD2A_DANRE SH3 and PX domain-containing protein 2A OS=Danio rerio OX=7955 GN=sh3pxd2a PE=3 SV=2,,,,,,
OG_05149,1.004910633551695,FUN_023431-T1,Peve_00019220,Pocillopora_meandrina_HIv1___RNAseq.g563.t1,three_way,61.802166666666665,FUN_023431-T1,O13076,,,,,23.0,309.0,6e-08,60.1,sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1,,,,,,
OG_05183,3.565661824223517,FUN_023529-T1,Peve_00044316,Pocillopora_meandrina_HIv1___TS.g7657.t1,three_way,73.594,,,,,,,,,,,,,,,,,
OG_05189,1.280828535370303,FUN_023555-T1,Peve_00009058,Pocillopora_meandrina_HIv1___RNAseq.g3555.t1,three_way,64.18966666666667,FUN_023555-T1,Q9UIF7,MUTYH_HUMAN,,Adenine DNA glycosylase (EC 3.2.2.31) (MutY homolog) (hMYH),Homo sapiens (Human),47.7,472.0,1.2e-110,401.7,sp|Q9UIF7|MUTYH_HUMAN Adenine DNA glycosylase OS=Homo sapiens OX=9606 GN=MUTYH PE=1 SV=1,GO:0000701; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006298; GO:0019104; GO:0032357; GO:0032407; GO:0034039; GO:0035485; GO:0045007; GO:0046872; GO:0051539; GO:0060546,base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; negative regulation of necroptotic process [GO:0060546],mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0016787; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_05194,1.1379180927046544,FUN_023565-T2,Peve_00037262,Pocillopora_meandrina_HIv1___RNAseq.g514.t1,three_way,79.68733333333333,FUN_023565-T2,Q14642,,,,,45.9,386.0,2e-98,360.9,sp|Q14642|I5P1_HUMAN Inositol polyphosphate-5-phosphatase A OS=Homo sapiens OX=9606 GN=INPP5A PE=1 SV=1,,,,,,
OG_05198,2.72122285645755,FUN_023578-T1,Peve_00035142,Pocillopora_meandrina_HIv1___RNAseq.g3534.t2,three_way,64.644,FUN_023578-T1,O95786,RIGI_HUMAN,,Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),Homo sapiens (Human),35.5,716.0,2.1e-106,388.7,sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2,GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005829; GO:0005856; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; cytosol; cytoskeleton; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; molecular transducer activity; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05208,1.0486622421136795,FUN_023592-T1,Peve_00023919,Pocillopora_meandrina_HIv1___RNAseq.g3311.t1,three_way,44.60383333333333,FUN_023592-T1,E9PVX6,KI67_MOUSE,,Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog),Mus musculus (Mouse),42.2,135.0,5.7e-18,95.9,sp|E9PVX6|KI67_MOUSE Proliferation marker protein Ki-67 OS=Mus musculus OX=10090 GN=Mki67 PE=1 SV=1,GO:0000775; GO:0000793; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0007059; GO:0007088; GO:0008283; GO:0050673; GO:0051321; GO:0072089; GO:0072574; GO:0140693; GO:1902275; GO:1990705,cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; chromosome segregation [GO:0007059]; epithelial cell proliferation [GO:0050673]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of mitotic nuclear division [GO:0007088]; stem cell proliferation [GO:0072089],"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; molecular condensate scaffold activity [GO:0140693]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0007059; GO:0022414; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; chromosome; nucleolus; chromosome segregation; reproductive process; organelle; molecular adaptor activity
OG_05226,2.9210130064293622,FUN_023639-T1,Peve_00027828,Pocillopora_meandrina_HIv1___RNAseq.g17814.t1c,three_way,45.796,,,,,,,,,,,,,,,,,
OG_05234,1.062073759278125,FUN_023649-T1,Peve_00027829,Pocillopora_meandrina_HIv1___RNAseq.g19794.t1,three_way,56.414,FUN_023649-T1,O96790,,,,,33.2,277.0,5.8e-27,123.2,sp|O96790|DPGN_DIPMA Serine protease inhibitor dipetalogastin (Fragment) OS=Dipetalogaster maximus OX=72496 PE=1 SV=2,,,,,,
OG_05248,1.0152368008577366,FUN_023694-T1,Peve_00017435,Pocillopora_meandrina_HIv1___RNAseq.g17612.t1,three_way,85.42266666666667,FUN_023694-T1,Q28G26,P4K2B_XENTR,,Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),61.3,434.0,4.4e-152,539.3,sp|Q28G26|P4K2B_XENTR Phosphatidylinositol 4-kinase type 2-beta OS=Xenopus tropicalis OX=8364 GN=pi4k2b PE=2 SV=1,GO:0000139; GO:0004430; GO:0005524; GO:0005789; GO:0005829; GO:0005886; GO:0031901; GO:0046854,phosphatidylinositol phosphate biosynthetic process [GO:0046854],cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524],GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0016740,catalytic activity; cytosol; plasma membrane; lipid metabolic process; transferase activity
OG_05253,1.0938645638251816,FUN_023701-T1,Peve_00017415,Pocillopora_meandrina_HIv1___RNAseq.g17594.t1,three_way,79.94866666666667,FUN_023701-T1,Q8IYX7,SAXO1_HUMAN,,Stabilizer of axonemal microtubules 1,Homo sapiens (Human),21.5,498.0,2.4e-12,75.1,sp|Q8IYX7|SAXO1_HUMAN Stabilizer of axonemal microtubules 1 OS=Homo sapiens OX=9606 GN=SAXO1 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005856; GO:0005879; GO:0008017; GO:0009631; GO:0030030; GO:0031514; GO:0036064; GO:0036126; GO:0045724; GO:0050821; GO:0070417,cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821],axonemal microtubule [GO:0005879]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],microtubule binding [GO:0008017],GO:0005815; GO:0005856; GO:0005929; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton; cilium; cytoskeletal protein binding; organelle
OG_05259,1.0266902973146932,FUN_023765-T1,Peve_00030839,Pocillopora_meandrina_HIv1___TS.g9692.t1a,three_way,65.00833333333333,FUN_023765-T1,P17453,,,,,32.3,473.0,4.500000000000001e-65,250.4,sp|P17453|BPI_BOVIN Bactericidal permeability-increasing protein OS=Bos taurus OX=9913 GN=BPI PE=2 SV=2,,,,,,
OG_05286,1.5729173799715566,FUN_023949-T1,Peve_00016150,Pocillopora_meandrina_HIv1___RNAseq.2014_t,three_way,80.2065,FUN_023949-T1,P51830,,,,,39.3,1189.0,3.8999999999999997e-205,716.8,sp|P51830|ADCY9_MOUSE Adenylate cyclase type 9 OS=Mus musculus OX=10090 GN=Adcy9 PE=1 SV=1,,,,,,
OG_05305,2.1042018989339004,FUN_023978-T1,Peve_00020874,Pocillopora_meandrina_HIv1___RNAseq.g19435.t1,three_way,47.72816666666667,,,,,,,,,,,,,,,,,
OG_05331,1.2341047982094235,FUN_024037-T1,Peve_00020333,Pocillopora_meandrina_HIv1___RNAseq.g19274.t1,three_way,74.21233333333333,FUN_024037-T1,O00462,MANBA_HUMAN,,Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase),Homo sapiens (Human),47.2,885.0,1.1999999999999998e-243,844.3,sp|O00462|MANBA_HUMAN Beta-mannosidase OS=Homo sapiens OX=9606 GN=MANBA PE=1 SV=3,GO:0004567; GO:0005886; GO:0006516; GO:0009313; GO:0035577; GO:0036211; GO:0043202; GO:0043231,glycoprotein catabolic process [GO:0006516]; oligosaccharide catabolic process [GO:0009313]; protein modification process [GO:0036211],azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886],beta-mannosidase activity [GO:0004567],GO:0003824; GO:0005886; GO:0005975; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; plasma membrane; carbohydrate metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_05350,1.5218120649940363,FUN_024113-T1,Peve_00000184,Pocillopora_meandrina_HIv1___RNAseq.g19187.t1,three_way,78.90166666666667,FUN_024113-T1,Q9UI95,MD2L2_HUMAN,,Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2) (MAD2-like protein 2) (REV7 homolog) (hREV7),Homo sapiens (Human),55.6,160.0,4.5e-44,179.1,sp|Q9UI95|MD2L2_HUMAN Mitotic spindle assembly checkpoint protein MAD2B OS=Homo sapiens OX=9606 GN=MAD2L2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0001558; GO:0002208; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005819; GO:0006302; GO:0007015; GO:0007094; GO:0008432; GO:0010719; GO:0010944; GO:0016035; GO:0033138; GO:0035861; GO:0042177; GO:0042276; GO:0042772; GO:0043247; GO:0045830; GO:0045893; GO:0051301; GO:0061629; GO:0090090; GO:1904667; GO:2000042; GO:2000048; GO:2001034,"actin filament organization [GO:0007015]; cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; double-strand break repair [GO:0006302]; error-prone translesion synthesis [GO:0042276]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cell growth [GO:0001558]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247]",chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035],JUN kinase binding [GO:0008432]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006355; GO:0032200; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; nucleoplasm; chromosome; DNA repair; regulation of DNA-templated transcription; telomere organization; organelle; molecular adaptor activity; transcription regulator activity
OG_05351,2.9837067200428606,FUN_024121-T1,Peve_00000177,Pocillopora_meandrina_HIv1___RNAseq.g19176.t1,three_way,46.95433333333333,,,,,,,,,,,,,,,,,
OG_05402,1.3320947170942188,FUN_024333-T1,Peve_00016310,Pocillopora_meandrina_HIv1___RNAseq.g18942.t1,three_way,73.826,FUN_024333-T1,Q8BFR4,,,,,53.1,490.0,1.6e-153,544.3,sp|Q8BFR4|GNS_MOUSE N-acetylglucosamine-6-sulfatase OS=Mus musculus OX=10090 GN=Gns PE=1 SV=1,,,,,,
OG_05418,2.2746929729240497,FUN_024357-T1,Peve_00024183,Pocillopora_meandrina_HIv1___RNAseq.g18694.t1,three_way,60.891,,,,,,,,,,,,,,,,,
OG_05436,1.4439431284479167,FUN_024389-T1,Peve_00018044,Pocillopora_meandrina_HIv1___RNAseq.g18620.t1,three_way,74.58266666666667,FUN_024389-T1,O70433,,,,,39.0,269.0,1.3e-68,262.3,sp|O70433|FHL2_MOUSE Four and a half LIM domains protein 2 OS=Mus musculus OX=10090 GN=Fhl2 PE=1 SV=1,,,,,,
OG_05440,1.2009295204076145,FUN_024393-T1,Peve_00005016,Pocillopora_meandrina_HIv1___RNAseq.g18624.t1,three_way,66.556,FUN_024393-T1,P42674,,,,,48.3,201.0,1.4e-44,182.2,sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1,,,,,,
OG_05468,1.074687447080641,FUN_024451-T1,Peve_00003482,Pocillopora_meandrina_HIv1___RNAseq.g18852.t1,three_way,84.42533333333333,FUN_024451-T1,Q6P5I8,,,,,47.8,228.0,1.8e-45,184.1,sp|Q6P5I8|YIPF5_DANRE Protein YIPF5 OS=Danio rerio OX=7955 GN=yipf5 PE=2 SV=1,,,,,,
OG_05471,2.186989513578688,FUN_024454-T1,Peve_00010316,Pocillopora_meandrina_HIv1___RNAseq.g18577.t1,three_way,67.4025,FUN_024454-T1,Q5DTZ6,,,,,45.4,273.0,1.5e-58,228.4,sp|Q5DTZ6|RN150_MOUSE RING finger protein 150 OS=Mus musculus OX=10090 GN=Rnf150 PE=2 SV=2,,,,,,
OG_05474,1.2724608550093774,FUN_024457-T1,Peve_00010311,Pocillopora_meandrina_HIv1___TS.g27964.t1,three_way,63.876,FUN_024457-T1,Q9H8H3,TMT1A_HUMAN,,Thiol S-methyltransferase TMT1A (EC 2.1.1.9) (Methyltransferase-like protein 7A) (N6-adenosine-methyltransferase TMT1A) (EC 2.1.1.348) (Protein AAM-B) (Thiol methyltransferase 1A),Homo sapiens (Human),40.7,216.0,1.1e-40,168.3,sp|Q9H8H3|TMT1A_HUMAN Thiol S-methyltransferase TMT1A OS=Homo sapiens OX=9606 GN=TMT1A PE=1 SV=1,GO:0001649; GO:0001734; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0008168; GO:0008173; GO:0016020; GO:0018708; GO:0032259; GO:0042476; GO:0180035; GO:1904724,lncRNA processing [GO:0180035]; methylation [GO:0032259]; odontogenesis [GO:0042476]; osteoblast differentiation [GO:0001649],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724],methyltransferase activity [GO:0008168]; mRNA m(6)A methyltransferase activity [GO:0001734]; RNA methyltransferase activity [GO:0008173]; thiol S-methyltransferase activity [GO:0018708],GO:0003824; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0016740; GO:0030154; GO:0043226; GO:0140098,"catalytic activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; transferase activity; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_05476,2.12067907054395,FUN_024466-T1,Peve_00026420,Pocillopora_meandrina_HIv1___RNAseq.g18562.t1,three_way,72.03833333333334,FUN_024466-T1,J7GQ11,,,,,35.2,495.0,1e-70,270.0,sp|J7GQ11|TYRDC_LEVBR L-tyrosine decarboxylase OS=Levilactobacillus brevis OX=1580 GN=tdc PE=1 SV=1,,,,,,
OG_05478,2.030610586948759,FUN_024472-T1,Peve_00041386,Pocillopora_meandrina_HIv1___RNAseq.g29213.t1,three_way,48.294,,,,,,,,,,,,,,,,,
OG_05485,1.1733584721005748,FUN_024482-T1,Peve_00010582,Pocillopora_meandrina_HIv1___RNAseq.g19067.t1,three_way,60.68966666666667,,,,,,,,,,,,,,,,,
OG_05507,1.5140863682839325,FUN_024588-T1,Peve_00007644,Pocillopora_meandrina_HIv1___RNAseq.g19109.t1,three_way,76.148,FUN_024588-T1,P42785,PCP_HUMAN,,Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP),Homo sapiens (Human),59.5,444.0,2.2e-157,557.0,sp|P42785|PCP_HUMAN Lysosomal Pro-X carboxypeptidase OS=Homo sapiens OX=9606 GN=PRCP PE=1 SV=1,GO:0002003; GO:0002155; GO:0002353; GO:0003085; GO:0004181; GO:0004185; GO:0005886; GO:0008239; GO:0035577; GO:0042593; GO:0043231; GO:0043535; GO:0045178; GO:0060055; GO:0070062; GO:0097009; GO:0101003; GO:2000377,angiogenesis involved in wound healing [GO:0060055]; angiotensin maturation [GO:0002003]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; plasma kallikrein-kinin cascade [GO:0002353]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone receptor signaling pathway [GO:0002155],azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],dipeptidyl-peptidase activity [GO:0008239]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185],GO:0003824; GO:0005886; GO:0006954; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; inflammatory response; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_05531,1.229889074647216,FUN_024682-T1,Peve_00012723,Pocillopora_meandrina_HIv1___RNAseq.g18950.t1,three_way,76.55683333333333,FUN_024682-T1,Q17QB7,RAB30_BOVIN,,Ras-related protein Rab-30 (EC 3.6.5.2),Bos taurus (Bovine),53.8,184.0,3.0999999999999996e-55,216.5,sp|Q17QB7|RAB30_BOVIN Ras-related protein Rab-30 OS=Bos taurus OX=9913 GN=RAB30 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005801; GO:0005802; GO:0007030; GO:0016020; GO:0016192; GO:0031985; GO:0032482,Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; trans-Golgi network [GO:0005802],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; vesicle-mediated transport; hydrolase activity; organelle
OG_05537,1.499003922768146,FUN_024726-T1,Peve_00029154,Pocillopora_meandrina_HIv1___RNAseq.g18837.t1,three_way,72.15833333333333,FUN_024726-T1,A0A1J6KGJ9,,,,,30.6,563.0,1e-55,219.5,sp|A0A1J6KGJ9|JAR4_NICAT Jasmonoyl--L-amino acid synthetase JAR4 OS=Nicotiana attenuata OX=49451 GN=JAR4 PE=1 SV=1,,,,,,
OG_05548,1.6126768430236114,FUN_024755-T1,Peve_00041143,Pocillopora_meandrina_HIv1___RNAseq.2312_t,three_way,71.259,FUN_024755-T1,P22304,IDS_HUMAN,,Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain],Homo sapiens (Human),52.4,510.0,3.2e-146,520.0,sp|P22304|IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens OX=9606 GN=IDS PE=1 SV=1,GO:0004423; GO:0005509; GO:0005737; GO:0005764; GO:0006027; GO:0030200; GO:0030209; GO:0043202,dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200],cytoplasm [GO:0005737]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_05556,1.0437583675888171,FUN_024770-T1,Peve_00003488,Pocillopora_meandrina_HIv1___RNAseq.g18819.t1,three_way,69.99166666666666,FUN_024770-T1,A6H603,NWD1_MOUSE,,NACHT domain- and WD repeat-containing protein 1,Mus musculus (Mouse),33.2,918.0,1.8e-116,422.9,sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2,GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628],cytosol [GO:0005829]; nucleolus [GO:0005730],ATP binding [GO:0005524],GO:0005730; GO:0005829; GO:0006355; GO:0043226,nucleolus; cytosol; regulation of DNA-templated transcription; organelle
OG_05557,1.2563675995043333,FUN_024775-T1,Peve_00033053,Pocillopora_meandrina_HIv1___RNAseq.g18815.t1,three_way,70.15433333333333,FUN_024775-T1,Q92629,,,,,40.8,265.0,5.6999999999999996e-49,196.1,sp|Q92629|SGCD_HUMAN Delta-sarcoglycan OS=Homo sapiens OX=9606 GN=SGCD PE=1 SV=2,,,,,,
OG_05565,1.669188606677647,FUN_024794-T1,Peve_00007040,Pocillopora_meandrina_HIv1___RNAseq.2280_t,three_way,39.91566666666667,FUN_024794-T1,P79121,,,,,26.6,177.0,1.8e-13,77.8,sp|P79121|TIMP3_BOVIN Metalloproteinase inhibitor 3 OS=Bos taurus OX=9913 GN=TIMP3 PE=2 SV=1,,,,,,
OG_05567,1.0282340047988854,FUN_024797-T1,Peve_00026090,Pocillopora_meandrina_HIv1___RNAseq.g18789.t1,three_way,78.34133333333334,FUN_024797-T1,Q6NUT3,MFS12_HUMAN,,Major facilitator superfamily domain-containing protein 12,Homo sapiens (Human),32.6,482.0,4.4e-71,270.4,sp|Q6NUT3|MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens OX=9606 GN=MFSD12 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_05604,1.1729038117131043,FUN_025261-T1,Peve_00014013,Pocillopora_meandrina_HIv1___RNAseq.g13588.t1,three_way,47.211666666666666,,,,,,,,,,,,,,,,,
OG_05610,1.2159252524568789,FUN_025295-T1,Peve_00040954,Pocillopora_meandrina_HIv1___RNAseq.g13468.t1,three_way,62.326,,,,,,,,,,,,,,,,,
OG_05617,1.5176886000182583,FUN_025306-T1,Peve_00027097,Pocillopora_meandrina_HIv1___RNAseq.g13454.t1,three_way,78.10933333333332,FUN_025306-T1,Q95R48,,,,,28.5,396.0,5.8e-38,159.8,sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2,,,,,,
OG_05625,1.116980239044806,FUN_025319-T1,Peve_00027087,Pocillopora_meandrina_HIv1___RNAseq.g13424.t1,three_way,92.1145,FUN_025319-T1,P67827,KC1A_BOVIN,,Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1),Bos taurus (Bovine),92.5,280.0,1.9e-152,540.0,sp|P67827|KC1A_BOVIN Casein kinase I isoform alpha OS=Bos taurus OX=9913 GN=CSNK1A1 PE=1 SV=1,GO:0000139; GO:0000776; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007165; GO:0016055; GO:0016607; GO:0018105; GO:0036064; GO:0045104; GO:0051301; GO:0090090; GO:0106310; GO:1900226,cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; kinetochore [GO:0000776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0007010; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytoskeleton organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05627,1.6140407865412043,FUN_025322-T1,Peve_00027091,Pocillopora_meandrina_HIv1___RNAseq.g13422.t1,three_way,87.86033333333333,FUN_025322-T1,Q6PAX2,,,,,62.0,574.0,2.0000000000000005e-165,583.9,sp|Q6PAX2|ATD3B_XENLA ATPase family AAA domain-containing protein 3-B OS=Xenopus laevis OX=8355 GN=atad3-b PE=2 SV=1,,,,,,
OG_05636,2.271061578435754,FUN_025335-T1,Peve_00027053,Pocillopora_meandrina_HIv1___RNAseq.g13400.t1,three_way,76.48966666666666,FUN_025335-T1,Q5ZK62,ACAP2_CHICK,,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)",Gallus gallus (Chicken),42.7,858.0,2.3000000000000002e-170,600.9,"sp|Q5ZK62|ACAP2_CHICK Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 OS=Gallus gallus OX=9031 GN=ACAP2 PE=2 SV=1",GO:0005096; GO:0005886; GO:0008270; GO:0010008; GO:0032456; GO:1990090,cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005886; GO:0016192; GO:0098772,plasma membrane; vesicle-mediated transport; molecular function regulator activity
OG_05638,1.0446808476457894,FUN_025342-T1,Peve_00027052,Pocillopora_meandrina_HIv1___RNAseq.g13380.t1,three_way,69.806,FUN_025342-T1,Q7RYI0,,,,,42.1,57.0,4.4e-06,52.4,sp|Q7RYI0|MIC10_NEUCR MICOS complex subunit mic10 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=mic10 PE=3 SV=1,,,,,,
OG_05644,1.0344481411322153,FUN_025362-T1,Peve_00040527,Pocillopora_meandrina_HIv1___RNAseq.g13347.t1,three_way,93.85966666666668,FUN_025362-T1,Q5PQN7,,,,,68.9,190.0,6.3e-62,238.8,sp|Q5PQN7|LZIC_RAT Protein LZIC OS=Rattus norvegicus OX=10116 GN=Lzic PE=2 SV=1,,,,,,
OG_05654,2.158312177046972,FUN_025403-T1,Peve_00026689,Pocillopora_meandrina_HIv1___RNAseq.g13308.t1,three_way,71.69633333333334,FUN_025403-T1,Q7SXN5,DNM1L_DANRE,,Dynamin-1-like protein (EC 3.6.5.5),Danio rerio (Zebrafish) (Brachydanio rerio),21.1,701.0,1.2e-07,60.1,sp|Q7SXN5|DNM1L_DANRE Dynamin-1-like protein OS=Danio rerio OX=7955 GN=dnm1l PE=2 SV=1,GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0006897; GO:0008017; GO:0008289; GO:0016020; GO:0016559; GO:0030672; GO:0042803; GO:0043653; GO:0048312; GO:0048511; GO:0051259,endocytosis [GO:0006897]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; rhythmic process [GO:0048511],clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0065003,catalytic activity; GTPase activity; mitochondrion; peroxisome; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; protein-containing complex assembly
OG_05666,1.4659980025406392,FUN_025441-T1,Peve_00029478,Pocillopora_meandrina_HIv1___RNAseq.g13294.t1,three_way,72.48916666666666,FUN_025441-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),45.7,361.0,2.8e-94,349.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_05669,1.1004051597286968,FUN_025459-T1,Peve_00005466,Pocillopora_meandrina_HIv1___RNAseq.g13245.t1,three_way,94.06666666666666,FUN_025459-T1,Q2KJ93,CDC42_BOVIN,,Cell division control protein 42 homolog (EC 3.6.5.2),Bos taurus (Bovine),90.6,191.0,9e-99,360.9,sp|Q2KJ93|CDC42_BOVIN Cell division control protein 42 homolog OS=Bos taurus OX=9913 GN=CDC42 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005813; GO:0005886; GO:0006897; GO:0006911; GO:0007015; GO:0007165; GO:0007264; GO:0016020; GO:0019901; GO:0030010; GO:0030425; GO:0030496; GO:0031258; GO:0032467; GO:0034329; GO:0045198; GO:0048549; GO:0051233; GO:0051489; GO:0051491; GO:0051988; GO:0060997; GO:0072686; GO:1900026,"actin filament organization [GO:0007015]; cell junction assembly [GO:0034329]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of pinocytosis [GO:0048549]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005815; GO:0005886; GO:0007163; GO:0016192; GO:0016787; GO:0030154; GO:0034330; GO:0043226; GO:0061024; GO:0098772,catalytic activity; GTPase activity; microtubule organizing center; plasma membrane; establishment or maintenance of cell polarity; vesicle-mediated transport; hydrolase activity; cell differentiation; cell junction organization; organelle; membrane organization; molecular function regulator activity
OG_05698,1.334114939858844,FUN_025561-T1,Peve_00019806,Pocillopora_meandrina_HIv1___TS.g2789.t1,three_way,87.92233333333333,FUN_025561-T1,Q6VFT7,FOXL2_BOVIN,,Forkhead box protein L2,Bos taurus (Bovine),89.7,107.0,1.9e-52,207.6,sp|Q6VFT7|FOXL2_BOVIN Forkhead box protein L2 OS=Bos taurus OX=9913 GN=FOXL2 PE=2 SV=1,GO:0000978; GO:0000981; GO:0001541; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006309; GO:0006357; GO:0009653; GO:0019101; GO:0030154; GO:0031624; GO:0043028; GO:0043065; GO:0045892; GO:0045893; GO:0045944; GO:0048048; GO:0060014; GO:0090543,anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; embryonic eye morphogenesis [GO:0048048]; extraocular skeletal muscle development [GO:0002074]; female somatic sex determination [GO:0019101]; granulosa cell differentiation [GO:0060014]; negative regulation of DNA-templated transcription [GO:0045892]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin conjugating enzyme binding [GO:0031624]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_05704,1.436955314838103,FUN_025577-T1,Peve_00001263,Pocillopora_meandrina_HIv1___RNAseq.g13761.t1,three_way,75.097,FUN_025577-T1,P30437,,,,,36.5,419.0,8.600000000000001e-73,275.8,"sp|P30437|CP17A_ONCMY Steroid 17-alpha-hydroxylase/17,20 lyase OS=Oncorhynchus mykiss OX=8022 GN=cyp17a1 PE=2 SV=1",,,,,,
OG_05726,1.0775702027649767,FUN_025649-T1,Peve_00039652,Pocillopora_meandrina_HIv1___RNAseq.g23087.t2c,three_way,52.45816666666667,,,,,,,,,,,,,,,,,
OG_05727,1.0238995897033647,FUN_025650-T1,Peve_00002528,Pocillopora_meandrina_HIv1___RNAseq.g23087.t2a,three_way,85.454,,,,,,,,,,,,,,,,,
OG_05749,1.3432827907877831,FUN_025681-T1,Peve_00000455,Pocillopora_meandrina_HIv1___RNAseq.g13115.t1,three_way,68.22683333333333,FUN_025681-T1,P98064,,,,,39.3,690.0,1.5999999999999999e-137,491.5,sp|P98064|MASP1_MOUSE Mannan-binding lectin serine protease 1 OS=Mus musculus OX=10090 GN=Masp1 PE=1 SV=2,,,,,,
OG_05755,1.2657833516075996,FUN_025690-T1,Peve_00005581,Pocillopora_meandrina_HIv1___RNAseq.g13163.t2b,three_way,57.99366666666667,,,,,,,,,,,,,,,,,
OG_05757,1.2908777838241796,FUN_025692-T1,Peve_00005578,Pocillopora_meandrina_HIv1___RNAseq.g13161.t2,three_way,54.39333333333333,,,,,,,,,,,,,,,,,
OG_05764,1.5102820736772928,FUN_025722-T1,Peve_00014085,Pocillopora_meandrina_HIv1___RNAseq.g10452.t1,three_way,58.814,FUN_025722-T1,A8MY62,,,,,29.3,447.0,1.5e-46,188.7,sp|A8MY62|BLML_HUMAN Putative beta-lactamase-like 1 OS=Homo sapiens OX=9606 GN=LACTBL1 PE=1 SV=2,,,,,,
OG_05770,1.2168076971673871,FUN_025730-T1,Peve_00035630,Pocillopora_meandrina_HIv1___RNAseq.g10436.t1,three_way,81.93766666666667,FUN_025730-T1,A5D8W1,CFA69_HUMAN,,Cilia- and flagella-associated protein 69,Homo sapiens (Human),40.2,895.0,9.3e-194,678.7,sp|A5D8W1|CFA69_HUMAN Cilia- and flagella-associated protein 69 OS=Homo sapiens OX=9606 GN=CFAP69 PE=1 SV=3,GO:0005737; GO:0007288; GO:0007608; GO:0030317; GO:0042048; GO:0097225; GO:0097730; GO:1902093; GO:1905516; GO:1990834,flagellated sperm motility [GO:0030317]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sperm axoneme assembly [GO:0007288],cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225],,GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0050877,cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cell motility; nervous system process
OG_05777,1.6647937833597508,FUN_025746-T1,Peve_00008534,Pocillopora_meandrina_HIv1___RNAseq.g10426.t1,three_way,57.30083333333333,FUN_025746-T1,Q6P132,,,,,40.8,152.0,1.9999999999999998e-32,142.9,sp|Q6P132|TXB1B_DANRE Tax1-binding protein 1 homolog B OS=Danio rerio OX=7955 GN=tax1bp1b PE=2 SV=3,,,,,,
OG_05794,1.9911105035691488,FUN_025775-T1,Peve_00012555,Pocillopora_meandrina_HIv1___RNAseq.g10363.t1,three_way,91.0985,FUN_025775-T1,P79145,,,,,50.4,254.0,2.7e-39,164.1,sp|P79145|CREM_CANLF cAMP-responsive element modulator OS=Canis lupus familiaris OX=9615 GN=CREM PE=2 SV=2,,,,,,
OG_05805,1.2873216021921643,FUN_025800-T1,Peve_00017926,Pocillopora_meandrina_HIv1___RNAseq.g10386.t2,three_way,84.613,FUN_025800-T1,Q8VDT1,,,,,52.0,666.0,8.599999999999999e-189,661.8,sp|Q8VDT1|SC5A9_MOUSE Sodium/glucose cotransporter 4 OS=Mus musculus OX=10090 GN=Slc5a9 PE=1 SV=3,,,,,,
OG_05817,1.3681722207308638,FUN_025824-T1,Peve_00036284,Pocillopora_meandrina_HIv1___RNAseq.g9344.t1,three_way,88.77216666666666,FUN_025824-T1,Q9GM70,,,,,50.4,282.0,9e-78,292.0,sp|Q9GM70|ST17A_RABIT Serine/threonine-protein kinase 17A OS=Oryctolagus cuniculus OX=9986 GN=STK17A PE=2 SV=1,,,,,,
OG_05826,1.2120460852222472,FUN_025843-T1,Peve_00028316,Pocillopora_meandrina_HIv1___RNAseq.g10339.t1,three_way,66.52566666666667,,,,,,,,,,,,,,,,,
OG_05844,1.3049836566789528,FUN_025913-T1,Peve_00010174,Pocillopora_meandrina_HIv1___RNAseq.g10545.t1,three_way,67.16866666666667,FUN_025913-T1,Q8NEG5,,,,,38.3,384.0,5.6e-76,287.0,sp|Q8NEG5|ZSWM2_HUMAN E3 ubiquitin-protein ligase ZSWIM2 OS=Homo sapiens OX=9606 GN=ZSWIM2 PE=1 SV=2,,,,,,
OG_05850,1.5681082593158062,FUN_025923-T1,Peve_00018907,Pocillopora_meandrina_HIv1___TS.g13940.t2,three_way,74.94983333333333,FUN_025923-T1,A1A5K2,CLA1B_XENLA,,CLIP-associating protein 1-B (Cytoplasmic linker-associated protein 1-B) (Protein Orbit homolog) (Xorbit) (Xorbit/CLASP),Xenopus laevis (African clawed frog),42.2,756.0,1.2e-134,482.3,sp|A1A5K2|CLA1B_XENLA CLIP-associating protein 1-B OS=Xenopus laevis OX=8355 GN=clasp1b PE=1 SV=1,GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0008017; GO:0031023; GO:0031110; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307; GO:1902903,cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of supramolecular fiber organization [GO:1902903],basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876],kinetochore binding [GO:0043515]; microtubule binding [GO:0008017],GO:0005794; GO:0005815; GO:0007010; GO:0008092; GO:0043226,Golgi apparatus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_05851,1.6239021281530746,FUN_025924-T1,Peve_00027741,Pocillopora_meandrina_HIv1___RNAseq.g10523.t1,three_way,81.66433333333333,FUN_025924-T1,Q80TV8,CLAP1_MOUSE,,CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1),Mus musculus (Mouse),41.3,726.0,1.1e-131,472.2,sp|Q80TV8|CLAP1_MOUSE CLIP-associating protein 1 OS=Mus musculus OX=10090 GN=Clasp1 PE=1 SV=2,GO:0000776; GO:0005794; GO:0005813; GO:0005819; GO:0005874; GO:0005938; GO:0007020; GO:0007026; GO:0008017; GO:0015630; GO:0016477; GO:0030010; GO:0031023; GO:0034453; GO:0051294; GO:0051301,cell division [GO:0051301]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; establishment of spindle orientation [GO:0051294]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; negative regulation of microtubule depolymerization [GO:0007026],cell cortex [GO:0005938]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819],microtubule binding [GO:0008017],GO:0005794; GO:0005815; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0043226; GO:0048870,Golgi apparatus; microtubule organizing center; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; organelle; cell motility
OG_05855,1.6955553533538366,FUN_025934-T1,Peve_00027751,Pocillopora_meandrina_HIv1___RNAseq.g10534.t1,three_way,60.88033333333333,FUN_025934-T1,Q6BZG7,KAPR_DEBHA,,cAMP-dependent protein kinase regulatory subunit (PKA regulatory subunit),Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) (Yeast) (Torulaspora hansenii),25.1,215.0,2.8e-06,55.1,sp|Q6BZG7|KAPR_DEBHA cAMP-dependent protein kinase regulatory subunit OS=Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) OX=284592 GN=PKAR PE=3 SV=2,GO:0000785; GO:0004862; GO:0005634; GO:0005829; GO:0005886; GO:0005952; GO:0006995; GO:0007189; GO:0010603; GO:0030552; GO:0034236; GO:0042149; GO:0042802; GO:0045944; GO:0046580; GO:0046827; GO:0097271,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to glucose starvation [GO:0042149]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to bud neck [GO:0097271]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603],cAMP-dependent protein kinase complex [GO:0005952]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; identical protein binding [GO:0042802]; protein kinase A catalytic subunit binding [GO:0034236],GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0098772,nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_05874,1.3051835019250324,FUN_026023-T1,Peve_00026728,Pocillopora_meandrina_HIv1___RNAseq.g10495.t1,three_way,61.43916666666667,FUN_026023-T1,Q91717,,,,,31.0,277.0,2.3e-26,123.6,sp|Q91717|CO2A1_XENLA Collagen alpha-1(II) chain OS=Xenopus laevis OX=8355 GN=col2a1 PE=2 SV=2,,,,,,
OG_05875,1.3828437851317674,FUN_026024-T1,Peve_00026729,Pocillopora_meandrina_HIv1___RNAseq.g10496.t1,three_way,59.858,FUN_026024-T1,O46392,,,,,37.0,216.0,5.4e-35,152.1,sp|O46392|CO1A2_CANLF Collagen alpha-2(I) chain OS=Canis lupus familiaris OX=9615 GN=COL1A2 PE=2 SV=2,,,,,,
OG_05883,1.2248984646065624,FUN_026036-T1,Peve_00022187,Pocillopora_meandrina_HIv1___RNAseq.g10549.t1,three_way,71.13533333333334,,,,,,,,,,,,,,,,,
OG_05895,1.00675042038344,FUN_026071-T1,Peve_00010393,Pocillopora_meandrina_HIv1___TS.g13984.t1,three_way,67.47733333333333,FUN_026071-T1,O82333,,,,,27.7,573.0,9e-47,189.9,sp|O82333|GH31_ARATH Probable indole-3-acetic acid-amido synthetase GH3.1 OS=Arabidopsis thaliana OX=3702 GN=GH3.1 PE=2 SV=1,,,,,,
OG_05902,1.0351950346686372,FUN_026081-T1,Peve_00004132,Pocillopora_meandrina_HIv1___RNAseq.g10570.t1,three_way,97.37833333333332,FUN_026081-T1,Q96KC2,,,,,79.0,176.0,5.6e-79,295.0,sp|Q96KC2|ARL5B_HUMAN ADP-ribosylation factor-like protein 5B OS=Homo sapiens OX=9606 GN=ARL5B PE=1 SV=1,,,,,,
OG_05933,1.894148079929542,FUN_026161-T1,Peve_00006892,Pocillopora_meandrina_HIv1___RNAseq.g3202.t1,three_way,65.80033333333333,FUN_026161-T1,Q8N0W4,NLGNX_HUMAN,,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",Homo sapiens (Human),33.2,564.0,2.7999999999999997e-82,307.8,"sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1",GO:0003360; GO:0005886; GO:0007158; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634,adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625],"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]",cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],GO:0005886; GO:0007155; GO:0030154; GO:0034330; GO:0048856; GO:0050877; GO:0061024,plasma membrane; cell adhesion; cell differentiation; cell junction organization; anatomical structure development; nervous system process; membrane organization
OG_05938,1.1606732269662705,FUN_026173-T1,Peve_00039168,Pocillopora_meandrina_HIv1___RNAseq.g3177.t1,three_way,35.60133333333333,FUN_026173-T1,P24668,MPRD_MOUSE,,Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46),Mus musculus (Mouse),51.8,56.0,7e-07,56.2,sp|P24668|MPRD_MOUSE Cation-dependent mannose-6-phosphate receptor OS=Mus musculus OX=10090 GN=M6pr PE=1 SV=1,GO:0005765; GO:0005768; GO:0005770; GO:0005794; GO:0006622; GO:0006886; GO:0007041; GO:0019904; GO:0033299; GO:0048471; GO:1905394,intracellular protein transport [GO:0006886]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471],protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394],GO:0005768; GO:0005794; GO:0006886; GO:0031410; GO:0043226,endosome; Golgi apparatus; intracellular protein transport; cytoplasmic vesicle; organelle
OG_05949,1.0832986543952623,FUN_026199-T1,Peve_00010232,Pocillopora_meandrina_HIv1___RNAseq.g3044.t1,three_way,45.858,,,,,,,,,,,,,,,,,
OG_05952,1.0934032790236348,FUN_026214-T1,Peve_00004859,Pocillopora_meandrina_HIv1___TS.g18166.t1,three_way,63.017,FUN_026214-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,371.0,3.5e-20,102.4,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_05955,1.170349867409515,FUN_026298-T1,Peve_00030620,Pocillopora_meandrina_HIv1___RNAseq.g3053.t1,three_way,82.72766666666666,FUN_026298-T1,Q13617,,,,,50.9,748.0,3.7e-225,782.7,sp|Q13617|CUL2_HUMAN Cullin-2 OS=Homo sapiens OX=9606 GN=CUL2 PE=1 SV=2,,,,,,
OG_05983,1.035923039760728,FUN_026415-T1,Peve_00006089,Pocillopora_meandrina_HIv1___RNAseq.g3014.t1,three_way,79.76233333333333,FUN_026415-T1,Q9EPR4,S23A2_MOUSE,,Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2),Mus musculus (Mouse),54.1,549.0,1.1e-163,578.2,sp|Q9EPR4|S23A2_MOUSE Solute carrier family 23 member 2 OS=Mus musculus OX=10090 GN=Slc23a2 PE=1 SV=2,GO:0005737; GO:0006979; GO:0007155; GO:0008015; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0071361; GO:1903861,blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229],GO:0003013; GO:0005215; GO:0005975; GO:0007155; GO:0055085,circulatory system process; transporter activity; carbohydrate metabolic process; cell adhesion; transmembrane transport
OG_05988,1.1909707455517964,FUN_026474-T1,Peve_00002337,Pocillopora_meandrina_HIv1___RNAseq.g4183.t1,three_way,68.71333333333334,FUN_026474-T1,P35244,RFA3_HUMAN,,Replication protein A 14 kDa subunit (RP-A p14) (Replication factor A protein 3) (RF-A protein 3),Homo sapiens (Human),38.3,107.0,2.6e-13,76.3,sp|P35244|RFA3_HUMAN Replication protein A 14 kDa subunit OS=Homo sapiens OX=9606 GN=RPA3 PE=1 SV=1,GO:0000723; GO:0000724; GO:0003684; GO:0003697; GO:0005654; GO:0005662; GO:0006260; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0007346; GO:0035861; GO:0042127,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; regulation of cell population proliferation [GO:0042127]; regulation of mitotic cell cycle [GO:0007346]; telomere maintenance [GO:0000723],DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861],damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0005654; GO:0006260; GO:0006281; GO:0006310; GO:0032200,DNA binding; nucleoplasm; DNA replication; DNA repair; DNA recombination; telomere organization
OG_06005,1.046149659518948,FUN_026501-T1,Peve_00004184,Pocillopora_meandrina_HIv1___TS.g21607.t1,three_way,44.153333333333336,FUN_026501-T1,Q9VTT0,SEM5C_DROME,,Semaphorin 5c,Drosophila melanogaster (Fruit fly),27.1,630.0,1.7e-51,206.1,sp|Q9VTT0|SEM5C_DROME Semaphorin 5c OS=Drosophila melanogaster OX=7227 GN=Sema5c PE=1 SV=3,GO:0001700; GO:0005768; GO:0005886; GO:0007411; GO:0016324; GO:0016328; GO:0030215; GO:0030335; GO:0042048; GO:0045499; GO:0048036; GO:0071526,axon guidance [GO:0007411]; central complex development [GO:0048036]; embryonic development via the syncytial blastoderm [GO:0001700]; olfactory behavior [GO:0042048]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526],apical plasma membrane [GO:0016324]; endosome [GO:0005768]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886],chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215],GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0048018; GO:0048856; GO:0098772,endosome; plasma membrane; cytoplasmic vesicle; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_06016,1.190047468625188,FUN_026543-T1,Peve_00020319,Pocillopora_meandrina_HIv1___RNAseq.g4238.t1,three_way,56.20633333333333,,,,,,,,,,,,,,,,,
OG_06046,1.0176729167033969,FUN_026714-T1,Peve_00018519,Pocillopora_meandrina_HIv1___RNAseq.g9373.t1,three_way,56.48,FUN_026714-T1,Q96EW2,,,,,42.0,138.0,4.4e-20,99.4,sp|Q96EW2|HBAP1_HUMAN HSPB1-associated protein 1 OS=Homo sapiens OX=9606 GN=HSPBAP1 PE=1 SV=1,,,,,,
OG_06047,1.114458173029691,FUN_026715-T1,Peve_00018524,Pocillopora_meandrina_HIv1___TS.g19669.t1,three_way,89.792,,,,,,,,,,,,,,,,,
OG_06092,1.1797580502198062,FUN_027218-T1,Peve_00018289,Pocillopora_meandrina_HIv1___RNAseq.g15249.t1,three_way,69.15166666666667,FUN_027218-T1,Q8IW92,,,,,43.8,665.0,4.3e-148,526.6,sp|Q8IW92|GLBL2_HUMAN Beta-galactosidase-1-like protein 2 OS=Homo sapiens OX=9606 GN=GLB1L2 PE=1 SV=1,,,,,,
OG_06095,1.096588458813221,FUN_027269-T1,Peve_00034309,Pocillopora_meandrina_HIv1___RNAseq.g4020.t1,three_way,51.61,,,,,,,,,,,,,,,,,
OG_06096,1.9130606126135816,FUN_027270-T1,Peve_00018292,Pocillopora_meandrina_HIv1___TS.g10917.t1,three_way,87.52583333333334,FUN_027270-T1,Q80W99,CTSR3_MOUSE,,Cation channel sperm-associated protein 3 (CatSper3),Mus musculus (Mouse),34.5,383.0,1.4e-53,211.8,sp|Q80W99|CTSR3_MOUSE Cation channel sperm-associated protein 3 OS=Mus musculus OX=10090 GN=Catsper3 PE=1 SV=2,GO:0001669; GO:0005245; GO:0005783; GO:0006814; GO:0030317; GO:0031514; GO:0036128; GO:0048240; GO:0051649,establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240],acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; endoplasmic reticulum [GO:0005783]; motile cilium [GO:0031514],voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0005783; GO:0005929; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0048870,transporter activity; endoplasmic reticulum; cilium; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_06132,2.2751610954319004,FUN_027938-T2,Peve_00032459,Pocillopora_meandrina_HIv1___RNAseq.g14030.t1,three_way,71.97066666666667,,,,,,,,,,,,,,,,,
OG_06144,1.1570459046897568,FUN_027971-T1,Peve_00031357,Pocillopora_meandrina_HIv1___RNAseq.g14053.t1,three_way,64.43966666666667,FUN_027971-T1,Q7PCJ9,,,,,47.6,168.0,1.4e-37,157.5,sp|Q7PCJ9|SAT2_PIG Thialysine N-epsilon-acetyltransferase OS=Sus scrofa OX=9823 GN=SAT2 PE=2 SV=1,,,,,,
OG_06150,1.1413674811095489,FUN_027982-T1,Peve_00033314,Pocillopora_meandrina_HIv1___RNAseq.g14062.t1,three_way,57.83766666666667,FUN_027982-T1,O88623,UBP2_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2),Mus musculus (Mouse),50.1,385.0,1.5999999999999999e-96,355.1,sp|O88623|UBP2_MOUSE Ubiquitin carboxyl-terminal hydrolase 2 OS=Mus musculus OX=10090 GN=Usp2 PE=1 SV=3,GO:0000122; GO:0004843; GO:0005634; GO:0005737; GO:0005813; GO:0005938; GO:0006508; GO:0007517; GO:0016020; GO:0016579; GO:0030332; GO:0031625; GO:0032922; GO:0042802; GO:0043153; GO:0045475; GO:0045931; GO:0046872; GO:0048471; GO:0048512; GO:0050821; GO:0051926,circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; muscle organ development [GO:0007517]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mitotic cell cycle [GO:0045931]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508],cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],cyclin binding [GO:0030332]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06166,1.5587561176023983,FUN_028019-T1,Peve_00036500,Pocillopora_meandrina_HIv1___RNAseq.g13910.t1,three_way,60.98683333333333,FUN_028019-T1,Q6DCD5,TMTC2_XENLA,,Protein O-mannosyl-transferase tmtc2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2),Xenopus laevis (African clawed frog),36.7,581.0,5.800000000000001e-86,320.5,sp|Q6DCD5|TMTC2_XENLA Protein O-mannosyl-transferase tmtc2 OS=Xenopus laevis OX=8355 GN=tmtc2 PE=2 SV=1,GO:0000030; GO:0004169; GO:0005789; GO:0035269,protein O-linked mannosylation [GO:0035269],endoplasmic reticulum membrane [GO:0005789],dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030],GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06173,1.30531697744264,FUN_028028-T1,Peve_00044200,Pocillopora_meandrina_HIv1___RNAseq.g13931.t1,three_way,54.44433333333333,,,,,,,,,,,,,,,,,
OG_06186,1.5467943750088806,FUN_028098-T1,Peve_00026162,Pocillopora_meandrina_HIv1___RNAseq.g15579.t1b,three_way,70.61933333333333,FUN_028098-T1,Q08D62,,,,,33.1,350.0,9e-46,186.4,sp|Q08D62|MAEL_XENTR Protein maelstrom homolog OS=Xenopus tropicalis OX=8364 GN=mael PE=2 SV=1,,,,,,
OG_06218,3.3777524732261086,FUN_028160-T1,Peve_00000617,Pocillopora_meandrina_HIv1___RNAseq.g29828.t1,three_way,77.55183333333333,,,,,,,,,,,,,,,,,
OG_06230,1.0368256177962318,FUN_028180-T1,Peve_00001282,Pocillopora_meandrina_HIv1___RNAseq.g16511.t1,three_way,66.941,FUN_028180-T1,Q8BLN6,UNC80_MOUSE,,Protein unc-80 homolog (mUNC-80),Mus musculus (Mouse),29.5,3133.0,7.3e-307,1056.2,sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3,GO:0005886; GO:0030425; GO:0034706,,dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706],,GO:0005886,plasma membrane
OG_06234,1.2833797249051502,FUN_028187-T1,Peve_00000861,Pocillopora_meandrina_HIv1___RNAseq.g16542.t1,three_way,56.39333333333333,FUN_028187-T1,Q9YH85,,,,,27.1,284.0,4.2e-15,84.0,sp|Q9YH85|TECTA_CHICK Alpha-tectorin OS=Gallus gallus OX=9031 GN=TECTA PE=1 SV=1,,,,,,
OG_06275,1.0141576421341036,FUN_028312-T1,Peve_00025176,Pocillopora_meandrina_HIv1___RNAseq.g16422.t1,three_way,50.10016666666667,FUN_028312-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),47.0,304.0,1.7e-73,279.3,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_06279,1.8026326052862576,FUN_028447-T1,Peve_00026233,Pocillopora_meandrina_HIv1___RNAseq.g16195.t1,three_way,59.692,FUN_028447-T1,Q60997,DMBT1_MOUSE,,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80),Mus musculus (Mouse),40.3,573.0,9.700000000000001e-117,423.7,sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2,GO:0001824; GO:0001833; GO:0002065; GO:0005576; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023,blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],zymogen binding [GO:0035375],GO:0005576; GO:0030154; GO:0030312; GO:0031012; GO:0048856,extracellular region; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_06280,1.002489830223796,FUN_028449-T1,Peve_00031080,Pocillopora_meandrina_HIv1___TS.g11207.t1,three_way,39.0405,FUN_028449-T1,Q62718,NTRI_RAT,,Neurotrimin (GP65),Rattus norvegicus (Rat),31.4,204.0,2.4e-18,95.9,sp|Q62718|NTRI_RAT Neurotrimin OS=Rattus norvegicus OX=10116 GN=Ntm PE=1 SV=1,GO:0005615; GO:0007155; GO:0009986; GO:0010976; GO:0010977; GO:0021549; GO:0030424; GO:0032355; GO:0042802; GO:0048471; GO:0048787; GO:0060076; GO:0060253; GO:0071392; GO:0098552; GO:0098686; GO:0098839; GO:1900149,cell adhesion [GO:0007155]; cellular response to estradiol stimulus [GO:0071392]; cerebellum development [GO:0021549]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuron projection development [GO:0010977]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Schwann cell migration [GO:1900149]; response to estradiol [GO:0032355],axon [GO:0030424]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; side of membrane [GO:0098552],identical protein binding [GO:0042802],GO:0005615; GO:0007155; GO:0048856,extracellular space; cell adhesion; anatomical structure development
OG_06291,1.141975396319638,FUN_028486-T1,Peve_00039740,Pocillopora_meandrina_HIv1___TS.g11105.t3a,three_way,50.81666666666667,FUN_028486-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),33.2,368.0,2.2e-41,172.6,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_06305,1.5369973068459897,FUN_028511-T1,Peve_00008102,Pocillopora_meandrina_HIv1___RNAseq.g14117.t1,three_way,72.03616666666667,FUN_028511-T1,Q6GLC9,FMR1_XENTR,,Fragile X messenger ribonucleoprotein 1 homolog (XtFmrp),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),45.6,377.0,2e-87,324.7,sp|Q6GLC9|FMR1_XENTR Fragile X messenger ribonucleoprotein 1 homolog OS=Xenopus tropicalis OX=8364 GN=fmr1 PE=2 SV=1,GO:0000381; GO:0000775; GO:0002092; GO:0002151; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006281; GO:0006397; GO:0006406; GO:0007215; GO:0007399; GO:0008017; GO:0008266; GO:0008380; GO:0010369; GO:0010494; GO:0010629; GO:0014069; GO:0017148; GO:0030371; GO:0030424; GO:0030425; GO:0030426; GO:0032433; GO:0033592; GO:0034046; GO:0034063; GO:0035195; GO:0035197; GO:0035198; GO:0035613; GO:0036464; GO:0042734; GO:0042803; GO:0042995; GO:0043005; GO:0043197; GO:0043204; GO:0043232; GO:0043488; GO:0043679; GO:0045202; GO:0045211; GO:0045727; GO:0045947; GO:0046928; GO:0046982; GO:0048027; GO:0048471; GO:0051028; GO:0051489; GO:0051491; GO:0060538; GO:0060965; GO:0060998; GO:0060999; GO:0070840; GO:0071598; GO:0097386; GO:0098793; GO:0098794; GO:0098908; GO:0140006; GO:0140693; GO:0140694; GO:1900453; GO:1901386; GO:1901800; GO:1902737; GO:1990247; GO:1990812; GO:1990825; GO:1990904; GO:2000301; GO:2000637; GO:2000766,"DNA repair [GO:0006281]; glutamate receptor signaling pathway [GO:0007215]; membraneless organelle assembly [GO:0140694]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of receptor internalization [GO:0002092]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]; skeletal muscle organ development [GO:0060538]; stress granule assembly [GO:0034063]","axon [GO:0030424]; axon terminus [GO:0043679]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; intracellular membraneless organelle [GO:0043232]; neuron projection [GO:0043005]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]",chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; histone H3 reader activity [GO:0140006]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; molecular condensate scaffold activity [GO:0140693]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation repressor activity [GO:0030371],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006913; GO:0008092; GO:0016071; GO:0016853; GO:0031047; GO:0043226; GO:0045182; GO:0048856; GO:0060090; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; nucleocytoplasmic transport; cytoskeletal protein binding; mRNA metabolic process; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; translation regulator activity; anatomical structure development; molecular adaptor activity; catalytic activity, acting on RNA"
OG_06323,1.8492569632354936,FUN_028831-T1,Peve_00024573,Pocillopora_meandrina_HIv1___RNAseq.g20708.t1,three_way,60.382666666666665,FUN_028831-T1,Q9NVH0,EXD2_HUMAN,,Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2),Homo sapiens (Human),34.2,669.0,3.8e-100,367.5,sp|Q9NVH0|EXD2_HUMAN Exonuclease 3'-5' domain-containing protein 2 OS=Homo sapiens OX=9606 GN=EXD2 PE=1 SV=2,GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0030145; GO:0031297; GO:0042803; GO:0045111; GO:0090304; GO:0090734,DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid metabolic process [GO:0090304]; replication fork processing [GO:0031297],cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734],3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310],GO:0003824; GO:0005634; GO:0005739; GO:0005856; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0140097; GO:0140098,"catalytic activity; nucleus; mitochondrion; cytoskeleton; DNA repair; DNA recombination; hydrolase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_06330,1.0887381157881666,FUN_028886-T1,Peve_00044601,Pocillopora_meandrina_HIv1___RNAseq.g12807.t1,three_way,57.31466666666667,,,,,,,,,,,,,,,,,
OG_06352,1.0084989020271289,FUN_028939-T1,Peve_00026871,Pocillopora_meandrina_HIv1___TS.g9025.t1,three_way,60.138,FUN_028939-T1,P16305,,,,,34.0,418.0,2.2e-52,208.0,sp|P16305|GBRA6_MOUSE Gamma-aminobutyric acid receptor subunit alpha-6 OS=Mus musculus OX=10090 GN=Gabra6 PE=1 SV=3,,,,,,
OG_06353,2.0084070365956865,FUN_028946-T1,Peve_00026868,Pocillopora_meandrina_HIv1___RNAseq.g25583.t1,three_way,40.32216666666666,,,,,,,,,,,,,,,,,
OG_06381,1.863051167675198,FUN_028993-T1,Peve_00034527,Pocillopora_meandrina_HIv1___TS.g9080.t1b,three_way,53.91833333333334,FUN_028993-T1,A2AVA0,SVEP1_MOUSE,,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)",Mus musculus (Mouse),33.5,191.0,1e-20,102.4,"sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1",GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193,cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193],cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640],GO:0003013; GO:0005576; GO:0005615; GO:0005634; GO:0007155; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0098631,circulatory system process; extracellular region; extracellular space; nucleus; cell adhesion; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; cell motility; cell adhesion mediator activity
OG_06382,1.929944432717735,FUN_028994-T1,Peve_00034531,Pocillopora_meandrina_HIv1___RNAseq.g25641.t1,three_way,71.23533333333333,FUN_028994-T1,Q9UI42,CBPA4_HUMAN,,Carboxypeptidase A4 (EC 3.4.17.-) (Carboxypeptidase A3),Homo sapiens (Human),39.8,402.0,5.9000000000000005e-87,322.8,sp|Q9UI42|CBPA4_HUMAN Carboxypeptidase A4 OS=Homo sapiens OX=9606 GN=CPA4 PE=1 SV=2,GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0042447; GO:0043171,hormone catabolic process [GO:0042447]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],extracellular space [GO:0005615],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_06384,1.0949034708445338,FUN_029014-T1,Peve_00003118,Pocillopora_meandrina_HIv1___TS.g9087.t1,three_way,52.617,FUN_029014-T1,B8VIW9,,,,,40.2,1040.0,3.2999999999999996e-188,660.6,sp|B8VIW9|FP_ACRMI Fibronectin type III domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_06388,1.5876154637170194,FUN_029031-T1,Peve_00003119,Pocillopora_meandrina_HIv1___RNAseq.g20773.t1,three_way,58.98433333333333,,,,,,,,,,,,,,,,,
OG_06401,1.0104417041374614,FUN_029062-T1,Peve_00043257,Pocillopora_meandrina_HIv1___RNAseq.g25809.t1,three_way,72.04133333333333,FUN_029062-T1,Q02360,,,,,47.4,114.0,6.8e-21,104.0,sp|Q02360|FOXL1_DROME Fork head domain-containing protein L1 OS=Drosophila melanogaster OX=7227 GN=FoxL1 PE=1 SV=2,,,,,,
OG_06409,1.3838973089296709,FUN_029091-T1,Peve_00033472,Pocillopora_meandrina_HIv1___RNAseq.g25753.t1,three_way,63.12366666666667,FUN_029091-T1,Q8R4U0,STAB2_MOUSE,,"Stabilin-2 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) [Cleaved into: Short form stabilin-2]",Mus musculus (Mouse),35.9,2141.0,2.6e-153,545.8,sp|Q8R4U0|STAB2_MOUSE Stabilin-2 OS=Mus musculus OX=10090 GN=Stab2 PE=1 SV=1,GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0030169; GO:0030214; GO:0038024; GO:0050830,cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898],cytosol [GO:0005829]; external side of plasma membrane [GO:0009897],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044],GO:0005829; GO:0007155; GO:0016192; GO:0038024; GO:1901135,cytosol; cell adhesion; vesicle-mediated transport; cargo receptor activity; carbohydrate derivative metabolic process
OG_06416,1.3864646759544896,FUN_029099-T1,Peve_00038062,Pocillopora_meandrina_HIv1___RNAseq.g25485.t1,three_way,55.33266666666667,FUN_029099-T1,P20105,E74EA_DROME,,Ecdysone-induced protein 74EF isoform A (ETS-related protein E74A),Drosophila melanogaster (Fruit fly),52.4,105.0,3.5e-21,103.6,sp|P20105|E74EA_DROME Ecdysone-induced protein 74EF isoform A OS=Drosophila melanogaster OX=7227 GN=Eip74EF PE=2 SV=2,GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006914; GO:0030154; GO:0040034; GO:0043565; GO:0045944; GO:0048102; GO:0048477,"autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]",nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0006914; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; autophagy; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_06428,1.3428620386352654,FUN_029119-T1,Peve_00024538,Pocillopora_meandrina_HIv1___RNAseq.g25774.t1,three_way,82.585,FUN_029119-T1,C4R7Z3,C9MT_KOMPG,,Sphingolipid C9-methyltransferase (C-9-MT) (EC 2.1.1.317),Komagataella phaffii (strain GS115 / ATCC 20864) (Yeast) (Pichia pastoris),54.4,377.0,3.3e-115,416.8,sp|C4R7Z3|C9MT_KOMPG Sphingolipid C9-methyltransferase OS=Komagataella phaffii (strain GS115 / ATCC 20864) OX=644223 GN=PAS_chr4_0465 PE=1 SV=1,GO:0006665; GO:0008168; GO:0016020; GO:0032259,methylation [GO:0032259]; sphingolipid metabolic process [GO:0006665],membrane [GO:0016020],methyltransferase activity [GO:0008168],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_06434,1.2267049118504816,FUN_029128-T1,Peve_00004674,Pocillopora_meandrina_HIv1___RNAseq.g25780.t1,three_way,76.54333333333334,FUN_029128-T1,I6V1W0,,,,,40.1,409.0,1.2e-79,298.9,sp|I6V1W0|BMBL_DANRE Protein brambleberry OS=Danio rerio OX=7955 GN=bmb PE=2 SV=1,,,,,,
OG_06436,1.2694827728192122,FUN_029130-T1,Peve_00033155,Pocillopora_meandrina_HIv1___RNAseq.g25785.t1,three_way,48.33016666666666,,,,,,,,,,,,,,,,,
OG_06458,1.4954656164591116,FUN_029187-T1,Peve_00031211,Pocillopora_meandrina_HIv1___RNAseq.g25505.t1,three_way,77.81533333333333,FUN_029187-T1,Q63481,RAB7L_RAT,,Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29),Rattus norvegicus (Rat),52.6,209.0,3e-57,223.4,sp|Q63481|RAB7L_RAT Ras-related protein Rab-7L1 OS=Rattus norvegicus OX=10116 GN=Rab29 PE=1 SV=1,GO:0000139; GO:0001921; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0012505; GO:0019003; GO:0019894; GO:0030154; GO:0031267; GO:0031965; GO:0031982; GO:0032438; GO:0042110; GO:0042147; GO:0042470; GO:0044788; GO:0048471; GO:0050862; GO:0055037; GO:0060271; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1903441; GO:1905279; GO:1990748,"cell differentiation [GO:0030154]; cellular detoxification [GO:1990748]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; modulation by host of viral process [GO:0044788]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]",cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; vesicle [GO:0031982],dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267],GO:0002376; GO:0003824; GO:0003924; GO:0005654; GO:0005739; GO:0005768; GO:0005773; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0008092; GO:0016192; GO:0016787; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0044782; GO:0098754,immune system process; catalytic activity; GTPase activity; nucleoplasm; mitochondrion; endosome; vacuole; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; intracellular protein transport; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; cilium organization; detoxification
OG_06480,1.011159530628645,FUN_029250-T1,Peve_00024382,Pocillopora_meandrina_HIv1___TS.g9401.t1,three_way,59.02816666666666,FUN_029250-T1,Q8IZF6,AGRG4_HUMAN,,"Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)]",Homo sapiens (Human),26.0,665.0,5.099999999999999e-55,218.4,sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_06498,1.4157696026245246,FUN_029288-T1,Peve_00036556,Pocillopora_meandrina_HIv1___RNAseq.g11161.t1,three_way,72.14083333333333,FUN_029288-T1,A8EZG1,,,,,38.9,478.0,1e-82,308.9,sp|A8EZG1|MUTS_RICCK DNA mismatch repair protein MutS OS=Rickettsia canadensis (strain McKiel) OX=293613 GN=mutS PE=3 SV=1,,,,,,
OG_06515,1.0128300303366349,FUN_029315-T1,Peve_00038260,Pocillopora_meandrina_HIv1___RNAseq.g12576.t1,three_way,59.641666666666666,FUN_029315-T1,Q6RI86,TRPA1_RAT,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),Rattus norvegicus (Rat),28.2,181.0,5e-07,57.0,sp|Q6RI86|TRPA1_RAT Transient receptor potential cation channel subfamily A member 1 OS=Rattus norvegicus OX=10116 GN=Trpa1 PE=1 SV=2,GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_06520,1.956026784265105,FUN_029330-T1,Peve_00010682,Pocillopora_meandrina_HIv1___TS.g2875.t1,three_way,40.08233333333333,FUN_029330-T1,Q9VC47,TOK_DROME,,Protein tolkin (EC 3.4.24.-) (Tolloid-related protein) (Tolloid-related protein 1),Drosophila melanogaster (Fruit fly),26.6,218.0,6.4e-11,70.1,sp|Q9VC47|TOK_DROME Protein tolkin OS=Drosophila melanogaster OX=7227 GN=tok PE=1 SV=1,GO:0004222; GO:0005509; GO:0005615; GO:0007411; GO:0007415; GO:0008045; GO:0008270; GO:0008586; GO:0009953; GO:0016485; GO:0030424; GO:0030513; GO:0032927; GO:0043204,axon guidance [GO:0007411]; defasciculation of motor neuron axon [GO:0007415]; dorsal/ventral pattern formation [GO:0009953]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; motor neuron axon guidance [GO:0008045]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of BMP signaling pathway [GO:0030513]; protein processing [GO:0016485],axon [GO:0030424]; extracellular space [GO:0005615]; perikaryon [GO:0043204],calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_06539,1.0767230182488456,FUN_029401-T1,Peve_00044530,Pocillopora_meandrina_HIv1___RNAseq.g17142.t1,three_way,73.958,,,,,,,,,,,,,,,,,
OG_06553,1.7272568016936374,FUN_029428-T1,Peve_00039462,Pocillopora_meandrina_HIv1___RNAseq.g17173.t1,three_way,68.539,,,,,,,,,,,,,,,,,
OG_06554,1.0594179133956891,FUN_029431-T1,Peve_00039461,Pocillopora_meandrina_HIv1___RNAseq.g17172.t1,three_way,70.55433333333333,,,,,,,,,,,,,,,,,
OG_06577,1.0841347828666326,FUN_029524-T1,Peve_00010676,Pocillopora_meandrina_HIv1___RNAseq.g17110.t1,three_way,64.472,,,,,,,,,,,,,,,,,
OG_06584,1.2824427332271284,FUN_029556-T1,Peve_00023360,Pocillopora_meandrina_HIv1___TS.g3028.t1,three_way,49.354,,,,,,,,,,,,,,,,,
OG_06592,1.425931118570298,FUN_029640-T1,Peve_00037895,Pocillopora_meandrina_HIv1___RNAseq.g17204.t1,three_way,61.37616666666666,FUN_029640-T1,A2ARV4,LRP2_MOUSE,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Mus musculus (Mouse),38.1,428.0,4.3e-50,201.4,sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1,GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0016020; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0034311; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045177; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1904888,aorta development [GO:0035904]; cell population proliferation [GO:0008283]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006629; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085,endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; lipid metabolic process; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_06599,1.7683662646935387,FUN_029673-T1,Peve_00038759,Pocillopora_meandrina_HIv1___RNAseq.g17212.t1,three_way,61.962,FUN_029673-T1,O88572,LRP6_MOUSE,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Mus musculus (Mouse),38.7,310.0,4.200000000000001e-58,228.0,sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1,GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043065; GO:0045121; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0110135; GO:1990963; GO:2000051; GO:2000648,anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],apolipoprotein binding [GO:0034185]; low-density lipoprotein particle receptor activity [GO:0005041]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005768; GO:0005783; GO:0005886; GO:0006355; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0048870; GO:0060089,transporter activity; endosome; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_06609,1.139848629655347,FUN_029759-T1,Peve_00019499,Pocillopora_meandrina_HIv1___RNAseq.g17321.t1,three_way,95.305,FUN_029759-T1,Q9QYK7,RNF11_MOUSE,,RING finger protein 11 (NEDD4 WW domain-binding protein 2) (Sid 1669),Mus musculus (Mouse),62.2,156.0,3.2e-45,182.6,sp|Q9QYK7|RNF11_MOUSE RING finger protein 11 OS=Mus musculus OX=10090 GN=Rnf11 PE=1 SV=1,GO:0000151; GO:0005634; GO:0005769; GO:0006511; GO:0008270; GO:0051865; GO:0055037; GO:0061630,protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511],early endosome [GO:0005769]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005768; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_06616,1.5960020793815632,FUN_029772-T1,Peve_00013611,Pocillopora_meandrina_HIv1___RNAseq.g17328.t1a,three_way,49.64566666666666,FUN_029772-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),21.8,458.0,5e-18,94.7,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06663,2.118072891482385,FUN_031054-T1,Peve_00028185,Pocillopora_meandrina_HIv1___RNAseq.g30322.t1,three_way,84.973,FUN_031054-T1,Q8CIB5,FERM2_MOUSE,,Fermitin family homolog 2 (Kindlin-2) (Pleckstrin homology domain-containing family C member 1),Mus musculus (Mouse),47.4,694.0,4.1000000000000004e-170,599.7,sp|Q8CIB5|FERM2_MOUSE Fermitin family homolog 2 OS=Mus musculus OX=10090 GN=Fermt2 PE=1 SV=1,GO:0001725; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005912; GO:0005925; GO:0005938; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009898; GO:0009986; GO:0010718; GO:0016055; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035025; GO:0043116; GO:0043539; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0070374; GO:0072657; GO:0120283; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691,"adherens junction maintenance [GO:0034334]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]",adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; I band [GO:0031674]; lamellipodium membrane [GO:0031258]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725],"actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; SMAD binding [GO:0046332]; type I transforming growth factor beta receptor binding [GO:0034713]",GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0007155; GO:0008092; GO:0008289; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,circulatory system process; nucleus; nucleoplasm; cytosol; cell adhesion; cytoskeletal protein binding; lipid binding; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_06670,1.875033131000475,FUN_031070-T1,Peve_00025081,Pocillopora_meandrina_HIv1___RNAseq.g6195.t1,three_way,68.65666666666667,FUN_031070-T1,Q93VC9,,,,,40.9,320.0,1.6e-60,234.6,sp|Q93VC9|CATB2_ARATH Cathepsin B-like protease 2 OS=Arabidopsis thaliana OX=3702 GN=CATHB2 PE=2 SV=1,,,,,,
OG_06680,1.0007998499186106,FUN_031176-T1,Peve_00016087,Pocillopora_meandrina_HIv1___TS.g23938.t1b,three_way,56.30883333333333,,,,,,,,,,,,,,,,,
OG_06719,1.1652277468918282,FUN_031470-T1,Peve_00026552,Pocillopora_meandrina_HIv1___RNAseq.g5082.t1,three_way,68.5885,FUN_031470-T1,Q9JLC8,,,,,30.2,4722.0,0.0,1872.1,sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2,,,,,,
OG_06735,1.3995792036699275,FUN_031519-T1,Peve_00045247,Pocillopora_meandrina_HIv1___RNAseq.g5126.t1,three_way,70.90833333333333,,,,,,,,,,,,,,,,,
OG_06757,3.065594368117431,FUN_031570-T1,Peve_00021507,Pocillopora_meandrina_HIv1___RNAseq.g5065.t1,three_way,57.521,FUN_031570-T1,D4A218,,,,,32.0,303.0,1.1e-26,122.5,sp|D4A218|DMRT3_RAT Doublesex and mab-3 related transcription factor 3 OS=Rattus norvegicus OX=10116 GN=Dmrt3 PE=3 SV=1,,,,,,
OG_06759,1.3536211926780048,FUN_031590-T1,Peve_00012525,Pocillopora_meandrina_HIv1___RNAseq.g5062.t1,three_way,79.86133333333333,FUN_031590-T1,Q86VP3,PACS2_HUMAN,,Phosphofurin acidic cluster sorting protein 2 (PACS-2) (PACS1-like protein),Homo sapiens (Human),37.8,886.0,1.1e-132,475.7,sp|Q86VP3|PACS2_HUMAN Phosphofurin acidic cluster sorting protein 2 OS=Homo sapiens OX=9606 GN=PACS2 PE=1 SV=3,GO:0000045; GO:0005739; GO:0005783; GO:0006915; GO:0032469; GO:0034497; GO:0044325; GO:0072659; GO:1990456,apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659],endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739],transmembrane transporter binding [GO:0044325],GO:0005739; GO:0005783; GO:0012501; GO:0043226; GO:0072659,mitochondrion; endoplasmic reticulum; programmed cell death; organelle; protein localization to plasma membrane
OG_06765,1.744146477752609,FUN_031597-T1,Peve_00012517,Pocillopora_meandrina_HIv1___RNAseq.g5995.t1,three_way,76.125,,,,,,,,,,,,,,,,,
OG_06769,1.6905661719017022,FUN_031627-T1,Peve_00019757,Pocillopora_meandrina_HIv1___RNAseq.g5964.t1,three_way,88.16233333333334,,,,,,,,,,,,,,,,,
OG_06771,1.6154420220124317,FUN_031635-T1,Peve_00032682,Pocillopora_meandrina_HIv1___RNAseq.g5688.t1,three_way,60.882666666666665,FUN_031635-T1,Q9DBY8,NVL_MOUSE,,Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein),Mus musculus (Mouse),44.8,562.0,1.9e-102,374.8,sp|Q9DBY8|NVL_MOUSE Nuclear valosin-containing protein-like OS=Mus musculus OX=10090 GN=Nvl PE=1 SV=1,GO:0000176; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016887; GO:0032092; GO:0032206; GO:0042254; GO:0042273; GO:1904749; GO:1905323; GO:1990275,positive regulation of protein binding [GO:0032092]; positive regulation of telomere maintenance [GO:0032206]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; telomerase holoenzyme complex assembly [GO:1905323],nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0042254; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; ribosome biogenesis; organelle; protein-containing complex assembly
OG_06776,1.2045920863579491,FUN_031642-T1,Peve_00032678,Pocillopora_meandrina_HIv1___RNAseq.g5693.t1,three_way,79.11933333333333,FUN_031642-T1,Q16975,,,,,57.8,742.0,1.7000000000000001e-248,860.1,sp|Q16975|KPC2_APLCA Calcium-independent protein kinase C OS=Aplysia californica OX=6500 GN=PRKC2 PE=1 SV=1,,,,,,
OG_06782,1.790448997873886,FUN_031649-T1,Peve_00043575,Pocillopora_meandrina_HIv1___TS.g24400.t2a,three_way,66.82783333333333,FUN_031649-T1,Q96PN7,TREF1_HUMAN,,Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132),Homo sapiens (Human),29.4,486.0,4e-39,165.6,sp|Q96PN7|TREF1_HUMAN Transcriptional-regulating factor 1 OS=Homo sapiens OX=9606 GN=TRERF1 PE=1 SV=1,GO:0000118; GO:0001223; GO:0001650; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0008270; GO:0033142; GO:0045892; GO:0045893; GO:0045944; GO:0050847; GO:0071393,cellular response to progesterone stimulus [GO:0071393]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],DNA binding [GO:0003677]; nuclear progesterone receptor binding [GO:0033142]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_06783,1.046151228982786,FUN_031650-T1,Peve_00043578,Pocillopora_meandrina_HIv1___TS.g24400.t2b,three_way,70.58166666666666,FUN_031650-T1,Q5R5D8,BODG_PONAB,,"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),35.3,380.0,3e-73,277.3,sp|Q5R5D8|BODG_PONAB Gamma-butyrobetaine dioxygenase OS=Pongo abelii OX=9601 GN=BBOX1 PE=2 SV=1,GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0045329,carnitine biosynthetic process [GO:0045329],mitochondrion [GO:0005739],gamma-butyrobetaine dioxygenase activity [GO:0008336]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_06794,1.1646606804262387,FUN_031681-T1,Peve_00012830,Pocillopora_meandrina_HIv1___RNAseq.g5749.t1,three_way,56.66333333333333,,,,,,,,,,,,,,,,,
OG_06805,1.741706207298237,FUN_031703-T1,Peve_00018219,Pocillopora_meandrina_HIv1___RNAseq.g5760.t1,three_way,62.979,FUN_031703-T1,Q9H1A4,APC1_HUMAN,,Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein),Homo sapiens (Human),31.9,1180.0,1.5000000000000001e-145,518.8,sp|Q9H1A4|APC1_HUMAN Anaphase-promoting complex subunit 1 OS=Homo sapiens OX=9606 GN=ANAPC1 PE=1 SV=1,GO:0005654; GO:0005680; GO:0005829; GO:0007091; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0060090; GO:0070936; GO:0070979; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],molecular adaptor activity [GO:0060090],GO:0005654; GO:0005829; GO:0030163; GO:0060090,nucleoplasm; cytosol; protein catabolic process; molecular adaptor activity
OG_06831,1.1326548300038968,FUN_031743-T1,Peve_00028289,Pocillopora_meandrina_HIv1___RNAseq.g5527.t1,three_way,46.6595,,,,,,,,,,,,,,,,,
OG_06842,1.3808680832523303,FUN_031782-T1,Peve_00010427,Pocillopora_meandrina_HIv1___RNAseq.g5565.t1,three_way,65.31783333333333,FUN_031782-T1,P29176,,,,,44.2,77.0,1.2e-06,55.1,sp|P29176|FOSX_MSVFR Transforming protein v-Fos/v-Fox OS=FBR murine osteosarcoma virus OX=353765 GN=FOS-FOX PE=3 SV=1,,,,,,
OG_06849,1.1609017401830244,FUN_031790-T1,Peve_00019330,Pocillopora_meandrina_HIv1___TS.g24291.t1,three_way,72.05833333333334,,,,,,,,,,,,,,,,,
OG_06850,1.924516262749934,FUN_031791-T1,Peve_00019321,Pocillopora_meandrina_HIv1___RNAseq.g5572.t1,three_way,73.44166666666666,FUN_031791-T1,K7VCB9,,,,,43.1,232.0,1e-38,161.8,sp|K7VCB9|THIM_MAIZE Hydroxyethylthiazole kinase OS=Zea mays OX=4577 GN=THIM PE=1 SV=1,,,,,,
OG_06853,1.7789402426105596,FUN_031802-T1,Peve_00030270,Pocillopora_meandrina_HIv1___RNAseq.g5589.t1,three_way,72.05866666666667,FUN_031802-T1,Q0V9J5,,,,,66.4,107.0,1.6999999999999999e-35,150.6,sp|Q0V9J5|EIF1A_XENTR Probable RNA-binding protein EIF1AD OS=Xenopus tropicalis OX=8364 GN=eif1ad PE=2 SV=1,,,,,,
OG_06863,1.619563267009705,FUN_031856-T1,Peve_00011072,Pocillopora_meandrina_HIv1___RNAseq.g5630.t1,three_way,86.09033333333333,FUN_031856-T1,P13255,GNMT_RAT,,Glycine N-methyltransferase (EC 2.1.1.20) (Folate-binding protein),Rattus norvegicus (Rat),55.3,309.0,1.1e-88,328.2,sp|P13255|GNMT_RAT Glycine N-methyltransferase OS=Rattus norvegicus OX=10116 GN=Gnmt PE=1 SV=2,GO:0005542; GO:0005829; GO:0005977; GO:0006111; GO:0006544; GO:0006555; GO:0006730; GO:0008757; GO:0016594; GO:0017174; GO:0032259; GO:0034708; GO:0042802; GO:0046498; GO:0046500; GO:0051289; GO:0098603; GO:1901052; GO:1904047,glycine metabolic process [GO:0006544]; glycogen metabolic process [GO:0005977]; methionine metabolic process [GO:0006555]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052],cytosol [GO:0005829]; methyltransferase complex [GO:0034708],folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; selenol Se-methyltransferase activity [GO:0098603],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0006520; GO:0006575; GO:0006790; GO:0016740; GO:0055086; GO:0065003; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_06875,1.3679171644445298,FUN_031878-T1,Peve_00031835,Pocillopora_meandrina_HIv1___TS.g24761.t1,three_way,73.57633333333334,FUN_031878-T1,Q05973,,,,,36.1,1564.0,1.8000000000000003e-248,861.3,sp|Q05973|SCN1_HETBL Sodium channel protein 1 brain OS=Heterololigo bleekeri OX=1423826 PE=2 SV=1,,,,,,
OG_06877,1.141175826510481,FUN_031894-T1,Peve_00031826,Pocillopora_meandrina_HIv1___RNAseq.g6060.t1,three_way,53.31966666666666,,,,,,,,,,,,,,,,,
OG_06882,1.17771194846799,FUN_031903-T1,Peve_00037702,Pocillopora_meandrina_HIv1___RNAseq.g30040.t1,three_way,82.041,FUN_031903-T1,Q7ZXY0,,,,,73.9,506.0,4.6e-220,765.4,sp|Q7ZXY0|INO1A_XENLA Inositol-3-phosphate synthase 1-A OS=Xenopus laevis OX=8355 GN=isyna1-a PE=2 SV=1,,,,,,
OG_06888,1.458193300703538,FUN_031925-T1,Peve_00004245,Pocillopora_meandrina_HIv1___TS.g21220.t1,three_way,43.71983333333333,,,,,,,,,,,,,,,,,
OG_06891,1.751727196555012,FUN_031930-T1,Peve_00004237,Pocillopora_meandrina_HIv1___RNAseq.g18237.t1,three_way,54.86833333333333,,,,,,,,,,,,,,,,,
OG_06895,1.6692091900787414,FUN_031937-T1,Peve_00024805,Pocillopora_meandrina_HIv1___RNAseq.g18211.t1,three_way,52.65616666666666,,,,,,,,,,,,,,,,,
OG_06909,2.3902069941301245,FUN_031967-T1,Peve_00013260,Pocillopora_meandrina_HIv1___RNAseq.g17806.t1,three_way,83.551,FUN_031967-T1,Q95M17,CHIA_BOVIN,,Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04),Bos taurus (Bovine),46.4,390.0,4.3999999999999996e-91,336.7,sp|Q95M17|CHIA_BOVIN Acidic mammalian chitinase OS=Bos taurus OX=9913 GN=CHIA PE=1 SV=1,GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0008843; GO:0032722,apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843],GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005975; GO:0012501; GO:0016787; GO:1901135,immune system process; catalytic activity; extracellular region; extracellular space; carbohydrate metabolic process; programmed cell death; hydrolase activity; carbohydrate derivative metabolic process
OG_06924,1.6885422000416836,FUN_032014-T1,Peve_00041128,Pocillopora_meandrina_HIv1___RNAseq.g30270.t1,three_way,57.59433333333333,FUN_032014-T1,P14824,ANXA6_MOUSE,,Annexin A6 (67 kDa calelectrin) (Annexin VI) (Annexin-6) (Calphobindin-II) (CPB-II) (Chromobindin-20) (Lipocortin VI) (Protein III) (p68) (p70),Mus musculus (Mouse),25.3,292.0,1.3e-17,92.0,sp|P14824|ANXA6_MOUSE Annexin A6 OS=Mus musculus OX=10090 GN=Anxa6 PE=1 SV=3,GO:0005509; GO:0005525; GO:0005544; GO:0005739; GO:0005765; GO:0005829; GO:0006816; GO:0006937; GO:0015276; GO:0015485; GO:0016020; GO:0031902; GO:0042470; GO:0042802; GO:0048306; GO:0048471; GO:0051560; GO:0062023; GO:0097190,apoptotic signaling pathway [GO:0097190]; calcium ion transport [GO:0006816]; mitochondrial calcium ion homeostasis [GO:0051560]; regulation of muscle contraction [GO:0006937],collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cholesterol binding [GO:0015485]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0005215; GO:0005739; GO:0005829; GO:0008289; GO:0031410; GO:0043226,transporter activity; mitochondrion; cytosol; lipid binding; cytoplasmic vesicle; organelle
OG_06948,1.7750268940374434,FUN_032061-T2,Peve_00040453,Pocillopora_meandrina_HIv1___RNAseq.g6047.t1,three_way,65.65933333333334,FUN_032061-T2,P39428,TRAF1_MOUSE,,TNF receptor-associated factor 1,Mus musculus (Mouse),31.4,264.0,1.1000000000000001e-27,125.9,sp|P39428|TRAF1_MOUSE TNF receptor-associated factor 1 OS=Mus musculus OX=10090 GN=Traf1 PE=1 SV=2,GO:0005164; GO:0005737; GO:0006915; GO:0007165; GO:0008270; GO:0031625; GO:0031996; GO:0042802; GO:2001236,apoptotic process [GO:0006915]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; signal transduction [GO:0007165],cytoplasm [GO:0005737],identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0012501,programmed cell death
OG_06956,2.9331351432400714,FUN_032081-T1,Peve_00039910,Pocillopora_meandrina_HIv1___RNAseq.g5227.t1,three_way,79.99466666666666,FUN_032081-T1,Q5RE98,AOFB_PONAB,,Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),47.7,486.0,1.1000000000000001e-130,468.4,sp|Q5RE98|AOFB_PONAB Amine oxidase [flavin-containing] B OS=Pongo abelii OX=9601 GN=MAOB PE=2 SV=3,GO:0005739; GO:0005741; GO:0008131; GO:0050660; GO:0097621,,mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_06957,1.3786042484290488,FUN_032082-T1,Peve_00039909,Pocillopora_meandrina_HIv1___RNAseq.g5228.t1,three_way,70.91216666666666,FUN_032082-T1,Q6UWX4,,,,,47.1,605.0,4.7e-163,576.2,sp|Q6UWX4|HIPL2_HUMAN HHIP-like protein 2 OS=Homo sapiens OX=9606 GN=HHIPL2 PE=1 SV=1,,,,,,
OG_06960,1.3929803741957538,FUN_032089-T1,Peve_00012817,Pocillopora_meandrina_HIv1___RNAseq.g2588.t1,three_way,67.0965,,,,,,,,,,,,,,,,,
OG_06964,1.1353798778715778,FUN_032095-T1,Peve_00012823,Pocillopora_meandrina_HIv1___RNAseq.g5274.t1,three_way,65.23833333333333,,,,,,,,,,,,,,,,,
OG_06981,1.655201410230255,FUN_032118-T1,Peve_00030238,Pocillopora_meandrina_HIv1___RNAseq.g5380.t1,three_way,76.23633333333333,FUN_032118-T1,Q5ZL91,INT7_CHICK,,Integrator complex subunit 7 (Int7),Gallus gallus (Chicken),45.5,927.0,3.2e-212,740.3,sp|Q5ZL91|INT7_CHICK Integrator complex subunit 7 OS=Gallus gallus OX=9031 GN=INTS7 PE=2 SV=1,GO:0005634; GO:0005694; GO:0005737; GO:0006974; GO:0032039; GO:0034472; GO:0160232; GO:0160240,DNA damage response [GO:0006974]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472],chromosome [GO:0005694]; cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634],,GO:0005634; GO:0005694; GO:0016073; GO:0043226,nucleus; chromosome; snRNA metabolic process; organelle
OG_06991,1.7219783647267777,FUN_032133-T1,Peve_00029139,Pocillopora_meandrina_HIv1___RNAseq.g5353.t1,three_way,78.61566666666667,FUN_032133-T1,Q9ULQ1,,,,,28.8,552.0,2.7000000000000004e-44,181.8,sp|Q9ULQ1|TPC1_HUMAN Two pore channel protein 1 OS=Homo sapiens OX=9606 GN=TPCN1 PE=1 SV=3,,,,,,
OG_06995,1.2266654646785211,FUN_032143-T1,Peve_00007909,Pocillopora_meandrina_HIv1___RNAseq.g5346.t1,three_way,75.438,FUN_032143-T1,Q9H0R1,AP5M1_HUMAN,,AP-5 complex subunit mu-1 (Adaptor-related protein complex 5 subunit mu-1) (Mu5) (Mu-2-related death-inducing protein) (MuD) (Putative HIV-1 infection-related protein),Homo sapiens (Human),34.8,515.0,1.2e-78,295.4,sp|Q9H0R1|AP5M1_HUMAN AP-5 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP5M1 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016020; GO:0016192; GO:0016197; GO:0030119; GO:0031902; GO:0044599,endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020],,GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_07000,2.044994953305025,FUN_032151-T1,Peve_00003236,Pocillopora_meandrina_HIv1___RNAseq.g5328.t1,three_way,63.626333333333335,FUN_032151-T1,Q9NPA2,MMP25_HUMAN,,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-) (Leukolysin) (Membrane-type matrix metalloproteinase 6) (MT-MMP 6) (MTMMP6) (Membrane-type-6 matrix metalloproteinase) (MT6-MMP) (MT6MMP),Homo sapiens (Human),36.2,384.0,6.7e-56,219.9,sp|Q9NPA2|MMP25_HUMAN Matrix metalloproteinase-25 OS=Homo sapiens OX=9606 GN=MMP25 PE=1 SV=1,GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0006954; GO:0008270; GO:0016020; GO:0030198; GO:0030574; GO:0031012; GO:0035579; GO:0060022; GO:0098552,collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; proteolysis [GO:0006508],extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; specific granule membrane [GO:0035579],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0006954; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0140096,"catalytic activity; extracellular space; plasma membrane; inflammatory response; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; catalytic activity, acting on a protein"
OG_07031,1.3046774231544436,FUN_032223-T1,Peve_00015541,Pocillopora_meandrina_HIv1___RNAseq.g24284.t1,three_way,70.46133333333333,FUN_032223-T1,C3ZQF9,,,,,30.2,305.0,1.9e-25,118.2,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_07035,1.5248207833225913,FUN_032229-T1,Peve_00027503,Pocillopora_meandrina_HIv1___RNAseq.g24831.t1,three_way,71.70400000000001,FUN_032229-T1,Q66GV0,,,,,49.1,175.0,1.7e-41,170.6,sp|Q66GV0|MPV17_XENLA Mitochondrial inner membrane protein Mpv17 OS=Xenopus laevis OX=8355 GN=mpv17 PE=2 SV=2,,,,,,
OG_07039,1.0388372838091031,FUN_032235-T1,Peve_00043486,Pocillopora_meandrina_HIv1___RNAseq.g24841.t1,three_way,59.83833333333334,,,,,,,,,,,,,,,,,
OG_07050,1.1795149545089552,FUN_032270-T1,Peve_00014263,Pocillopora_meandrina_HIv1___RNAseq.g24972.t1,three_way,76.632,,,,,,,,,,,,,,,,,
OG_07052,1.1056170956944291,FUN_032274-T1,Peve_00011763,Pocillopora_meandrina_HIv1___RNAseq.g24974.t1,three_way,68.399,FUN_032274-T1,A8E7N9,,,,,31.6,370.0,2.9e-44,181.0,sp|A8E7N9|GDF6B_DANRE Growth/differentiation factor 6-B OS=Danio rerio OX=7955 GN=gdf6b PE=2 SV=1,,,,,,
OG_07053,1.041295827403023,FUN_032276-T1,Peve_00011761,Pocillopora_meandrina_HIv1___RNAseq.g24976.t1,three_way,83.19833333333334,FUN_032276-T1,Q8QZZ8,RAB38_MOUSE,,Ras-related protein Rab-38 (EC 3.6.5.2),Mus musculus (Mouse),70.5,129.0,3.4e-52,205.7,sp|Q8QZZ8|RAB38_MOUSE Ras-related protein Rab-38 OS=Mus musculus OX=10090 GN=Rab38 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005739; GO:0005764; GO:0005769; GO:0005802; GO:0005886; GO:0007005; GO:0015031; GO:0016192; GO:0030670; GO:0030742; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0044297; GO:0045335; GO:0048023; GO:0048471; GO:0060155; GO:0072657; GO:0090383; GO:1903232; GO:1904377; GO:2001247,endosome to melanosome transport [GO:0035646]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome acidification [GO:0090383]; platelet dense granule organization [GO:0060155]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of protein localization to cell periphery [GO:1904377]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],cell body [GO:0044297]; early endosome [GO:0005769]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0007005; GO:0016192; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; mitochondrion; lysosome; endosome; vacuole; plasma membrane; mitochondrion organization; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_07066,1.0259718961698965,FUN_032299-T1,Peve_00020128,Pocillopora_meandrina_HIv1___RNAseq.g24900.t1,three_way,50.632333333333335,FUN_032299-T1,Q3ZT31,SNX25_MOUSE,,Sorting nexin-25,Mus musculus (Mouse),27.2,125.0,1.3e-07,60.8,sp|Q3ZT31|SNX25_MOUSE Sorting nexin-25 OS=Mus musculus OX=10090 GN=Snx25 PE=1 SV=3,GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091,negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801],endosome [GO:0005768]; endosome membrane [GO:0010008],phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713],GO:0005768; GO:0008289; GO:0031410; GO:0043226,endosome; lipid binding; cytoplasmic vesicle; organelle
OG_07079,1.020472897134838,FUN_032317-T1,Peve_00031925,Pocillopora_meandrina_HIv1___RNAseq.g24788.t1,three_way,48.4895,FUN_032317-T1,Q3ULM6,,,,,29.3,300.0,2.1e-30,135.6,sp|Q3ULM6|USPL1_MOUSE SUMO-specific isopeptidase USPL1 OS=Mus musculus OX=10090 GN=Uspl1 PE=2 SV=2,,,,,,
OG_07103,1.23243400289092,FUN_032365-T1,Peve_00020147,Pocillopora_meandrina_HIv1___RNAseq.g29821.t1,three_way,68.24633333333333,FUN_032365-T1,Q2KIA4,SCD5_BOVIN,,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase),Bos taurus (Bovine),56.5,283.0,1.6e-100,367.5,sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1,GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491,unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_07120,1.1615634566591648,FUN_032405-T1,Peve_00009164,Pocillopora_meandrina_HIv1___RNAseq.g29839.t1,three_way,82.7025,FUN_032405-T1,Q6GNS3,,,,,57.4,509.0,6.3000000000000005e-168,592.0,sp|Q6GNS3|NMD3_XENLA 60S ribosomal export protein NMD3 OS=Xenopus laevis OX=8355 GN=nmd3 PE=2 SV=1,,,,,,
OG_07121,1.5320860282717057,FUN_032420-T1,Peve_00041753,Pocillopora_meandrina_HIv1___RNAseq.g24395.t1,three_way,71.22583333333333,,,,,,,,,,,,,,,,,
OG_07129,1.900977921568118,FUN_032429-T1,Peve_00027369,Pocillopora_meandrina_HIv1___RNAseq.g24121.t1,three_way,86.55766666666666,FUN_032429-T1,O95847,UCP4_HUMAN,,Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27),Homo sapiens (Human),60.4,303.0,4.3e-103,375.9,sp|O95847|UCP4_HUMAN Mitochondrial uncoupling protein 4 OS=Homo sapiens OX=9606 GN=SLC25A27 PE=1 SV=1,GO:0005739; GO:0005743; GO:0008284; GO:0009409; GO:0010917; GO:0015078; GO:0015108; GO:0022857; GO:0031966; GO:0035356; GO:0042803; GO:0043025; GO:0043524; GO:0045177; GO:0046324; GO:0048839; GO:0051562,inner ear development [GO:0048839]; intracellular triglyceride homeostasis [GO:0035356]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; regulation of D-glucose import [GO:0046324]; response to cold [GO:0009409],apical part of cell [GO:0045177]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025],chloride transmembrane transporter activity [GO:0015108]; protein homodimerization activity [GO:0042803]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005739; GO:0043226; GO:0048856,transporter activity; mitochondrion; organelle; anatomical structure development
OG_07134,1.7512449686991003,FUN_032459-T1,Peve_00009149,Pocillopora_meandrina_HIv1___RNAseq.g24151.t1,three_way,75.24633333333333,,,,,,,,,,,,,,,,,
OG_07136,1.0001791174850123,FUN_032461-T1,Peve_00009147,Pocillopora_meandrina_HIv1___RNAseq.g24160.t1,three_way,52.884,FUN_032461-T1,G5ECX0,LPLT2_CAEEL,,Latrophilin-like protein LAT-2,Caenorhabditis elegans,35.2,369.0,3.4e-52,208.0,sp|G5ECX0|LPLT2_CAEEL Latrophilin-like protein LAT-2 OS=Caenorhabditis elegans OX=6239 GN=lat-2 PE=2 SV=1,GO:0004175; GO:0004930; GO:0005886; GO:0007166; GO:0030246; GO:0097264,cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264],plasma membrane [GO:0005886],carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930],GO:0003824; GO:0005886; GO:0016787; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_07150,1.5407992980814105,FUN_032503-T1,Peve_00042404,Pocillopora_meandrina_HIv1___TS.g12263.t1,three_way,58.67733333333334,FUN_032503-T1,Q20191,,,,,47.1,204.0,5.400000000000001e-44,181.0,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_07160,1.5019913524419422,FUN_032571-T1,Peve_00000701,Pocillopora_meandrina_HIv1___RNAseq.g24714.t1,three_way,68.33,FUN_032571-T1,O95497,VNN1_HUMAN,,Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1),Homo sapiens (Human),45.2,496.0,7.1e-112,406.0,sp|O95497|VNN1_HUMAN Pantetheinase OS=Homo sapiens OX=9606 GN=VNN1 PE=1 SV=2,GO:0002526; GO:0002544; GO:0005576; GO:0005886; GO:0006954; GO:0006979; GO:0015938; GO:0015939; GO:0016020; GO:0017159; GO:0033089; GO:0035577; GO:0045087; GO:0098552; GO:0098609; GO:1902177,acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; coenzyme A catabolic process [GO:0015938]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pantothenate metabolic process [GO:0015939]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979],azurophil granule membrane [GO:0035577]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],pantetheine hydrolase activity [GO:0017159],GO:0002376; GO:0003824; GO:0005576; GO:0005886; GO:0006575; GO:0006790; GO:0006954; GO:0007155; GO:0016787; GO:0055086; GO:0098542,immune system process; catalytic activity; extracellular region; plasma membrane; modified amino acid metabolic process; sulfur compound metabolic process; inflammatory response; cell adhesion; hydrolase activity; nucleobase-containing small molecule metabolic process; defense response to other organism
OG_07161,1.5091032638057855,FUN_032573-T1,Peve_00020057,Pocillopora_meandrina_HIv1___RNAseq.g24657.t1,three_way,46.22766666666666,FUN_032573-T1,Q90876,,,,,34.0,153.0,5.600000000000001e-23,109.4,sp|Q90876|IRF1_CHICK Interferon regulatory factor 1 OS=Gallus gallus OX=9031 GN=IRF1 PE=2 SV=1,,,,,,
OG_07178,1.4306279576379446,FUN_032629-T1,Peve_00033684,Pocillopora_meandrina_HIv1___RNAseq.g24118.t1,three_way,65.04233333333333,FUN_032629-T1,Q91175,,,,,32.9,316.0,2.3000000000000002e-33,144.4,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_07185,1.3027088854355957,FUN_032676-T1,Peve_00015960,Pocillopora_meandrina_HIv1___RNAseq.g24112.t1,three_way,78.02799999999999,FUN_032676-T1,Q4KMZ8,NKAI1_HUMAN,,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 1) (Protein FAM77C),Homo sapiens (Human),45.9,205.0,1.6e-45,184.1,sp|Q4KMZ8|NKAI1_HUMAN Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 OS=Homo sapiens OX=9606 GN=NKAIN1 PE=2 SV=3,GO:0002028; GO:0005886; GO:0051117,regulation of sodium ion transport [GO:0002028],plasma membrane [GO:0005886],ATPase binding [GO:0051117],GO:0005886,plasma membrane
OG_07188,1.764455965978769,FUN_032679-T1,Peve_00015963,Pocillopora_meandrina_HIv1___RNAseq.g24109.t1,three_way,79.57666666666667,FUN_032679-T1,A4L9J0,MIP_RABIT,,Lens fiber major intrinsic protein (Aquaporin-0),Oryctolagus cuniculus (Rabbit),39.3,229.0,3.4e-33,143.7,sp|A4L9J0|MIP_RABIT Lens fiber major intrinsic protein OS=Oryctolagus cuniculus OX=9986 GN=MIP PE=2 SV=1,GO:0002088; GO:0005212; GO:0005516; GO:0005886; GO:0006833; GO:0007601; GO:0015250; GO:0016324; GO:0034109; GO:0036438; GO:0070161; GO:0098631; GO:1990349,gap junction-mediated intercellular transport [GO:1990349]; homotypic cell-cell adhesion [GO:0034109]; lens development in camera-type eye [GO:0002088]; maintenance of lens transparency [GO:0036438]; visual perception [GO:0007601]; water transport [GO:0006833],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],calmodulin binding [GO:0005516]; cell adhesion mediator activity [GO:0098631]; structural constituent of eye lens [GO:0005212]; water channel activity [GO:0015250],GO:0005198; GO:0005215; GO:0005886; GO:0007155; GO:0048856; GO:0050877; GO:0098631,structural molecule activity; transporter activity; plasma membrane; cell adhesion; anatomical structure development; nervous system process; cell adhesion mediator activity
OG_07205,1.5524373233259952,FUN_032745-T1,Peve_00029929,Pocillopora_meandrina_HIv1___RNAseq.g29880.t1,three_way,55.068333333333335,FUN_032745-T1,Q9HAR2,AGRL3_HUMAN,,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),Homo sapiens (Human),29.8,540.0,7.7e-54,213.8,sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2,GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0016020; GO:0030246; GO:0030424; GO:0098631; GO:0098742; GO:0098978; GO:0140693; GO:0160221; GO:1904861,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; excitatory synapse assembly [GO:1904861]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221]; synapse assembly [GO:0007416],axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; cell adhesion mediator activity [GO:0098631]; G protein-coupled receptor activity [GO:0004930]; molecular condensate scaffold activity [GO:0140693],GO:0005886; GO:0007155; GO:0034330; GO:0048870; GO:0060089; GO:0060090; GO:0098631,plasma membrane; cell adhesion; cell junction organization; cell motility; molecular transducer activity; molecular adaptor activity; cell adhesion mediator activity
OG_07218,1.2985127295022598,FUN_032790-T1,Peve_00010373,Pocillopora_meandrina_HIv1___RNAseq.g29721.t1,three_way,55.391333333333336,FUN_032790-T1,Q68LP1,MIB2_RAT,,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RBSC-skeletrophin/dystrophin-like polypeptide) (RING-type E3 ubiquitin transferase MIB2),Rattus norvegicus (Rat),38.8,456.0,1.5999999999999999e-83,312.8,sp|Q68LP1|MIB2_RAT E3 ubiquitin-protein ligase MIB2 OS=Rattus norvegicus OX=10116 GN=Mib2 PE=1 SV=2,GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005886; GO:0007219; GO:0008270; GO:0016567; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation protein catabolic process at postsynapse [GO:0140252],cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151],actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005886; GO:0008092; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; plasma membrane; cytoskeletal protein binding; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07224,1.1385828501880304,FUN_032825-T1,Peve_00014525,Pocillopora_meandrina_HIv1___TS.g24937.t1a,three_way,59.772,FUN_032825-T1,A1ZAY1,DLISH_DROME,,SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains),Drosophila melanogaster (Fruit fly),55.6,63.0,2.3e-14,81.6,sp|A1ZAY1|DLISH_DROME SH3 domain-containing protein Dlish OS=Drosophila melanogaster OX=7227 GN=Dlish PE=1 SV=1,GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219,establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251],apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cilium [GO:0005929]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219],cadherin binding [GO:0045296],GO:0005929; GO:0007163; GO:0043226,cilium; establishment or maintenance of cell polarity; organelle
OG_07243,1.0927669351439973,FUN_032973-T1,Peve_00015586,Pocillopora_meandrina_HIv1___RNAseq.g29689.t1,three_way,85.39766666666667,FUN_032973-T1,Q4QRK0,MAP11_DANRE,,Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1),Danio rerio (Zebrafish) (Brachydanio rerio),68.7,380.0,8.099999999999999e-160,564.7,sp|Q4QRK0|MAP11_DANRE Methionine aminopeptidase 1 OS=Danio rerio OX=7955 GN=metap1 PE=2 SV=2,GO:0004239; GO:0005829; GO:0006882; GO:0008270; GO:0016485; GO:0022626; GO:0070006,intracellular zinc ion homeostasis [GO:0006882]; protein processing [GO:0016485],cytosol [GO:0005829]; cytosolic ribosome [GO:0022626],initiator methionyl aminopeptidase activity [GO:0004239]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005840; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; cytosol; ribosome; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_07250,1.1696065563167295,FUN_032992-T1,Peve_00014540,Pocillopora_meandrina_HIv1___RNAseq.g24473.t1,three_way,73.003,FUN_032992-T1,Q8RCT3,,,,,57.0,302.0,2.5e-88,328.2,sp|Q8RCT3|PSUG_CALS4 Pseudouridine-5'-phosphate glycosidase OS=Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) OX=273068 GN=psuG PE=3 SV=1,,,,,,
OG_07282,1.2703181386938636,FUN_033509-T1,Peve_00009172,Pocillopora_meandrina_HIv1___RNAseq.g24179.t1,three_way,62.28966666666666,FUN_033509-T1,P14942,GSTA4_RAT,,Glutathione S-transferase alpha-4 (EC 2.5.1.18) (GST 8-8) (GST A4-4) (GST K) (Glutathione S-transferase Yk) (GST Yk),Rattus norvegicus (Rat),30.8,211.0,1.5e-17,91.3,sp|P14942|GSTA4_RAT Glutathione S-transferase alpha-4 OS=Rattus norvegicus OX=10116 GN=Gsta4 PE=1 SV=2,GO:0004364; GO:0005739; GO:0005829; GO:0006749; GO:0006805; GO:0009635; GO:0010043; GO:0015643; GO:0035094; GO:0042802; GO:0042803; GO:0071285,cellular response to lithium ion [GO:0071285]; glutathione metabolic process [GO:0006749]; response to herbicide [GO:0009635]; response to nicotine [GO:0035094]; response to zinc ion [GO:0010043]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; mitochondrion [GO:0005739],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643],GO:0003824; GO:0005739; GO:0005829; GO:0006575; GO:0006790; GO:0016740; GO:0043226,catalytic activity; mitochondrion; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle
OG_07289,1.5620359139631383,FUN_033670-T1,Peve_00037062,Pocillopora_meandrina_HIv1___RNAseq.g28727.t1,three_way,77.678,,,,,,,,,,,,,,,,,
OG_07321,1.362873726636673,FUN_033714-T1,Peve_00017869,Pocillopora_meandrina_HIv1___RNAseq.g28832.t1,three_way,41.261,,,,,,,,,,,,,,,,,
OG_07334,1.5419364557356123,FUN_033738-T1,Peve_00027592,Pocillopora_meandrina_HIv1___RNAseq.g28761.t1,three_way,77.64833333333334,FUN_033738-T1,Q3ZBH3,,,,,37.7,244.0,3e-46,186.8,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_07343,1.175345201120524,FUN_033748-T1,Peve_00004932,Pocillopora_meandrina_HIv1___RNAseq.g28754.t1,three_way,36.10916666666667,,,,,,,,,,,,,,,,,
OG_07344,2.198819103460424,FUN_033751-T1,Peve_00004933,Pocillopora_meandrina_HIv1___TS.g8542.t1,three_way,79.90966666666667,FUN_033751-T1,O95461,,,,,60.2,689.0,6.4e-254,878.2,sp|O95461|LARG1_HUMAN Xylosyl- and glucuronyltransferase LARGE1 OS=Homo sapiens OX=9606 GN=LARGE1 PE=1 SV=1,,,,,,
OG_07351,1.5145995310757114,FUN_033759-T1,Peve_00009253,Pocillopora_meandrina_HIv1___RNAseq.g28744.t1,three_way,61.443,FUN_033759-T1,Q28005,LSHR_BOVIN,,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R),Bos taurus (Bovine),36.1,498.0,3.2000000000000003e-80,301.6,sp|Q28005|LSHR_BOVIN Lutropin-choriogonadotropic hormone receptor OS=Bos taurus OX=9913 GN=LHCGR PE=2 SV=1,GO:0001541; GO:0004964; GO:0005886; GO:0007189; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0042700; GO:0071373,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_07359,1.3243270669370266,FUN_033770-T1,Peve_00006489,Pocillopora_meandrina_HIv1___RNAseq.g26661.t1,three_way,47.22,FUN_033770-T1,P10733,,,,,27.9,204.0,1.2e-17,92.4,sp|P10733|SEVE_DICDI Severin OS=Dictyostelium discoideum OX=44689 GN=sevA PE=1 SV=1,,,,,,
OG_07360,1.5003356115316733,FUN_033771-T1,Peve_00006491,Pocillopora_meandrina_HIv1___RNAseq.g26660.t1,three_way,47.66133333333333,FUN_033771-T1,Q7JQD3,GELS1_LUMTE,,Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1),Lumbricus terrestris (Common earthworm),34.7,340.0,7.799999999999999e-49,196.1,sp|Q7JQD3|GELS1_LUMTE Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1,GO:0003779; GO:0005509; GO:0005737; GO:0015629; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693,actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737],actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0005856; GO:0008092; GO:0043226; GO:0065003,cytoskeleton; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_07373,1.1742351874662018,FUN_033793-T2,Peve_00029690,Pocillopora_meandrina_HIv1___RNAseq.g26316.t1,three_way,63.531666666666666,,,,,,,,,,,,,,,,,
OG_07394,1.159850292864535,FUN_033824-T1,Peve_00028770,Pocillopora_meandrina_HIv1___RNAseq.g26355.t1,three_way,53.976,,,,,,,,,,,,,,,,,
OG_07400,2.4009992146791155,FUN_033839-T1,Peve_00016490,Pocillopora_meandrina_HIv1___RNAseq.g26367.t1,three_way,53.79466666666666,,,,,,,,,,,,,,,,,
OG_07405,1.405803529752111,FUN_033856-T2,Peve_00043300,Pocillopora_meandrina_HIv1___TS.g8205.t2,three_way,77.4,FUN_033856-T2,Q96KP4,CNDP2_HUMAN,,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase),Homo sapiens (Human),65.4,474.0,6.799999999999999e-188,658.3,sp|Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=Homo sapiens OX=9606 GN=CNDP2 PE=1 SV=2,GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0016805; GO:0046872; GO:0070062; GO:0070573,proteolysis [GO:0006508],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07409,1.4332266294296478,FUN_033862-T1,Peve_00043295,Pocillopora_meandrina_HIv1___RNAseq.g28416.t1,three_way,77.74766666666666,,,,,,,,,,,,,,,,,
OG_07430,1.2261436121246114,FUN_033917-T1,Peve_00022631,Pocillopora_meandrina_HIv1___TS.g19347.t2a,three_way,44.82383333333333,,,,,,,,,,,,,,,,,
OG_07455,1.414888669043067,FUN_033951-T1,Peve_00032117,Pocillopora_meandrina_HIv1___RNAseq.g28360.t1,three_way,65.717,,,,,,,,,,,,,,,,,
OG_07470,2.1541694471140707,FUN_033980-T1,Peve_00004847,Pocillopora_meandrina_HIv1___RNAseq.g26110.t1,three_way,64.06066666666666,FUN_033980-T1,Q1EHB4,SC5AC_HUMAN,,Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12),Homo sapiens (Human),34.5,560.0,3.3e-86,320.9,sp|Q1EHB4|SC5AC_HUMAN Sodium-coupled monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC5A12 PE=1 SV=2,GO:0005343; GO:0005654; GO:0005886; GO:0006811; GO:0006814; GO:0015129; GO:0015293; GO:0015718; GO:0016324; GO:0070062; GO:0140161,monoatomic ion transport [GO:0006811]; monocarboxylic acid transport [GO:0015718]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; symporter activity [GO:0015293],GO:0005215; GO:0005654; GO:0005886; GO:0043226,transporter activity; nucleoplasm; plasma membrane; organelle
OG_07496,1.176996707147972,FUN_034028-T1,Peve_00043490,Pocillopora_meandrina_HIv1___RNAseq.g16571.t1,three_way,51.52466666666667,,,,,,,,,,,,,,,,,
OG_07543,1.127663687634582,FUN_034124-T1,Peve_00006391,Pocillopora_meandrina_HIv1___RNAseq.g25944.t1,three_way,74.825,FUN_034124-T1,Q9NZV8,KCND2_HUMAN,,A-type voltage-gated potassium channel KCND2 (Potassium voltage-gated channel subfamily D member 2) (Voltage-gated potassium channel subunit Kv4.2),Homo sapiens (Human),41.2,279.0,9.3e-45,182.2,sp|Q9NZV8|KCND2_HUMAN A-type voltage-gated potassium channel KCND2 OS=Homo sapiens OX=9606 GN=KCND2 PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006936; GO:0007268; GO:0008016; GO:0008076; GO:0019228; GO:0019233; GO:0032809; GO:0043025; GO:0043197; GO:0043204; GO:0044853; GO:0045211; GO:0045475; GO:0046872; GO:0051260; GO:0070161; GO:0071193; GO:0071456; GO:0071805; GO:0086009; GO:0098978; GO:0098982; GO:0099634; GO:1905030,action potential [GO:0001508]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; locomotor rhythm [GO:0045475]; membrane repolarization [GO:0086009]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; sensory perception of pain [GO:0019233],anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Kv4.2-KChIP2 channel complex [GO:0071193]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated potassium channel activity [GO:0005249],GO:0003012; GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,muscle system process; transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_07554,1.1808617872003926,FUN_034149-T1,Peve_00026010,Pocillopora_meandrina_HIv1___TS.g23718.t1b,three_way,50.663833333333336,,,,,,,,,,,,,,,,,
OG_07596,1.3745579285721563,FUN_034303-T1,Peve_00019148,Pocillopora_meandrina_HIv1___RNAseq.g28500.t1,three_way,76.81366666666666,FUN_034303-T1,Q15256,,,,,35.3,544.0,8.4e-69,263.1,sp|Q15256|PTPRR_HUMAN Receptor-type tyrosine-protein phosphatase R OS=Homo sapiens OX=9606 GN=PTPRR PE=1 SV=2,,,,,,
OG_07606,1.1056091091793063,FUN_034323-T1,Peve_00015002,Pocillopora_meandrina_HIv1___RNAseq.g28481.t1,three_way,65.10766666666666,FUN_034323-T1,Q3UR85,MYRF_MOUSE,,"Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal]",Mus musculus (Mouse),54.0,404.0,1.5000000000000001e-117,425.6,sp|Q3UR85|MYRF_MOUSE Myelin regulatory factor OS=Mus musculus OX=10090 GN=Myrf PE=1 SV=2,GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0008233; GO:0014003; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0035902; GO:0042220; GO:0043565; GO:0045893; GO:0048709; GO:0048714,central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein autoprocessing [GO:0016540]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; response to immobilization stress [GO:0035902],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0061024; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; Golgi apparatus; cytosol; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein maturation; membrane organization; catalytic activity, acting on a protein; transcription regulator activity"
OG_07608,1.5572609006595304,FUN_034327-T1,Peve_00019143,Pocillopora_meandrina_HIv1___RNAseq.g28477.t1,three_way,46.769666666666666,,,,,,,,,,,,,,,,,
OG_07631,1.5161526721995189,FUN_034387-T1,Peve_00027164,Pocillopora_meandrina_HIv1___TS.g18900.t1,three_way,70.562,FUN_034387-T1,Q95K73,ELOV4_MACFA,,Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),52.3,279.0,3e-77,290.0,sp|Q95K73|ELOV4_MACFA Very long chain fatty acid elongase 4 OS=Macaca fascicularis OX=9541 GN=ELOVL4 PE=2 SV=1,GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761,"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07641,1.0970424883549563,FUN_034420-T1,Peve_00021291,Pocillopora_meandrina_HIv1___RNAseq.g28575.t1,three_way,76.00066666666666,FUN_034420-T1,Q32LP4,S4A10_BOVIN,,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),Bos taurus (Bovine),48.4,1093.0,1.6000000000000002e-273,944.1,sp|Q32LP4|S4A10_BOVIN Sodium-driven chloride bicarbonate exchanger OS=Bos taurus OX=9913 GN=SLC4A10 PE=2 SV=1,GO:0005452; GO:0005886; GO:0007601; GO:0008509; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0030425; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0051453; GO:0055085; GO:0098794; GO:0098982,bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; transmembrane transport [GO:0055085]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202],monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_07642,1.742233478126475,FUN_034421-T1,Peve_00038701,Pocillopora_meandrina_HIv1___RNAseq.g28564.t1,three_way,82.62766666666667,FUN_034421-T1,Q3MHQ7,,,,,47.0,230.0,2.9e-47,190.3,sp|Q3MHQ7|TM86A_BOVIN Lysoplasmalogenase TMEM86A OS=Bos taurus OX=9913 GN=TMEM86A PE=2 SV=1,,,,,,
OG_07648,1.1965791191525943,FUN_034480-T1,Peve_00008656,Pocillopora_meandrina_HIv1___RNAseq.g25905.t1,three_way,72.97983333333333,,,,,,,,,,,,,,,,,
OG_07649,1.4015818935343487,FUN_034481-T1,Peve_00010882,Pocillopora_meandrina_HIv1___RNAseq.g28844.t1,three_way,80.02866666666667,FUN_034481-T1,P80147,GABT_PIG,,"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)",Sus scrofa (Pig),53.6,459.0,4.2e-148,526.2,"sp|P80147|GABT_PIG 4-aminobutyrate aminotransferase, mitochondrial OS=Sus scrofa OX=9823 GN=ABAT PE=1 SV=2",GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0050877; GO:0051537,gamma-aminobutyric acid catabolic process [GO:0009450]; nervous system process [GO:0050877],4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]",GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016740; GO:0043226; GO:0050877,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; transferase activity; organelle; nervous system process
OG_07659,1.638407118693125,FUN_034604-T1,Peve_00037084,Pocillopora_meandrina_HIv1___TS.g18635.t1,three_way,65.48566666666666,FUN_034604-T1,Q90XE6,KLF1_DANRE,,Kruppel-like factor 1 (Erythroid krueppel-like transcription factor) (Kruppel-like factor d),Danio rerio (Zebrafish) (Brachydanio rerio),80.0,80.0,5.7e-08,59.7,sp|Q90XE6|KLF1_DANRE Kruppel-like factor 1 OS=Danio rerio OX=7955 GN=klf1 PE=2 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0008270; GO:0010628; GO:0010725; GO:0031100; GO:0043565; GO:0043697; GO:0045214; GO:0055007; GO:0060038; GO:0060319,animal organ regeneration [GO:0031100]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cell dedifferentiation [GO:0043697]; positive regulation of gene expression [GO:0010628]; primitive erythrocyte differentiation [GO:0060319]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0007010; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07677,1.3616395181303544,FUN_034795-T1,Peve_00007519,Pocillopora_meandrina_HIv1___RNAseq.g12295.t1,three_way,68.32300000000001,FUN_034795-T1,Q5RFU0,,,,,42.2,500.0,3.2999999999999996e-114,413.7,sp|Q5RFU0|SIAE_PONAB Sialate O-acetylesterase OS=Pongo abelii OX=9601 GN=SIAE PE=2 SV=1,,,,,,
OG_07692,2.491407719259701,FUN_034819-T1,Peve_00041509,Pocillopora_meandrina_HIv1___RNAseq.g27216.t1,three_way,74.395,FUN_034819-T1,Q9R088,,,,,47.5,204.0,1.1e-52,208.4,"sp|Q9R088|KITM_MOUSE Thymidine kinase 2, mitochondrial OS=Mus musculus OX=10090 GN=Tk2 PE=1 SV=2",,,,,,
OG_07703,1.0441504990087176,FUN_034837-T1,Peve_00010449,Pocillopora_meandrina_HIv1___RNAseq.g27187.t1,three_way,85.81433333333334,FUN_034837-T1,Q6IWL4,TRAF6_DANRE,,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),Danio rerio (Zebrafish) (Brachydanio rerio),29.9,157.0,1.4e-08,62.0,sp|Q6IWL4|TRAF6_DANRE TNF receptor-associated factor 6 OS=Danio rerio OX=7955 GN=traf6 PE=1 SV=2,GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005938; GO:0008270; GO:0009615; GO:0009617; GO:0009898; GO:0031663; GO:0035591; GO:0038061; GO:0042981; GO:0043122; GO:0045087; GO:0045893; GO:0061630; GO:0070534; GO:0098978,innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of DNA-templated transcription [GO:0045893]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; response to bacterium [GO:0009617]; response to virus [GO:0009615],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634],signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005811; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; lipid droplet; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_07706,1.2574776101657603,FUN_034848-T1,Peve_00037381,Pocillopora_meandrina_HIv1___RNAseq.g27197.t1,three_way,73.5195,FUN_034848-T1,A6NE52,WDR97_HUMAN,,WD repeat-containing protein 97,Homo sapiens (Human),27.0,677.0,3.8999999999999995e-70,268.9,sp|A6NE52|WDR97_HUMAN WD repeat-containing protein 97 OS=Homo sapiens OX=9606 GN=WDR97 PE=1 SV=2,,,,,,
OG_07730,1.143180115426838,FUN_034891-T1,Peve_00037339,Pocillopora_meandrina_HIv1___TS.g15151.t2,three_way,94.67133333333334,FUN_034891-T1,Q13951,,,,,57.1,170.0,1.1e-48,194.5,sp|Q13951|PEBB_HUMAN Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2,,,,,,
OG_07731,1.926207913331707,FUN_034892-T1,Peve_00037338,Pocillopora_meandrina_HIv1___TS.g15150.t1,three_way,61.52,,,,,,,,,,,,,,,,,
OG_07734,1.4119856835173612,FUN_034896-T1,Peve_00037331,Pocillopora_meandrina_HIv1___RNAseq.g27802.t1,three_way,54.4095,,,,,,,,,,,,,,,,,
OG_07762,1.454593479611294,FUN_034956-T1,Peve_00036680,Pocillopora_meandrina_HIv1___RNAseq.g27836.t1,three_way,74.127,FUN_034956-T1,P39949,CCNE1_RAT,,G1/S-specific cyclin-E1,Rattus norvegicus (Rat),51.8,311.0,1.5e-85,318.2,sp|P39949|CCNE1_RAT G1/S-specific cyclin-E1 OS=Rattus norvegicus OX=10116 GN=Ccne1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000307; GO:0000723; GO:0001547; GO:0001889; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0006270; GO:0007129; GO:0009410; GO:0014074; GO:0016055; GO:0016301; GO:0016538; GO:0019901; GO:0031100; GO:0031670; GO:0032355; GO:0032570; GO:0032880; GO:0033197; GO:0034097; GO:0044877; GO:0045471; GO:0045597; GO:0048545; GO:0051301; GO:0051412; GO:0051597; GO:0051726; GO:0070192; GO:0097134; GO:1900087; GO:1902462,animal organ regeneration [GO:0031100]; antral ovarian follicle growth [GO:0001547]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; liver development [GO:0001889]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to progesterone [GO:0032570]; response to purine-containing compound [GO:0014074]; response to steroid hormone [GO:0048545]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016740; GO:0022414; GO:0032200; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; transferase activity; reproductive process; telomere organization; organelle; anatomical structure development; molecular function regulator activity
OG_07777,1.3760991833675666,FUN_034993-T1,Peve_00024607,Pocillopora_meandrina_HIv1___RNAseq.g12122.t1,three_way,65.4765,FUN_034993-T1,Q90WY6,ADA2C_DANRE,,Alpha-2C adrenergic receptor (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR),Danio rerio (Zebrafish) (Brachydanio rerio),29.2,233.0,3.5e-14,80.9,sp|Q90WY6|ADA2C_DANRE Alpha-2C adrenergic receptor OS=Danio rerio OX=7955 GN=adra2c PE=3 SV=1,GO:0004938; GO:0005886; GO:0006940; GO:0007186; GO:0019229; GO:0030168; GO:0051379; GO:0071881,adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; G protein-coupled receptor signaling pathway [GO:0007186]; platelet activation [GO:0030168]; regulation of smooth muscle contraction [GO:0006940]; regulation of vasoconstriction [GO:0019229],plasma membrane [GO:0005886],alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379],GO:0003013; GO:0005886; GO:0060089,circulatory system process; plasma membrane; molecular transducer activity
OG_07780,1.4468814720458263,FUN_034997-T1,Peve_00024600,Pocillopora_meandrina_HIv1___RNAseq.g4153.t1,three_way,61.30266666666667,FUN_034997-T1,Q8K4Z4,,,,,28.7,310.0,2e-22,108.2,sp|Q8K4Z4|ADRB2_CAVPO Beta-2 adrenergic receptor OS=Cavia porcellus OX=10141 GN=Adrb2 PE=3 SV=1,,,,,,
OG_07787,1.7881791360472257,FUN_035008-T1,Peve_00024587,Pocillopora_meandrina_HIv1___RNAseq.g12134.t1,three_way,76.40066666666667,FUN_035008-T1,Q9VCA2,,,,,32.9,538.0,3.9e-72,273.9,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_07806,1.094103021869901,FUN_035044-T2,Peve_00044754,Pocillopora_meandrina_HIv1___RNAseq.g27745.t1,three_way,63.242,FUN_035044-T2,P0DOX0,,,,,32.3,486.0,1.3e-70,268.9,sp|P0DOX0|C27C1_AQUCT Cytochrome P450 27C1 OS=Aquarana catesbeiana OX=8400 GN=cyp27c1 PE=1 SV=1,,,,,,
OG_07817,1.3765255299089232,FUN_035069-T1,Peve_00026039,Pocillopora_meandrina_HIv1___RNAseq.g27720.t1,three_way,65.01733333333334,FUN_035069-T1,Q6DEL1,S38A7_DANRE,,Sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7),Danio rerio (Zebrafish) (Brachydanio rerio),41.4,406.0,1.6000000000000001e-80,301.6,sp|Q6DEL1|S38A7_DANRE Sodium-coupled neutral amino acid transporter 7 OS=Danio rerio OX=7955 GN=slc38a7 PE=2 SV=1,GO:0003333; GO:0005765; GO:0006867; GO:0006868; GO:0015182; GO:0015186; GO:0016020; GO:0030424; GO:0140901; GO:0140902,amino acid transmembrane transport [GO:0003333]; asparagine transport [GO:0006867]; glutamine transport [GO:0006868],axon [GO:0030424]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],L-asparagine transmembrane transporter activity [GO:0015182]; L-asparagine:sodium symporter activity [GO:0140901]; L-glutamine transmembrane transporter activity [GO:0015186]; L-glutamine:sodium symporter activity [GO:0140902],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_07835,2.750076867728385,FUN_035161-T1,Peve_00006324,Pocillopora_meandrina_HIv1___RNAseq.11026_t,three_way,61.05166666666667,FUN_035161-T1,Q923Y6,,,,,26.7,330.0,9.8e-13,75.9,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_07836,1.6605079108874654,FUN_035166-T1,Peve_00036194,Pocillopora_meandrina_HIv1___RNAseq.g27915.t1,three_way,52.95516666666667,FUN_035166-T1,Q29477,TRFL_CAPHI,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-),Capra hircus (Goat),35.5,366.0,2.5e-42,174.5,sp|Q29477|TRFL_CAPHI Lactotransferrin OS=Capra hircus OX=9925 GN=LTF PE=1 SV=1,GO:0001503; GO:0001817; GO:0002227; GO:0005615; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0008236; GO:0019731; GO:0019732; GO:0031665; GO:0032680; GO:0033690; GO:0042581; GO:0043066; GO:0045669; GO:0046872; GO:0055037; GO:0060349; GO:1900159; GO:1900229; GO:1902732; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; bone morphogenesis [GO:0060349]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule [GO:0042581],metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236],GO:0002376; GO:0003824; GO:0005615; GO:0005768; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; endosome; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_07851,1.1503210730336138,FUN_035194-T1,Peve_00016110,Pocillopora_meandrina_HIv1___RNAseq.g8466.t1,three_way,62.026,,,,,,,,,,,,,,,,,
OG_07855,1.0536116617907965,FUN_035210-T1,Peve_00027693,Pocillopora_meandrina_HIv1___RNAseq.g27630.t1,three_way,70.29866666666666,,,,,,,,,,,,,,,,,
OG_07864,1.1708125804746554,FUN_035221-T1,Peve_00035886,Pocillopora_meandrina_HIv1___RNAseq.g27610.t1,three_way,84.449,FUN_035221-T1,Q6DE14,E2F4_XENLA,,Transcription factor E2F4 (E2F-4),Xenopus laevis (African clawed frog),54.9,368.0,1.1e-96,354.8,sp|Q6DE14|E2F4_XENLA Transcription factor E2F4 OS=Xenopus laevis OX=8355 GN=e2f4 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003700; GO:0006357; GO:0044458; GO:0045944; GO:0046983; GO:0090575; GO:0098534; GO:1903251,centriole assembly [GO:0098534]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0006355; GO:0030154; GO:0044782; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; cilium organization; transcription regulator activity
OG_07869,1.3647897168998662,FUN_035227-T1,Peve_00043182,Pocillopora_meandrina_HIv1___RNAseq.g27605.t1,three_way,65.062,,,,,,,,,,,,,,,,,
OG_07872,1.718097352273927,FUN_035231-T1,Peve_00044486,Pocillopora_meandrina_HIv1___RNAseq.g27905.t1,three_way,73.57433333333333,,,,,,,,,,,,,,,,,
OG_07887,1.6329313658242324,FUN_035265-T1,Peve_00032654,Pocillopora_meandrina_HIv1___RNAseq.g27870.t1,three_way,70.16533333333334,FUN_035265-T1,Q2LKW6,NL1B1_MOUSE,,"NACHT, LRR and PYD domains-containing protein 1b allele 1 (EC 3.4.-.-) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1b, C-terminus (Nlrp1b1-CT); NACHT, LRR and PYD domains-containing protein 1b, N-terminus (Nlrp1b1-NT)]",Mus musculus (Mouse),24.6,346.0,2.5e-09,65.9,"sp|Q2LKW6|NL1B1_MOUSE NACHT, LRR and PYD domains-containing protein 1b allele 1 OS=Mus musculus OX=10090 GN=Nlrp1b PE=1 SV=1",GO:0002221; GO:0005524; GO:0005737; GO:0006508; GO:0008233; GO:0012501; GO:0016020; GO:0030163; GO:0032731; GO:0042981; GO:0045087; GO:0050729; GO:0070269; GO:0072558,innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; programmed cell death [GO:0012501]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; pyroptotic inflammatory response [GO:0070269]; regulation of apoptotic process [GO:0042981],cytoplasm [GO:0005737]; membrane [GO:0016020]; NLRP1 inflammasome complex [GO:0072558],ATP binding [GO:0005524]; peptidase activity [GO:0008233],GO:0002376; GO:0003824; GO:0006954; GO:0012501; GO:0016787; GO:0030163; GO:0098542; GO:0140096,"immune system process; catalytic activity; inflammatory response; programmed cell death; hydrolase activity; protein catabolic process; defense response to other organism; catalytic activity, acting on a protein"
OG_07891,1.178348339347624,FUN_035270-T1,Peve_00029230,Pocillopora_meandrina_HIv1___RNAseq.g27866.t1,three_way,78.87733333333333,FUN_035270-T1,Q32KJ8,ARSI_RAT,,Arylsulfatase I (ASI) (EC 3.1.6.-),Rattus norvegicus (Rat),53.0,485.0,1.4e-154,547.7,sp|Q32KJ8|ARSI_RAT Arylsulfatase I OS=Rattus norvegicus OX=10116 GN=Arsi PE=2 SV=1,GO:0005576; GO:0005783; GO:0008484; GO:0046872,,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484],GO:0003824; GO:0005576; GO:0005783; GO:0016787; GO:0043226,catalytic activity; extracellular region; endoplasmic reticulum; hydrolase activity; organelle
OG_07910,1.2296300149753483,FUN_035368-T1,Peve_00016220,Pocillopora_meandrina_HIv1___TS.g3560.t1,three_way,68.399,FUN_035368-T1,P10611,,,,,35.0,451.0,5.5e-78,293.1,sp|P10611|CP4A4_RABIT Cytochrome P450 4A4 OS=Oryctolagus cuniculus OX=9986 GN=CYP4A4 PE=1 SV=3,,,,,,
OG_07911,3.7342997236463167,FUN_035369-T1,Peve_00016219,Pocillopora_meandrina_HIv1___TS.g3559.t1,three_way,73.006,FUN_035369-T1,Q5ZIJ9,,,,,36.0,100.0,7e-11,70.1,sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1,,,,,,
OG_07912,1.035870599434084,FUN_035371-T1,Peve_00016216,Pocillopora_meandrina_HIv1___RNAseq.g12225.t1,three_way,67.83666666666667,,,,,,,,,,,,,,,,,
OG_07919,1.1446046214343089,FUN_035404-T1,Peve_00002644,Pocillopora_meandrina_HIv1___TS.g3527.t2,three_way,68.768,FUN_035404-T1,Q9WYX8,,,,,49.4,172.0,3.9e-43,176.4,sp|Q9WYX8|Y508_THEMA Uncharacterized protein TM_0508 OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=TM_0508 PE=3 SV=1,,,,,,
OG_07929,2.661089646193604,FUN_035418-T1,Peve_00039851,Pocillopora_meandrina_HIv1___RNAseq.g27566.t1,three_way,69.55066666666667,FUN_035418-T1,B8AJ09,,,,,28.2,312.0,1.7e-16,88.6,"sp|B8AJ09|BASS4_ORYSI Probable sodium/metabolite cotransporter BASS4, chloroplastic OS=Oryza sativa subsp. indica OX=39946 GN=BASS4 PE=3 SV=1",,,,,,
OG_07933,1.092260557844159,FUN_035426-T1,Peve_00007639,Pocillopora_meandrina_HIv1___RNAseq.g27573.t1,three_way,42.896,,,,,,,,,,,,,,,,,
OG_07947,1.1168562744678312,FUN_035468-T1,Peve_00012132,Pocillopora_meandrina_HIv1___TS.g14397.t1,three_way,83.6845,FUN_035468-T1,Q8BH04,PCKGM_MOUSE,,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)",Mus musculus (Mouse),65.5,611.0,6.100000000000001e-248,858.2,"sp|Q8BH04|PCKGM_MOUSE Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Mus musculus OX=10090 GN=Pck2 PE=1 SV=1",GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0006090; GO:0006094; GO:0006107; GO:0030145; GO:0032024; GO:0032496; GO:0071333; GO:0071356; GO:0071548,cellular response to glucose stimulus [GO:0071333]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; pyruvate metabolic process [GO:0006090]; response to dexamethasone [GO:0071548]; response to lipopolysaccharide [GO:0032496],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613],GO:0003824; GO:0005739; GO:0005975; GO:0016829; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lyase activity; organelle
OG_07954,1.350146253830035,FUN_035494-T1,Peve_00033964,Pocillopora_meandrina_HIv1___RNAseq.g26989.t1,three_way,76.04083333333334,FUN_035494-T1,P52171,,,,,53.8,240.0,1.4e-69,265.4,sp|P52171|IMA1_XENLA Importin subunit alpha-1 OS=Xenopus laevis OX=8355 GN=kpna2 PE=1 SV=2,,,,,,
OG_07956,1.3862179713344542,FUN_035500-T1,Peve_00033958,Pocillopora_meandrina_HIv1___RNAseq.g26993.t1,three_way,59.97516666666667,FUN_035500-T1,Q5R2J4,,,,,34.4,430.0,2.7999999999999997e-68,261.2,sp|Q5R2J4|APCD1_PELSI Protein APCDD1 OS=Pelodiscus sinensis OX=13735 GN=APCDD1 PE=2 SV=1,,,,,,
OG_07961,1.467806797628822,FUN_035519-T1,Peve_00007927,Pocillopora_meandrina_HIv1___RNAseq.g26966.t1,three_way,53.88283333333334,FUN_035519-T1,A3KMR8,MAFA_DANRE,,Transcription factor MafAa (Somite Maf1) (SMaf1),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,97.0,4.2e-09,63.2,sp|A3KMR8|MAFA_DANRE Transcription factor MafAa OS=Danio rerio OX=7955 GN=mafaa PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0043565,regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07963,1.2487884484949785,FUN_035524-T1,Peve_00020842,Pocillopora_meandrina_HIv1___RNAseq.g26954.t1,three_way,73.49983333333333,FUN_035524-T1,O54975,XPP1_RAT,,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",Rattus norvegicus (Rat),44.4,626.0,4.6e-150,533.1,sp|O54975|XPP1_RAT Xaa-Pro aminopeptidase 1 OS=Rattus norvegicus OX=10116 GN=Xpnpep1 PE=1 SV=1,GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006,bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829],aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0016787; GO:0140096,"catalytic activity; cytosol; hydrolase activity; catalytic activity, acting on a protein"
OG_07985,1.8000090051240594,FUN_035612-T1,Peve_00019611,Pocillopora_meandrina_HIv1___RNAseq.g28060.t1,three_way,40.537333333333336,,,,,,,,,,,,,,,,,
OG_07998,1.6146980612965838,FUN_035639-T1,Peve_00029727,Pocillopora_meandrina_HIv1___RNAseq.g28088.t1,three_way,57.65466666666666,,,,,,,,,,,,,,,,,
OG_08046,1.0188609069051775,FUN_035734-T1,Peve_00044083,Pocillopora_meandrina_HIv1___RNAseq.g11861.t1,three_way,58.831,FUN_035734-T1,Q8C080,,,,,51.9,162.0,2.9e-41,171.0,sp|Q8C080|SNX16_MOUSE Sorting nexin-16 OS=Mus musculus OX=10090 GN=Snx16 PE=1 SV=2,,,,,,
OG_08065,1.0630944715415884,FUN_035765-T1,Peve_00033443,Pocillopora_meandrina_HIv1___RNAseq.g11894.t1,three_way,90.73666666666666,FUN_035765-T1,Q6GL41,MCM4_XENTR,,DNA replication licensing factor mcm4 (EC 3.6.4.12) (Minichromosome maintenance protein 4),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),68.7,836.0,0.0,1105.1,sp|Q6GL41|MCM4_XENTR DNA replication licensing factor mcm4 OS=Xenopus tropicalis OX=8364 GN=mcm4 PE=2 SV=1,GO:0000785; GO:0001878; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0006270; GO:0008270; GO:0016887; GO:0030174; GO:0042555; GO:0044786; GO:0071162,cell cycle DNA replication [GO:0044786]; DNA replication initiation [GO:0006270]; regulation of DNA-templated DNA replication initiation [GO:0030174]; response to yeast [GO:0001878],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0006260; GO:0016787; GO:0016853; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA replication; hydrolase activity; isomerase activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_08083,1.1387000624357655,FUN_035810-T1,Peve_00037792,Pocillopora_meandrina_HIv1___RNAseq.g11929.t1,three_way,63.96066666666667,FUN_035810-T1,O15943,CADN_DROME,,Neural-cadherin (Cadherin-N) (dN-cadherin),Drosophila melanogaster (Fruit fly),31.2,2035.0,2.2e-241,838.2,sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2,GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016020; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609,axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290],axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803],GO:0005886; GO:0007155; GO:0048856,plasma membrane; cell adhesion; anatomical structure development
OG_08091,1.1045924436366703,FUN_035824-T1,Peve_00037802,Pocillopora_meandrina_HIv1___RNAseq.g11933.t1,three_way,90.67833333333334,FUN_035824-T1,P08239,,,,,72.6,354.0,3e-148,526.2,sp|P08239|GNAO_BOVIN Guanine nucleotide-binding protein G(o) subunit alpha OS=Bos taurus OX=9913 GN=GNAO1 PE=1 SV=4,,,,,,
OG_08095,1.036228955046146,FUN_035833-T1,Peve_00002593,Pocillopora_meandrina_HIv1___RNAseq.g11963.t1,three_way,82.79166666666667,FUN_035833-T1,O74212,,,,,49.9,443.0,1.9999999999999999e-128,460.7,sp|O74212|D5FAD_MORAP Acyl-lipid (8-3)-desaturase OS=Mortierella alpina OX=64518 GN=DES1 PE=1 SV=1,,,,,,
OG_08097,2.7988167320287696,FUN_035839-T1,Peve_00032500,Pocillopora_meandrina_HIv1___RNAseq.g11958.t2,three_way,68.27866666666667,,,,,,,,,,,,,,,,,
OG_08098,2.7611233395684005,FUN_035840-T1,Peve_00032502,Pocillopora_meandrina_HIv1___RNAseq.g11957.t1,three_way,76.54033333333332,FUN_035840-T1,P38532,HSF1_MOUSE,,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Mus musculus (Mouse),55.7,176.0,1.1e-44,182.6,sp|P38532|HSF1_MOUSE Heat shock factor protein 1 OS=Mus musculus OX=10090 GN=Hsf1 PE=1 SV=2,GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235,cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]",GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006355; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0065003; GO:0140013; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; organelle; anatomical structure development; protein-containing complex assembly; meiotic nuclear division; transcription regulator activity
OG_08126,1.2711760373122196,FUN_035885-T1,Peve_00029403,Pocillopora_meandrina_HIv1___TS.g3340.t1,three_way,58.976333333333336,FUN_035885-T1,P0C0T2,ANKS6_RAT,,Ankyrin repeat and SAM domain-containing protein 6 (Polycystic kidney disease protein 1) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6),Rattus norvegicus (Rat),30.4,717.0,2.1e-37,159.1,sp|P0C0T2|ANKS6_RAT Ankyrin repeat and SAM domain-containing protein 6 OS=Rattus norvegicus OX=10116 GN=Anks6 PE=1 SV=2,GO:0001701; GO:0001822; GO:0005737; GO:0007368; GO:0007507; GO:0042802; GO:0045087; GO:0097543,determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; kidney development [GO:0001822],ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737],identical protein binding [GO:0042802],GO:0002376; GO:0048856; GO:0098542,immune system process; anatomical structure development; defense response to other organism
OG_08140,1.294691222194398,FUN_035902-T1,Peve_00006711,Pocillopora_meandrina_HIv1___TS.g3367.t1,three_way,85.12433333333334,FUN_035902-T1,Q9JJ94,SSNA1_MOUSE,,Microtubule nucleation factor SSNA1 (Sjoegren syndrome nuclear autoantigen 1 homolog),Mus musculus (Mouse),44.7,114.0,9e-12,71.2,sp|Q9JJ94|SSNA1_MOUSE Microtubule nucleation factor SSNA1 OS=Mus musculus OX=10090 GN=Ssna1 PE=1 SV=1,GO:0000226; GO:0005634; GO:0005813; GO:0005814; GO:0005886; GO:0005930; GO:0007020; GO:0007409; GO:0008017; GO:0030424; GO:0030496; GO:0031514; GO:0036064; GO:0042073; GO:0042802; GO:0043113; GO:0048675; GO:0051301; GO:0099512; GO:0140060,axon arborization [GO:0140060]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell division [GO:0051301]; intraciliary transport [GO:0042073]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; receptor clustering [GO:0043113],axon [GO:0030424]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; midbody [GO:0030496]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; supramolecular fiber [GO:0099512],identical protein binding [GO:0042802]; microtubule binding [GO:0008017],GO:0005634; GO:0005815; GO:0005886; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0043226,nucleus; microtubule organizing center; plasma membrane; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; organelle
OG_08145,1.0548830566819114,FUN_035914-T1,Peve_00006728,Pocillopora_meandrina_HIv1___TS.g3385.t1,three_way,55.639,FUN_035914-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),29.7,1194.0,1.5999999999999999e-96,356.3,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_08151,1.0287884434311674,FUN_035923-T1,Peve_00006710,Pocillopora_meandrina_HIv1___RNAseq.g12052.t1,three_way,56.369166666666665,,,,,,,,,,,,,,,,,
OG_08155,1.3584695828211737,FUN_035933-T1,Peve_00036622,Pocillopora_meandrina_HIv1___RNAseq.g12069.t1,three_way,85.512,FUN_035933-T1,Q8HXG8,BCDO2_MACFA,,"Carotenoid-cleaving dioxygenase, mitochondrial (EC 1.13.11.-) (EC 1.13.11.71) (Beta-carotene dioxygenase 2)",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),35.6,368.0,2.7e-56,220.7,"sp|Q8HXG8|BCDO2_MACFA Carotenoid-cleaving dioxygenase, mitochondrial OS=Macaca fascicularis OX=9541 GN=BCO2 PE=2 SV=2",GO:0003834; GO:0005739; GO:0010437; GO:0016119; GO:0016121; GO:0016124; GO:0016702; GO:0042574; GO:0046872; GO:0062172; GO:0102076; GO:1901176; GO:1901826,carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; lutein catabolic process [GO:0062172]; lycopene catabolic process [GO:1901176]; retinal metabolic process [GO:0042574]; xanthophyll catabolic process [GO:0016124]; zeaxanthin catabolic process [GO:1901826],mitochondrion [GO:0005739],"9,10 (9', 10')-carotenoid-cleaving dioxygenase activity [GO:0010437]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]",GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle
OG_08217,2.2992003974921165,FUN_036077-T1,Peve_00018989,Pocillopora_meandrina_HIv1___RNAseq.g27413.t1,three_way,66.047,,,,,,,,,,,,,,,,,
OG_08222,1.225588547074741,FUN_036093-T1,Peve_00032189,Pocillopora_meandrina_HIv1___RNAseq.g27441.t1,three_way,76.63133333333333,FUN_036093-T1,Q68DA7,FMN1_HUMAN,,Formin-1 (Limb deformity protein homolog),Homo sapiens (Human),33.3,471.0,1.5e-63,246.1,sp|Q68DA7|FMN1_HUMAN Formin-1 OS=Homo sapiens OX=9606 GN=FMN1 PE=1 SV=3,GO:0003779; GO:0005634; GO:0005789; GO:0005884; GO:0005886; GO:0005912; GO:0008017; GO:0030036; GO:0045010,actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010],actin filament [GO:0005884]; adherens junction [GO:0005912]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886],actin binding [GO:0003779]; microtubule binding [GO:0008017],GO:0005634; GO:0005886; GO:0007010; GO:0008092; GO:0043226,nucleus; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08226,2.5674378615154314,FUN_036097-T2,Peve_00032194,Pocillopora_meandrina_HIv1___RNAseq.g27437.t1,three_way,61.02516666666666,FUN_036097-T2,Q801E2,ANLN_XENLA,,Anillin,Xenopus laevis (African clawed frog),34.7,432.0,4.6e-56,221.5,sp|Q801E2|ANLN_XENLA Anillin OS=Xenopus laevis OX=8355 GN=anln PE=1 SV=1,GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005826; GO:0005938; GO:0031106; GO:0032059; GO:1904172,actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; septin ring organization [GO:0031106],actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; nucleus [GO:0005634],actin binding [GO:0003779],GO:0000910; GO:0005634; GO:0007010; GO:0008092; GO:0043226,cytokinesis; nucleus; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08227,1.2856088724798964,FUN_036099-T1,Peve_00032195,Pocillopora_meandrina_HIv1___RNAseq.g27436.t1,three_way,72.92099999999999,FUN_036099-T1,Q66JZ4,,,,,33.3,475.0,4.2000000000000004e-60,233.8,"sp|Q66JZ4|TCAIM_MOUSE T-cell activation inhibitor, mitochondrial OS=Mus musculus OX=10090 GN=TCAIM PE=1 SV=1",,,,,,
OG_08230,1.1680206248678666,FUN_036103-T1,Peve_00003702,Pocillopora_meandrina_HIv1___RNAseq.g27433.t1,three_way,73.634,FUN_036103-T1,P82160,,,,,38.8,147.0,1.8000000000000001e-22,107.8,"sp|P82160|MLE3_CHERA Myosin light chain 3, skeletal muscle isoform OS=Chelon ramada OX=30804 PE=1 SV=1",,,,,,
OG_08313,1.1467896396642916,FUN_036513-T1,Peve_00031408,Pocillopora_meandrina_HIv1___RNAseq.g27052.t1,three_way,58.79833333333333,FUN_036513-T1,A0A8I3PDQ1,CASL_CANLF,,Enhancer of filamentation 1 (CRK-associated substrate-related protein) (CAS-L) (Neural precursor cell expressed developmentally down-regulated protein 9) (NEDD-9) (p105),Canis lupus familiaris (Dog) (Canis familiaris),22.2,968.0,2.6e-26,122.5,sp|A0A8I3PDQ1|CASL_CANLF Enhancer of filamentation 1 OS=Canis lupus familiaris OX=9615 GN=NEDD9 PE=1 SV=1,GO:0000922; GO:0001772; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0005938; GO:0007155; GO:0007169; GO:0007611; GO:0016323; GO:0016477; GO:0030027; GO:0030336; GO:0032956; GO:0036064; GO:0045672; GO:0051301; GO:0061523; GO:0072686; GO:0097021; GO:0140131; GO:1900026; GO:1902952; GO:1903829; GO:1990782; GO:2000522,cell adhesion [GO:0007155]; cell division [GO:0051301]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cilium disassembly [GO:0061523]; learning or memory [GO:0007611]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of lymphocyte chemotaxis [GO:0140131]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein localization [GO:1903829]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956],basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],protein tyrosine kinase binding [GO:1990782],GO:0002376; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0007155; GO:0043226; GO:0044782; GO:0048870; GO:0050877,immune system process; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; cell adhesion; organelle; cilium organization; cell motility; nervous system process
OG_08314,1.10356427644608,FUN_036524-T1,Peve_00031406,Pocillopora_meandrina_HIv1___RNAseq.g12097.t1,three_way,72.94333333333334,FUN_036524-T1,Q8NG66,NEK11_HUMAN,,Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11),Homo sapiens (Human),37.1,631.0,1.6e-98,361.7,sp|Q8NG66|NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens OX=9606 GN=NEK11 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006468; GO:0031573; GO:0035556; GO:0046872; GO:0106310; GO:1901990,intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08337,1.5464002141550617,FUN_036850-T1,Peve_00036530,Pocillopora_meandrina_HIv1___RNAseq.g10652.t1,three_way,46.763666666666666,,,,,,,,,,,,,,,,,
OG_08341,3.104704489911292,FUN_036858-T1,Peve_00001065,Pocillopora_meandrina_HIv1___RNAseq.g27061.t1,three_way,76.1845,FUN_036858-T1,P22412,,,,,50.9,369.0,1.1e-104,381.7,sp|P22412|DPEP1_PIG Dipeptidase 1 OS=Sus scrofa OX=9823 GN=DPEP1 PE=1 SV=1,,,,,,
OG_08342,1.8751283566831989,FUN_036865-T1,Peve_00044052,Pocillopora_meandrina_HIv1___RNAseq.g28988.t1,three_way,35.233666666666664,,,,,,,,,,,,,,,,,
OG_08355,1.5632075539663424,FUN_036899-T1,Peve_00018371,Pocillopora_meandrina_HIv1___RNAseq.g26703.t1,three_way,78.23133333333332,FUN_036899-T1,Q8VZ42,,,,,40.3,129.0,1.3e-25,117.5,sp|Q8VZ42|SAP11_ARATH Zinc finger AN1 and C2H2 domain-containing stress-associated protein 11 OS=Arabidopsis thaliana OX=3702 GN=SAP11 PE=2 SV=1,,,,,,
OG_08362,1.8689385294280785,FUN_036911-T1,Peve_00018411,Pocillopora_meandrina_HIv1___RNAseq.g10816.t1,three_way,73.75933333333333,FUN_036911-T1,P51614,,,,,32.5,292.0,1.1e-35,152.5,sp|P51614|CHIT3_VITVI Acidic endochitinase OS=Vitis vinifera OX=29760 GN=CHIT3 PE=2 SV=1,,,,,,
OG_08367,1.6077109025909586,FUN_036919-T1,Peve_00018354,Pocillopora_meandrina_HIv1___RNAseq.g10824.t1,three_way,88.945,FUN_036919-T1,Q8BWT1,THIM_MOUSE,,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-, EC 3.1.2.1, EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)",Mus musculus (Mouse),65.7,394.0,5.2e-149,528.9,"sp|Q8BWT1|THIM_MOUSE 3-ketoacyl-CoA thiolase, mitochondrial OS=Mus musculus OX=10090 GN=Acaa2 PE=1 SV=3",GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005743; GO:0006635; GO:0016604; GO:0036064; GO:0047617; GO:0071456; GO:1901029; GO:1902109,cellular response to hypoxia [GO:0071456]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029],ciliary basal body [GO:0036064]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604],acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; fatty acyl-CoA hydrolase activity [GO:0047617],GO:0003824; GO:0005739; GO:0005815; GO:0006629; GO:0007005; GO:0016740; GO:0016787; GO:0043226; GO:0061024,catalytic activity; mitochondrion; microtubule organizing center; lipid metabolic process; mitochondrion organization; transferase activity; hydrolase activity; organelle; membrane organization
OG_08380,1.033361083853482,FUN_036957-T1,Peve_00040027,Pocillopora_meandrina_HIv1___RNAseq.g10871.t1,three_way,78.528,FUN_036957-T1,Q68F72,S15A4_XENLA,,Solute carrier family 15 member 4,Xenopus laevis (African clawed frog),36.0,483.0,8.700000000000001e-78,292.7,sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1,GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206,"dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],GO:0002376; GO:0005215; GO:0055085; GO:0098542,immune system process; transporter activity; transmembrane transport; defense response to other organism
OG_08392,1.2631664817940351,FUN_037004-T1,Peve_00002158,Pocillopora_meandrina_HIv1___RNAseq.g26681.t1,three_way,58.53766666666667,FUN_037004-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),35.2,267.0,1.5999999999999998e-41,172.9,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08412,1.2911189199297028,FUN_037063-T1,Peve_00018397,Pocillopora_meandrina_HIv1___RNAseq.g26780.t1,three_way,79.46383333333334,FUN_037063-T1,Q5RJA1,RFX6_DANRE,,DNA-binding protein RFX6 (Regulatory factor X 6),Danio rerio (Zebrafish) (Brachydanio rerio),57.0,293.0,4.9e-93,343.6,sp|Q5RJA1|RFX6_DANRE DNA-binding protein RFX6 OS=Danio rerio OX=7955 GN=rfx6 PE=2 SV=2,GO:0000976; GO:0000978; GO:0000981; GO:0003309; GO:0003310; GO:0003311; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0045893; GO:0045944; GO:0050796; GO:0090104,endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_08427,1.4952759865874323,FUN_037089-T1,Peve_00004758,Pocillopora_meandrina_HIv1___RNAseq.g11095.t1,three_way,84.80416666666667,FUN_037089-T1,Q9NQ94,,,,,49.9,583.0,6.8e-140,499.2,sp|Q9NQ94|A1CF_HUMAN APOBEC1 complementation factor OS=Homo sapiens OX=9606 GN=A1CF PE=1 SV=1,,,,,,
OG_08452,1.3067651441636103,FUN_037217-T2,Peve_00006683,Pocillopora_meandrina_HIv1___RNAseq.g11057.t1,three_way,61.09466666666667,FUN_037217-T2,Q8BFR2,,,,,25.6,789.0,5.4e-64,247.3,sp|Q8BFR2|FSTL5_MOUSE Follistatin-related protein 5 OS=Mus musculus OX=10090 GN=Fstl5 PE=2 SV=1,,,,,,
OG_08484,1.6278662572482288,FUN_037320-T1,Peve_00006220,Pocillopora_meandrina_HIv1___RNAseq.g10703.t1,three_way,66.359,FUN_037320-T1,A2VE04,FRRS1_BOVIN,,Ferric-chelate reductase 1 (EC 1.-.-.-),Bos taurus (Bovine),29.7,202.0,6.1e-07,57.4,sp|A2VE04|FRRS1_BOVIN Ferric-chelate reductase 1 OS=Bos taurus OX=9913 GN=FRRS1 PE=2 SV=1,GO:0006879; GO:0016020; GO:0016722; GO:0046872,intracellular iron ion homeostasis [GO:0006879],membrane [GO:0016020],"metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]",GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_08485,1.2740506066291402,FUN_037321-T1,Peve_00006223,Pocillopora_meandrina_HIv1___RNAseq.g10702.t1,three_way,81.63366666666667,FUN_037321-T1,A4IFE4,,,,,53.6,440.0,2.4e-126,454.1,sp|A4IFE4|RGF1B_BOVIN Ras-GEF domain-containing family member 1B OS=Bos taurus OX=9913 GN=RASGEF1B PE=2 SV=1,,,,,,
OG_08487,1.0758391509210523,FUN_037323-T1,Peve_00006230,Pocillopora_meandrina_HIv1___RNAseq.g10700.t1,three_way,56.69433333333333,FUN_037323-T1,B3LYS5,,,,,43.9,123.0,2e-18,94.7,sp|B3LYS5|FOXO_DROAN Forkhead box protein O OS=Drosophila ananassae OX=7217 GN=foxo PE=3 SV=2,,,,,,
OG_08508,1.3132698572608863,FUN_037416-T2,Peve_00028857,Pocillopora_meandrina_HIv1___RNAseq.g10945.t1,three_way,60.57983333333333,FUN_037416-T2,Q569T7,,,,,33.2,400.0,7.700000000000001e-48,193.0,sp|Q569T7|MFS4B_XENLA Sodium-dependent glucose transporter 1 OS=Xenopus laevis OX=8355 GN=mfsd4b PE=2 SV=1,,,,,,
OG_08509,1.071575195823673,FUN_037422-T1,Peve_00000594,Pocillopora_meandrina_HIv1___RNAseq.g10949.t1,three_way,81.52333333333333,FUN_037422-T1,Q6QA33,,,,,49.3,306.0,1.5e-71,271.2,sp|Q6QA33|DH12B_DANRE Very-long-chain 3-oxoacyl-CoA reductase-B OS=Danio rerio OX=7955 GN=hsd17b12b PE=2 SV=2,,,,,,
OG_08512,1.1260908612688412,FUN_037430-T2,Peve_00014228,Pocillopora_meandrina_HIv1___RNAseq.g10960.t1,three_way,48.326,,,,,,,,,,,,,,,,,
OG_08515,1.0739487098587843,FUN_037441-T2,Peve_00034993,Pocillopora_meandrina_HIv1___RNAseq.g10964.t1,three_way,68.80016666666667,FUN_037441-T2,Q08BH7,UBE2T_DANRE,,Ubiquitin-conjugating enzyme E2 T (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T),Danio rerio (Zebrafish) (Brachydanio rerio),65.6,151.0,2.1e-59,230.3,sp|Q08BH7|UBE2T_DANRE Ubiquitin-conjugating enzyme E2 T OS=Danio rerio OX=7955 GN=ube2t PE=2 SV=1,GO:0000209; GO:0003682; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006974; GO:0051865; GO:0061631,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],nucleus [GO:0005634],ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0006281; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA repair; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08519,1.2487310091300683,FUN_037451-T1,Peve_00044121,Pocillopora_meandrina_HIv1___RNAseq.g1365.t1,three_way,62.06366666666667,,,,,,,,,,,,,,,,,
OG_08520,1.469275738628918,FUN_037452-T1,Peve_00044119,Pocillopora_meandrina_HIv1___RNAseq.g1368.t1,three_way,59.91483333333333,FUN_037452-T1,Q9IA95,,,,,32.7,266.0,2.4e-45,184.1,sp|Q9IA95|SFRP3_CHICK Secreted frizzled-related protein 3 OS=Gallus gallus OX=9031 GN=FRZB PE=2 SV=1,,,,,,
OG_08530,1.0556086452502922,FUN_037477-T1,Peve_00020433,Pocillopora_meandrina_HIv1___RNAseq.g1391.t1,three_way,71.99733333333333,FUN_037477-T1,Q3TDN2,FAF2_MOUSE,,FAS-associated factor 2 (UBX domain-containing protein 8),Mus musculus (Mouse),45.3,267.0,3.1e-59,230.3,sp|Q3TDN2|FAF2_MOUSE FAS-associated factor 2 OS=Mus musculus OX=10090 GN=Faf2 PE=1 SV=2,GO:0005783; GO:0005811; GO:0006986; GO:0030674; GO:0030970; GO:0031625; GO:0034098; GO:0034389; GO:0035473; GO:0035617; GO:0036503; GO:0043130; GO:0043161; GO:0055102,"ERAD pathway [GO:0036503]; lipid droplet organization [GO:0034389]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]",endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005783; GO:0005811; GO:0006886; GO:0030163; GO:0043226; GO:0060090; GO:0098772,endoplasmic reticulum; lipid droplet; intracellular protein transport; protein catabolic process; organelle; molecular adaptor activity; molecular function regulator activity
OG_08536,1.575022800105395,FUN_037486-T1,Peve_00020414,Pocillopora_meandrina_HIv1___RNAseq.g1300.t1,three_way,64.04466666666667,FUN_037486-T1,Q6TLI7,AA2AR_HORSE,,Adenosine receptor A2a,Equus caballus (Horse),24.3,296.0,4.7e-07,57.0,sp|Q6TLI7|AA2AR_HORSE Adenosine receptor A2a OS=Equus caballus OX=9796 GN=ADORA2A PE=2 SV=1,GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005886; GO:0007189; GO:0007626; GO:0008289; GO:0014074; GO:0019899; GO:0032230; GO:0042755; GO:0042802; GO:0046636; GO:0050728; GO:0060080; GO:0097190; GO:0098794; GO:2001235,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic signaling pathway [GO:0097190]; eating behavior [GO:0042755]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; response to amphetamine [GO:0001975]; response to purine-containing compound [GO:0014074]; synaptic transmission, dopaminergic [GO:0001963]",plasma membrane [GO:0005886]; postsynapse [GO:0098794],calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289],GO:0005886; GO:0008289; GO:0023052; GO:0060089,plasma membrane; lipid binding; signaling; molecular transducer activity
OG_08540,1.07486708885494,FUN_037491-T1,Peve_00028570,Pocillopora_meandrina_HIv1___RNAseq.g1307.t1,three_way,88.51766666666667,FUN_037491-T1,P31153,METK2_HUMAN,,S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II),Homo sapiens (Human),79.0,381.0,3.6e-177,622.5,sp|P31153|METK2_HUMAN S-adenosylmethionine synthase isoform type-2 OS=Homo sapiens OX=9606 GN=MAT2A PE=1 SV=1,GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0034214; GO:0036094; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:0061431; GO:1904263; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to methionine [GO:0061431]; one-carbon metabolic process [GO:0006730]; positive regulation of TORC1 signaling [GO:1904263]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556],cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; small molecule binding [GO:0036094],GO:0003824; GO:0005829; GO:0006790; GO:0016740; GO:0065003,catalytic activity; cytosol; sulfur compound metabolic process; transferase activity; protein-containing complex assembly
OG_08555,2.4704961356096784,FUN_037537-T2,Peve_00032233,Pocillopora_meandrina_HIv1___RNAseq.g1638.t1,three_way,66.20966666666666,,,,,,,,,,,,,,,,,
OG_08557,1.543667594789897,FUN_037545-T1,Peve_00032229,Pocillopora_meandrina_HIv1___RNAseq.g1633.t2,three_way,65.51433333333333,FUN_037545-T1,P60483,,,,,47.9,382.0,1.2e-98,361.7,"sp|P60483|PTEN_CANLF Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Canis lupus familiaris OX=9615 GN=PTEN PE=2 SV=1",,,,,,
OG_08578,1.3026587888703156,FUN_037681-T1,Peve_00042426,Pocillopora_meandrina_HIv1___RNAseq.g1611.t1,three_way,55.60116666666666,,,,,,,,,,,,,,,,,
OG_08611,1.1600864472416894,FUN_037758-T1,Peve_00014340,Pocillopora_meandrina_HIv1___RNAseq.g1498.t1,three_way,47.662333333333336,,,,,,,,,,,,,,,,,
OG_08614,1.0143953759894335,FUN_037761-T1,Peve_00014333,Pocillopora_meandrina_HIv1___RNAseq.g1495.t2a,three_way,37.405,,,,,,,,,,,,,,,,,
OG_08621,1.282394152281547,FUN_037776-T1,Peve_00040706,Pocillopora_meandrina_HIv1___RNAseq.g1509.t1,three_way,81.93966666666667,,,,,,,,,,,,,,,,,
OG_08638,1.658760869884757,FUN_037810-T1,Peve_00028101,Pocillopora_meandrina_HIv1___RNAseq.g1572.t1,three_way,58.22133333333333,,,,,,,,,,,,,,,,,
OG_08639,1.1565322526126385,FUN_037812-T1,Peve_00007681,Pocillopora_meandrina_HIv1___RNAseq.g1463.t1,three_way,71.19466666666666,FUN_037812-T1,B3EWZ6,,,,,97.5,7299.0,0.0,14917.2,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_08644,1.0903937541227435,FUN_037835-T1,Peve_00000571,Pocillopora_meandrina_HIv1___RNAseq.g1459.t1,three_way,87.0945,FUN_037835-T1,A0JNC1,CDS2_BOVIN,,Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2),Bos taurus (Bovine),57.1,410.0,3.5e-138,493.0,sp|A0JNC1|CDS2_BOVIN Phosphatidate cytidylyltransferase 2 OS=Bos taurus OX=9913 GN=CDS2 PE=2 SV=1,GO:0004605; GO:0005783; GO:0005789; GO:0016020; GO:0016024; GO:0140042,CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],phosphatidate cytidylyltransferase activity [GO:0004605],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_08705,1.3597494119796627,FUN_037955-T1,Peve_00040732,Pocillopora_meandrina_HIv1___TS.g19261.t1,three_way,55.23566666666667,FUN_037955-T1,Q9PVY9,,,,,40.6,217.0,5.7000000000000006e-36,153.3,sp|Q9PVY9|FXC2A_XENLA Forkhead box protein C2-A OS=Xenopus laevis OX=8355 GN=foxc2-a PE=2 SV=1,,,,,,
OG_08715,1.3854454972771866,FUN_037967-T1,Peve_00012656,Pocillopora_meandrina_HIv1___RNAseq.g26236.t1,three_way,59.54,FUN_037967-T1,Q09630,,,,,24.1,906.0,2.2e-38,162.5,sp|Q09630|GRM1_CAEEL Probable metabotropic glutamate receptor mgl-1 OS=Caenorhabditis elegans OX=6239 GN=mgl-1 PE=3 SV=1,,,,,,
OG_08744,1.088130275115899,FUN_038004-T1,Peve_00004462,Pocillopora_meandrina_HIv1___RNAseq.g26252.t1,three_way,74.46366666666667,FUN_038004-T1,Q5XX13,FBW10_HUMAN,,F-box/WD repeat-containing protein 10 (F-box and WD-40 domain-containing protein 10) (Ubiquitin ligase-specificity factor),Homo sapiens (Human),35.0,762.0,7.6e-99,363.6,sp|Q5XX13|FBW10_HUMAN F-box/WD repeat-containing protein 10 OS=Homo sapiens OX=9606 GN=FBXW10 PE=1 SV=2,GO:0005829,,cytosol [GO:0005829],,GO:0005829,cytosol
OG_08765,1.1808906526680254,FUN_038040-T1,Peve_00024877,Pocillopora_meandrina_HIv1___RNAseq.g26549.t1,three_way,88.22833333333332,FUN_038040-T1,Q5DU02,UBP22_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22),Mus musculus (Mouse),61.3,530.0,6.3e-179,628.6,sp|Q5DU02|UBP22_MOUSE Ubiquitin carboxyl-terminal hydrolase 22 OS=Mus musculus OX=10090 GN=Usp22 PE=1 SV=2,GO:0000086; GO:0000124; GO:0003713; GO:0004843; GO:0005737; GO:0006282; GO:0006357; GO:0006511; GO:0008270; GO:0010485; GO:0016579; GO:0019899; GO:0032481; GO:0033276; GO:0043484; GO:0045893; GO:0045931; GO:0140936; GO:0140950,G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of type I interferon production [GO:0032481]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276],cysteine-type deubiquitinase activity [GO:0004843]; enzyme binding [GO:0019899]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; histone H4 acetyltransferase activity [GO:0010485]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0006355; GO:0016740; GO:0016787; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; regulation of DNA-templated transcription; transferase activity; hydrolase activity; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_08774,1.0015708753146586,FUN_038058-T1,Peve_00000945,Pocillopora_meandrina_HIv1___RNAseq.g798.t1,three_way,76.90766666666667,,,,,,,,,,,,,,,,,
OG_08779,1.4264304023661465,FUN_038065-T1,Peve_00010941,Pocillopora_meandrina_HIv1___RNAseq.g789.t1,three_way,67.371,FUN_038065-T1,O66515,,,,,27.3,388.0,2.3e-27,125.9,sp|O66515|AMT_AQUAE Ammonium transporter OS=Aquifex aeolicus (strain VF5) OX=224324 GN=amt PE=1 SV=1,,,,,,
OG_08799,1.873754409400464,FUN_038101-T2,Peve_00009167,Pocillopora_meandrina_HIv1___RNAseq.g25708.t1,three_way,60.379666666666665,,,,,,,,,,,,,,,,,
OG_08842,2.0841137567938586,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_08847,1.4357373035388836,FUN_038205-T2,Peve_00038838,Pocillopora_meandrina_HIv1___TS.g5464.t1,three_way,60.227,FUN_038205-T2,D3ZQF9,LX12E_RAT,,"Polyunsaturated fatty acid (12S)/(13S)-lipoxygenase, epidermal-type (EC 1.13.11.-) (Arachidonate (12S)-lipoxygenase, epidermal-type) (12-LOX-e) (e(12S)-LOX) (EC 1.13.11.31) (Linoleate (13S)-lipoxygenase)",Rattus norvegicus (Rat),24.7,425.0,4.2e-26,120.9,"sp|D3ZQF9|LX12E_RAT Polyunsaturated fatty acid (12S)/(13S)-lipoxygenase, epidermal-type OS=Rattus norvegicus OX=10116 GN=Alox12e PE=3 SV=1",GO:0004052; GO:0005506; GO:0005829; GO:0005886; GO:0016165; GO:0019369; GO:0019372; GO:0034440; GO:0050473,arachidonate metabolic process [GO:0019369]; lipid oxidation [GO:0034440]; lipoxygenase pathway [GO:0019372],cytosol [GO:0005829]; plasma membrane [GO:0005886],arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165],GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0016491,catalytic activity; cytosol; plasma membrane; lipid metabolic process; oxidoreductase activity
OG_08849,1.962649910282018,FUN_038210-T1,Peve_00038842,Pocillopora_meandrina_HIv1___TS.g5429.t1,three_way,51.66433333333333,FUN_038210-T1,Q7TN88,,,,,27.8,967.0,4.1e-93,344.7,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08850,1.0117071287906685,FUN_038213-T1,Peve_00038850,Pocillopora_meandrina_HIv1___RNAseq.g897.t1,three_way,68.68866666666666,FUN_038213-T1,Q7Z402,,,,,32.1,639.0,1e-79,299.7,sp|Q7Z402|TMC7_HUMAN Transmembrane channel-like protein 7 OS=Homo sapiens OX=9606 GN=TMC7 PE=1 SV=1,,,,,,
OG_08859,1.0718462843336105,FUN_038245-T1,Peve_00007985,Pocillopora_meandrina_HIv1___TS.g5460.t2,three_way,84.75483333333334,FUN_038245-T1,P24733,,,,,61.2,841.0,5e-306,1052.7,"sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1",,,,,,
OG_08903,1.5799708863848154,FUN_038332-T1,Peve_00023107,Pocillopora_meandrina_HIv1___RNAseq.g1118.t1,three_way,64.6005,FUN_038332-T1,Q6ZPJ0,,,,,28.1,720.0,3.7e-42,175.3,sp|Q6ZPJ0|TEX2_MOUSE Testis-expressed protein 2 OS=Mus musculus OX=10090 GN=Tex2 PE=1 SV=2,,,,,,
OG_08922,1.003767649543102,FUN_038378-T1,Peve_00000075,Pocillopora_meandrina_HIv1___TS.g5619.t2,three_way,74.34866666666667,FUN_038378-T1,Q08170,SRSF4_HUMAN,,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",Homo sapiens (Human),55.8,190.0,7.6e-51,202.2,sp|Q08170|SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens OX=9606 GN=SRSF4 PE=1 SV=2,GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032868; GO:0048025; GO:1990825,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_08937,1.5593275358761565,FUN_038401-T1,Peve_00000033,Pocillopora_meandrina_HIv1___RNAseq.g28276.t1,three_way,76.06083333333333,FUN_038401-T1,Q9BG91,,,,,65.5,148.0,5e-50,200.3,sp|Q9BG91|SOX9_CALJA Transcription factor SOX-9 OS=Callithrix jacchus OX=9483 GN=SOX9 PE=2 SV=1,,,,,,
OG_08941,1.1964586550880218,FUN_038410-T1,Peve_00000012,Pocillopora_meandrina_HIv1___RNAseq.g28285.t1,three_way,90.88266666666668,FUN_038410-T1,Q66IZ7,,,,,48.4,287.0,1.4e-49,198.4,sp|Q66IZ7|NDL1B_XENLA Nuclear distribution protein nudE-like 1-B OS=Xenopus laevis OX=8355 GN=ndel1-b PE=2 SV=1,,,,,,
OG_08946,1.1103315435398506,FUN_038419-T1,Peve_00000005,Pocillopora_meandrina_HIv1___RNAseq.g1185.t2,three_way,81.85316666666667,FUN_038419-T1,Q5E9X2,MP2K6_BOVIN,,Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6),Bos taurus (Bovine),59.4,342.0,1e-108,394.8,sp|Q5E9X2|MP2K6_BOVIN Dual specificity mitogen-activated protein kinase kinase 6 OS=Bos taurus OX=9913 GN=MAP2K6 PE=2 SV=1,GO:0000165; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006915; GO:0106310,apoptotic process [GO:0006915]; MAPK cascade [GO:0000165],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634],ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005856; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytoskeleton; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08952,1.5357367334450094,FUN_038426-T1,Peve_00000114,Pocillopora_meandrina_HIv1___RNAseq.g1178.t1,three_way,77.04633333333334,FUN_038426-T1,F1R8Z9,FXJ1B_DANRE,,Forkhead box protein J1-B,Danio rerio (Zebrafish) (Brachydanio rerio),45.4,282.0,2.2e-51,204.5,sp|F1R8Z9|FXJ1B_DANRE Forkhead box protein J1-B OS=Danio rerio OX=7955 GN=foxj1b PE=2 SV=1,GO:0000978; GO:0000981; GO:0001947; GO:0003146; GO:0005634; GO:0006357; GO:0007368; GO:0044458; GO:0060088; GO:0060271,auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0044782; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; cilium organization; transcription regulator activity
OG_08959,1.9626527929535824,FUN_038437-T2,Peve_00029447,Pocillopora_meandrina_HIv1___RNAseq.25797_t,three_way,40.388666666666666,,,,,,,,,,,,,,,,,
OG_08960,1.175780893461798,FUN_038438-T1,Peve_00029444,Pocillopora_meandrina_HIv1___RNAseq.g885.t1,three_way,75.46883333333334,FUN_038438-T1,O43670,ZN207_HUMAN,,BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (hBuGZ) (Zinc finger protein 207),Homo sapiens (Human),86.7,90.0,2.7e-43,177.9,sp|O43670|ZN207_HUMAN BUB3-interacting and GLEBS motif-containing protein ZNF207 OS=Homo sapiens OX=9606 GN=ZNF207 PE=1 SV=1,GO:0000070; GO:0000776; GO:0001578; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008201; GO:0008270; GO:0008608; GO:0046785; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047,attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983],cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047],DNA binding [GO:0003677]; heparin binding [GO:0008201]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0007010; GO:0007059; GO:0008092; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; nucleolus; cytoskeleton organization; chromosome segregation; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_08967,2.266477867926811,FUN_038472-T1,Peve_00039876,Pocillopora_meandrina_HIv1___RNAseq.g28229.t1,three_way,51.10716666666666,,,,,,,,,,,,,,,,,
OG_08975,1.5682668720250996,FUN_038482-T1,Peve_00013523,Pocillopora_meandrina_HIv1___RNAseq.g6991.t1,three_way,43.61266666666667,,,,,,,,,,,,,,,,,
OG_08982,1.0278409117582854,FUN_038500-T1,Peve_00013485,Pocillopora_meandrina_HIv1___RNAseq.g28194.t1,three_way,84.38300000000001,FUN_038500-T1,Q8K4R4,,,,,65.7,251.0,8.2e-100,364.8,sp|Q8K4R4|PITC1_MOUSE Cytoplasmic phosphatidylinositol transfer protein 1 OS=Mus musculus OX=10090 GN=Pitpnc1 PE=1 SV=1,,,,,,
OG_08984,1.580941865883846,FUN_038503-T1,Peve_00041694,Pocillopora_meandrina_HIv1___RNAseq.g28159.t1,three_way,62.70366666666667,,,,,,,,,,,,,,,,,
OG_09003,1.0046714811850077,FUN_038548-T1,Peve_00037483,Pocillopora_meandrina_HIv1___RNAseq.g1036.t1,three_way,61.59066666666666,FUN_038548-T1,Q9Z0Y8,CAC1I_RAT,,Voltage-dependent T-type calcium channel subunit alpha-1I (CaVT.3) (Voltage-gated calcium channel subunit alpha Cav3.3),Rattus norvegicus (Rat),37.5,1870.0,1.6e-259,898.3,sp|Q9Z0Y8|CAC1I_RAT Voltage-dependent T-type calcium channel subunit alpha-1I OS=Rattus norvegicus OX=10116 GN=Cacna1i PE=1 SV=3,GO:0001518; GO:0005245; GO:0005248; GO:0005891; GO:0006816; GO:0008332; GO:0019228; GO:0030431; GO:0042391; GO:0043005; GO:0045956; GO:0060402; GO:0070509; GO:0086010,calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of membrane potential [GO:0042391]; sleep [GO:0030431],neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518],low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_09009,1.2639780218939276,FUN_038568-T1,Peve_00020181,Pocillopora_meandrina_HIv1___RNAseq.g1018.t1,three_way,78.31666666666666,FUN_038568-T1,A2AHL1,ANO3_MOUSE,,Anoctamin-3 (Transmembrane protein 16C),Mus musculus (Mouse),39.6,847.0,1.3e-160,568.5,sp|A2AHL1|ANO3_MOUSE Anoctamin-3 OS=Mus musculus OX=10090 GN=Ano3 PE=1 SV=1,GO:0005886; GO:0016048; GO:0017128; GO:0046983; GO:0050982; GO:0051649; GO:0061590; GO:0061591,calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; establishment of localization in cell [GO:0051649],plasma membrane [GO:0005886],phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0061024,transporter activity; plasma membrane; membrane organization
OG_09029,1.3943615718839193,FUN_038622-T1,Peve_00042048,Pocillopora_meandrina_HIv1___RNAseq.g1159.t1,three_way,78.449,FUN_038622-T1,P22448,,,,,31.8,349.0,7.2e-41,169.5,sp|P22448|RARB_CHICK Retinoic acid receptor beta OS=Gallus gallus OX=9031 GN=RARB PE=2 SV=2,,,,,,
OG_09042,1.20638744707218,FUN_038695-T1,Peve_00013474,Pocillopora_meandrina_HIv1___RNAseq.g26473.t1,three_way,63.010333333333335,,,,,,,,,,,,,,,,,
OG_09091,2.6171238411875,FUN_038889-T1,Peve_00028699,Pocillopora_meandrina_HIv1___RNAseq.g28663.t1,three_way,51.704,,,,,,,,,,,,,,,,,
OG_09092,1.1833026907010569,FUN_038890-T1,Peve_00028701,Pocillopora_meandrina_HIv1___RNAseq.g28661.t1,three_way,58.92133333333333,,,,,,,,,,,,,,,,,
OG_09106,1.3205250069474102,FUN_038933-T1,Peve_00043963,Pocillopora_meandrina_HIv1___TS.g5573.t1,three_way,82.23966666666666,FUN_038933-T1,S4R2P9,NAC3_MOUSE,,Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3),Mus musculus (Mouse),37.2,888.0,1.1e-137,492.3,sp|S4R2P9|NAC3_MOUSE Sodium/calcium exchanger 3 OS=Mus musculus OX=10090 GN=Slc8a3 PE=1 SV=1,GO:0002244; GO:0005432; GO:0005516; GO:0005654; GO:0005741; GO:0005789; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015368; GO:0016528; GO:0021537; GO:0030001; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0045211; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0060402; GO:0070161; GO:0070588; GO:0071320; GO:0071456; GO:0098703; GO:0098815; GO:1902532; GO:1905060; GO:1990034,calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of intracellular signal transduction [GO:1902532]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; telencephalon development [GO:0021537],anchoring junction [GO:0070161]; axon terminus [GO:0043679]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202],calcium:monoatomic cation antiporter activity [GO:0015368]; calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0005215; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0055085,transporter activity; nucleoplasm; microtubule organizing center; cytosol; plasma membrane; cell differentiation; cell junction organization; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_09120,1.3604522345537884,FUN_039266-T1,Peve_00002772,Pocillopora_meandrina_HIv1___RNAseq.g13577.t1,three_way,76.14266666666667,FUN_039266-T1,P12394,,,,,43.7,462.0,3.8999999999999998e-109,396.7,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_09121,1.268959101584527,FUN_039269-T1,Peve_00002766,Pocillopora_meandrina_HIv1___RNAseq.14855_t,three_way,50.418,FUN_039269-T1,P15384,,,,,32.5,428.0,1e-50,202.6,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_09130,2.9264402740613766,FUN_039512-T1,Peve_00003617,Pocillopora_meandrina_HIv1___RNAseq.g27137.t1,three_way,55.90733333333333,,,,,,,,,,,,,,,,,
OG_09135,1.0249020153447177,FUN_039740-T1,Peve_00033350,Pocillopora_meandrina_HIv1___RNAseq.g15605.t1,three_way,62.17133333333333,,,,,,,,,,,,,,,,,
OG_09164,1.2552864294308037,FUN_039826-T2,Peve_00014198,Pocillopora_meandrina_HIv1___RNAseq.g25896.t1,three_way,49.993833333333335,,,,,,,,,,,,,,,,,
OG_09178,1.172166012589578,FUN_039858-T1,Peve_00020641,Pocillopora_meandrina_HIv1___RNAseq.g7287.t1a,three_way,34.05316666666667,,,,,,,,,,,,,,,,,
OG_09188,1.128062944049667,FUN_039870-T1,Peve_00006913,Pocillopora_meandrina_HIv1___RNAseq.g7377.t1,three_way,54.30833333333333,,,,,,,,,,,,,,,,,
OG_09197,1.3868411160328862,FUN_039880-T1,Peve_00004942,Pocillopora_meandrina_HIv1___RNAseq.g7353.t1,three_way,56.60916666666667,FUN_039880-T1,Q9NX45,,,,,52.0,75.0,2.7e-12,75.5,sp|Q9NX45|SOLH2_HUMAN Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2 OS=Homo sapiens OX=9606 GN=SOHLH2 PE=1 SV=2,,,,,,
OG_09233,1.3420358586633314,FUN_039977-T1,Peve_00029897,Pocillopora_meandrina_HIv1___RNAseq.g7542.t1,three_way,56.55166666666666,FUN_039977-T1,Q9ULJ7,,,,,25.1,427.0,1.1e-26,124.8,sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4,,,,,,
OG_09237,1.1003728900037697,FUN_039990-T1,Peve_00004422,Pocillopora_meandrina_HIv1___RNAseq.g7562.t1,three_way,81.36533333333333,FUN_039990-T1,Q96CN4,EVI5L_HUMAN,,EVI5-like protein (Ecotropic viral integration site 5-like protein),Homo sapiens (Human),45.3,516.0,1.2e-114,415.2,sp|Q96CN4|EVI5L_HUMAN EVI5-like protein OS=Homo sapiens OX=9606 GN=EVI5L PE=1 SV=1,GO:0005096; GO:0031267; GO:0043547; GO:1902018,negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547],,GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0098772,molecular function regulator activity
OG_09247,2.341879389480677,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09262,1.6002845370927408,FUN_040067-T1,Peve_00033898,Pocillopora_meandrina_HIv1___RNAseq.g7701.t2,three_way,60.609,FUN_040067-T1,A8VU90,ANKL1_MOUSE,,Ankyrin repeat and LEM domain-containing protein 1 (EC 3.1.-.-) (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3),Mus musculus (Mouse),45.4,251.0,4.0999999999999996e-53,210.7,sp|A8VU90|ANKL1_MOUSE Ankyrin repeat and LEM domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ankle1 PE=2 SV=1,GO:0004519; GO:0005654; GO:0005829; GO:0006611; GO:0045950; GO:1905453; GO:1905456,negative regulation of mitotic recombination [GO:0045950]; protein export from nucleus [GO:0006611]; regulation of lymphoid progenitor cell differentiation [GO:1905456]; regulation of myeloid progenitor cell differentiation [GO:1905453],cytosol [GO:0005829]; nucleoplasm [GO:0005654],endonuclease activity [GO:0004519],GO:0003824; GO:0005654; GO:0005829; GO:0006886; GO:0006913,catalytic activity; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport
OG_09269,1.0817804461782712,FUN_040075-T1,Peve_00021003,Pocillopora_meandrina_HIv1___RNAseq.g7690.t1,three_way,38.61383333333333,,,,,,,,,,,,,,,,,
OG_09272,1.142942600960622,FUN_040078-T1,Peve_00011677,Pocillopora_meandrina_HIv1___TS.g1373.t1,three_way,72.69366666666666,FUN_040078-T1,Q9GZQ6,NPFF1_HUMAN,,Neuropeptide FF receptor 1 (G-protein coupled receptor 147) (RFamide-related peptide receptor OT7T022),Homo sapiens (Human),30.8,331.0,3.7000000000000003e-34,147.1,sp|Q9GZQ6|NPFF1_HUMAN Neuropeptide FF receptor 1 OS=Homo sapiens OX=9606 GN=NPFFR1 PE=1 SV=1,GO:0004930; GO:0005886; GO:0005929; GO:0007186; GO:0007218; GO:0008188; GO:0032870,cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218],cilium [GO:0005929]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188],GO:0005886; GO:0005929; GO:0043226; GO:0060089,plasma membrane; cilium; organelle; molecular transducer activity
OG_09282,1.5265421520506746,FUN_040097-T1,Peve_00037195,Pocillopora_meandrina_HIv1___RNAseq.g7573.t1,three_way,68.70466666666667,,,,,,,,,,,,,,,,,
OG_09295,3.018813127286441,FUN_040146-T1,Peve_00038108,Pocillopora_meandrina_HIv1___RNAseq.g8511.t1,three_way,40.80866666666667,,,,,,,,,,,,,,,,,
OG_09320,1.6077282494862186,FUN_040234-T1,Peve_00042156,Pocillopora_meandrina_HIv1___RNAseq.g7774.t1,three_way,43.47166666666666,,,,,,,,,,,,,,,,,
OG_09334,1.2588997863277367,FUN_040273-T1,Peve_00014971,Pocillopora_meandrina_HIv1___RNAseq.g9069.t1,three_way,63.76,FUN_040273-T1,Q3ZBH3,,,,,27.7,242.0,9e-19,95.5,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_09336,1.179799055247628,FUN_040299-T1,Peve_00038649,Pocillopora_meandrina_HIv1___TS.g20792.t1,three_way,42.627833333333335,FUN_040299-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),24.5,4769.0,0.0,1096.6,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_09380,1.8004296909881383,FUN_040663-T1,Peve_00015413,Pocillopora_meandrina_HIv1___RNAseq.g6468.t1,three_way,48.03816666666667,,,,,,,,,,,,,,,,,
OG_09396,1.0845616819342023,FUN_040694-T1,Peve_00029582,Pocillopora_meandrina_HIv1___TS.g20808.t2,three_way,54.065333333333335,FUN_040694-T1,Q24322,SEM1A_DROME,,Semaphorin-1A (Semaphorin-I) (Sema I),Drosophila melanogaster (Fruit fly),31.1,550.0,8.8e-52,206.8,sp|Q24322|SEM1A_DROME Semaphorin-1A OS=Drosophila melanogaster OX=7227 GN=Sema1a PE=1 SV=3,GO:0005886; GO:0007411; GO:0007416; GO:0008039; GO:0008045; GO:0008201; GO:0016020; GO:0016199; GO:0030215; GO:0030335; GO:0045499; GO:0045792; GO:0048813; GO:0050919; GO:0071526; GO:0072499,axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of cell size [GO:0045792]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039],membrane [GO:0016020]; plasma membrane [GO:0005886],chemorepellent activity [GO:0045499]; heparin binding [GO:0008201]; semaphorin receptor binding [GO:0030215],GO:0005886; GO:0034330; GO:0048018; GO:0098772,plasma membrane; cell junction organization; receptor ligand activity; molecular function regulator activity
OG_09427,1.2991646238709418,FUN_041311-T1,Peve_00036795,Pocillopora_meandrina_HIv1___RNAseq.g16009.t1,three_way,64.30933333333334,FUN_041311-T1,A7MFZ8,,,,,30.6,288.0,3.9e-34,147.1,sp|A7MFZ8|GHRA_CROS8 Glyoxylate/hydroxypyruvate reductase A OS=Cronobacter sakazakii (strain ATCC BAA-894) OX=290339 GN=ghrA PE=3 SV=1,,,,,,
OG_09432,1.4524708812326288,FUN_041389-T1,Peve_00044211,Pocillopora_meandrina_HIv1___RNAseq.g15715.t1,three_way,84.4495,FUN_041389-T1,Q32PP9,,,,,49.8,245.0,5.5e-50,199.5,sp|Q32PP9|SOX14_DANRE Transcription factor Sox-14 OS=Danio rerio OX=7955 GN=sox14 PE=2 SV=1,,,,,,
OG_09434,1.3799578353102084,FUN_041404-T1,Peve_00020588,Pocillopora_meandrina_HIv1___RNAseq.g15720.t1,three_way,81.456,,,,,,,,,,,,,,,,,
OG_09440,1.0505601128174773,FUN_041426-T1,Peve_00008987,Pocillopora_meandrina_HIv1___RNAseq.g15735.t2,three_way,80.48633333333333,FUN_041426-T1,P97360,ETV6_MOUSE,,Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel),Mus musculus (Mouse),44.6,65.0,1.7e-11,70.9,sp|P97360|ETV6_MOUSE Transcription factor ETV6 OS=Mus musculus OX=10090 GN=Etv6 PE=1 SV=1,GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005730; GO:0005829; GO:0006355; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0045944; GO:0071425; GO:0097152,cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; vitellogenesis [GO:0007296],cytosol [GO:0005829]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005730; GO:0005829; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleolus; cytosol; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; transcription regulator activity
OG_09443,1.4092766055705486,FUN_041432-T2,Peve_00027845,Pocillopora_meandrina_HIv1___RNAseq.g15740.t1,three_way,86.71633333333334,FUN_041432-T2,Q90837,,,,,41.4,459.0,1.8000000000000002e-81,304.7,sp|Q90837|ERG_CHICK Transcriptional regulator Erg OS=Gallus gallus OX=9031 GN=ERG PE=2 SV=1,,,,,,
OG_09465,1.282397226312168,FUN_041488-T1,Peve_00004075,Pocillopora_meandrina_HIv1___RNAseq.g15670.t1,three_way,61.912,FUN_041488-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),36.2,549.0,2.0999999999999998e-95,351.3,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_09466,1.6858502021192578,FUN_041490-T1,Peve_00004073,Pocillopora_meandrina_HIv1___RNAseq.g15669.t1,three_way,79.144,FUN_041490-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),33.6,420.0,1.3e-68,262.3,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_09472,1.6562748654669004,FUN_041498-T1,Peve_00007700,Pocillopora_meandrina_HIv1___TS.g10682.t1,three_way,80.48866666666666,FUN_041498-T1,Q6Q2B2,,,,,39.5,253.0,1.1e-33,145.6,sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1,,,,,,
OG_09475,1.3859942382778974,FUN_041502-T1,Peve_00021434,Pocillopora_meandrina_HIv1___RNAseq.g15963.t1,three_way,73.652,FUN_041502-T1,Q62623,CDC20_RAT,,Cell division cycle protein 20 homolog (p55CDC),Rattus norvegicus (Rat),51.9,507.0,4.4999999999999997e-129,463.0,sp|Q62623|CDC20_RAT Cell division cycle protein 20 homolog OS=Rattus norvegicus OX=10116 GN=Cdc20 PE=1 SV=2,GO:0000776; GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005829; GO:0007064; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031915; GO:0032991; GO:0033597; GO:0040020; GO:0042826; GO:0044784; GO:0045842; GO:0048471; GO:0050773; GO:0051301; GO:0090129; GO:0090307; GO:1904146; GO:1904668; GO:1905786; GO:1990756; GO:1990757; GO:1990949,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of cell cycle [GO:0044784]; metaphase/anaphase transition of meiosis I [GO:1990949]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020],anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922],anaphase-promoting complex binding [GO:0010997]; histone deacetylase binding [GO:0042826]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0022414; GO:0030163; GO:0043226; GO:0060090; GO:0098772,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; reproductive process; protein catabolic process; organelle; molecular adaptor activity; molecular function regulator activity
OG_09482,1.20647571783736,FUN_041510-T1,Peve_00025394,Pocillopora_meandrina_HIv1___RNAseq.g16083.t1,three_way,76.65133333333333,FUN_041510-T1,Q9EQN9,,,,,45.4,449.0,1.5e-99,364.8,sp|Q9EQN9|S19A2_MOUSE Thiamine transporter 1 OS=Mus musculus OX=10090 GN=Slc19a2 PE=1 SV=1,,,,,,
OG_09518,1.5092767976901065,FUN_041578-T1,Peve_00028459,Pocillopora_meandrina_HIv1___TS.g10950.t2,three_way,69.42166666666667,FUN_041578-T1,Q6GPD0,,,,,44.5,659.0,2.9e-150,534.3,sp|Q6GPD0|RHG32_XENLA Rho GTPase-activating protein 32 OS=Xenopus laevis OX=8355 GN=arhgap32 PE=2 SV=1,,,,,,
OG_09535,1.1005925670568624,FUN_041622-T1,Peve_00036084,Pocillopora_meandrina_HIv1___TS.g10312.t1b,three_way,81.132,FUN_041622-T1,P41247,PLPL4_HUMAN,,Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2),Homo sapiens (Human),48.4,248.0,4.7999999999999995e-61,236.1,sp|P41247|PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=PNPLA4 PE=1 SV=3,GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088,lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739],"acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806]",GO:0003824; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; mitochondrion; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_09539,1.3285660525934604,FUN_041633-T1,Peve_00023646,Pocillopora_meandrina_HIv1___RNAseq.g14223.t1,three_way,72.00033333333333,FUN_041633-T1,Q47898,ASPG_ELIMR,,N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain],Elizabethkingia miricola (Chryseobacterium miricola),40.3,119.0,4.7e-17,89.0,sp|Q47898|ASPG_ELIMR N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase OS=Elizabethkingia miricola OX=172045 PE=1 SV=1,GO:0003948; GO:0005737; GO:0006508; GO:0008233; GO:0042597,proteolysis [GO:0006508],cytoplasm [GO:0005737]; periplasmic space [GO:0042597],N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_09540,1.706046905305723,FUN_041634-T1,Peve_00023645,Pocillopora_meandrina_HIv1___RNAseq.g14222.t1,three_way,82.26466666666667,FUN_041634-T1,Q9H0K1,SIK2_HUMAN,,Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2),Homo sapiens (Human),46.9,631.0,4.8999999999999996e-135,483.4,sp|Q9H0K1|SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens OX=9606 GN=SIK2 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0006468; GO:0035556; GO:0046626; GO:0046777; GO:0106310,intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09560,1.053124284977737,FUN_041669-T1,Peve_00031770,Pocillopora_meandrina_HIv1___RNAseq.g13997.t1,three_way,78.03516666666667,FUN_041669-T1,Q32NT4,,,,,52.5,118.0,7.100000000000001e-28,126.3,sp|Q32NT4|LRC58_XENLA Leucine-rich repeat-containing protein 58 OS=Xenopus laevis OX=8355 GN=lrrc58 PE=2 SV=1,,,,,,
OG_09584,2.360065166375464,FUN_041722-T1,Peve_00014616,Pocillopora_meandrina_HIv1___RNAseq.g15476.t1,three_way,61.13666666666667,,,,,,,,,,,,,,,,,
OG_09596,1.1771285406028849,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_09597,1.112127388310108,FUN_041744-T1,Peve_00000340,Pocillopora_meandrina_HIv1___RNAseq.g15789.t1,three_way,72.12516666666667,,,,,,,,,,,,,,,,,
OG_09599,1.414006167314546,FUN_041749-T1,Peve_00042718,Pocillopora_meandrina_HIv1___RNAseq.g15090.t1,three_way,53.022333333333336,,,,,,,,,,,,,,,,,
OG_09717,1.1699593751132715,FUN_041963-T1,Peve_00043506,Pocillopora_meandrina_HIv1___RNAseq.g15912.t1,three_way,78.311,FUN_041963-T1,O35547,ACSL4_RAT,,Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4),Rattus norvegicus (Rat),53.7,706.0,2.6e-220,766.5,sp|O35547|ACSL4_RAT Long-chain-fatty-acid--CoA ligase 4 OS=Rattus norvegicus OX=10116 GN=Acsl4 PE=1 SV=2,GO:0001676; GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0006631; GO:0007584; GO:0015908; GO:0019432; GO:0030182; GO:0031957; GO:0031966; GO:0032024; GO:0035336; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672,dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886],arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957],GO:0003824; GO:0005739; GO:0005777; GO:0005783; GO:0005811; GO:0005886; GO:0006629; GO:0006790; GO:0016874; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:0140657,catalytic activity; mitochondrion; peroxisome; endoplasmic reticulum; lipid droplet; plasma membrane; lipid metabolic process; sulfur compound metabolic process; ligase activity; reproductive process; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; ATP-dependent activity
OG_09728,1.7803730131784674,FUN_041981-T1,Peve_00001546,Pocillopora_meandrina_HIv1___RNAseq.g15162.t1,three_way,54.784666666666666,FUN_041981-T1,P06400,RB_HUMAN,,Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110),Homo sapiens (Human),27.8,857.0,8.2e-74,280.0,sp|P06400|RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens OX=9606 GN=RB1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000785; GO:0000977; GO:0001894; GO:0002062; GO:0003180; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006338; GO:0006355; GO:0006366; GO:0006469; GO:0007224; GO:0007265; GO:0007283; GO:0007346; GO:0010629; GO:0014009; GO:0016514; GO:0016605; GO:0019900; GO:0030154; GO:0030308; GO:0031134; GO:0031175; GO:0031507; GO:0031625; GO:0032869; GO:0034088; GO:0034349; GO:0035189; GO:0035914; GO:0042551; GO:0042802; GO:0043353; GO:0043433; GO:0043550; GO:0045445; GO:0045651; GO:0045786; GO:0045842; GO:0045879; GO:0045892; GO:0045944; GO:0048565; GO:0048667; GO:0050673; GO:0050680; GO:0050728; GO:0051146; GO:0051219; GO:0051276; GO:0051301; GO:0051402; GO:0051726; GO:0060090; GO:0060253; GO:0061629; GO:0061676; GO:0061793; GO:0071459; GO:0071466; GO:0090230; GO:0097284; GO:0097718; GO:0120163; GO:0140297; GO:1903055; GO:1903944; GO:1904028; GO:1904761; GO:2000134; GO:2000679; GO:2001234,"aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; chromatin remodeling [GO:0006338]; chromosome organization [GO:0051276]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell proliferation [GO:0050673]; G1/S transition of mitotic cell cycle [GO:0000082]; glial cell apoptotic process [GO:0034349]; glial cell proliferation [GO:0014009]; hepatocyte apoptotic process [GO:0097284]; heterochromatin formation [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of centromere complex assembly [GO:0090230]; regulation of DNA-templated transcription [GO:0006355]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]; transcription by RNA polymerase II [GO:0006366]",chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Rb-E2F complex [GO:0035189]; spindle [GO:0005819]; SWI/SNF complex [GO:0016514],disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; phosphoprotein binding [GO:0051219]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_09730,1.3257738232521863,FUN_041986-T1,Peve_00010444,Pocillopora_meandrina_HIv1___RNAseq.g15235.t1,three_way,60.22733333333333,,,,,,,,,,,,,,,,,
OG_09741,1.5715532809909123,FUN_042004-T1,Peve_00026002,Pocillopora_meandrina_HIv1___TS.g7940.t2,three_way,74.858,FUN_042004-T1,P15848,ARSB_HUMAN,,Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S),Homo sapiens (Human),45.7,497.0,4.5e-123,443.0,sp|P15848|ARSB_HUMAN Arylsulfatase B OS=Homo sapiens OX=9606 GN=ARSB PE=1 SV=1,GO:0003943; GO:0004065; GO:0005576; GO:0005764; GO:0005788; GO:0006914; GO:0007040; GO:0007041; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813,autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0006914; GO:0007040; GO:0016787; GO:0043226; GO:0048870,catalytic activity; extracellular region; lysosome; vacuole; autophagy; lysosome organization; hydrolase activity; organelle; cell motility
OG_09743,1.9601283693809632,FUN_042009-T1,Peve_00031038,Pocillopora_meandrina_HIv1___RNAseq.g15212.t1,three_way,48.658166666666666,,,,,,,,,,,,,,,,,
OG_09746,1.2373451818472094,FUN_042013-T1,Peve_00026003,Pocillopora_meandrina_HIv1___RNAseq.g28153.t1,three_way,77.80266666666667,FUN_042013-T1,P50430,,,,,49.3,495.0,9.7e-137,488.4,sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2,,,,,,
OG_09757,1.8604839035438832,FUN_042029-T1,Peve_00025063,Pocillopora_meandrina_HIv1___RNAseq.g15174.t1,three_way,47.64533333333333,FUN_042029-T1,Q9QYM2,,,,,31.9,354.0,1.1e-38,163.7,sp|Q9QYM2|PARG_RAT Poly(ADP-ribose) glycohydrolase OS=Rattus norvegicus OX=10116 GN=Parg PE=1 SV=1,,,,,,
OG_09764,1.236157027887907,FUN_042043-T1,Peve_00025406,Pocillopora_meandrina_HIv1___RNAseq.g15137.t1,three_way,85.81366666666666,FUN_042043-T1,Q70VZ7,MOGT1_BOVIN,,2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Monoacylglycerol O-acyltransferase 1),Bos taurus (Bovine),56.3,332.0,2.7e-106,386.7,sp|Q70VZ7|MOGT1_BOVIN 2-acylglycerol O-acyltransferase 1 OS=Bos taurus OX=9913 GN=MOGAT1 PE=2 SV=1,GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006651; GO:0019432,diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum membrane [GO:0005789],2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144],GO:0003824; GO:0005975; GO:0006629; GO:0016740,catalytic activity; carbohydrate metabolic process; lipid metabolic process; transferase activity
OG_09767,1.0097888423887609,FUN_042048-T1,Peve_00025414,Pocillopora_meandrina_HIv1___RNAseq.g15142.t1,three_way,77.533,FUN_042048-T1,Q8BH01,,,,,43.5,666.0,3.1e-136,487.3,sp|Q8BH01|TMCO3_MOUSE Transmembrane and coiled-coil domain-containing protein 3 OS=Mus musculus OX=10090 GN=Tmco3 PE=2 SV=1,,,,,,
OG_09774,1.1131387358250928,FUN_042060-T1,Peve_00019715,Pocillopora_meandrina_HIv1___RNAseq.g22263.t1,three_way,39.5205,,,,,,,,,,,,,,,,,
OG_09789,1.7435439179429133,FUN_042591-T1,Peve_00012673,Pocillopora_meandrina_HIv1___RNAseq.g16869.t1,three_way,79.75733333333334,FUN_042591-T1,Q87PP5,,,,,36.3,535.0,8.499999999999999e-92,339.7,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_09806,1.4443961671404253,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_09812,1.1337666596032514,FUN_042636-T1,Peve_00030037,Pocillopora_meandrina_HIv1___RNAseq.g11500.t1,three_way,76.48533333333333,FUN_042636-T1,Q9HBI6,CP4FB_HUMAN,,Cytochrome P450 4F11 (CYPIVF11) (EC 1.14.14.1) (3-hydroxy fatty acids omega-hydroxylase CYP4F11) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) (Phylloquinone omega-hydroxylase CYP4F11) (EC 1.14.14.78),Homo sapiens (Human),42.0,471.0,8.3e-107,389.0,sp|Q9HBI6|CP4FB_HUMAN Cytochrome P450 4F11 OS=Homo sapiens OX=9606 GN=CYP4F11 PE=1 SV=3,GO:0004497; GO:0005504; GO:0005506; GO:0005789; GO:0006631; GO:0007596; GO:0016709; GO:0019369; GO:0020037; GO:0031408; GO:0042361; GO:0042376; GO:0042377; GO:0052869; GO:0097267; GO:0102033; GO:1903604,arachidonate metabolic process [GO:0019369]; blood coagulation [GO:0007596]; cytochrome metabolic process [GO:1903604]; fatty acid metabolic process [GO:0006631]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; phylloquinone catabolic process [GO:0042376]; vitamin K catabolic process [GO:0042377],endoplasmic reticulum membrane [GO:0005789],"arachidonate omega-hydroxylase activity [GO:0052869]; fatty acid binding [GO:0005504]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0006629; GO:0006766; GO:0008289; GO:0016491,catalytic activity; lipid metabolic process; vitamin metabolic process; lipid binding; oxidoreductase activity
OG_09826,2.914848742824512,FUN_042659-T1,Peve_00031591,Pocillopora_meandrina_HIv1___RNAseq.g4898.t1,three_way,46.13633333333333,,,,,,,,,,,,,,,,,
OG_09846,1.4016393045382334,FUN_042835-T1,Peve_00022002,Pocillopora_meandrina_HIv1___RNAseq.g7265.t1,three_way,62.422,,,,,,,,,,,,,,,,,
OG_09881,1.513422799125613,FUN_042949-T1,Peve_00019972,Pocillopora_meandrina_HIv1___TS.g886.t1,three_way,68.23983333333334,FUN_042949-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),34.1,560.0,6.8e-78,293.1,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_09890,1.2112037066166097,FUN_042969-T1,Peve_00039038,Pocillopora_meandrina_HIv1___RNAseq.g7107.t1,three_way,70.73766666666667,FUN_042969-T1,Q9UJX4,,,,,33.8,754.0,2.1e-106,388.3,sp|Q9UJX4|APC5_HUMAN Anaphase-promoting complex subunit 5 OS=Homo sapiens OX=9606 GN=ANAPC5 PE=1 SV=2,,,,,,
OG_09906,1.1860590380094524,FUN_043003-T1,Peve_00017777,Pocillopora_meandrina_HIv1___RNAseq.g7027.t1,three_way,86.71766666666667,FUN_043003-T1,Q66L49,SCMC1_DANRE,,Mitochondrial adenyl nucleotide antiporter SLC25A24 (Small calcium-binding mitochondrial carrier protein 1) (SCaMC-1) (Solute carrier family 25 member 24),Danio rerio (Zebrafish) (Brachydanio rerio),54.6,467.0,1e-146,521.5,sp|Q66L49|SCMC1_DANRE Mitochondrial adenyl nucleotide antiporter SLC25A24 OS=Danio rerio OX=7955 GN=slc25a24 PE=2 SV=1,GO:0000295; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0015866; GO:0015867; GO:0016020; GO:0051503; GO:0071277; GO:0140987; GO:0140988; GO:1990544,adenine nucleotide transport [GO:0051503]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; mitochondrial ATP transmembrane transport [GO:1990544],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP:phosphate antiporter activity [GO:0140988]; ATP transmembrane transporter activity [GO:0005347]; ATP:phosphate antiporter activity [GO:0140987]; calcium ion binding [GO:0005509],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_09917,1.2417482206988266,FUN_043027-T1,Peve_00026962,Pocillopora_meandrina_HIv1___TS.g790.t1,three_way,57.98016666666667,FUN_043027-T1,Q8AYG3,TTK_DANRE,,Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap),Danio rerio (Zebrafish) (Brachydanio rerio),30.7,960.0,1.6999999999999998e-92,342.4,sp|Q8AYG3|TTK_DANRE Dual specificity protein kinase Ttk OS=Danio rerio OX=7955 GN=ttk PE=1 SV=2,GO:0000776; GO:0001100; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0007059; GO:0007060; GO:0007094; GO:0016321; GO:0031101; GO:0033316; GO:0034501; GO:0042246; GO:0046872; GO:0051301; GO:0060249; GO:0106310,anatomical structure homeostasis [GO:0060249]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; female meiosis chromosome segregation [GO:0016321]; fin regeneration [GO:0031101]; male meiosis chromosome segregation [GO:0007060]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of exit from mitosis [GO:0001100]; protein localization to kinetochore [GO:0034501]; tissue regeneration [GO:0042246],kinetochore [GO:0000776]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; chromosome segregation; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09928,1.0504979391603864,FUN_043084-T1,Peve_00026456,Pocillopora_meandrina_HIv1___RNAseq.g7081.t1,three_way,62.529833333333336,FUN_043084-T1,Q9UBN4,,,,,30.1,742.0,4.2e-83,310.8,sp|Q9UBN4|TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1,,,,,,
OG_09930,1.0434832962402207,FUN_043086-T1,Peve_00001644,Pocillopora_meandrina_HIv1___TS.g825.t1,three_way,66.956,FUN_043086-T1,Q501I9,,,,,35.5,445.0,2.3000000000000002e-74,281.2,sp|Q501I9|DIRC2_XENTR Solute carrier family 49 member 4 homolog OS=Xenopus tropicalis OX=8364 GN=slc49a4 PE=2 SV=1,,,,,,
OG_09937,1.0655903860851603,FUN_043097-T2,Peve_00033762,Pocillopora_meandrina_HIv1___RNAseq.g7007.t1,three_way,79.86333333333333,FUN_043097-T2,Q6DD44,XPR1_XENLA,,Xenotropic and polytropic retrovirus receptor 1 homolog,Xenopus laevis (African clawed frog),51.0,700.0,4.5e-193,676.0,sp|Q6DD44|XPR1_XENLA Xenotropic and polytropic retrovirus receptor 1 homolog OS=Xenopus laevis OX=8355 GN=xpr1 PE=2 SV=1,GO:0000822; GO:0005315; GO:0005794; GO:0005886; GO:0006817; GO:0015562; GO:0016036; GO:0030643; GO:0035435,cellular response to phosphate starvation [GO:0016036]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817],Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate transmembrane transporter activity [GO:0005315],GO:0005215; GO:0005794; GO:0005886; GO:0043226; GO:0055085,transporter activity; Golgi apparatus; plasma membrane; organelle; transmembrane transport
OG_09962,1.097262717601941,FUN_043143-T1,Peve_00034956,Pocillopora_meandrina_HIv1___RNAseq.g6885.t1,three_way,65.38133333333333,FUN_043143-T1,O89110,CASP8_MOUSE,,Caspase-8 (CASP-8) (EC 3.4.22.61) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10],Mus musculus (Mouse),26.6,533.0,8.6e-51,203.0,sp|O89110|CASP8_MOUSE Caspase-8 OS=Mus musculus OX=10090 GN=Casp8 PE=1 SV=1,GO:0001525; GO:0001817; GO:0001841; GO:0004175; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005886; GO:0006915; GO:0007507; GO:0008233; GO:0008625; GO:0008656; GO:0016485; GO:0030225; GO:0030690; GO:0043065; GO:0045088; GO:0048738; GO:0051603; GO:0060546; GO:0070243; GO:0070266; GO:0070269; GO:0097190; GO:0097191; GO:0097194; GO:0097264; GO:0097284; GO:0097342; GO:1900119; GO:2001233; GO:2001238,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cardiac muscle tissue development [GO:0048738]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; heart development [GO:0007507]; hepatocyte apoptotic process [GO:0097284]; macrophage differentiation [GO:0030225]; necroptotic process [GO:0070266]; negative regulation of necroptotic process [GO:0060546]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein processing [GO:0016485]; proteolysis involved in protein catabolic process [GO:0051603]; pyroptotic inflammatory response [GO:0070269]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of cytokine production [GO:0001817]; regulation of innate immune response [GO:0045088]; regulation of thymocyte apoptotic process [GO:0070243]; self proteolysis [GO:0097264],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; Noc1p-Noc2p complex [GO:0030690]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ripoptosome [GO:0097342],cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233],GO:0003824; GO:0005634; GO:0005739; GO:0005886; GO:0006954; GO:0012501; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; nucleus; mitochondrion; plasma membrane; inflammatory response; programmed cell death; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09972,1.0631847562595562,FUN_043155-T1,Peve_00011378,Pocillopora_meandrina_HIv1___RNAseq.g6836.t1,three_way,39.551,,,,,,,,,,,,,,,,,
OG_09994,1.0473140186168626,FUN_043207-T1,Peve_00039862,Pocillopora_meandrina_HIv1___RNAseq.g6814.t1,three_way,65.258,FUN_043207-T1,Q6DCP1,,,,,40.3,273.0,5.8e-50,199.1,sp|Q6DCP1|FXRD1_XENLA FAD-dependent oxidoreductase domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=foxred1 PE=2 SV=1,,,,,,
OG_10002,1.3139466609198034,FUN_043236-T1,Peve_00001435,Pocillopora_meandrina_HIv1___RNAseq.g6748.t1,three_way,69.04316666666666,FUN_043236-T1,Q30D77,COOA1_MOUSE,,Collagen alpha-1(XXIV) chain,Mus musculus (Mouse),41.1,107.0,1.5e-17,94.0,sp|Q30D77|COOA1_MOUSE Collagen alpha-1(XXIV) chain OS=Mus musculus OX=10090 GN=Col24a1 PE=2 SV=2,GO:0002244; GO:0005201; GO:0005576; GO:0005581; GO:0062023,hematopoietic progenitor cell differentiation [GO:0002244],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030154,structural molecule activity; extracellular region; cell differentiation
OG_10021,1.083542672363237,FUN_043262-T1,Peve_00032608,Pocillopora_meandrina_HIv1___RNAseq.g8892.t1,three_way,72.44983333333333,FUN_043262-T1,Q9Z0H0,,,,,35.1,559.0,3.6e-82,307.4,sp|Q9Z0H0|CDC7_MOUSE Cell division cycle 7-related protein kinase OS=Mus musculus OX=10090 GN=Cdc7 PE=1 SV=2,,,,,,
OG_10026,1.098683672029408,FUN_043279-T1,Peve_00007455,Pocillopora_meandrina_HIv1___RNAseq.g8875.t1,three_way,77.92,FUN_043279-T1,Q08832,GBRB3_DROME,,Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor),Drosophila melanogaster (Fruit fly),34.6,457.0,7.399999999999999e-75,282.7,sp|Q08832|GBRB3_DROME Gamma-aminobutyric acid receptor subunit beta-like OS=Drosophila melanogaster OX=7227 GN=Lcch3 PE=1 SV=2,GO:0004890; GO:0005886; GO:0022851; GO:0034707; GO:0045211; GO:1902476; GO:1902711,chloride transmembrane transport [GO:1902476],chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_10039,1.4478514372692703,FUN_043309-T1,Peve_00007495,Pocillopora_meandrina_HIv1___RNAseq.g8924.t1,three_way,66.18766666666667,FUN_043309-T1,P33450,FAT_DROME,,Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito],Drosophila melanogaster (Fruit fly),27.1,816.0,1.3e-70,270.0,sp|P33450|FAT_DROME Cadherin-related tumor suppressor OS=Drosophila melanogaster OX=7227 GN=ft PE=1 SV=3,GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0090175; GO:0090176; GO:0090251; GO:0098609,"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]",apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509],GO:0005739; GO:0005886; GO:0007010; GO:0007155; GO:0007163; GO:0043226; GO:0048856,mitochondrion; plasma membrane; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; organelle; anatomical structure development
OG_10041,1.067415610804489,FUN_043312-T1,Peve_00007499,Pocillopora_meandrina_HIv1___RNAseq.g8928.t1,three_way,77.94933333333333,FUN_043312-T1,P36916,,,,,53.7,488.0,4.9e-143,509.6,sp|P36916|GNL1_MOUSE Guanine nucleotide-binding protein-like 1 OS=Mus musculus OX=10090 GN=Gnl1 PE=1 SV=4,,,,,,
OG_10047,2.2072635352176797,FUN_043320-T1,Peve_00018052,Pocillopora_meandrina_HIv1___TS.g20669.t1,three_way,62.268,FUN_043320-T1,Q5TYP4,,,,,30.4,859.0,4.3e-98,360.9,sp|Q5TYP4|FIRRM_DANRE FIGNL1-interacting regulator of recombination and mitosis OS=Danio rerio OX=7955 GN=firrm PE=2 SV=1,,,,,,
OG_10052,1.0651930039026416,FUN_043326-T1,Peve_00043041,Pocillopora_meandrina_HIv1___RNAseq.g8953.t1,three_way,56.76033333333333,FUN_043326-T1,D3ZAZ5,BCAR3_RAT,,"Breast cancer anti-estrogen resistance protein 3 homolog (BCAR3 adapter protein, NSP family member) (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B) (p130Cas-binding protein AND-34)",Rattus norvegicus (Rat),23.4,785.0,4.2e-25,118.2,sp|D3ZAZ5|BCAR3_RAT Breast cancer anti-estrogen resistance protein 3 homolog OS=Rattus norvegicus OX=10116 GN=Bcar3 PE=1 SV=1,GO:0001784; GO:0002089; GO:0005085; GO:0005737; GO:0005925; GO:0007173; GO:0007264; GO:0008284; GO:0008286; GO:0016020; GO:0019900; GO:0043410; GO:0043547; GO:0086100,endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020],guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784],GO:0098772,molecular function regulator activity
OG_10067,1.1046240520991752,FUN_043371-T1,Peve_00004903,Pocillopora_meandrina_HIv1___RNAseq.g8976.t1,three_way,72.36966666666666,FUN_043371-T1,Q8VHQ9,ACO11_MOUSE,,Acyl-coenzyme A thioesterase 11 (Acyl-CoA thioesterase 11) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 11) (Adipose-associated thioesterase) (Brown fat-inducible thioesterase) (BFIT) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2),Mus musculus (Mouse),44.0,550.0,4.4e-114,413.3,sp|Q8VHQ9|ACO11_MOUSE Acyl-coenzyme A thioesterase 11 OS=Mus musculus OX=10090 GN=Acot11 PE=1 SV=1,GO:0005737; GO:0005759; GO:0005829; GO:0006631; GO:0008289; GO:0009266; GO:0009409; GO:0035556; GO:0047617; GO:0052689; GO:0052816; GO:0120163,fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; response to cold [GO:0009409]; response to temperature stimulus [GO:0009266],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759],carboxylic ester hydrolase activity [GO:0052689]; fatty acyl-CoA hydrolase activity [GO:0047617]; lipid binding [GO:0008289]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816],GO:0003824; GO:0005829; GO:0006629; GO:0008289; GO:0016787,catalytic activity; cytosol; lipid metabolic process; lipid binding; hydrolase activity
OG_10069,1.055527842803535,FUN_043374-T1,Peve_00004909,Pocillopora_meandrina_HIv1___RNAseq.g8978.t1,three_way,63.316,,,,,,,,,,,,,,,,,
OG_10079,1.0182265756469888,FUN_043389-T1,Peve_00024250,Pocillopora_meandrina_HIv1___RNAseq.g9000.t1,three_way,64.57716666666667,FUN_043389-T1,Q64322,,,,,41.2,131.0,5.3e-15,83.6,sp|Q64322|NPDC1_MOUSE Neural proliferation differentiation and control protein 1 OS=Mus musculus OX=10090 GN=Npdc1 PE=2 SV=2,,,,,,
OG_10087,1.164229043012819,FUN_043414-T1,Peve_00045005,Pocillopora_meandrina_HIv1___RNAseq.g7825.t1,three_way,56.5365,FUN_043414-T1,Q69Z28,ATS16_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Mus musculus (Mouse),30.5,1138.0,9.8e-129,463.0,sp|Q69Z28|ATS16_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Mus musculus OX=10090 GN=Adamts16 PE=2 SV=2,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; catalytic activity, acting on a protein"
OG_10089,1.6031855133879989,FUN_043418-T1,Peve_00026856,Pocillopora_meandrina_HIv1___RNAseq.g7830.t1,three_way,78.10233333333333,,,,,,,,,,,,,,,,,
OG_10099,2.461340008610189,FUN_043435-T1,Peve_00028842,Pocillopora_meandrina_HIv1___RNAseq.g7834.t1,three_way,66.19233333333334,FUN_043435-T1,Q9WU63,,,,,37.7,151.0,4.9e-23,110.5,sp|Q9WU63|HEBP2_MOUSE Heme-binding protein 2 OS=Mus musculus OX=10090 GN=Hebp2 PE=1 SV=1,,,,,,
OG_10102,1.3482021508099775,FUN_043440-T1,Peve_00028850,Pocillopora_meandrina_HIv1___RNAseq.g7001.t1,three_way,87.993,FUN_043440-T1,P62167,,,,,77.4,190.0,1.3999999999999999e-83,310.5,sp|P62167|NCS1_CHICK Neuronal calcium sensor 1 OS=Gallus gallus OX=9031 GN=NCS1 PE=1 SV=2,,,,,,
OG_10107,1.1187187637573506,FUN_043455-T1,Peve_00031074,Pocillopora_meandrina_HIv1___RNAseq.g7903.t1,three_way,72.78833333333333,,,,,,,,,,,,,,,,,
OG_10116,1.7888828304164168,FUN_043491-T1,Peve_00008684,Pocillopora_meandrina_HIv1___RNAseq.g7963.t1,three_way,83.608,FUN_043491-T1,A8WGF7,,,,,26.4,406.0,2.9e-13,78.6,sp|A8WGF7|SPNS1_XENTR Protein spinster homolog 1 OS=Xenopus tropicalis OX=8364 GN=spns1 PE=2 SV=2,,,,,,
OG_10137,1.000933825993379,FUN_043522-T1,Peve_00015611,Pocillopora_meandrina_HIv1___RNAseq.g8037.t1,three_way,57.667,FUN_043522-T1,P63157,BARH1_MOUSE,,BarH-like 1 homeobox protein (Bar-class homeodomain protein MBH2) (BarH-related homeobox protein 1),Mus musculus (Mouse),43.9,132.0,9.9e-17,88.6,sp|P63157|BARH1_MOUSE BarH-like 1 homeobox protein OS=Mus musculus OX=10090 GN=Barhl1 PE=2 SV=1,GO:0001228; GO:0001764; GO:0005634; GO:0007605; GO:0030901; GO:0043524; GO:0045944; GO:0051402; GO:1905584; GO:1905586; GO:1990837,midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of outer hair cell apoptotic process [GO:1905586]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; outer hair cell apoptotic process [GO:1905584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory perception of sound [GO:0007605],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_10177,1.2063488432514726,FUN_043586-T1,Peve_00045222,Pocillopora_meandrina_HIv1___RNAseq.g6984.t1,three_way,54.448,,,,,,,,,,,,,,,,,
OG_10200,1.0445657789654983,FUN_043628-T1,Peve_00008239,Pocillopora_meandrina_HIv1___TS.g640.t1b,three_way,64.35733333333333,FUN_043628-T1,Q504Y2,PKDCC_HUMAN,,"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)",Homo sapiens (Human),40.7,243.0,2.7e-47,190.3,sp|Q504Y2|PKDCC_HUMAN Extracellular tyrosine-protein kinase PKDCC OS=Homo sapiens OX=9606 GN=PKDCC PE=1 SV=2,GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021,bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501],extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672],GO:0003824; GO:0005576; GO:0005794; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular region; Golgi apparatus; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10216,1.1528644791035474,FUN_043662-T1,Peve_00001429,Pocillopora_meandrina_HIv1___RNAseq.g7395.t2,three_way,79.739,FUN_043662-T1,P98198,AT8B2_HUMAN,,Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2),Homo sapiens (Human),52.5,1179.0,0.0,1144.4,sp|P98198|AT8B2_HUMAN Phospholipid-transporting ATPase ID OS=Homo sapiens OX=9606 GN=ATP8B2 PE=1 SV=2,GO:0000287; GO:0005524; GO:0005730; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:1990531,Golgi organization [GO:0007030]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554],GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; nucleolus; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; organelle; transmembrane transport; membrane organization; ATP-dependent activity
